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Abstract 
 
Haematological cancers in bone marrow (leukaemia) and the immune system (lymphomas or 
myeloma) represent the sixth most common adult tumour group in Australia. These cancers 
often develop without warning and require intensive treatment regimes that last on average 
eight months, but may continue for a lifetime depending on the diagnosis. Encouragingly, 
advancing cancer treatments, a key accomplishment of cancer research over the past 40 years, 
have resulted in a growing community of cancer survivors. Approximately two in three adults 
diagnosed with haematological cancer (HC) can now expect to survive more than five years. 
However, they must attempt to navigate the potential side-effects of cancer treatment. Several 
studies have highlighted the negative physical, social and psychological consequences of a 
cancer diagnosis such as fear of reoccurrence, infertility, fatigue and depression. However, few 
studies have explored how these individuals adjust or cope following successful cancer 
treatment. Cancer survivors who maintain a positive outlook, effectively deal with their health 
issues and are able to resume normality in their lives are deemed to be resilient. This study 
aimed to investigate the resilience process that HC survivors adopt following treatment, in 
order to overcome such adversity. The goal was to enable identification of protective factors 
that lead to positive mental health outcomes, and risk factors that impede resilience, for the 
growing HC survivor population. 
 
A two-phase, sequential, mixed methods design was adopted. The first (qualitative) developed 
a model of resilience, by exploring factors that fostered or inhibited HC survivors’ abilities to 
cope with this health crisis. Data were collected though semi-structured, in-depth, interviews 
with 23 adult HC survivors from Western Australia (M age = 52.87, SD = 16.72). Thematic 
and Leximancer software analyses of the interview data identified four main themes and sub-
themes pertaining to the cancer experience faced by these individuals: (1) the burden 
associated with a HC diagnosis; (2) resilience: coping with HC; (3) pathways and barriers to 
resilience; and, (4) survivor outcomes. These themes were then developed into a model, based 
on the current findings and those that had been identified in the literature.  
 
Subsequently, in Phase Two (quantitative), a questionnaire was created using factors that 
surfaced during the interviews or were identified from the literature. It was first piloted (Stage 
I) among a convenience sample of 17 mixed cancer survivors to determine clarity, reliability 
and internal consistency. Afterwards, a large survey was conducted (Stage II) to test the 
validity of the model developed in Phase One. Twenty-four variables were investigated for 
their ability to predict resilience and 222 (M age = 54.35, SD = 14.31) eligible questionnaires 
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were obtained. Using a standard multiple regression analysis, the combined effect of the 24 
variables accounted for 61% of the variance in resilience scores. Active coping, positive 
reframing, exercise and support from family and friends were found to positively influence 
resilience, while self-blame negatively predicted resilience. Only three variables, venting, self-
distraction and substance use, did not contribute significantly. Greater scores on each of the 
remaining variables; emotional support, instrumental support, planning, acceptance, religion, 
humour, support (healthcare professional and significant other), appearance, researching 
information, alternative treatments, time-out and diet, were associated with higher levels of 
resilience, except for, behavioural disengagement and denial which were negatively correlated. 
The results identified that higher resilience levels were significantly associated with lower 
depression and anxiety. In addition, younger participants (< 40 years of age) or those more 
recently diagnosed (< 5 years) scored significantly higher on depression and anxiety and lower 
on resilience. 
 
The findings highlight that the model developed in this thesis appropriately represented 
resilience factors identified among other cancer survivor populations. This research contributes 
to theory, policy and clinical practice, by providing greater insight into the experience of those 
living with HC and how these individuals cope. Clinicians including psychologists can use the 
study’s results to improve their clinical assessment and therapeutic approaches to enhance 
cancer survivor wellbeing. In addition, this information can assist the federal and state 
governments in formulating improved support infrastructure. Future research should explore 
how these theoretical findings can be applied practically, and assess the application of this 
model across cultures. 
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Operational Definitions  
 
There is a great deal of debate in the cancer survivor literature about issues such as 
when cancer survivorship begins or the definition of terms such as resilience. These will be 
discussed in greater depth in the literature review chapter. However, for the purpose of the 
current study, the following operational definitions will be used within this thesis. 
 
Active treatment: The period when a person is having surgery, chemotherapy, radiation 
therapy, or other treatment to slow, stop, or eliminate the cancer (ASCO, 2014) 
Acute survivorship: A term describing the period when a person is diagnosed with cancer 
and/or receiving active treatment.  
Adaptation: refers to the secondary response to stress, often after a crisis where the initial 
adjustment changes become inadequate. In this phase the response is often influenced by the 
initial response, appraisal of stress (strengths), family functioning and family resources 
(McCubbin, Thompson, Thompson, & Fromer, 1998).  
Adjustment:  refers to the initial response to the stress where changes are required to manage 
the stress (McCubbin, et al., 1998).  
Advanced Cancer: Cancer that has spread (metastasized) which may be unlikely to be cured 
(Leukaemia Foundation, 2011). 
Alopecia: Hair loss, a common side-effect of chemotherapy/radiotherapy, which is usually 
temporary (Leukaemia Foundation, 2011). 
Anxiety: Feelings of nervousness, fear, apprehension, and worry (ASCO, 2014).  
Bone marrow: The tissue found at the centre of many flat or large bones in the body. The 
bone marrow contains stem cells from which all blood cells are produced (Leukaemia 
Foundation, 2011). 
Cancer: A general term for more than 100 life-threatening diseases characterized by the 
uncontrolled, abnormal growth of malignant cells. 
Cancer Survivorship: The experience of living with, through and beyond a diagnosis of 
cancer (Feuerstein, 2007). 
Cancer Patients: Refer to individuals who are clinically diagnosed for cancer and suffering 
with cancer and receiving treatment. 
Case manager: A health care professional who helps coordinate a person’s medical care 
before, during, and after treatment. At a medical centre, a case manager may provide a wide 
range of services including managing treatment plans, coordinating health insurance approvals, 
and locating support services. Insurance companies also employ case managers (ASCO, 2014).  
Chemotherapy: is generally a combination drugs given to reduce the number of cancer cells 
that remain in nodes or circulating blood. It is delivered in a number of treatment cycles, which 
may take weeks to months. The purpose of these cycles is to enable the patient to recover from 
the more severe effects of treatment such as neutropenia before undertaking the next course.  
Chronic illness: A significant illness or disability, which may be physical, emotional or 
cognitive and persists for at least six months, involving ongoing medical intervention to treat 
acute episodes and/or ongoing health complication (Vickers, Parris, & Bailey, 2004).  
Clinical trial: A research study that involves volunteers. Many clinical trials test new 
approaches to treatment and/or prevention to find out whether they are safe, effective, and 
possibly better than the current standard of care (the best known treatment) (ASCO, 2014) 
Complementary Therapy: Therapies such as reflexology or meditation, which are used in 
addition to medical treatment, to assist with the management of symptoms and side-effects 
(Leukaemia Foundation, 2011).
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Coping: Coping is the individual’s efforts to problem solve through the stressful event 
(Friedman, Bowden, & Jones, 2003; Lazarus, 1999)  
Cure: To fully restore health. This term is sometimes used when a person’s cancer has not 
returned for at least five years after treatment. However, the concept of “cure” is difficult to 
apply to cancer because undetected cancer cells can sometimes remain in the body after 
treatment, causing the cancer to return later. Recurrence after five years is still possible 
(ASCO, 2104) 
Depression: Defined as having a low mood and/or feeling numb consistently for more than 
two weeks, every day and much of the day (ASCO, 2014)  
Extended survivorship: A term describing the period when a person has just completed 
active treatment, usually measured in months (ASCO, 2014).  
Follow-up care plan: A personalized schedule of follow-up examinations and tests that a 
doctor recommends after the active treatment period. This may include regular physical 
examinations and/or medical tests to monitor the person’s recovery for the coming months and 
years. This may also be called a survivorship care plan; it is often used in conjunction with a 
treatment summary (ASCO, 2014).  
Haematological Cancer: Cancers of the bone marrow (leukaemia) and the immune system 
(lymphoma and myeloma) (Lobb et al., 2009). 
Health adversity: Defined as a change in health caused by illness both mental and physical 
health which has adverse effects either short-term or long-term.  
High-dose therapy: Using higher than normal doses of chemotherapy to eradicate resistant 
cancer cells that have survived standard-dose therapy (Leukaemia Foundation, 2011). 
Hodgkin’s lymphoma: A type of lymphoma (cancer of the lymphatic system).  
Late effects: Side-effects of cancer or its treatment that occur months or years after the active 
treatment period has ended (ASCO, 2014).  
Leukaemia: A cancer of the blood and bone marrow characterised by uncontrolled, 
widespread production of large numbers of abnormal and/or immature blood cells. (Leukaemia 
Foundation, 2011). 
Lymphatic system: A network of vessels, similar to blood vessels, that branch out into all the 
tissues of the body carrying a watery fluid containing lymphocytes (specialised white cells) 
responsible for protecting against disease and infection. Considered part of the immune system 
(Leukaemia Foundation, 2011). 
Maintenance Treatment: Maintenance treatment is defined as treatment occurring in the 
period following active treatment with an aim to reduce the risk of recurrence. This may be in 
the form of ongoing oral chemotherapy. During maintenance treatment the HC survivor may 
experience ongoing but different stressors. 
Medicare: Medicare is Australia’s system for financing services provided by private doctors, 
public hospitals and additional health costs. It allows Australians have access to free or low 
cost medical, ancillary and hospital care. Medicare is jointly funded by the Australian 
government, State and Territory governments and is administered by State and Territory health 
departments. 
Myeloma: Also referred to as myelomatosis or multiple myeloma is a cancer that usually 
arises in the bone marrow when mature B-lymphocytes known as plasma cells, undergo a 
malignant change (Leukaemia Foundation, 2011).  
Neutropaenia: A reduction in the number of circulating neutrophils, an important type of 
white cell, which results in an increased risk of infection (Leukaemia Foundation, 2011).  
Neutrophils: The most common type of white cell responsible for fighting infections 
especially bacteria and fungi (Leukaemia Foundation, 2011). 
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Neurological: Conditions causing disturbance in structure or functions of the nervous system 
such as epilepsy. 
Non-Hodgkin lymphoma: Also known as B and T-cell lymphoma (cancer of the lymphatic 
system) and differs from Hodgkin lymphoma. Non-Hodgkin lymphoma can be slow growing 
(low grade) or fast growing (intermediate or high grade) (Leukaemia Foundation, 2011). 
Oncologist: A doctor who specializes in treating cancer. The five main types are medical, 
surgical, radiation, gynaecologic, and paediatric oncologists (ASCO, 2014).  
Oncology nurse: A nurse who specializes in caring for people with cancer (ASCO, 2014).  
Permanent survivorship: A longer time that has passed since active treatment has finished 
(usually after 5 years) often measured in years. Also called long-term survivorship (ASCO, 
2014). 
Prevalence: Refers to the numbers of individuals who have previously received a cancer 
diagnosis and who are still alive at a given point in time (AIHW, 2014). 
Prognosis: Chance of recovery; a prediction of the outcome of a disease.  
Primary cancer: In survivorship care, this means the original (first) cancer with which a 
person was diagnosed (ASCO, 2014).  
Psychologist/psychiatrist: Mental health professionals who work to address a person’s 
emotional, psychological, and behavioural needs ASCO, 2014)  
Psychological Illness: A range of feelings and emotions that people experience in reaction to 
illness or its treatment such as depression or anxiety.  
Quality of Life: A broad ranging concept based on person’s physical health, culture, 
psychological state, personal beliefs, social relationships, and environment in relation to their 
goal, standards and concerns (World Health Organisation, 2007). 
Radiotherapy: is typically administered as X-rays or gamma rays to destroy cancer cells and 
reduce the risk of a local recurrence. It is also completed in cycles over an extended period, for 
much the same reasons as chemotherapy (Leukaemia Foundation, 2011). 
Recurrence: Cancer that has returned after a period during which the cancer could not be 
detected. Local recurrence means the cancer has come back in the same general area where the 
original cancer was located. Regional recurrence refers to cancer that has come back in the 
lymph nodes or other tissues near the original cancer site, usually by direct spread. Distant 
recurrence refers to cancer that has come back and has spread to other parts of the body, 
usually by traveling through the lymphatic system or bloodstream (ASCO, 2014). .  
Referral: Recommendation provided by a doctor to get help or information from another 
health care professional, specialist, or resource (ASCO, 2014).  
Rehabilitation: Services and resources that help a person with cancer obtain the best physical, 
social, psychological, and work-related functioning during and after cancer treatment. The goal 
of rehabilitation is to help people regain control over many aspects of their lives and remain as 
independent and productive as possible (ASCO, 2014). 
Remission: When there is no evidence of cancer detectable in the body. Remission differs 
from cure as relapse may still occur (Leukaemia Foundation, 2011).  
Resilience: Refers to ability to bounce back from negative emotional experiences and to adapt 
to stressful experiences.  
Respiratory disorders: Conditions that affects the respiratory system. Examples include: 
asthma, hay fever, croup, bronchiolitis, and emphysema. 
Risk: The likelihood of an event (ASCO, 2014).  
Secondary cancer: Describes either a new primary cancer (a different type of cancer) that 
develops after treatment for the first type of cancer, or cancer that has spread to other parts of 
the body from the place where it started (metastasized) (ASCO, 2014). 
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Staging: An assessment of the extent or spread of the disease (Leukaemia Foundation, 2011). 
Stem cells: Are primitive blood cells that can give rise to more than one cell type. There are 
many types of stem cells in the body. Bone marrow (blood) stem cells have the ability to grow 
and produce all the various blood cells including red cells, white cells and platelets 
(Leukaemia Foundation, 2011). 
Stem cell transplant: A treatment used to support high-dose chemotherapy and/or 
radiotherapy in the treatment of a wide range of blood cancers, certain solid tumours and other 
serious diseases. 
Stress: Stress is the response of the individual’s threat appraisal of an event (Friedman, et al., 
2003; Lazarus, 1999).  
Stressor: A stressor is the precipitating event(s) that activated the stress response (Lazarus, 
1999; Lazarus & Folkman, 1984). 
Support needs: The physical, psychological, social, informational and financial needs of an 
individual (ASCO, 2014). 
Survivorship: This term means different things to different people. Two common definitions 
include having no disease after the completion of treatment and the process of living with, 
through, and beyond cancer (ASCO, 2014).  
Systemic disorders: A medical condition that involves the body as a whole, not limited to 
conditions that affect particular parts of the body. Examples include: diabetes, anaphylaxis and 
metabolic disorders. 
Targeted treatment: Treatment that targets specific genes, proteins, or other molecules that 
contributes to cancer growth and survival (ASCO, 2014).  
Treatment summary: A written summary of the therapies that a person had during his or her 
active treatment period. This is often used in conjunction with a follow-up care plan to help 
monitor a survivor’s long-term health (ASCO, 2014). 
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Chapter 1 
Introduction  
 
 
The Storm of Cancer  
“Before cancer, you’re sailing along in generally fair weather. You’re travelling in one 
direction. You have maps, navigation aids and provisions. You might even be part of a flotilla 
– you and some other boats, sailing in the same direction at the same speed. Life is fine, good 
even. Then a massive storm hits – cancer.  
 
Your boat is seriously damaged. Maybe parts of it are lost or broken. Your maps and 
provisions are swept overboard. In the eye of the storm you lose all sense of direction. Your 
main terror is that the boat will sink. Then your cancer team appear. 
 
They are your lifeboat; your rescuers. They attach ropes, patch your boat up and keep it 
afloat; they come alongside you, and take control of the steering and direction. Slowly, they 
tow you back to port. Sometimes this journey towards the port is even stormier than the 
catastrophe itself. But you know you are not alone – you have the lifeboat staff, you make a 
good team. As the lifeboat tows your boat back to port you see friends and family on the shore 
waving and cheering. They are so relieved to have you back. But then your boat just stops. You 
are not quiet back in port. You can see the lights, and your happy loved ones. But you’re 
moored just outside the mouth of the harbour.  
Then your lifeboat, and its team goes. 
 
They drop the ropes into the water and sail away. You might think: I can get back to port on 
my own. You’ve been there before after all. And you can see it right there, quite close. But it 
all feels different now. Your boat is still damaged. You need time for repairs. You need to get a 
new map and provisions. And you keep looking at the sky – is the storm coming back? You 
listen constantly, obsessively, to the weather forecast – you hear reports of hurricanes. They 
may be far away, but you can’t stop yourself from feeling that they are coming for you” 
(Goodhart & Atkins, 2011, p.1-2).  
  
Chapter Overview 
This chapter aims to outline the context and rationale for the current thesis. First, 
cancer and resilience research is briefly introduced, in order to provide a basic 
understanding of the population of interest. Next an overview of cancer, including 
a definition of a cancer survivor is explained to provide relevant background 
material. The research context will then be presented, with an overview of 
haematological cancer (HC) and the incidence of psychological distress among 
this population. This is followed by a discussion outlining the history of resilience 
research and a description of the relevant terminology. Finally, the justification for 
research will be summarized before outlining the aims and research questions for 
this study. 	
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Setting the Context - The Cancer Resilience Research 
The analogy provided above (Goodhart & Atkins, 2011) may seem long-winded. 
However, it accurately describes the challenges that approximately 370,000 Australian cancer 
survivors face following cancer therapy (AIHW, 2014). The intensive treatment required to 
treat cancer can be life changing and may involve painful procedures, multiple side-effects and 
long hospitalizations. Consequently, being diagnosed with cancer, a potentially terminal 
disease, is considered a traumatic and stressful experience affecting many aspects of an 
individual’s life, including mental health (Hollingshaus & Utz, 2013). 
Tedeschi and Calhoun (1995) identified four characteristics that make an event 
traumatic, being: sudden; unexpected; uncontrollable; and, producing ongoing, sometimes 
lifelong effects. All of these characteristics echo and reflect the cancer experience. The 
literature has found that treatment may affect an individual’s quality of life (QOL). This could 
involve: physical suffering (i.e., fatigue, pain, scaring, weight changes and infertility) (Bennett, 
Goldstein, Friedlander, Hickie, & Lloyd et al., 2007; Deimling, Sterns, Bowman, & Kahana, 
2005; Doyle, 2008); psychological difficulties (e.g., fear, uncertainty, anxiety, and depression) 
(Butow, Fardell, & Smith, 2015; Jefford et al., 2008; Llewellyn et al., 2013; Mitchell et al., 
2011); and, altered social functioning (i.e., interpersonal relationships, isolation, financial 
stress, disruption of home and family roles) (Aziz, 2002; Lobb et al., 2009; Min et al., 2013; 
Mosher et al., 2011). These examples of the physical and psychosocial costs of surviving 
cancer, that may carry tremendous potential to cause morbidity, have been well documented 
(Aziz, 2002; Kelly & Dowling, 2011).  
The literature describing the negative consequences of surviving cancer is a valued 
and comprehensive resource that will be discussed in more detail in the following chapter. 
However, there has been comparatively less research that explores how survivors cope with 
this experience (Stewart & Yuen, 2011). Several studies have recently suggested that many 
cancer survivors are able to avoid psychological distress and go on to live purposeful and 
fulfilling lives following treatment (Alim et al., 2008; McGrath & Clarke, 2003; Schumacher, 
Sauerland, Silling, Berdel, & Stelljes, 2014; Xuereb & Dunlop, 2003). However, this process, 
which may lead to better psychological wellbeing among cancer survivors, has not been fully 
investigated.  
At the end of 2009, there were 861,057 Australians living, who had been diagnosed 
with cancer in the previous 28 years (from 1982 – 2009) (AIHW, 2012). Understanding the 
factors that influence positive outcomes in cancer survivors is an important topic for research, 
as these individuals, along with family and friends are searching for the strength and resources 
to navigate this traumatic time. The literature reports that the outcome of each individual’s 
experience may be influenced by a variety of internal (i.e., individual coping or personality 
style) and external factors (i.e. treatment regime, support networks and healthcare resources) 
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(James et al., 2011; Knott, Turnbull, Olver, & Winefield, 2012). Yet, to date, there has been 
less attention given to research exploring how these, and other factors, may influence cancer 
survivor outcomes (Stewart & Yuen, 2011; Windle, Bennett, & Noyes, 2011). This will, 
therefore, be the emphasis of the current research.  
The topic of survivorship of cancer has been of interest, predominantly within the 
medical field, since the early 1900’s (Mukherjee, 2010). Earlier literature was dominated by 
extensive efforts to understand the causes, prevention and treatment of cancer. However, 
during this period the challenges faced by long-term survivors were not a priority, as, at that 
time, cancer was considered a likely death sentence (Mukherjee, 2010). Nevertheless, there 
have been many advances, predominantly since the 1980’s, in earlier detection (i.e., enhanced 
imaging equipment), improved treatment (i.e., targeted chemotherapy, radiotherapy and 
surgery), and, lifestyle changes among the general population (Aziz, 2002; Mukherjee, 2010). 
These achievements have more recently led researchers to also consider the increasing number 
of individuals who survive cancer (Jefford, et al., 2008; Kelly & Dowling, 2011).  
Worldwide, the number of cancer survivors is expected to triple from 25 million in 
2008 to 75 million in 2030 (Ferlay et al., 2010). Statistics also indicate that, in the absence of 
any other competing causes of death, approximately 67% of Australian adults currently 
diagnosed can expect to live beyond five years (AIHW, 2014). However, it has only been in 
the last decade that research involving cancer survivors’ issues, commonly referred to as 
“survivorship research” (to be discussed in the next chapter in more detail) has flourished 
(Ganz, 2011). Given the recency of this focus, several important gaps exist within the current 
cancer survivorship literature (Feuerstein, 2007b; Girgis & Butow, 2009; Jefford et al., 2008).  
First, the emphasis of cancer research has been on childhood cancer survivors and 
adult survivors of more common cancers, such as breast and prostate cancer. For example, in a 
database search using PubMed, it was found that, between 2005 and 2015, there were 129,816 
breast cancer and 58,564 prostate cancer citations compared with less common cancers, with 
only 15,249 papers referring to haematological cancers (HC). Accordingly, there is a need to 
investigate understudied cancers, such as HC’s, survivors of which are the population of 
interest in this research. Haematological malignancies are cancers of the bone marrow 
(haematopoietic) and the immune system (lymphoid) and collectively represent the sixth most 
commonly diagnosed tumour group in Australia (AIHW, 2014). In 2002, there were 
approximately 8030 diagnoses of HC’s in Australia, which increased by 28.5 % to 10,347 
during 2011 (AIHW, 2014). There are many reasons why the HC survivor population has been 
selected for this research, several of which will be discussed shortly. 
Second, although the negative physical and psychosocial consequences of cancer on 
survivors and their families have been well documented (Bevans et al., 2011; McGrath, 2004a; 
Stewart & Yuen, 2011), to date, there has been less focus on addressing how many individuals 
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manage to adapt and live with dignity and purpose, despite a cancer diagnosis (Swaminath & 
Ravi Shankar Rao, 2010). Researchers are beginning to recognise that many survivors may 
experience positive adjustment outcomes (Jefford et al., 2008; Llewellyn et al., 2011). For 
example, a growing body of literature suggests that cancer survivors may be highly resilient 
(Gouzman et al., 2015; Pieters, 2015; Schumacher et al., 2014). In this context, resilience 
refers to an individual’s capacity to effectively adapt to psychosocial adversity, as a direct 
result of having been diagnosed and treated for cancer (Stewart & Yuen, 2011; Windle, 
Bennett, & Noyes, 2011; Wu, Sheen, Shu, Chang, & Hsiao, 2012). Some research reports that 
resilience has been inversely associated with depression, anxiety and perceived stress, whilst 
being positively associated with greater life satisfaction (Wagnild, 2009). Yet, conversely, it 
may be that resilience is defined by the absence of depression and anxiety and improved QOL 
(Agaibi & Wilson 2005). Therefore, resilience is an important concept to investigate, as there 
is a history of debate surrounding the definitional complexities and process of resilience. By 
clarifying the factors that influence the resilience process, clinicians and the extended 
community will better understand how to improve QOL and mental-wellbeing of HC survivors 
through appropriate interventions.  
Third, research to date has concentrated on the initial diagnosis and earlier treatment 
phase in the survivorship trajectory, with less emphasis on long-term survivors; that is, the 
percentage of cancer patients who are alive after an elected time period (usually 5 years) 
relative to those without cancer (the survival rate) (Hewitt, Greenfield, & Stovall, 2005). 
Hence, there has been less research describing the experiences of a growing population who 
have been cancer survivors for over five years (Stanton et al., 2005). Previously, the possibility 
of long-term cancer survivors was unforeseen, especially among rare and aggressive cancers 
such as HC (Ananda & Scott, 2015). However, due to the previously described medical 
advances, there is now a growing population of survivors who are living beyond the five year 
marker, including those with HC (Chew & Roberts, 2015; Kelly & Dowling, 2011; Paul et al., 
2011). Nevertheless, prognosis and survival rates do vary significantly among the different 
types of HC. For example, in adults diagnosed with myeloma, approximately 45% will survive 
beyond five years. However, the five-year survival rate increases to 72% for non-Hodgkin’s 
lymphomas and to approximately 87% for those diagnosed with Hodgkin’s lymphoma 
(AIHW, 2014).  
The increasing 5-year relative survival rate is helpful in demonstrating progress in the 
early detection and treatment of many cancers. However, since cancer-related deaths can occur 
beyond 5 years after diagnosis, the reporting of survival rates do not differentiate between 
survivors who are still in treatment, those who have relapsed or survivors who are permanently 
cured (AIHW, 2014). 
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In addition, survival rates, while informative, only cover a fraction of the total impact. 
These figures do not reflect the overall personal and social costs of cancer (Boyle, 2006). For 
example, little is known about how the cancer survivor coped with the physical effects of 
illness, managed their roles at work, or interpersonal relationships and how these survivors 
adapted to cancer from a psychological perspective (Boyle, 2006). These additional questions 
are important, so that as a community we can address the level and type of care that will be 
required for the ongoing medical and psychosocial needs of this growing population.  
In summary, it is imperative that we further investigate the experiences of those with 
less common, aggressive cancers such as HC, as these remain an under-researched population 
across the survivorship trajectory. In addition, research in cancer survivorship together with 
resilience across the lifespan, will improve progress toward enhancing the health and QOL of 
all cancer survivors and their families. The next section provides a more detailed overview of 
cancer. 
 
An Overview of Cancer  
Cancer is defined by the AIHW (2014) as a diverse group of more than 100 diseases in 
which several of the body’s cells become abnormal. As a result of changes (mutations) in the 
genetic information of a cell, the cell begins to spread and multiply out of control (AIHW, 
2014). The site in the body in which the disease originates is what differentiates cancers from 
each other. Not all cancers are invasive. Benign tumours are rarely life threatening and do not 
spread to other parts of the body (AIHW, 2014). However, malignant cancer may be life 
threatening, occurring when there is an invasion of abnormal cells that spread to other parts of 
the body through the lymphatic system or blood stream (AIHW, 2014). In this case, the 
original site of the tumour is known as the primary cancer and the spread or metastasis to 
another area in the body is referred to as the secondary cancer (AIHW, 2014).  
In Australia, cancer has a greater impact on health than any other disease group, 
accounting for nearly one-fifth of the total disease burden (AIHW, 2014). On average, one in 
two Australians will be diagnosed with cancer and one in five will die from the disease before 
the age of 85 (AIHW, 2014). Although not all causes of cancer have been recognised, there are 
numerous risk factors that have been identified as increasing the incidence of cancer. Some of 
these include, but are not limited to: lifestyle factors (smoking, sexual behaviour, alcohol, diet 
and obesity); environmental elements (sunlight, pollution, occupational exposures, radiation); 
biomedical factors (hormones); genetic susceptibility; and, chronic infections (AIHW, 2014). 
Approximately 123,920 new cases of cancer (excluding squamous and basal cell 
carcinomas of the skin) will be diagnosed during 2014 in Australia (AIHW, 2014). Of these, 
the six most commonly diagnosed cancers in Australia during 2007 included prostate, bowel, 
breast, melanoma, lung, and lymphoid cancers (AIHW, 2014). It is estimated that over fifty-
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five percent of newly diagnosed cancers during 2014 were found in males. In addition, 70% of 
cases were diagnosed in individuals aged 60 years and older (AIHW, 2014). Cancer is 
predominantly a disease affecting the elderly and, as a result of the aging population, Australia 
is likely to experience an increase in the number of individuals diagnosed (AIHW, 2014). 
Consequently, cancer not only represents a significant cost to the economy and community, 
but also impacts on both the physical and emotional wellbeing of individuals and their families 
(ABS, 2012).  
Although survival rates are not consistent across all forms of cancer, the proportion of 
cancer patients surviving five years or longer has generally increased. In Australia, between 
the years 1982-1986 to 2007-2011, the 5-year survival rate percentages increased from 52% to 
68% for women and from 40% to 66% for men (AIHW, 2014). Between 2007 and 2011, the 
5–year survival rate for all cancers combined was approximately 67% (AIHW, 2014). This 
large and growing community of cancer survivors is one of the key accomplishments of cancer 
research over the past 40 years (Aziz, 2002). For many, cancer is now regarded as either a 
chronic or curable disease, rather than representing its historical association involving a death 
sentence (Jefford et al., 2008). However, the cancer experience remains embedded within the 
larger context of one’s life experiences, perceptions and future goals. Therefore, the predicted 
increase in cancer diagnoses, related to a rapidly increasing older population, warrants research 
that explores the context of this experience. 
 
Definition 
The word survivor originates from the Latin word ‘supervivere’ to live more and from 
the middle French word ‘survivre’ to outlive (Merriam-Webster, 2013; Platt, 2012). In the 
mid-1900s, when cancer represented a certain death sentence, family members were often 
regarded as the survivors, following the death of a loved one (Boyle, 2006; Leigh, 1990, 
Mukherjee, 2010).  
However, the cancer survivorship movement that has arisen over the last three 
decades, due to the increasing number of survivors and an ageing population, has led to much 
debate. Izsak and Medalie (1971) were first credited with prompting this deliberation, 
suggesting that the historical medical model, previously used to classify cancer survivors, was 
not comprehensive enough (Boyle, 2006). Then, in July of 1985, a thought provoking paper 
entitled "Seasons of Survival: Reflections of a Physician with Cancer" appeared in The New 
England Journal of Medicine (Feuerstein, 2007). This paper, written by Dr. Fitzhugh Mullan, 
would become the starting point for a major medical and cultural shift in the United States 
(US) moving the discussion from just cancer ‘patients’ to cancer patients and cancer 
‘survivors’ (Feuerstein, 2007; Hoffman & Stovall, 2006). Mullan addressed the shortcomings 
of the definitional paradigm at that time, stating that there was no "moment of cure" or 
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"invisible line" that a patient crossed to become a survivor (Boyle, 2006). Consequently, this 
has led to many proposed definitions. However, for several reasons, the precise meaning of 
cancer survivorship remains complex and controversial.  
First, there is a lack of agreement in the literature as to when a patient becomes a 
cancer survivor (Rendle 1997). Do individuals slowly come to think of themselves as survivors 
following treatment, when they feel well again or, when and if they return to pre-cancer 
activities such as work (Dow et al., 1999, Little, Paul, Jordens, & Sayers, 2000)? Alternatively 
is this process influenced by the medical community’s specified timeframe of 5-year survival 
rates, where patients then identify as survivors (Dow et al., 1999; Ganz, 2005)? If defined bio-
medically, survivorship may reflect the phase after treatment. However, if using a particular 
time frame, it may be classified as after 2, 5 or 10 years after diagnosis or completion of 
treatment, or as a treatment outcome when a cure is reached (Leigh, 1999). Some researchers 
believe the survivorship process begins at diagnosis (Dow, 1990; Little et al., 2000; Mullan, 
1985), but Carter (1989, 1993) suggested that an individual should live for at least 5 years 
before being considered to be a survivor. More recently, however, many researchers are of the 
opinion that it is not important if there is recurrent disease, any patient living beyond a cancer 
diagnosis, should be considered a survivor (Hewitt, Greenfields, & Stoval, 2005; Jefford et al., 
2008; Little et al., 2000). 
Second, is ‘cancer survivor’ the best and most appropriate term to be used globally for 
those who have been diagnosed and treated for cancer? For example, Hewitt and colleagues 
(2005) implied that the term cancer survivor was less acceptable among Europeans, as a result 
of the previous holocaust associations. Consequently, in several European countries the term 
cancer survivor is not always used, rather cancer is regarded as “another chronic illness” 
(Feuerstein, 2007a). In addition, being linked with cancer may represent a negative social 
stigma and individuals may not appreciate being categorized as a survivor or being formally 
identified as different to others (Markus, 2004).  
A recent study investigated how cancers survivors perceived themselves in the first 
one to three years post diagnosis (Park, Zlateva, & Blank, 2009). Several labels were proposed 
including, “victim”, “patient” “survivor” or a “person with cancer”. The most common label 
identified by these participants was “survivor” for 83% of the cohort (Park, Zlateva, & Blank, 
2009). This study proposed that each identity term represented meaning for the participant that 
impacted not only interactions with others, but also with health behaviours. For example, those 
who identified with the “patient” label could potentially perceive feelings of less control and 
hope. In addition, these participants may also portray a more passive role by relinquishing 
responsibility for their health to their specialist or healthcare team. In this study, Park and 
colleagues (2009) found a relationship between identifying as “survivors” and having reduced 
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psychological distress. The results from this research were similar to a previous study 
involving long-term cancer survivors (Deimling, Kahana, & Schumacher, 1997).  
Advances in medicine, which have greatly improved prognosis and survival, have led 
to more comprehensive definitions (Table 1). However, as can be seen in Table 1, there 
remains much deliberation by cancer organisations on how to comprehensively define a cancer 
survivor. A current and generally accepted definition is advocated by the National Coalition 
for Cancer Survivorship as, “the experience of living with, through, and beyond a diagnosis of 
cancer” (cited by Jefford et al., 2008, p. 20) to the end of life, also embracing family members 
and friends affected by the illness experience (Hewitt, Greenfield, & Stovall, 2005; Jefford et 
al., 2008; NCCS, 2012). As a result, cancer survivorship is beginning to signify a process 
through which not only the patient, but also their family, learns to live with the uncertainty of a 
life-threatening chronic illness, rather than with a terminal disease (Aziz, 2002; Feuerstein, 
2007; Kelly et al., 2010). Moreover, survivorship includes those patients with recurrent 
metastatic disease, where prognosis may be measured in years not months, and patients who 
are in a ‘watch and wait’ scenario, neither cured nor dying (Maher & Fenlon, 2010). 
 
Table. 1.1 
Definitions of a Cancer Survivor 
____________________________________________________________________________ 
 
Organisation     Definition of a Survivor 
____________________________________________________________________________ 
National Coalition for Cancer Survivorship An individual diagnosed with cancer from the 
moment of diagnosis and for the balance of 
life. Family members, friends, and caregivers 
are also impacted by the survivorship 
experience and are therefore included in this 
definition (NCCS, 2012). 
NCI Office of Cancer Survivorship A person with cancer from the time of 
diagnosis, through the balance of his or her 
life (Kelly, 2011).  
MacMillian Cancer Support Anyone who has concluded initial treatment 
with no evidence of active disease, is living 
with progressive disease and may be 
receiving treatment however is not in the 
terminal phase of illness, or an individual 
who has had cancer in the past (Kelly, 2011).  
Livestrong/Lance Armstrong Foundation A survivor might be the person diagnosed, a 
spouse, a child, a parent, a friend or any 
caregiver (Lance Armstrong Foundation, 
2010). 
____________________________________________________________________________ 
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In summary, the survivorship concept is relatively new. There are several challenges 
faced in proposing one accepted definition that holistically reflects who a cancer survivor is, 
and when the survivorship journey begins. In addition, the term ‘cancer survivor’ continues to 
be used inter-changeably with associated terminology, such as ‘cancer aftercare’ and ‘people 
living after a cancer diagnosis’ (Doyle, 2008). A more comprehensive definition of cancer 
survivorship is likely to evolve as personal experiences following primary treatment, until end 
of life, continue to be substantiated (Feuerstein, 2007a). However, the general consensus from 
key researchers in this field is that cancer survivors have several unique needs, which are 
currently not fully appreciated or understood (Feuerstein, 2007b; Ganz, 2011; Girgis & Butow, 
2009; Jefford et al., 2008). For this dissertion, cancer survivorship is deemed to represent any 
individual with cancer from the time of diagnosis, throughout his or her life. A more detailed 
overview of the history and contributors to the developing survivorship movement is presented 
(See Appendix 1), including a timeline highlighting key events (Appendix 2). The next section 
will focus on the population of interest, by describing HC and will also discuss its mental 
health implications.  
 
Haematological Cancer Survivors and Psychological Distress 
According to Lichtman (2008), the discovery of HCs began during the 19th century, 
when similarities were detected among patients with lymph node tumours and an enlarged 
spleen, which is now identified as Hodgkin's disease. Shortly after, other HCs including 
leukaemia and myeloma were discovered (Lichtman, 2008). To date, HC remains a life 
threatening illness, and, as a consequence, survivors face an uncertain future that can impact 
on their physical and mental wellbeing (Allart et al., 2013; Mitchell, Ferguson, Gill, Paul, & 
Symonds, 2013). According to research, many patients cope well, and their level of grief is 
considered a normal response to a diagnosis of cancer (Aziz, 2002; Mitchell et al., 2013). 
However, in times of crisis during the survivorship journey, the degree of these symptoms may 
fluctuate and result in psychological illness (Cunningham, 1995; Norris, Pratt-Chapman, 
Noblick, & Cowens-Alvarado, 2011; Swash, Hulbert-Williams, & Bramwell, 2014). 
Consequently, psychological screening has become recognized as an essential component of 
holistic oncology care (Syrjala et al., 2004) and is considered by some to be the ‘sixth vital 
sign’ (Bultz & Johansen, 2011). 
Although the instruments used and estimates vary depending on the study population, 
the documented literature provides strong evidence that HC survivors are at greater risk of 
psychological distress than those diagnosed with other chronic illnesses (Krebber et al., 2014; 
Lobb et al., 2009; Mosher et al., 2011). This may be due to several unique and challenging 
characteristics involving HC (i.e., the specific treatment regime and lack of preventative 
screening) that will be discussed in the next chapter. The literature also reports that HC 
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survivors tend to take longer to recover from the impact of psychological sequelae, such as 
anxiety and depression, than the physical effects of cancer treatment (Syrjala et al., 2004). This 
means that HC survivors may be more likely to require psychological intervention. Yet, 
research reports that a cancer survivor’s mental health is often overlooked by busy clinicians in 
many healthcare settings (Mitchell et al., 2011). This may be problematic, as evidence 
indicates that psychological distress may lead to reduced participation in medical care and 
potentially prolong hospitalization (Prieto et al., 2002).  
However, understanding depression among cancer survivors can be a challenge, partly 
due to conflicting results. According to research, this is predominantly due to numerous 
methodological issues (i.e., instruments used, cancer type, prognosis and treatment phase) 
(Krebber et al., 2014; Mitchell et al., 2013; Walker, et al., 2013). For example, previous 
research has reported prevalence rates of depression that vary between 0% and 58% (Massie, 
2004). Likewise, in two recent meta-analyses, the rates of depression among mixed cancer 
populations differed substantially, from 8% to 24% (Krebber et al., 2014) and from 1.0% to  
77 % (Mitchell et al., 2013). In addition, anxiety, which is often overlooked as an outcome in 
cancer survivors, is also reported to be prevalent among cancer survivors (Mitchell et al., 
2013). Research has found the rates to be double that of depression, among long-term 
survivors (Mitchell et al., 2013).  
There are several other reported psychological disorders, including post-traumatic 
stress (PTSD) and adjustment disorders, among cancer survivors (Knobf, 2011; Rodin et al., 
2013). However, depression and anxiety are reported in the literature to be the most common 
psychological problems causing distress among HC survivors (Lobb, et al., 2009; Mitchell et 
al., 2011) and will therefore be the main focus of this research. The next section defines 
resilience and related concepts before providing a background into the history of resilience 
research.  
 
Resilience 
Definition 
Resilience originates from the Latin ‘resilire’ meaning ‘to leap back’ (Windle, 
Bennett, & Noyes, 2011). Research on resilience suggests that some individuals are better able 
to adapt to stress and hardship, whilst others are less able to cope ( Luthar, Cicchetti, & 
Becker, 2000; Tedeschi & Calhoun, 2004). One of the simplest definitions of resilience is 
provided by Berk (2000) as “the ability to adapt effectively in the face of adversity” (p. 543). 
As this definition suggests, resilience could hold the key to explaining how individuals 'bounce 
back' and deal with various challenges, such as ill health throughout life. Although the concept 
of resilience is not recent, according to Stewart and Yuen (2011), approximately 85 percent of 
articles investigating resilience have been published in the last ten years. Consequently, the 
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complexity of defining the construct of resilience has been widely recognized and debated 
(Luthar, Cicchetti, & Becker, 2000; Vanderbilt Adriance & Shaw, 2008). This is largely due to 
issues in both terminology and definition, in what is required to be demonstrated by 
individuals in order to be labelled resilient, and, heterogeneity in the type and level (i.e., 
personal meaning) of risk experienced for a person to be termed ‘resilient’ (Davydov et al., 
2010; Windle, Bennett, & Noyes, 2011).   
For example, researchers have argued that the concept of resilience may be a set of 
individual traits (Rutter, 1966; Richardson, 2002), a process (Richardson, Neiger, Jensen, & 
Kumpfer, 1990), or a positive outcome (Masten, 2001; Olsson, Bond, Burns, Vella-Brodrick, 
& Sawer, 2003). In addition, resilience has been viewed more recently as multidimensional 
construct that is influenced by context and culture (Pooley & Cohen, 2010; Ungar, 2001). This 
has resulted in more comprehensive definitions such as one provided by Ungar (2004), who 
describes resilience as “the outcome from the negotiations between individuals and their 
environments for the resources to define themselves as healthy amidst conditions collectively 
viewed as adverse” (p. 342).  
Another recent definition was proposed by Windle, Bennett, and Noyes (2011) 
following a systematic review of 271 resilience-related articles, which identified three 
necessary requirements for resilience: “the need for a significant adversity/risk, the presence of 
assets or resources to offset the effects of the adversity, and positive adaptation or the 
avoidance of a negative outcome” (p. 163). Based on this review, which provided a useful 
benchmark, the following operational definition was proposed, as, according to Windle, 
Bennett, and Noyes, it encompassed all of the described key characteristics:  
“Resilience is the process of effectively negotiating, adapting to, or managing 
significant sources of stress or trauma. Assets and resources within the individual, 
their life and environment facilitate this capacity for adaptation and ‘bouncing back’ in 
the face of adversity. Across the life course, the experience of resilience will vary” 
(Windle, Bennett, & Noyes, 2011, p. 163).  
 
According to Masten (2007), many of the controversies surrounding the definition of 
resilience could be addressed by better science. This not only includes more rigorous attention 
to methodology, but also through clarification of related concepts, for example, by 
operationally defining resilience terminology in all settings. In this way, each research context 
will have a unique set of risks and positive outcomes that are dependent upon the resources 
and demands of that context.  
While this addresses the differences between contexts, it does not address individual 
variations. For example, what represents a successful outcome in one context may not be 
extended to another, as perception of risks and positive outcomes can differ between 
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individuals within the same context (Luthar, Sawyer, & Brown, 2006; Ungar et al., 2007). This 
suggests that risks and positive outcomes are not only dependent on context; they are also 
dependent on how the person within the context perceives their circumstances. Take two 
individuals following the diagnosis of cancer, a situation collectively viewed as adverse. 
Within this context, one person may perceive their situation to be more adverse than the other. 
Hence, the way in which each individual manages this experience, including the resources 
available to them, may differ. For example, one individual may perceive the involvement in 
online support groups as a protective factor, whereas the other may perceive that situation as a 
risk, both of which impact in some manner on individual outcomes. Therefore, it is important 
to understand how each individual perceives the resources and restrictions available to them 
and how this may impact on their process of resilience following an adverse event such as HC. 
However, this is complex as specific analytical tools to assess such a model are not yet widely 
available. With this in mind, it is beneficial in this research to first outline resilience 
terminology, before providing a brief insight into the history of resilience research.  
 
Terminology and Related Concepts  
As discussed above, resilience has been operationalized in many ways. However, the 
majority of researchers view this phenomenon as a positive outcome resulting from protective 
factors in the context of risk or adversity (Luthar et al., 2000a). These risk and protective 
factors, reported to affect individual outcomes differently, operate concurrently at the 
individual, family and community level (Carver, 2005; Unger, 2008; Windle, Bennett, & 
Noyes, 2011). However, similar to the issues surrounding the definition, there is also 
controversy surrounding resilience semantics (Vanderbilt-Adriance & Shaw, 2005).  
First, risk factors are conditions or situations, which have been linked to negative 
psychosocial outcomes. Risk factors, either singly or in combination, have the potential to 
decrease the chances of resilience (Masten, 2007; Ungar, 2008). Since the first identification of 
parental psychopathology as a risk factor for mental illness, many studies have identified and 
explored other risk factors mainly among children including: poverty (Rutter, 1979, Werner & 
Smith, 1982, 1993); maltreatment (Cicchetti & Rogosch, 1996); chronic illness (O’Dougherty 
& Wright, 1990); urban poverty and community violence (Gorman-Smith, Henry & Tolan, 
2004; Hammack, Richards, Luo, Edlynn, & Roy, 2004; Richters & Martinez, 1993); and, 
repeated hospital admission (Rutter, 1982). While all of these factors are associated with 
negative outcomes, it is important to note that they are not necessarily equivalent in severity; 
rather, severity depends upon both the risk factor and the person in question (Vanderbilt-
Adriance & Shaw, 2005). Thus, there may be vast contrast in the context of risk severity 
among diverse populations. For example, some researchers have included normative middle 
class samples (e.g., Masten et al., 1999), while others have investigated ethnically diverse 
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samples of children growing up in violent neighbourhoods (e.g., Gorman-Smith, Henry & 
Tolan, 2004).  
Findings on risk factors have also led resilience researchers to propose the existence of 
factors that ‘protect’ individuals from poor outcomes. Thus, protective factors increase the 
likelihood of resilience. Research into protective factors moves away from the traditional 
deficit approach in resilience research, towards a more positive view of an individual’s skills 
and attributes (Masten & Powell, 2003). For example, Rutter (1992) defined three broad 
variables as protective factors: (a) personality coherence; (b) family cohesion; and, (c) social 
support. Personality factors include level of autonomy, self-esteem and self-efficacy, good 
temperament, and positive social outlook. In the area of traumatic stress research, Raphael and 
Wilson (1993) identified similar factors associated with resilience, which included internal 
locus of control, altruism, the perception of social and economic resources, self-disclosure, and 
the formation of a clear sense of identity as a survivor. External support systems, whether 
perceived or actually used, such as family cohesion, and a lack of family tension have also 
been identified as protective factors that promote resilience (Agaibi & Wilson, 2005; Garmezy 
& Masten, 1991). 
Akin to the challenges surrounding the definition of resilience, controversy extends to 
the operationalization of protective factors. Some researchers have argued that a protective 
factor should interact with risk status to predict outcome (Garmezy, Masten, & Tellegen, 1984; 
Rutter, 1992). By this definition, only variables that are more strongly associated with positive 
outcomes in the context of high risk, as opposed to low risk, are considered to be protective. In 
more recent years, however, the term, protective factor, has been used to refer to all factors 
associated with positive outcomes (Vanderbilt-Adriance & Shaw, 2008). Likewise, there are 
important differences in the operationalization of ‘positive outcomes’ with some studies 
focusing on the absence of psychopathology, while others require more positive outcomes 
such as academic achievement, social competence, or meeting appropriate developmental 
milestones.  
Whether resilience is operationalized as the absence of a negative outcome or the 
presence of a positive outcome (or the combination of both) is both a matter of theoretical 
perspective and the nature of the risk factor in question. For example, some risk factors are 
considered to be so powerful (i.e., child abuse) that the absence of mental illness may be quite 
remarkable, while other risk factors (i.e., parental separation) may necessitate more evidence 
of a positive outcome (Luther & Zelazo, 2003). As resilience is not an “all-or-nothing” 
phenomenon, Luther and Zelazo (2003) assert that it must be measured across multiple 
domains to ensure that an accurate portrait of positive adjustment is provided. For example, 
individuals may be doing well on external measures of functioning such as career 
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achievement, yet simultaneously demonstrate high levels of internal distress (Luther, 1991; 
Vanderbilt-Adriance & Shaw, 2008).  
Finally, several other concepts related to resilience have been discussed in the 
literature, such as benefit finding, thriving and posttraumatic growth. Benefit finding is the 
capacity of an individual to make sense of adversity by focusing on personal growth or 
positive changes (Herman et al., 2011). Thriving is considered a step beyond resilience 
(Carver, 2010). This occurs when a person not only returns to a baseline or pre-stress level, but 
also achieves a higher level of functioning by gaining knowledge, new skills, increased 
confidence and improved relationships (Carver, 2010). Posttraumatic growth (PTG) goes 
beyond both resilience and thriving. This is a construct with multiple elements that include an 
ability to unearth new opportunities, enhanced appreciation of life, greater strength and 
personal satisfaction, more intimate relationships and increased spiritual development 
(Tedeschi & Calhoun, 2004). Although the concepts of thriving and PTG are gaining 
momentum within positive psychology, the present research aims to focus on the process of 
resilience. The next section moves to providing a brief history of resilience research.  
History  
The idea of resilience was first introduced during the 1970’s in the field of 
developmental psychology (Vanderbilt-Adriance & Shaw, 2008). Norman Garmezy, Emmy 
Wearner and Michael Rutter were among many of the influential contributors to earlier studies 
that were interested in stress-resistant children affected by risk, such as poor parenting and 
impoverished living conditions (Garmezy; 1983; Rutter, 1992; Vanderbilt-Adriance & Shaw, 
2008). These earlier publications set the scene for more recent work by researchers, including 
Ann Masden, Glenn Richardson, Suniya Luther and Michael Ungar, to explore not only 
individual traits but also how protective factors might function as an evolving process across 
contexts and throughout the lifespan (Gartland, Bond, Olsson, Buzwell, & Sawyer, 2011). As a 
result, over the past few decades, research into resilience has flourished to include a more 
dynamic and broader ecological approach (Bronfenbrenner, 1986). This has embraced the 
contribution of both internal processes (such as personal, biological or psychological factors) 
and external processes (including environment, family or community systems) which influence 
resilience among individuals (Mandleco & Perry, 2000). 
Previously resilience research stemmed from investigations, not of childhood 
resilience, but of childhood vulnerability. Researchers prior to the 1970’s were more interested 
in the adverse outcomes resulting from traumatic situations rather than the positive aspect of 
adapting to adversity (Masten & Powell, 2003). For example, studies during the 1940’s and 
1950’s attempted to understand the behaviour of patients with schizophrenia. In these early 
studies, patients who demonstrated more adaptive behaviour were considered a rarity and 
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largely ignored, as the focus at this time, was primarily on the patients with negative outcomes 
(Masten & Powell, 2003).  
However, during the 1970’s researchers began questioning why patients with the same 
apparent risk displayed marked differences in their coping abilities and health outcomes. 
According to Masten and Powell (2003), early investigations revealed the schizophrenic 
patients with the least severe courses of illness had remarkably similar premorbid histories of 
competence at work, in social and intimate relationships, including the capacity to fulfil 
responsibility. Researchers began to question whether specific factors could be identified 
which led to more successful behavioural outcomes for patients with schizophrenia. This 
represented one of the first suggestions that specific factors may be related to resilience, or 
more positive outcomes in otherwise unfavourable circumstances.  
At the same time, researchers began to investigate the behavioural and mental health 
outcomes of children who were exposed to identified risk factors such as poverty, 
developmental problems and maltreatment (Hawley & DeHaan, 1996; Masten, 2001). For 
example, Garmezy (1974) investigated the behavioural and mental health outcomes of children 
with mentally ill parents, finding these children to be at a higher risk of experiencing neglect 
and adverse outcomes during their lifetime. However, some children seemed to be able to 
overcome this adversity and thrive. This prompted an interest among researchers on 
understanding individual variations in response to adversity. The results of this research 
indicated that some children demonstrated stable individual characteristics (i.e., high IQ) and 
were more resilient than others (Garmezy, 1974; Masten & Powell, 2003).  
One of the largest studies examining risk and protective factors was undertaken in 
Kauai, Hawaii in the 1970’s by Emmy Werner and Ruth Smith (Masten & Powell, 2003; 
Werner & Smith, 1982). This 40 year longitudinal study followed the development of 700 
children born in 1955 at 1, 2, 10, 18 and 41 years of age. The study began as an exploration of 
the long-term negative effects of risk factors that included high poverty, mothers with little or 
no formal education, few material possessions, and a higher than average rate of premature 
births and perinatal stress (Werner & Smith, 1982). Most of the children (n = 442) were born 
without complications and grew up in supportive environments. Some, however, grew up in 
families where they experienced disadvantage and neglect and as a result, many of these 
children had serious coping problems (20%), committed serious offences (15%), and suffered 
mental illness (10%). However, Werner and Smith also identified 10% of the cohort who 
“worked well, played well, loved well, and expected well” (1982, p. xv). According to Werner 
and Smith, ‘expected well’ referred to feelings of hope and positivity shown by this cohort of 
children. 
Thus, Werner and Smith (1982) examined the characteristics and life experiences of 
the children at high-risk who overcame adversity in this way, compared with those who had 
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developed serious behavioural, mental health or learning problems. Several processes were 
identified as contributing to the resilient outcomes for these children, but were absent from the 
lives of others who presented with problematic outcomes (Werner & Smith, 1982). First were 
characteristics of the individual, such as being active, physically strong, sensitive, nurturing, 
responsible, gentle, socially perceptive, and mature. Second were family characteristics such 
as having a close positive relationship with an adult. Finally, there were factors external to the 
family such as support outside the family unit such as access to caregivers (Werner & Smith, 
1982). 
This research by Werner and Smith (1982) and prior research by Rutter (1966, 1987, 
1992) and Garmezy (1974) provided the foundation for subsequent resilience research. This 
has resulted in several waves of resilience research (Masten, 2007; Richardson, 2002). These 
approaches will be discussed in Chapter 3, as it is important to understand the changes in how 
resilience has been studied, defined, and measured including the manner in which a “resilient” 
individual is conceptualized. The relevance of the association between resilience and illness, 
including HC will now be highlighted. Following this, the underlying theoretical framework 
will be discussed, before closing with a brief summary and outlining the main research 
questions.  
 
Haematological Cancer and Resilience 
Due to the fairly universal outcome of death once diagnosed with cancer in earlier 
times, the majority of early research addressing resilience was among individuals with other 
physical illnesses, such as cardiovascular disease (Chan, Ho, Fu, & Chow, 2006; Helgeson, 
1992), diabetes (Pollock, 1989), Parkinson’s disease and multiple sclerosis (De Ridder, 
Schreurs, & Bensing, 2000). In addition, diseases such as AIDS (Farber, Schwartz, Schaper, 
Moonen, & McDaniel, 2000), were also studied in the resilience literature, which is interesting 
given that AIDS resulted in an actual death sentence when first diagnosed in the early 1980’s, 
whereas cancers at the time had better overall survival rates. However, the increase in cancer 
diagnoses and survival rates has led to a more recent rise in resilience-related publications 
among mixed cancer patients, yet this is less evident in the HC survivor population.  
Recently, Stewart and Yuen (2011) conducted a systematic review of 52 articles 
published between 1950 and 2009 that specifically investigated psychological resilience 
among individuals with physical illness, including cancer. The aim of this review was to 
determine the factors associated with promoting or predicting resilience among this specific 
population. The analysis by Stewart and Yuen (2011) acknowledged that several of the 
features reported to be predictive of resilience and to reflect positive adaptation in chronic 
illness (e.g., individual personality and psychological factors, social support and coping 
strategies) were those identified in earlier studies that did not focus on chronic illness. This 
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result is not unexpected, given that environmental, genetic, coping strategies and past events 
all contribute to resilience, despite the type of adversity experienced (Stewart & Yuen). 
However, this review also identified resilience factors specifically associated with, and 
pertinent to, physical illness. These included illness perceptions, self-care, compliance with 
treatment recommendations, health-related QOL, perception of pain and adherence to exercise 
(Stewart & Yuen). Other recurring psychological themes reported by patients successfully 
living with cancer included empowerment, determination and acceptance of illness (Bulsara, 
Ward, & Joske, 2004; Stewart & Yuen, 2011). 
Importantly, this review discussed numerous notable omissions amid the research 
relating to resilience among the physically ill (Stewart & Yuen, 2011). For example, despite 
‘family support’ being a protective factor in children, its relevance to resilience in physically 
ill adults was not examined specifically by any study, but only generally categorised under 
‘social support’ (Stewart & Yuen). Additionally, despite the importance of the role of 
healthcare professionals reported in previous literature (Bulsara, Ward, & Joske, 2004; 
McGrath & Clarke, 2003), there was no mention of their part in contributing to resilience 
among the physically ill in the articles reviewed (Stewart & Yuen, 2011). This review provides 
further justification for the current study, as it outlined several deficits in our understanding of 
resilience among those with physical illness.  
 
Summary 
There are a number of significant reasons for the conduct of this research. First, 
although available published studies on resilience and cancer offer important data on the role 
of resilience in cancer, they are limited in number. Second, several studies have highlighted 
the negative consequences of a cancer diagnosis, yet there is less literature on how survivors 
adapt and cope following treatment. Finally, there has been less interest in the wellbeing of 
long-term survivors of less common cancers. Research to date has focused on the initial 
diagnosis and earlier treatment phase of more prevalent cancers in the survivorship trajectory. 
Consequently, although a few studies have explored the experiences of patients with HC, little 
is known about the resilience shown in these populations over the long-term. Those patients 
who have completed potentially curative treatment are not only at jeopardy of recurrence or 
secondary cancer, but also face many psychosocial challenges. This study takes the 
opportunity to address these limitations. In conclusion, as resilience is a dynamic construct that 
interacts with contextual variables (Stewart & Yuen, 2011), the factors associated with 
resilience may vary in this population as compared to others previously identified. A key 
question is whether the factors that lead to resilience among adult survivors of HC follow a 
similar profile to those found in other individuals with chronic illness (Windle, Bennett, & 
Noyes, 2011). The overarching aim in this research was, therefore, to identify the key factors 
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and processes that contribute to, or impede resilience in survivors of haematological cancer. 
The study aims and research questions will now be outlined. 
 
Aim and Research Questions  
The current research was conducted in two phases. The aim of the first phase was to 
develop a conceptual model that explained how HC survivors exhibit and maintain resilience. 
This involved in-depth, semi-structured interviews. The questions addressed in Phase One 
were:  
1. As a result of their experience, what are the common individual, family and 
community level factors that the HC survivors identified as contributing to their 
positive or negative mental health outcomes?  
2. Which key factors made it easier or more difficult for HC survivors to achieve and 
maintain their resilience? and,  
3. Were there any factors mentioned during the interviews that were not previously 
identified in the proposed conceptual framework?  
 
 
The aim of Phase Two was to test the validity of the developed model on a larger 
national sample of Australian HC survivors. The questions asked in Phase Two were: 
 
1. What is the relationship between resilience and depression and anxiety?  
2. What are the significant factors that contribute to resilience among HC survivors?  
3. Who in the clinical team provides the most and least support and relevant 
information? and,  
4. As a result of personal experience, what advice can current HC survivors provide 
to those who are newly-diagnosed that may help them to cope?  
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Chapter 2 
Literature Review  
Part A - Haematological Cancer and Cancer Survivorship 
 
 
Literature Search Strategy  
The main focus of this literature search was on publications that discussed the 
resilience process and how related risk and protective factors impact on the psycho-social 
wellbeing of survivors. Electronic searches were performed in PsychINFO (1967 - 2015); 
CINHAL (1981 - 2015); PubMed (1946 - 2015); MEDLINE (1950 - 2015), and ProQuest 
Nursing & Allied Health Source (1996 - 2015) with final searches completed by September 
2015. The main search strategy used combinations of keywords for resilience (coping OR 
positive adaptation OR adjustment OR wellbeing OR quality of life OR hardiness OR benefit 
finding OR growth OR psychological functioning) and haematological cancer (blood cancers 
OR leukaemia OR lymphoma OR myeloma OR oncology OR cancer survivorship) and 
psychological distress (psychosocial OR depression OR anxiety OR stress).  
The inclusion process comprised four stages. First the initial search results were de-
duplicated and titles were visually screened for relevance. Second, abstracts of remaining 
papers were compared to the inclusion criteria and those falling outside the criteria excluded. 
Third, papers with suitable abstracts were read in full by the author to determine which were 
eligible for inclusion. Finally, the reference lists of all included papers were screened for any 
further eligible studies that had not been found within the initial searches.  
Chapter Overview  
This section (comprising Part A and B) provides a review of available literature 
that specifically investigates resilience and illness, including the survivorship 
experience for individuals following the diagnosis and treatment of HC. The first 
section, Part A (Chapter 2) will begin by explaining the literature search strategy 
and provide an illustration that visually represents the structure and layout of this 
review. The treatment and associated challenges faced by those diagnosed with 
HC will follow. Cancer survivorship will then be described by highlighting the 
focus of current and previous research interventions and quality of life issues 
among survivors. Mullan’s (1985) stages of cancer survivorship is then outlined, 
followed by a brief explanation of the many barriers to meeting the psychosocial 
needs of cancer survivors. The influence and importance of resilience will be 
deliberated in Part B (Chapter 3). This will also discuss positive and negative 
outcomes and conclude with a conceptual model of resilience. 		
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A total of 1,288 titles were identified by the combined searches. Initially, the inclusion 
criteria were broad, in order to capture as many articles as possible. English publications that 
examined resilience and related concepts associated with cancer were included regardless of 
age, gender or ethnicity of participants in the study. However, the majority of papers were 
excluded as they were either duplicated or not relevant (i.e., they discussed drug-related 
research trials), rather than cancer survivorship research. This resulted in 478 remaining titles. 
At this point, to further narrow the focus of the literature search, articles that investigated 
children or teenagers (<18 years of age) were excluded mainly due to the differences in the 
survivorship issues among these populations. In addition, those studies that referred 
specifically to the ‘family experience’, except from the viewpoint of the person diagnosed with 
cancer, were also omitted. As outlined in Figure 2.1 these procedures resulted in a final total of 
58 articles included in this review. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
Figure 2.1. Literature review search and selection process 
  
Electronic	searches	performed	in:	Psych	INFO,	CINHAL,	PubMed	MEDLINE,	&	ProQUEST	Nursing	and	Allied	Health	Source	for	articles	in	English	
1,288	Articles	retrieved	
478	Article	abstracts	screened	for	inclusion	 Excluded	articles	(n	=	420)	- Not	specifically	adults		- No	access	to	full	text	- Not	health	related	consequences		- Only	focued	on	family		 	 	58	Articles	included	in	the	final	review	
Excluded	articles	(n	=	810)	- Duplicates	- Not	relevant	(i.e.	drug	related	research	trials)	
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For the purposes of this review, studies were organised into two categories. First those 
papers outlining the challenges and risk factors (predicted to impede resilience) were grouped 
together. These studies included topics related to psychological distress, such as depression, 
anxiety, unmet needs, and psychosocial issues among HC survivors. The second group of 
articles investigated the protective factors (predicted to facilitate the resilience process). These 
included studies that discussed resilience-related topics such as coping and adaptation.  
Among those articles that specifically examined resilience, the majority reported on 
more common cancers, childhood survivors and/or focused on patients in the earlier 
survivorship phases of diagnosis and treatment. Hence, to gain a more thorough understanding 
of the resilience process in short- and long-term survivors, it was necessary to also include 
articles that discussed psychosocial factors associated with enhanced coping and PTG, as well 
as articles that included mixed cancer populations. As discussed, 58 articles were included in 
the literature review due to their relevance, of these the six most pertinent articles have been 
more comprehensively outlined in Table 2.1. These include papers that will be referred to 
throughout this literature review and were selected as they focused solely on investigating the 
experiences of HC survivors, yet remain relatively recent (≤ 6 years).  
Following Table 2.1, Figure 2.2 presents a visual illustration representing the HC 
survivor trajectory and outlines the potential resilience processes and possible outcomes as 
experienced by many cancer survivors. This illustration, which has been created by the author, 
based on her understanding of the literature, is intended to assist the reader by visually 
depicting the direction and layout of this literature review. It is hoped this will exemplify a 
similar journey, as experienced by many adults who are diagnosed with HC cancer. Thus, this 
review will begin by briefly outlining the non-modifiable factors (i.e., previous experience 
with adversity) that each individual may have developed prior to their cancer diagnosis. Next, 
the adverse event of an HC and the associated challenges will be described. This is followed 
by an outline of current cancer survivorship research and the stages proposed by Mullan 
(1985) that each survivor will transition through. As outlined in Figure 2.2, resilience is then 
reviewed in terms of the risk and protective factors among individuals, families and 
communities. Finally, the positive and negative outcomes that HC survivors experience, as 
part of this journey, will be discussed.  
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Table 2.1 
 
Summary of Relevant Articles Investigating the HC Survivors Experience 
 
_______________________________________________________________________________________________________________________ 
Author/Year/Aim Setting/Sample Method/Design   Scales  HC  Findings             Relevance to Study  
__________________________________________________________________________________________________________________________________ 
 
Korszun et al.  UK   Quantitative    EuroQOL  HL (n = 280) 15% significant psych                Outlined the importance  
(2014)   n = 718        IOC    NHL (n = 326) distress; 18% high level             of understanding those  
Assess the impact  56.8% male       HADS  AL (n = 112) fatigue; 10% functional              who experience +ve &  
of cancer (IOC) on  M = 37 (age at diag)       Chalder fatigue    impairment.               -ve IOC. Identified a   
psycho-social   M = 20.3 (years since          Social support (SSI)    Higher –ve IOC scores     subgroup that reports 
factors in long-term  diagnosis)         Work & social    significantly associated               poor QOL with anxiety 
HC survivors           adjustment (WSAS)   with psych distress, lower          & depression most 
             social support, high fatigue         worrying problem.  
             & functional impairment 
 
 
Swash et al.  UK   Systematic    N/A   Mixed HC Key need areas identified           Highlighted specific  
(2014)   14,549 titles   review > 6       inc: psychological, fear         gaps in the current  
Review studies  identified by  databases      of reoccurrence,     literature on unmet 
Investigating the search.          information, family &                 psychosocial needs 
unmet psychosocial  Final inc18 papers        HCP need               among HC survivors 
needs in HC   reporting on                     especially among  
survivors  17 studies                     those who have 
                                  ended treatment. 
 
 
 
 
 
RESILIENCE IN HC SURVIVORS 23	
Table 2. Continued 
_______________________________________________________________________________________________________________________ 
Author/Year/Aim Setting/Sample Method/Design   Scales  HC  Findings             Relevance to Study 
_______________________________________________________________________________________________________________________ 
 
Schumacher et al. Germany  Quantitative    Resilience Scale Leukaemia Resilience +ly correlated Identified a potential 
(2014)   n = 75        (RS-25)  Lymphoma with QOL (0.587) &   influence on time  
Examine resilience age range =       HADS  Myeloma &       social functioning (0.472), since diagnosis & 
factors in patients (20-76 yrs)       EORTC QOL-C30 Aplastic negatively with anxiety  resilience. Concluded 
after allogeneic stem M Age = 48         anaemia (-0.491) & depression  that resilience is an 
cell transplant   60% males         (-0.577). High resilience pts important factor in 
(alloSCT).  Time span ≥ Tx         reported less anxiety   HC survivors that has 
6 mth to 7.6 years        depression, higher   a positive impact on
           physical, emotional &   QOL and resuming 
             social functioning  normal life after 
             & better QOL than low  treatment. More  
             low resilience patient’s  research suggested to
            .  Strong r/ship resilience   further understand 
             & self-efficacy (r=0.698) influencing factors 
 
 
Allart et al.  France   Critical Review   N/A   Mixed HC QOL +ly associated with              Outlined that clinical  
(2013)  986 studies   Medline      sense of coherence;                 care could be better  
Review literature identified by   Science Direct       self-esteem, social                individualised by   
investigating the search.   PsychInfo      support, global meaning               furthering research in  
psychosocial factors Final inc 14          locus of control & coping             the experience for HC  
linked to QOL in papers          strategies. Helplessness-               survivors. Proposed  
HC survivors  M Age = 48.1         hopelessness +ly related               impact on QOL may  
             to emotional distress                be influenced by age. 
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Table 2. Continued 
_______________________________________________________________________________________________________________________ 
Author/Year/Aim Setting/Sample Method/Design   Scales  HC  Findings             Relevance to Study 
_______________________________________________________________________________________________________________________ 
 
Paul et al.  Australian  Quantitative     Value weighting   Mixed  Patients rated the need to  Highlighted that pts  
(2011)   n = 117        web survey    identify who is at risk of  may feel psychosocial 
Identify the HP’s partners/carer (31)            psychosocial issues and who issues are not properly 
patients & carers patients (45)         is resilient as they’re highest  addressed by HCP’s 
psychosocial  HCP’s (41)         priority. Highest research  Suggested the need for 
research priorities for           priority given to newly  more research to find 
older adults with HC           diagnosed or Tx phase, less interventions that can 
             available for later stages improve HC outcomes  
 
 
Lobb et al.  West Australian Questionnaire    CaSUN  Mixed   59% stated it would have Confirmed a sub group 
(2009)   n = 66   (self-report) &    Demographics   been helpful to discuss  of pts who would have  
To determine  Age range (18-80) Qualitative       experience at end of Tx  found it helpful to talk  
emotional and   < 1year post Tx    for open ended      with a HCP. Most common   to with HCP at end of 
informational &    questions      reported unmet need related Tx as several unmet 
support needs at            to ‘care co-ordination and  psychosocial needs  
end of Tx             managing re-occurrence fears were identified.  
	 	 	 	 	 	 	 	 	 	 	 	 	 Those younger & single are Outlined that further  
	 	 	 	 	 	 	 	 	 	 	 	 	 more reliant on HCP support research is required 
                  
__________________________________________________________________________________________________________________________________	
Note. HC = Haematological Cancer; HL = Hodgkin’s Lymphoma; NHL = Non Hodgkin Lymphoma; AL= Acute Leukaemia; IOC = Impact of Cancer;  
QOL = Quality of Life; n/a = Not Applicable; HCP = Healthcare Professional; Tx = Treatment; HADS = Hospital Anxiety Depression Scale;  
EORTC QOL C30 = European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire; CaSUN = Cancer Survivors Unmet Needs 
Measure; +ly = positively; –ly = negatively; pts = patients; Tx = treatment; inc = includes. 	
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Figure 2.2. Visual representation of the HC survivor journey and factors influencing resilience outcomes.  
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Haematological Cancer  
Each individual arrives at a crisis event, such as a HC diagnosis, with predetermined 
resilience characteristics (Richardson, 2002). These include genetic, biological, cultural, 
environmental and social factors (Szanton, Gill, & Thorpe, 2010). In addition, according to 
research, the previous experience that people have in overcoming adversity often predicts the 
manner in which they tend to cope with future crises (Richardson, 2002). Therefore, it is 
important to first identify and acknowledge that all individuals will present with an array of 
resilient traits and behaviours that have developed during previous life experiences. Yet, the 
majority of researchers also maintain that, despite pre-determined characteristics, all 
individuals have the potential to develop resilience (Masten, 2007; Pooley & Cohen, 2010; 
Ungar, 2008; Wagnild, 2009). Before describing the value of resilience from this perspective, 
it is first important to explain the HC survivor journey in more detail and explain why HC is 
considered such an adverse event.  
 
Haematological Cancer Challenges and Treatment  
There are pathological differences inherent in HC that lead to specific psychosocial 
challenges and which are unique to survivors (Swash, Hulbert-Williams, & Bramwell, 2014). 
Compared with those with solid tumour cancers, both the method and setting in which HC 
patients are treated can vary (Howell, 2011; Swash, Hulbert-Williams, & Bramwell, 2014). 
For example, surgery is often of central importance in treating individuals diagnosed with solid 
tumours, whereas for those with HC, rather than being curative, surgery is used more for 
diagnostic purposes (Allart et al., 2013). It is important to discuss the factors that are unique to 
survivors of HC, as treatment therapies can be more intensive, potentially resulting in a high 
burden of illness (Sherman, Cooke, & Grant, 2005).  
There has been a recent and rapid improvement in molecular targeted therapies, which 
are best demonstrated by the advances in the management of haematological cancers 
(Hamilton, Gallipoli, Nicholson, & Holyoake, 2010). This has resulted in more HC survivors 
living long-term in the community. Previously in the 20th century, the discovery of x-radiation 
allowed palliative orthovoltage radiation therapy of Hodgkin's disease (Lichtman, 2008). Then 
following World War II, drug treatments for the HC’s were also introduced (i.e., nitrogen 
mustard, and cortisone acetate) (Lichtman, 2008). However, over the last decade, the enhanced 
understanding of tumour biology has created the opportunity to develop new intelligent 
targeted therapeutic strategies (Ananda & Scott, 2015; Piccaluga, Martinelli, & Baccarani, 
2006). Targeted therapy is defined as using a drug that specifically acts on a target area or 
biological pathway (Hamilton, et al., 2010; Ross et al., 2004). This triggers destruction or 
deterioration of the malignant process (Hamilton et al., 2010; Ross et al., 2004).  
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These targeted therapies are more effective and have a higher therapeutic index (a 
comparison of the amount of a therapeutic agent that causes the therapeutic effect to the 
amount that causes toxicity) (Hamilton et al., 2010). In addition, targeted therapies are less 
toxic than traditional chemotherapy regimens, as they are not as harmful to normal tissues 
(Hamilton et al., 2010). The last ten years has seen a rapidly growing awareness and 
recognition that targeting leukaemic stem cells may hold the key to minimising relapse and 
increasing survival rates in several HC’s (Hamilton et al., 2010). As a result of the 
development of these treatment options, an improved survival rate has been observed for 
haematological malignancy (Chew & Roberts, 2015; Kelly & Dowling, 2011). This has 
changed the landscape for many patients, as the risks associated with treatment also become 
more acceptable (Hamilton, et al., 2010). However, while medical advances have resulted in 
impressive statistics on survival; in contrast, only a modest effort has been devoted to explain 
the psychological sequelae of the experience for HC survivors (Hamilton et al., 2010).  
In addition, HC’s often present in more advanced stages, providing another rational for 
this research. Unlike more common cancers such as breast, prostate and colon cancer, there is 
no preventative-screening program routinely available to detect HC in the early stages (Lobb 
et al., 2009; Mukherjee, 2010). As a result, diagnosis generally only occurs as symptoms 
become apparent, at which point the stage of HC may be more advanced. This can result in the 
need for more aggressive therapies. In addition, unlike solid tumours, HC’s are one of a few 
cancer types that are unable to rely on surgery as a curative treatment. Thus, other aggressive 
treatments are often necessary to target advanced cancer sites and these can have significant 
effects upon an individual’s immune system and bone marrow function (Lobb et al., 2009; 
Rodin et al., 2013).  
Despite the advances in targeted therapies discussed above, which have revolutionised 
haematological care over the last 10 years, monotherapy (one treatment type) with these drugs, 
is unlikely to be curative in the majority of cases (Roberts & He, 2008). Therefore, to improve 
clinical outcomes, the most hopeful future approach for those individuals diagnosed is to 
combine these targeted therapies with conventional cytotoxic chemotherapy (Roberts & He, 
2008). This means that, while the majority of HC patients may survive longer due to recent 
advances in targeted therapy, the treatment may also require traditional chemotherapy (Roberts 
& He, 2008). Traditional chemotherapy is generally more toxic and debilitating than targeted 
therapy, and, therefore, can result in detrimental effects or post-treatment complications 
(Roberts & He, 2008). For example, this may affect the ability for patients to fulfil social, 
family and vocational responsibilities due to symptoms such as fatigue, depression, anxiety, 
fear, loss of identity and effects on sexuality and fertility (Lobb et al., Paul et al., 2011; 
Shrover, 2005) 
Haematological cancer patients may also require more life-threatening treatments, 
such as a bone marrow transplantation (BMT) (Lobb et al., 2009). This is due to the specific 
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treatment effects upon normal bone marrow and immune function (Lobb et al., 2009). 
Haematopoietic stem cell transplant (HSCT) encompasses BMT and stem cell transplants from 
peripheral blood or umbilical cord blood (Copelan, 2006). Patients undergoing this therapy 
have unique needs due to the intensity of treatment necessary to prepare them for 
transplantation that may result in severe complications and a range of ongoing health problems 
(Bevans et al., 2011; Braamse et al., 2014; Pillay, Lee, Katona, Burney, & Avery, 2014). A 
HSCT may involve several stages, beginning with the collection of the stem cells, the 
administration of high doses of chemotherapy (with possible total body irradiation), then the 
re-infusion of stem cells, followed by the initial and long-term recovery phase (Bevans et al., 
2011; Copelan, 2006). Allogeneic HSCT, which uses donor stem cells, may also lead to severe 
complications including a life-threatening illness referred to as graft-versus-host disease 
(GVHD) (Mosher, Redd, Rini, Burkhalter, & DuHamel, 2009; Syrjala et al., 2004). Studies by 
Syrjala and colleagues (2004) have reported that psychological and social recovery trails 
behind physical recovery in allogenic HSCT survivors.  
As expected, when the disease is more serious or severe, levels of psychological 
distress are likely to be higher (Braamse et al., 2014). When compared to chemotherapy-only 
treated survivors, transplant recipients were reported to have more impaired emotional and 
social functioning at both five and ten years following transplantation (Syrjala, Abrams, 
Storer, & Martin, 2004). Studies have reported that approximately 25% of allogeneic HSCT 
recipients describe significant depressive symptoms one year post-transplant (Chang, Orav, 
McNamara, Tong, & Antin, 2005; Jenks, Kettmann, & Altmaier, 2008). In addition to 
disturbed psychological functioning, severe physical effects associated with toxicity and 
immunosuppression can result in major physical and functional impairment (Pillay et al., 
2014). For example, physical side-effects of HSCT may involve sexual dysfunction and 
infertility in over 90% of cases (Hammond, Abrams, & Syrjala, 2007; Mosher et al., 2011). 
The differences between HC and solid tumours that been identified in the literature 
(Swash, Hulbert-Williams, & Bramwell, 2014) warrant further investigation to highlight the 
potential distinctions in the psychosocial needs of this population (Swash, Hulbert-Williams & 
Bramwell, 2014). Psychosocial need implies a desire or requirement for support that underlies 
a person’s psychological, social and emotional wellbeing (to be discussed in more detail at the 
end of this chapter). This is not a new concept in the wider cancer literature, yet remains a 
relatively unexplored area in relation to haematological malignancies. In addition, the 
challenges faced as a result of HC are experienced at different times and in varying levels of 
intensity. These directly influence each cancer survivors’ ability to cope, which impacts on 
their QOL and mental wellbeing. As reported by Ganz (2001), disruption of function at any 
age may be distressing if it involves valued life activities or a change in goals. The next section 
highlights the current focus on survivorship research, internationally and within Australia.  
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Cancer Survivorship Research 
Focus of Cancer Survivorship Research  
According to Ganz (2011), the focus of survivorship care falls into three major 
conceptual domains: palliation of ongoing symptoms such as pain, fatigue or depression; 
prevention and monitoring of late effects of cancer treatment such as osteoporosis or 
secondary cancers; and, health promotion to maximize future wellness, which is often 
overlooked due to the focus on treatment and monitoring for cancer recurrence (Ganz, 2011). 
The motive for the current focus on survivorship care is that, until the last decade, it 
had been largely overlooked (Ganz, 2011). The emphasis of cancer care had traditionally 
focused on medical diagnosis and treatment. Consequently, when compared with survivorship, 
there has been an abundance of literature published in these areas. For example, by 2004 the 
number of studies cited in PubMed relating to cancer survivorship (n=374) was minimal in 
contrast to the research addressing active cancer treatment and/or diagnosis (n=23,736) (Aziz 
& Rowland, 2003). However, there has been a considerable increase in published literature 
associated with cancer survivorship since 2005, with 179,366 citations available on the 
PubMed database in 2013.  
There are two main reasons we have witnessed a significant rise in cancer survivorship 
research. First, as previously mentioned, the advances in cancer treatment have enabled long-
term survival in a greater number of individuals we know little about (Boyle, 2006). Second, 
concerns over long-term and/or late effects of aggressive therapies, introduced during the 
1970s, warranted consideration of treatment-related secondary cancers (Matesich & Shapiro, 
2003; Marcu, Santos & Bezak, 2014; Theodoulou & Seidman, 2003).  
Long-term effects relate to any side-effect that a cancer patient experiences as a result 
of treatment. These long-term effects, such as anxiety and/or issues with intimacy, begin 
during treatment and persist beyond the end of treatment (Aziz, 2002). Late effects refers to 
unrecognised toxicities that are absent at the end of therapy but which manifest later often as a 
result of treatment (Aziz, 2002). Late effects may occur at any stage following the completion 
of treatment and these have been well documented, some of which include: fatigue, 
lymphedema, cognitive difficulties, disfigurement, weight changes, problems with fertility, 
serious damage in major organs and secondary tumours (Aziz, 2002; Baker, Denniston, Smith, 
& West, 2005; Goldstein et al., 2012; Bennett et al., 2010; Brennan, Butow, Spillane, Marven, 
& Boyle, 2011; Hogkinson et al., 2007). These late effects may result in the cancer survivor 
having to adjust to a lifestyle they were not expecting (Aziz, 2002). This has resulted in 
research that has investigated ongoing psychosocial issues and QOL among survivors.  
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Surviving Cancer and Quality of Life  
In 2008, Doyle published a conceptual analysis suggesting that the main themes of 
cancer survival experiences relate to physical, psychological, social and spiritual effects. These 
experiences represented below in Figure 2.3, have also been referred to under the umbrella of 
quality of life (QOL) factors (Pratt-Chapman, Simon, Patterson, Risendal, & Patierno, 2011). 
Internationally, and within Australia, several studies have attempted to report on the QOL 
issues faced by patients completing treatment for cancer. Many of these areas of interest have 
included: fear and anxiety related to cancer recurrence, the future and death (Butow, Fardell, & 
Smith, 2015; Jefford et al., 2008; Llewellyn et al., 2013); loneliness, uncertainty, isolation and 
abandonment (Boyle, 2006; Constanzo, Ryff, & Singer, 2009; Knobf, 2011); loss and grief 
(Ferrell & Dow, 1996); physical and psychological consequences, including late or longer term 
effects (Davydov et al., 2010; Foster, Wright, Hill, Hopkinson, & Roffe, 2009; Min et al., 
2013; Mitchell et al., 2011; Mosher et al., 2011); changes to identity, body image, intimacy 
and sexuality (Doyle, 2008; Foster et al., 2009; Jefford et al., 2008); uncertainty about health 
and effects of treatment (Davies, 2009); unmet needs (Campbell et al., 2011; Hall, D’Este, 
Tzelepis, Lynagh, & Sanson-Fisher, 2014; Hwang et al., 2004); returning to work, 
employment discrimination, financial impact and ongoing challenges acquiring insurances and 
mortgages (Amir & Brocky, 2009; Boyle, 2006; Feuerstein, 2005; Grunfeld, Drudge-Coates, 
Rixon, Eaton, & Cooper, 2013; Hara & Blum, 2009); the impact of cancer on family and 
caregivers (Boyle, 2006; Mitchell et al., 2013; Rowland, Aziz, Tesauro, & Feuer, 2001); and, 
reassessing life priorities, spirituality, meaning and hope (Dunn, Occhipinti, Campbell, 
Ferguson, & Chambers 2011; McGrath & Clarke, 2003; Tedeschi & Calhoun, 2004; Turner-
Sack, Menna & Setchell, 2012; Xuereb, 2003). 
 
 
 
 
Figure 2.3. QOL model applied to cancer survivors, by Pratt-Chapman, M., Simon, 
M.A., Patterson, A. K., Risendal, B. C., & Patierno, S. (2011). Survivorship 
navigation outcome measures. Cancer, 117(S15), 3573-3582.  
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Interventions for Cancer Survivorship 
 In addition, there has been a rise in the amount of research undertaken to develop and 
test interventions to enrich QOL and the survivorship experience. These publications have 
included studies on: the use and delivery of models of follow-up care (Brennan, Butow, 
Spillane, & Boyle, 2008; Ganz & Hahn, 2008; Jefford et al., 2008; Morgan, 2009); various 
measures and screening tools (Holland & Reznik, 2005; Meneses & Benz, 2010); lifestyle and 
health promotion interventions (Aziz, 2002; James et al., 2011; Rabin, Morrow, Simpson, & 
Pinto, 2011); supporting patients with advanced cancer (Hudson et al., 2008); and, the needs of 
specific populations such as migrants (Butow et al., 2013; Hollinshaus & Utz, 2013), rural 
patients (White et al., 2011) and the indigenous population (Condon, Armstrong, Barnes, & 
Cunningham, 2003).  
 A number of researchers have also explored the individual’s experience of being 
involved in specific interventions (Emery et al., 2008; Galvao & Newton, 2005); according to 
specific timeframes (Aziz, 2009; Bennett et al., 2010; Hogkinson et al., 2007); by tumour 
group (Bulsara, Ward, & Joske, 2004; Meneses & Benz, 2010; Maher & De Vries, 2001; 
Mosher et al., 2011 ); gender (Helgeson, Reynolds, & Tomich, 2006; Pudrovaska, 2010); and, 
age (Avis & Deimling, 2008; Bellizi, Mustian, Palesh, & Diefenbach, 2008; Rabin et al., 2011; 
Zebrack, 2011). However, despite the extensive amount of literature published on the 
consequences of cancer, what appears to be lacking is an understanding of the strategies used 
by these individuals to cope and/or maintain a level of resilience (Denz-Penhey &Campbell  
Murdoch, 2008; Mullen, 1985; Park et al., 2009; Pieters, 2015; Stewart & Yuen, 2011). In 
addition, when compared with international efforts, relatively few articles addressing cancer 
survivors have been published within the Australian context, especially among those with less 
common cancers (Girgis & Butow, 2009).  
This is important to address, as earlier research indicates that there is a need to 
improve the care of cancer survivors. For example, earlier Australian research involving 888 
cancer patients reported that 40% experienced unmet needs across several areas (Sanson-
Fisher et al., 2000). More recent research also indicates that the survivorship needs of 
distressed cancer patients have not previously been sufficiently met by the Australian 
healthcare system (Knott et al., 2012).  
This may be due, in part, to the fact that the approach to survivorship research in 
Australia has been rather fragmented. As reported by Girgis and Butow (2009), there have 
been very few integrated Australian efforts to formulate a comprehensive survivorship 
research agenda. Individual researchers have conducted a wide spectrum of research on 
survivorship in Australia, ranging from qualitative to epidemiological research that addressed 
several topics across the survivorship continuum. However, these isolated approaches to 
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survivorship research have made it challenging to direct and co-ordinate a national agenda 
(Breaden, 1997; Girgis & Butow, 2009). 
One of a few Australian studies that have emphasised the psychosocial aspects of 
cancer survivorship is a qualitative study undertaken by Jefford and colleagues (2008) at the 
Peter MacCallum Cancer Institute (PMCI) in Melbourne, Victoria. This research involved one 
focus group of 22 cancer survivors and two focus groups of 20 health professionals, in which 
the participants were asked, in a semi-structured format, to focus on their experiences at 
treatment completion and at one-year post treatment.  
The results indicated that the most commonly identified psychosocial issues included: 
dealing with fatigue; others expecting you to be back to normal; anxiety about cancer 
recurrence; having to create new expectations about physical ability; and, information needs 
and anxiety about leaving the hospital system (Jefford et al., 2008). The participants suggested 
strategies to meet these identified needs. These predominantly included a treatment completion 
session (where the patient has the opportunity to discuss concerns prior to leaving hospital) 
and adequate emotional and psychological support and reassurance, which was the most 
frequently identified need. Health professionals also emphasised a requirement for routine 
post-treatment psychosocial screening, whereas patients suggested occasional telephone 
follow-ups. This may reflect the health professionals’ experience or indicate that survivors are 
unaware of the potential for psychological distress (Jefford et al., 2008). 
Although this study was unable to achieve a sound representation for all cancer types, 
it was instrumental in identifying the psychosocial issues of cancer survivorship in the 
Australian context. This research resulted in the development of the Australian Survivorship 
Centre based at PMCI in Victoria. In addition, Jefford and colleagues’ (2008) findings 
provided the foundation on which more explicit research can now contribute to the awareness 
of survivorship concerns in Australia. For example, in order to address many of the unmet 
needs identified in this study, an intervention referred to as SurvivorCare has since been trialed 
(Jefford et al., 2013). The SurvivorCare intervention was developed by a multidisciplinary 
team using 3 key principles: (1) to promote patient involvement and engagement; (2) to 
address the specific needs of individual patients; and, (3) to use evidence-based strategies to 
promote well-being and reduce treatment sequelae (Jefford et al., 2011). SurvivorCare 
included educational materials, a tailored survivorship care plan, a tailored, nurse-led, end-of-
treatment consultation, and three follow-up telephone calls. According to Jefford et al. (2011), 
as a result of this initiative, SurvivorCare has become recognised as a well-received, 
comprehensive intervention aimed at improving QOL and reducing distress and unmet needs 
among cancer survivors.  
In Western Australia, Lobb and colleagues (2009) published a study that aimed to 
determine patients’ needs within the first year of completion of treatment for haematological 
cancer. A quantitative research method was adopted, that included 66 self-report 
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questionnaires completed by cancer survivors during the first 12 months post-treatment. 
Findings were consistent with those identified by Jefford (2008). The results indicated that the 
most frequently stated unmet patient needs related to care co-ordination and managing the fear 
of recurrence. Over half, 59% (n = 39) of patients suggested that it may have been helpful to 
discuss their experience at the completion of treatment with a HCP. Results also reported that 
patients without a partner were found to be more reliant on support from HCP’s. In addition, 
younger patients indicated significantly more needs around emotional and relationship issues 
following treatment. This study concluded that further research in the area of survivorship is 
needed in order to assess different patient outcomes and different unmet needs at various 
stages of survivorship (Lobb et al., 2009). 
Cancer survivorship research is recognised as way of organising a wealth of 
knowledge that will develop over time and ideally enhance the health and well-being of those 
diagnosed and treated for cancer (Feuerstein, 2007a). The summary provided above highlights 
that the focus of research currently undertaken in Australia is within the scope of survivorship 
research priority areas identified internationally. However, there continues to be growing 
evidence of unmet needs following treatment, with research indicating that one in four cancer 
survivors have at least five unmet physical or psychological needs (Lobb et al., 2009). 
Therefore, further efforts are required to further our understanding of survivorship issues 
beyond treatment within an Australian context (Girgis & Butow, 2009). The phases involved 
in the cancer trajectory and the associated challenges for survivors, will now be described in 
more detail.  
 
Stages and Associated Challenges of Cancer Survivorship 
Cancer survivorship has come to represent a series of phases through which any 
patient learns to adapt and live with a life-threatening, chronic illness (Jefford et al., 2008). 
Mullan (1985) originally proposed three stages (Table 2.2) that each cancer survivor may 
transition through and the potential psychosocial issues that could arise as a result of each. A 
“transition” entails progressing from one comparatively stable state, to an experience of 
disorganisation and upheaval, and then toward another relatively stable situation (Boyle, 2006; 
Clarke-Steffen, 1993). In general, transitions are regarded as stressful, as they lead to periods 
of readjustment, evoke anxiety and impose adaptational challenges (MacLean, Foley, 
Ruccione, & Sklar, 1996). Major adjustments within the cancer experience may involve 
changes in one's sense of self from ‘well individual’ to ‘cancer patient’ (upon diagnosis), 
‘cancer patient’ to ‘cancer survivor’ (at the end of successful treatment), and again episodic 
changes during intermittent hospitalizations, follow-up tests or when recurrence is diagnosed 
(Boyle, 2007).  
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These distinct phases were first introduced by Mullan (1985) as a series of periods, 
which he labelled as acute, extended, and permanent survival. Although not all cancer 
survivors pass through every phase and the length of time in each phase may vary, this 
framework was useful in outlining the diverse challenges faced by patients during the cancer 
survivorship trajectory.  
 
Table 2.2  
 
Phases and Experiences of Cancer Survival (adapted from Mullan, 1985) 
____________________________________________________________________________ 
Acute Survival   Extended Survival  Permanent Survival 
____________________________________________________________________________  
Extends from diagnosis  After treatment completion The extended disease free  
to completion of initial   and starting to return to  period with low likelihood of  
treatment   normal life   disease recurrence 
 
Dominated by cancer   Period of regular follow-up Adjustment to a ‘new  
treatment  coping with  and ‘watchful waiting’  normal’  
effects of therapy  with treatment if required 
 
Anxiety and fear are   Managing the physical,  Long-term physiological 
common emotions  social and psychological and psychological effects 
experienced   effects following treatment secondary to treatment  
 
Confronting one’s mortality Period where psychosocial  Financial, employment and 
reassessment of life goals services are important  health insurance concerns 
 
Community, healthcare and  Period dominated by fear of Health promotion and life 
family support are important recurrence     change strategies become the  
        focus 
____________________________________________________________________________ 
 
The ‘acute’ stage of survivorship commences when an individual receives a cancer 
diagnosis and extends to the completion of initial treatment (Mullan, 1985). This is also 
commonly referred to in the literature as a phase of ‘living with cancer’ (Wheeler, 2010). 
Although the timeframe varies between patients, the acute phase, as described by Mullan, is 
usually completed within one year. Whilst survivors are thankful to be ending treatment, many 
describe being unprepared to cope with the long-term and late effects of having had cancer 
(Maher & Fenlon, 2010).  
The acute stage of survivorship has been well researched (Ganz, 2011; Knobf, 2011; 
Maher & Fenlon, 2010). This phase has been identified as being particularly stressful for 
patients, with concerns related to fear, uncertainty, and anxiety about their cancer and 
psychosexual and financial issues, including the impact on family, friends and work (Armes et 
al., 2009; Butow, Girgis, & Schofield, 2013; Ganz, 2011; Hwang et al., 2004; Webber et al., 
2011). This period is dominated by focusing on ‘getting through’ treatment in order to be 
cured (Maher & Fenlon, 2010). Specific physical problems identified during this time may 
include fatigue (Bennett et al., 2007; Goldstein et al., 2012), nausea and pain (Armes et al., 
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2009; Menshadi, Bar-Tal, & Barnoy, 2013). In addition, the lack of appropriate social support 
and/or information provided by clinicians can be another source of stress for patients (Maher 
& Fenlon, 2010). 
The ‘extended’ stage begins with the completion of initial treatment for the primary 
cancer (Mullan, 1985). This phase has also been referred to as ‘living through cancer’ and a 
time when the patient not only experiences physical limitations following treatment, but also 
confronts the possibility of cancer recurrence (Wheeler, 2010). Survivors can feel elated, but 
also disoriented and confused following the end of treatment. In addition, they may have “no 
evidence of disease” or be pronounced “cancer free”, but rarely are patients told they are cured 
(Rancour, 2008). Widespread reviews of the available literature report that the period after 
completion of treatment brings its own unique and, in some cases, still poorly understood 
challenges that may interfere with QOL, relationships and employment (Knott et al., 2012; 
Maher & Fenlon, 2010). 
During this extended phase, most cancer survivors demonstrate a gradual 
improvement in overall QOL (Gang, 2001). However, this is often coupled with feelings of 
anxiety, uncertainty, and psychological distress that may continue (Deshields, Tibbs, Fan, & 
Taylor, 2006) because of unmet emotional and support needs (Campbell et al., 2011). Re-
integration into everyday life, once therapy ends, can be challenging and stressful for several 
reasons (Knobf, 2011). For example, once the immediate symptoms of active treatment have 
been dealt with, an ongoing problem for some cancer survivors is their altered body image 
(Doyle, 2008; Foster et al., 2009). Earlier research by Charmaz (1983) identified how people 
with chronic illness lose their previously held body image, largely due to physical challenges 
such as permanent scaring and/or weight and hair changes that challenge the identity of the 
individual. Consequently, cancer survivors report that they find themselves in adjusting to a 
'new normal' (Maher & Fenlon, 2010).   
In addition, social and emotional support from family and friends may diminish as 
treatment needs cease. Physically, the cancer survivor has showed signs of recovery (i.e., hair 
regrowth) and they may also appear to be regaining strength and increased energy levels 
(Goldstein et al., 2012; Knobf, 2011). As a result, partners and caregivers may not perceive the 
need for the same level of support. This is indicated in the literature by a reported decline in 
support following treatment (Knobf, 2011; Knott et al., 2012; Wheeler, 2010). This often 
coincides with a point in time when many patients remain anxious about leaving the healthcare 
system and losing contact with their specialist and fellow patients, who they had previously 
seen on a regular basis (Wheeler, 2010). Conversely, some survivors may experience a desire 
to avoid appointments with their specialist, which could impact on their future lifestyle and 
health behaviour decisions (Carr, 2004). 
Following treatment, cancer survivors have also expressed feeling powerless and 
unsure about their role of being personal health advocates (Carr, 2004). A systematic review of 
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information needs by Campbell et al. (2011) found that survivors wish to receive information 
in the year following treatment, including information on follow-up appointments, long-term 
effects and self-care (Maher & Fenlon, 2010). However, delivering a balance of information 
regarding follow-up care remains a challenge. The method, timing and amount of information 
provided requires consideration. For example, survivors have reported that it can be difficult to 
process large amounts of information given verbally following treatment (Hewitt, Bamundo, 
Day, & Harvey, 2007). 
During the extended stage, the weeks leading up to the first follow-up appointment 
after treatment are also an anxious time. The cancer survivor and their family are faced with 
the stress of awaiting test results and the fear of recurrence (Boyle, 2006; Butow, Fardell, & 
Smith, 2015; O’Neill, 1975). In the current health care system, follow-up visits over the first 
year usually focus on the cancer status and assessment of physical symptoms (Knobf, 2011). In 
addition, these appointments may be brief and, unfortunately, the adoption of supportive care 
interventions, including psychological screening during routine follow-up appointments, is not 
yet widespread practice (Knobf, 2011). 
The final stage, according to Mullan (1985), is referred to as ‘permanent’ survival and 
begins approximately five years following treatment. This phase is also described in the 
literature as ‘living beyond cancer’ and relates to post-treatment and long-term survivorship 
(Wheeler, 2010). Permanent survival is akin to the notion of "cure”, when the likelihood of 
recurrence is minimal (Henderson, 1997). During this stage, most survivors go back to the care 
of their primary physician and, preferably, they will have formulated a long-term health care 
plan (Wheeler, 2010). However, long-term and late effects on health, due to secondary effects 
of cancer treatment and/or secondary cancers, may represent another area of risk and distress 
(Hewitt, Greenfield, & Stovall, 2005; Wheeler, 2010). Cancer survivors have expressed that 
being considered disease free does not mean being free from disease (Alfano & Rowland, 
2006; Hewitt, Greenfield, & Stovall, 2005). While two out of three long-term survivors 
suggest that their lives return to normal, one-third report ongoing physical, psychosocial or 
financial challenges (Wheeler, 2010). 
Koocher and O'Malley (1981) published one of the earliest studies on the long-term 
adjustment of cancer survivors (those who were at least 5 years free of disease). Forty-seven 
percent of survivors in this study reported psychological symptoms, including low self-esteem, 
depression, anxiety, and mood fluctuations. Koocher and O'Malley concluded that cancer 
survivors were more likely to achieve normal psychosocial adjustment if they were diagnosed 
at a very early age, experienced long periods of remission, and/or received open 
communication and family support. Since Koocher and O'Malley's study, clinicians have 
researched the psychosocial challenges experienced by cancer survivors (Henderson, 1997). 
However, the transition from diagnosis and active treatment to long-term survivorship is 
currently an understudied phase in the cancer trajectory (Hewitt, Greenfield, & Stovall, 2005; 
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Stanton et al., 2005). Research to date has focused on the effects of cancer diagnosis and 
treatment during the acute phase, rather than how we can assist cancer survivors to cope 
throughout their life. 
Building on Mullan’s three-stage model, more recent qualitative research has 
identified another way of viewing an individual’s subjective experience of transitioning 
through the cancer survivorship trajectory. In one study by Little and colleagues (2000), an 
initial, acute phase of liminality was acknowledged. Liminality is derived from the Roman 
word ‘limen’ relating a place between two living spaces and is regarded as a state of being on 
the ‘threshold’ of, or between, two diverse existential planes (Little et al., 2000). According to 
Little and colleagues, survivors transition through the space of illness but do not return to their 
world as it was prior to illness. Rather, they experience disorientation, a loss of control and 
uncertainty, which is then followed by an adaptive phase in which the survivor constructs 
meaning from their experience. This view was also reinforced by other researchers, who 
implied that that surviving is a process, involving several phases without an endpoint and is, 
therefore, a lifelong journey (Deimling et al., 2005; Dow, 1991; Pelusi, 1997). 
Several Australian studies also reported that, during the transitions in this lifelong 
journey, survivors not only experience a lack of communication, but also a loss of support 
when leaving health services, which is compounded by the expectations of society, that 
survivors will return to normal after treatment (Butow et al., 2011, 2013; Knott et al., 2012). 
This is supported by Jefford and colleagues (2008) who suggested that there is inadequate 
information not only on the duration and prevalence of psychological consequences, but also 
on the coping strategies employed by cancer survivors following treatment.  
 
Healthcare Professional Factors Influencing Survivorship and QOL. 
In order to promote and assist the cancer-coping process, in addition to individual 
factors, HCP’s also need to consider social support and open communication (Butow et al., 
2011; Knott et al., 2012). According to Knott and colleagues, this support should occur across 
the cancer trajectory and not just following a cancer diagnosis. The visual representation in 
Figure 2.4 suggests that cancer patients experience a loss of support when leaving the 
healthcare service following treatment (Knott et al., 2012). This Australian model represents 
the typical cancer pathway from initial diagnosis through to survival, with an emphasis on the 
support from family, social networks and HCP’s and how this affects the cancer patient’s 
ability to cope. 
As identified in Knott and colleagues’ (2012) model, any transition along the cancer 
pathway, implies leaving what is familiar and letting go of current roles, relationships and 
routines, which may be accompanied by a sense of reduced support, uncertainty and loss.  
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Several studies have publicised that the periods of highest distress among cancer 
survivors are associated with transition points, not only when treatment commences, but also 
when this ends (Hewitt, Greenfield, & Stovall, 2005; Jefford, et al., 2008; Kaplan, 2008; Knott 
et al., 2012; Wheeler, 2010). 
 
 
 
 
 
 
Figure 2.4. Model of the cancer-coping process, by Knott, V., Turnbull, D., Olver, I., & 
Winefield, A. (2012). A grounded theory approach to understand the cancer-coping process. 
British Journal of Health Psychology, 17(3), 551-564.  
 
Although this is identified as a stressful time for many cancer survivors, these critical 
transition phases may also be opportunities to prepare patients for long-term survival by 
providing information on effective health practices (Denmark-Wahnefried, Aziz, Rowland & 
Pinto, 2005). For example, following cancer treatment, many patients want to be more 
responsible and involved in the self-management of their illness (Davies, 2009). Frequently 
cancer survivors ask how to deal with the effects of treatment, including where and how to 
access available support if required (Wilson 2008). In addition, survivors are keen to take up 
initiatives to improve their health, such as increasing exercise, improving their diet and 
maintaining health surveillance for osteoporosis, heart disease and secondary cancers 
(Demark-Wahnefried et al., 2000; Salminen, Bishop, Poussa, Drummond, & Salminen, 2004). 
This has been labelled by clinicians as a 'teachable moment' and a vital window in which to 
make a significant impact on the health decisions of cancer survivors (Maher & Fenlon, 2010).  
The ultimate goal of successful treatment for cancer throughout each phase is not just 
continued existence, but a quality survival (Jefford et al., 2008). This involves the ability to 
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rise above the trauma of experiencing cancer, in order to acquire a lifestyle that is compatible 
with achieving life goals. However, in Australia, for many of the 126,800 individuals 
diagnosed with cancer each year (AIHW, 2014), returning to a life of normality following 
treatment may be especially challenging. Many questions may surface regarding the next steps 
in the care continuum and anxiety over cancer recurrence may overshadow the recovery 
process during this time (Alfano & Rowland, 2006; Jefford et al., 2008). At each stage of the 
cancer journey, coping challenges can be considered analogous to "parachuting into a jungle 
with no survival skills" (Ferrell, 1996, p. 76). With little, inappropriate, misleading or badly 
timed information and/or communication to guide adaptation, patients and families often 
confront this life-threatening experience feeling unprepared (Butow et al., 2011; Campbell, 
2011; Jefford et al., 2008; Knott et al., 2012). These cancer-related challenges are particularly 
evident among migrant cancer survivors who also face language, cultural and social 
complexities. For example, more recent Australian research by Butow et al. (2013) identified a 
number of unmet needs among 596 cancer patients. The immigrant cancer patients (n = 277), 
predominately identified communication/language and information difficulties, whereas the 
Anglo-Australians (n = 319) referred more to fatigue and sexuality issues.  
Several other mediating factors may also influence the coping ability of survivors, 
including: a stable family unit; the nature and degree of role responsibilities; communication 
style; patient age and/or gender; level of social support; spiritual orientation; information 
requirements; pre-morbid history of mental illness; and, access to coping resources (Matthews, 
2003; Pudrovaska, 2010; Zebrack, 2011). The impact of many of these factors is not well 
understood (Boyle, 2006). In addition, as will be briefly discussed, there are also several 
barriers, predominantly within the healthcare system, to meeting the psychosocial needs of 
cancer survivors (Kaplan, 2008). 
 
Barriers to Meeting Psychosocial Needs of Cancer Survivors  
Whilst the intensive research effort into cancer detection and treatments has resulted in 
great success, the relative lack of comprehensive, evidence-based survivorship research has 
resulted in a failure to investigate, identify, and address the psychosocial needs of survivors 
(Davis & Batehup, 2011; Girgis & Butow, 2009; Kaplan, 2008). Although the neglect in this 
area is partly due to a lack of research, there are also several barriers that have contributed to 
difficulties in meeting the psychosocial needs of cancer survivors (Kaplan, 2008). These 
include: the limited time available during patient visits; the failure of many clinicians to ask 
about psychological wellbeing and consequently to refer patients for psychological assistance; 
the lack of simple and effective screening tools for emotional distress; a limited awareness of 
the psychosocial resources in the community; a general lack of knowledge of clinical practice 
guidelines for managing psychological distress; and, the stigma associated with seeking mental 
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health services (Girgis & Butow, 2009; Jefford et al., 2008; Kaplan, 2008).  
A further issue has been the fragmentation of provision of care and lack of 
coordination and communication between various treatment centres (Kaplan, 2008). For 
example, the models for cancer follow-up services within Australia are not yet fully 
developed. Consequently, the transition from inpatient care to care by general practitioners and 
outpatient centres is still in its infancy (Jefford et al., 2008; Kaplan, 2008). A major concern 
also relates to identifying and implementing an appropriate model of follow-up care that is 
viable within the current economic climate (Davis & Batehup, 2011). For example, the current 
model of follow-up services may become unachievable when increasing numbers of cancer 
diagnoses, resource limitations, and a rising cancer survivor population is taken into 
consideration (Davis & Batehup, 2011).  
 
Overview of Literature Review – Part A 
Cancer survival has been described as a life-changing experience, which begins at 
diagnosis and transitions through phase’s through-out life (Chapman, 2011; Mullan, 1985). 
The challenges faced by cancer survivors are multifaceted and are often referred to in the 
literature as the “price of survival” (Davies, 2009; Hewitt, Greenfield, & Stovall, 2005). In 
some circumstances, advances in cancer treatment have added years to life, but not necessarily 
life to years (Boyle, 2006). Patients have indicated that a cancer diagnosis increases anxiety, 
creates an awareness of mortality, uncertainty about the future, and leads to both positive and 
negative effects on health and lifestyle decisions (Chapman, 2011; Doyle 2008). Consequently, 
the complex nature of survivorship experiences effect many aspects of follow-up care, 
extending from prevention, screening, health promotion and rehabilitation, through to 
palliation and end-of-life care (Ganz, 2011; Morgan, 2009). These involve medical, physical, 
social, emotional, and economic health systems challenges, which will fluctuate over time 
(Doyle, 2008). Therefore, knowledge to manage and confront these issues will call for many 
diverse disciplines implementing several types of evidence-based research methodologies  
(Girgis & Butow, 2009; Feuerstein, 2007b).  
Based on the literature reviewed, the current study builds upon the earlier Australian 
cancer survivorship research of Girgis and Butow (2009), Jefford et al. (2008), Lobb et al. 
(2009) and Knott et al. (2012) by specifically targeting HC survivors and the resilience process 
adopted by these individuals following initial treatment. This research is a significant addition 
to the existing literature in that it not only includes short-and long-term adult HC survivors, but 
also several types of HC cancer diagnoses that ensures those survivors that have less common 
HC’s are represented. In addition, this work contributes to the literature in that the focus is on 
both positive (resilience) and negative mental health outcome measures (depression and 
anxiety). Although, it is not possible to include all variables, those modifiable factors reported 
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in the literature to influence resilience (i.e., personal coping strategies, social support, etc.) 
form the basis of the proposed conceptual model of resilience (discussed in more detail in the 
following chapter). 
As stated by Leigh (1990), quality of cancer survival is in the eye of the beholder. It is, 
therefore, essential that survivors' needs are individually assessed. This includes model 
development to improve the quality of long-term survivorship and the detection of potential or 
real psychological distress that may compromise continued coping (Boyle, 2006; Hewitt & 
Rowland, 2002). While there can be no argument that a cancer diagnosis and treatment is a 
negative experience, many HC survivors also report unexpected positive adjustment outcomes 
due, in part, to resiliency (Dunn et al., 2011). This leads to questions of who can experience 
positive adjustment outcomes, how and under which circumstances? The next section of this 
literature review (Part B) aims to answer many of these questions by explaining resilience in 
more detail. First, an outline of previous approaches to resilience research will be presented. 
This will be followed by a review of research investigating the risk and protective factors 
among individuals, their family and the community, each of which is reported to influence the 
resilience process.  
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Chapter 3 
Literature Review 
Part B – Resilience  
 
Resilience  
Approaches to Resilience Research 
According to Richardson (2002), the first wave of resilience research began with an 
“inquiry focused on the paradigm shift from looking at the risk factors that led to psychosocial 
problems to the identification of strengths of an individual” (p. 309). Specifically, researchers 
became interested in the ‘individual traits’ that highlighted personal characteristics useful in 
managing adversity (Richardson, 2002). A number of personality traits emerged from 
psychological research, some of which include self-control, self-efficacy, self-esteem, hope, 
optimism, coping strategies, happiness, self-determination, and forgiveness (Olsson et al., 
2003; Richardson, 2002). Aside from personality attributes, individual traits such as 
intelligence, positive temperament, communication skills and sociability have been highlighted 
among resilient people (Olsson et al., 2003). 
Although this list of individual characteristics has shown remarkable stability over the 
course of time (Masten, 2007), the examination of resilience by assessment of personality 
characteristics alone is contentious. The main point of controversy is that psychological 
resilience is viewed by some researchers as a fixed, stable personality trait and that others 
argue that resilience cannot be an observed trait (Rutter, 2007; Windle, Bennett, & Noyes, 
2011). This perspective suggests that it is not possible to detect and examine individual factors 
of resilience. According to Windle, Bennett, and Noyes (2011), this could also imply that an 
individual who does not possess such attributes may be a failure or unable to ‘learn resilience’. 
Another further constraint is that the individual trait approach to resilience does not take into 
account the impact of external factors such as family support.  
 
Chapter Overview  
Part B of the literature review will comprehensively examine resilience. Initially, 
an outline on the previous approaches to resilience research is presented. This is 
followed by a review examining relevant risk and protective factors, from the 
perspective of individual, family and community levels. The potential 
psychological outcomes that may be experienced by HC survivors are then 
highlighted, with a specific focus on depression and anxiety. Last, this literature 
review concludes by presenting a preliminary conceptual model of resilience 
among HC survivors that is informed by the literature.  
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As resilience research developed, the focus shifted from the individual and their 
unique qualities to a broader ecological approach that acknowledged the impact of the 
individual’s family, friends and extended community on their resilience (Bronfenbrenner, 
1986). Hence, the second wave of resilience research focused on addressing these limitations 
by exposing the ‘processes’ that might account for the observed correlates of resilience 
(Masten, 2007). Examples of the second wave of research include research on attachment 
relationships and family interactions as potentially protective stress regulators (Gunnar, 2006). 
The ‘process’ approach to resilience has resulted in comprehensive lists of possible 
risk and protective processes at various levels (Alvord & Grados, 2005; Kelly & Emery, 
2003). For example, one organisational framework for resilience includes internal processes 
that are either biological (temperament, gender, general health genetic disposition) or 
psychological (personality characteristics, coping, cognitive capacity), and external processes 
that exist either within the family (parenting, siblings, home environment, extended family) or 
the community (organisations, social services) (Mandleco & Perry, 2000).  
The Resiliency Model proposed by Richardson et al. (1990) highlighted the process 
approach. The underlying concept of the Resiliency Model is that resilience is developed 
through facing challenges, risks, and stressors. This process begins early in life, as individuals 
attempt to adapt to any challenge or disruption in an attempt to successfully cope. The 
Resiliency Model suggests that people decide, consciously or unconsciously, the outcomes of 
disruptions they encounter. This state is referred to as biopsychospiritual homeostasis, which 
refers to the combination of biological, psychological, and spiritual ‘normal’ functioning 
(Richardson et al., 1990). This homeostatic state is constantly at risk of disruption from 
various stressors. However, protective factors alleviate these effects and protect events from 
becoming too disturbing (Richardson, 2002; Richardson et al., 1990). However, according to 
Richardson’s Resiliency Model, when protective factors fail to alleviate stressors, the 
individual’s biopsychospiritual homeostasis becomes disrupted, resulting in one of three 
outcomes. First, ‘resilient reintegration’ is where the individual may exceed their initial 
homeostatic state, through accessing greater adaptive skills. Second is, ‘homeostatic 
reintegration’ where the individual returns to the state they were in prior to the stressor, or 
third ‘maladaptive reintegration’ when they may fail to reach their previous state. According to 
Richardson (2002), this may lead to ‘dysfunctional reintegration’ resulting in potential mental 
health problems if the homeostatic level is too low. The Resiliency model highlighted 
resilience as a function of the interaction between individual characteristics, risk and protective 
factors and the stressor, laying the foundation for subsequent research.  
Despite progress in the study of resilience, the second wave of research also uncovered 
further complications. Many of the researchers began to acknowledge that understanding 
resilience occurring naturally would be a long-term challenge for multiple reasons including 
the scope of the phenomena encompassed by the broad umbrella of resilience, the complexity 
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of human lives, and the imprecision in many of the concepts, measures, and analytic methods 
available (Masten, 2007). In addition, while it was advantageous to identify potential lists of 
risk and protective processes that may influence resilience, these lists became somewhat 
inflexible and there was an attempt to apply the same guidelines to all individuals in order to 
achieve resilience (Luthar et al., 2000a). The recognition that risk and protective processes are 
not universal resulted in a third approach to resilience that placed a greater emphasis on 
context and the perceptions of the individual who had experienced the risk (Ungar, 2001). 
The third wave in resilience research aimed to address resilience in terms of 
‘outcomes’. In this approach, the previously developed lists of processes are acknowledged, 
however, there is no assumption that these processes will have the same impact in different 
contexts with different individuals. This approach focused on the individual’s ability to 
maintain normal functioning and demonstrate a lack of psychopathology (Masten, 2001; 
Olsson et al., 2003). For example, outcomes that constitute resilience have been identified as 
stable mental health, functional capacity, and social competence (Olsson et al., 2003). The 
‘outcome’ approach led to numerous experiments that tested resilience ideas, directly through 
prevention and intervention. Some of the best evidence for the mediating role of specific 
protective processes in the resilience literature has come from experiments of this kind, 
including randomized controlled trials of interventions designed on the basis of resilience 
research to enhance protective processes (Luthar, 2006; Masten, 2007).  
However, the view of success and of positive outcomes that is contextually and 
individually interpreted is also often ‘value laden’ (Kumpfer, 1999; Ungar, 2004). Hence, the 
absence of risk or stress may not always be indicative of resilience. For example, Luthar 
(1991) reported that children who were identified as the most resilient also exhibited greater 
anxiety and depression rates. However, these children were labelled ‘resilient’ as they were 
able to continue functioning well and adjust appropriately to societal norms and expectations. 
This suggests that being resilient does not necessarily reflect the absence of psychological 
disorders.  
In addition, it also became apparent that what comprises a successful outcome in one 
context may not be extended to another (Kumpfer, 1999; Ungar et al., 2007). The lack of 
universality was emphasised by Ungar (2005) when he stated “arguably, the complexity of 
resilience, the myriad of ways individuals, families, and communities overcome adversity, 
cannot be simplified as to generate a single set of principles generalizable from one 
contextually specific study to the next” (p. xvii). Therefore, groups of processes may act as 
risk factors or protect individuals in some contexts, but these processes cannot be universally 
applied to all situations for every individual. For example, cultural beliefs may vary, therefore 
views of success in one culture may not be valued in another.  
Research on resilience characterized by a more contemporary approach involving 
multidimensional and multileveled analysis represents the fourth wave of resilience research 
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(Masten, 2007). Within this conceptualisation, resilience is viewed using an ecological 
approach that is both outcome-oriented and process-oriented, taking into account both context 
and culture (Pooley & Cohen, 2010; Ungar, 2008). Outcomes within this approach refer to the 
interaction between an individual and their environment, while processes are those that 
contribute to these outcomes (Ungar et al., 2007). This approach also considers the availability 
and quality of resources that a person can access within their environment, including personal 
characteristics, to enable positive adaptability in the face of adversity (Ungar et al., 2007). This 
ecological approach emphasizes the significance of the environment in providing health-
sustaining resources, which Ungar et al. (2007) argued need to be contextually and culturally 
pertinent.  
The ecological approach was investigated by Ungar et al. (2007) through their study of 
89 participants between the ages of 12-23 years involving 11 countries. This research 
suggested there were seven tensions (categories) which youth adopt to resolve difficult events 
and hardships. The seven tensions were defined factors within the individual’s environment 
that impact on their level of resilience. These included access to material resources, identity, 
relationships, cohesion, power and control, social justice, and cultural adherence (Ungar et al., 
2007). The researchers proposed that the resolution of these tensions is essential to experiences 
of resilience, as defined by the individual and the community (Ungar et al., 2007). In addition, 
there is no one definitive way to resolve these tensions, the navigation between the person, 
environment and outcome are unique to each individual (Ungar et al., 2007). Moreover, there 
is no definitive measure of success, which is influenced by culture and context and is, 
therefore, subjectively defined by the individual and community (Ungar et al., 2007). The 
ecological approach therefore highlighted the individuality of resilience, as well emphasizing 
the interaction between the individual and their environment.  
Four principles have been outlined by Ungar et al. (2007) that provide a framework for 
an ecological understanding of resilience. The first is ‘decentrality’, concerned with the need 
to focus concurrently on the person as well as protective and risk factors within the 
environment (Ungar, 2011). Consequently, it is important to investigate what the environment 
provides the person in terms of potential adaptive resources as well as associated risks. The 
second principle is ‘complexity’ and refers to the complex nature of resilience. According to 
Ungar (2011), as resilience is ecologically based, it is not possible to determine a simple linear 
process. Resilience involves navigation and is, therefore, reliant on a multitude of interactive 
patterns that vary between people. The third principle is ‘atypicality’, which refers to the 
determining outcomes and processes that are contextually significant, that are not 
predetermined, but rather assist as an adaptive function for an individual within that context 
(Ungar, 2011). Hence, successful outcomes and processes adaptive in one context may be 
considered as risk in another. The fourth principle is ‘cultural relativity’ and signifies the 
culturally-based definitions of adversity and success, including, risk and protective 
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processes (Ungar, 2011).  
In the ecological conceptualization of resilience, Ungar (2011) points out two 
important processes. First, the individual needs to able to identify potential coping and 
protective resources. Second, resources need to be available to that individual so that they can 
be accessed. For example, a cancer survivor seeking social support groups must first be willing 
to actively reach out and join others; however, this may only be possible if such support exists 
in community. Ungar (2008) argued that if the environment does not or cannot provide health-
sustaining resources (i.e., cancer support resources), the environment lacks resilience, not the 
individual. Thus, the individual including their context (family, social, cultural) are important 
aspects of resilience (Ungar, 2008, 2011).  
As the fourth wave of resilience research expands, it is becoming clear that it will 
continue to surpass earlier research efforts to explain this phenomenon (Masten, 2007). For 
example, building on the work of Ungar and previous research, Pooley and Cohen (2010) 
explain resilience to be “the potential to exhibit resourcefulness by using available internal and 
external resources in response to different contextual and developmental challenges” (p. 34). 
This conceptualization not only included context and culture, but also the developmental and 
transitional aspects of resilience. Another example is provided by Davydov and colleagues 
(2010), who have investigated resilience and mental health from individual, group and cultural 
perspectives. They suggested that resilience surfaces from a multifaceted interaction of several 
forces at various levels. These integrate the individuals’ gene-environment reactions, the effect 
of positive and negative experiences throughout life and include the impact of a person’s social 
and cultural setting (Davydov et al., 2010). According to this research, in order to investigate 
resilience through such layered interactions there is a need to move beyond a narrow focus on 
one particular origin or a small group of causes and consider more thorough and 
multidisciplinary approaches (Davydov et al., 2010). 
Regardless of the different perspectives on resilience, there is a general acceptance 
that this is a normal phenomenon and that all individuals have the potential to be resilient 
given appropriate resources (Masden, 2001). As stated by Windle, Bennett, and Noyes (2011), 
“the suggestion by Richardson (2002) that resilience may be the driving force that controls the 
universe may be a little overstated, but the capacity for ‘ordinary magic’ and the opportunity 
for positive adaptation should be an option for everyone” (p. 165).   
In summary, the majority of the literature into resilience acknowledges that there are 
various systems and factors that contribute as an interactive dynamic process that increases 
resilience relative to adversity. Furthermore, there appears to be a consensus that resilience 
could be time and context specific and may not present across all life domains (Herrman et al., 
2011; Masten and Powell, 2003). The current research investigating HC survivors is based on 
these contemporary principles of understanding how resilience operates in a specific context 
for different individuals and identifying how risk and protective factors function as processes.  
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Based on the available literature, the following section will now describe how risk and 
protective factors function as resilience processes within the individual, family and 
community.  
Individual (Internal) Level Processes 
Previous research has indicated that individual factors such as self-esteem, self-
efficacy, locus of control, empowerment, coping skills, life meaning and spirituality play an 
important role in building resilience and QOL among cancer survivors (Allart et al., 2014; 
Llewellyn et al., 2013; Stewart & Yuen, 2011; Swash, Hulbert-Williams, Bramwell, 2014). In 
addition, demographic factors such as age, gender and time since diagnosis are reported to 
influence the resilience process (Aziz, 2009; Bennett et al., 2011; Foster et al., 2009; 
Pudrovaska, 2010b; Rabin et al., 2011). However, although the literature has highlighted that 
an effective armoury of individual coping strategies may buffer an individual from the effects 
of a cancer diagnosis, this interaction has not been comprehensively investigated among HC 
survivors (Schumacher et al., 2014). The next section will attempt to explain many of these 
factors. However, a thorough investigation of all individual traits is not feasible. Thus, using 
available literature as a reference, only the most influential factors will be discussed.  
Self-Efficacy 
Self-efficacy represents the perception of one’s ability to alter events or manage new 
challenges appropriately (Bandura, 1977). Self-efficacy theory suggests that the greater an 
individual’s confidence in their ability to manage a course of action, the higher the probability 
they will conquer desired goals (Bandura, 1977). In health psychology, self-efficacy is seen as 
a positive resource and a protective factor that contributes to a patient’s adaptation of illness 
crises (Bandura, 1977).  
One of the first known studies to investigate the importance of self-efficacy among 
HC cancer survivors was published by Schumacher et al. (2014) in Germany (Table 2). This 
recent study examined the relationship of resilience with QOL, self-efficacy, anxiety and 
depression among those with HC and blood-related diseases, following an allogenic stem cell 
transplant (AlloSCT). The aim was to better identify which psychosocial variables are 
important factors for successful adaptation and re-integration following AlloSCT. The sample 
included 75 HC patients who were all in remission. The findings identified a high correlation 
between resilience and self-efficacy, indicating a strong relationship between the two concepts. 
The results also reported that resilience is positively correlated with QOL and social 
functioning and negatively with anxiety and depression. Although no effects on resilience 
were found for gender, age, and type of HC or disease, the results did point to a possible 
influence of time following the transplant on patients’ resilience. This finding could be 
interpreted as a sign of coping by successfully managing the process of readapting. The 
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authors highlighted that fostering resilience and self-efficacy across the life span, would assist 
cancer survivors to resume their everyday life by adapting to the challenges they face in an 
uncertain future (Schumacher et al., 2014).  
Previous research has also reported a positive relationship between self-efficacy and 
resilience, among individuals with solid tumours or chronic illness. For example, the role of 
self-efficacy: is positively correlated with family and social functioning in those with coronary 
heart disease (Sullivan, LaCroix, Russo, & Katon, 1988); impacts on the success of 
interventions to reduce distress in adults with type 1 diabetes (Fisher, Hessler, Masharani, & 
Strycker, 2014); including, the psychological wellbeing among individuals with ovarian cancer 
(Wenzel et al., 2002), rheumatoid arthritis (Schiaffino & Revenson, 1992), diabetes (Wu et al., 
2013), and stroke victims (Robinson-Smith, Johnston, & Allen., 2000).  
 
Self-Esteem  
Self-esteem is an individual characteristic reported to influence resilience (Kumpfer, 
1999; Masten & Coatsworth, 1998; Rutter, 1992). Self-esteem may be viewed as the subjective 
monitoring of others’ reaction to oneself, which directly impacts on an individual’s feelings of 
self-worth (Thompson & Kent, 2001). High self-esteem refers to increased appraisals of self 
and has been found to shield against psychological distress. For example, when individuals 
experience failure, maintaining a high self-esteem may protect individuals from feeling 
negatively about themselves (Brown, 2010). Conversely, low self-esteem generally occurs as a 
result of frequent rejections and interpersonal threats, where an individual’s subjective monitor 
becomes highly sensitive to negative influences, often derived from their social and 
psychological environments (Baumeister, Campbell, Krueger, & Vohs, 2003; Goodman, 
Stryker, & Owens, 2001; Thompson & Kent, 2001). 
In a recent meta-analysis, Sowislo and Orth (2013) highlight that self-esteem is a 
significant factor to consider in protecting against depression. This longitudinal analysis 
investigated the effects of self-esteem on depression (77 studies) and on anxiety (18 studies). 
The sample mean age was 27.7 years, with the sample size of the studies ranging between 44 
and 6,813. The reviewed studies varied widely in sample type, country of origin, and the 
measurements used. As a result, the authors proposed a high level of generalizability, as one of 
the strengths in the findings of this analysis. The results indicated a clear relationship between 
self-esteem and depression. Low self-esteem significantly contributed to greater depression, 
while depression had only a weak effect on self-esteem, though, anxiety and self-esteem were 
reported to equally influence each other. The results could not provide clear evidence as to 
whether self-esteem influences anxiety, or whether anxiety impacts self-esteem. However, it 
was reported that regardless of age, gender, scales used, or sample (convenience, clinical or 
representative), low self-esteem remained a stable risk factor for depression. In addition, 
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findings from the analysis proposed that low self-esteem precedes depression, rather than the 
reverse.  
Similar findings were outlined in a study by Rodin and colleagues (2013), which 
examined HC populations, reporting that self-esteem directly influences resilience among 
those with leukaemia. This research aimed to investigate the psychological impact, prevalence 
and correlates of post-traumatic stress among acute leukaemia patients. Two hundred and five 
leukaemia survivors, of which 58% were male (M age = 50 years), completed questionnaires 
comprising several psychosocial measures (i.e., Rosenberg Self-esteem Scale, Stanford Acute 
Stress Reaction Questionnaire). The multivariate regression analysis used to assess 
independent predictors of PTSD, reported that 14% of participants met criteria for acute stress 
disorder (ASD) with a further18% for subsyndromal ASD. This study verified that clinically 
significant symptoms of traumatic stress are usual in leukaemia survivors, and importantly, are 
predominantly linked to physical suffering, satisfaction in relationships with clinicians and 
individual psychological characteristics. The authors acknowledged that it was difficult to 
determine a causal relationship, due to the cross-sectional nature of this study. However, the 
findings of this research support a relationship between high self-esteem, perceived social 
support and a high degree of resilience among those with HC. 
Further research specifically investigating self-esteem in terms of its effect on 
resilience is limited among HC survivors. It was, therefore, necessary to elicit material from 
the literature investigating QOL and psychosocial adjustment. Previous findings from a 
longitudinal study involving 125 HC patients (ACL, CML and lymphoma) reported a positive 
correlation between high self-esteem and QOL three years following BMT (Broers, Kaplein, 
Le Cessie, Fibbe, & Hengeveld, 2000). The participants (M age = 37 years) completed 
questionnaires assessing anxiety, depression, self-esteem and locus of control at five 
independent time spans ranging from before treatment to three years following BMT. The 
results identified a positive relationship between self-esteem and psychosocial adjustment 
among in this population (Broers et al., 2000). 
Self-esteem is also reportedly linked to enhanced QOL in several other studies that 
have examined: mixed cancer survivor populations (Constanzo, Ryff, & Singer, 2009); those 
with chronic illness (Symister & Friend, 2003); HIV populations (Faber et al., 2003); and, 
individuals living with disfigurement (Hardy & Cotterill, 1982). However, it important to note 
that the majority of information concerning cancer survivor’s self-esteem relates to variables 
influencing self-esteem, rather than how self-esteem may influence resilience. This is because 
the majority of the literature investigating self-esteem, within the area of chronic illness and 
cancer, has focused on applying self-esteem as an outcome measure, rather than a predictor 
variable.  
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In addition, while research indicates that high self-esteem is protective, as the 
relationship between self-esteem and resilience is correlational, and not necessarily causal, it 
may also be the result of other protective processes. Thus, negative outcomes may produce low 
self-esteem or low self-esteem may result in negative outcomes. For example, in the study by 
Rodin and colleagues (2013), leukaemia patients may have reported poor interpersonal 
relationships with HCP’s as a result of experiencing low self-esteem or the reported low self-
esteem may have been partially a consequence of ineffective interpersonal relationships with 
clinicians. Furthermore, in the study by Broers et al. (2000), traumatic stress may impact on 
current self-esteem measures, conversely low self-esteem may contribute to distress.  
In summary, given the correlational nature of the evidence for a relationship between 
resilience and self-esteem, it is beneficial to understand the process of self-esteem, rather than 
simply collecting further data supporting the association between the two. There can be several 
processes occurring at the individual, family, and community level that impact an individual’s 
self-esteem. This point of view, is supported by Harter (1999), who maintains that there are 
several pathways that shape an individual’s self-esteem, each of which is influenced by context 
and is reliant on how each person perceives their situation.  
 
Optimism and Hope  
Positive trait dispositions, including hopefulness and optimism, can act as personal 
resources for cancer survivors and are reported in the literature to foster resilience (Dunn et al., 
2011; Gartland et al., 2011; Ho, Ho, Bonanno, Chu, & Chan, 2011; Pieters, 2015). 
Dispositional optimism refers to a stable personality trait where an individual has a generalised 
expectation that the future will be positive, even when negative events occur (Scheier & 
Carver, 1985). Similarly, dispositional hope is defined as a motivated state to reach desired 
goals, together with a belief that an individual will be able to effectively engender a plan to 
accomplish them (Snyder et al., 1991). Higher hope is consistently linked with superior 
outcomes in physical and psychological adjustment (Snyder, 2002; Snyder et al., 2005). 
The constructs of hope and optimism have been reported to facilitate resilience and 
PTG in individuals undergoing genetic testing for hereditary, colorectal cancer and in oral 
cavity cancer patients (Ho et al., 2010). There is also a discussion of the differential roles of 
hope and optimism in predicting growth and resilience. On a conceptual level, there has been 
interest in the amount of overlap and differences in the two constructs (Rand, 2009). For 
example, researchers maintain that hope and optimism might contribute differentially in the 
prediction of psychological adjustment and task performance (Gallagher, Lopez, & Preacher, 
2009; Rand, 2009). Specifically, hope may play a more vital role in scenarios where the 
outcome is more dependent on behaviour or personal effort, yet optimism is more pertinent in 
situations where the outcomes rely on external events and are less within one’s control (Rand, 
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2009). Optimism, the most studied positive emotion (Alim et al., 2008), will be detailed first, 
followed by a discussion on the literature outlining the benefits of hope.  
Scheier and Carver’s (1985) theory of optimism is based on expectancy-value models 
of motivation. Optimists hold positive future expectancies through positive emotions that keep 
individuals actively engaged in their goals, despite negative events. Conversely, pessimists are 
more likely to use avoidant coping in response to the negative emotions entrenched in their 
negative beliefs and expectancies. For example, research reports that optimists are more 
constructive in the use of health-related information and are inclined to exhibit more ‘fighting 
spirit’ as a coping mechanism, than pessimists (Schou, Ekeberg, Ruland, Sandvik, & Kåresen, 
2004). Building on Scheier and Carver’s theory, Seligman (1992) proposed that an optimistic 
person may attribute negative events to certain causes that are unstable and external. Yet, a 
pessimistic outlook attributes negative events to stable internal (individual) causes. 
In other cancer research, optimism has been positively related to many aspects of QOL 
such as worry about health and sexual intimacy among both prostate cancer patients (Thornton 
& Perez, 2006) and ovarian cancer patients (Smith & Zutra, 2008). The link between optimism 
and goal adjustment has also received attention by researchers investigating QOL among 
individuals with chronic illness (Rasmussen, Wrosch, Scheier, & Carver, 2006). For example, 
the literature reports that optimism may assist in the recovery from psychiatric conditions 
(Alim et al., 2008); diabetes (Yi et al., 2008); coronary heart disease (Chan, Lai & Wong., 
2006); and, multiple sclerosis and Parkinson’s disease (De Ridder, Schreurs, & Bensing, 
2000).  
To date, there are very few publications specifically investigating the influence of 
dispositional optimism on resilience among cancer survivors. Consequently, the relationship 
between optimism and resilience is not fully understood in this group. For example, research 
carried out by Bowen, Morasca, and Meischke (2003) illustrated that optimism was not 
correlated to any of the variables they used to compose their resilience scale, suggesting that 
these factors may be quite distinctive. In addition, research by Knott et al. (2102) suggests that 
the pressure on cancer survivors, to maintain an optimistic attitude or a ‘fighting spirit’ can 
create an addition burden. Yet, other research suggests that an optimistic outlook can develop 
an individual’s capacity to remain determined (Carver, 2010) and improve positive emotions 
(Alim et al., 2008) in times of adversity, therefore the relationship with resilience remains 
unclear.  
In summary, Lepore and Revenson (2006) report that optimists are more likely to 
demonstrate positive outcomes following adversity by positively reframing negative life 
events, adopting new and more adaptive world-views and by readily eliciting social support 
resources more easily. While these findings are encouraging, further research is necessary to 
understand how optimism functions and its relationship with other protective processes. As 
Aspinwall and MacNamara (2005) assert, “positive emotions and beliefs seem not only to be 
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associated with good outcomes among people experiencing adversity, but also to play a role in 
realizing them” (p. 2549). 
In addition to optimism, the second construct of hope is also reported to enhance 
psychological well-being and generally has an inverse relationship with depression (Snyder et 
al., 1991). The theory of hope was conceptualised by Snyder (2002) as three interrelated 
cognitive components: agency, goals and pathways. Agency thinking provides the mental 
energy and motivation in pursuing goals, while pathways reflect the cognitive ability to find 
the available routes to achieve goals. The emphasis of Snyder's hope model is that individual 
actions are goal-directed and these goals themselves are the cognitive anchors of hopeful 
thinking (Synder, 2002). As such, Snyder's model assumes that when faced with negative 
events such as HC, although high-hope individuals may be distressed or troubled temporarily, 
they are more likely to create and achieve their life goals (Ho et al., 2010).   
Snyder’s hope model and Bandura’s self-efficacy theory are similar in that they both 
refer to the motivation of goal-directed behaviour. However, Synder (2002) maintains that the 
aetiology of emotions was not explicitly explained in Bandura’s theory. Likewise, Rand (2009) 
concurs with Snyder proposing that, “hope goes beyond self-efficacy in that it also consists of 
agency thinking, the appraisal of available energy/motivation to use one’s abilities in goal 
pursuits” (p. 253). As such, hope theory highlights whether an individual intends to initiate 
their actions, whereas Bandura suggested that people evaluate their capacity to carry out the 
actions to achieve a goal. Thus, perhaps Bandura emphasizes the “can do” while Snyder 
emphasized the “will do” (Rand, 2009; Synder, 2002).  
Several studies have reported that feeling hopeful about the future is linked with 
improved QOL in leukaemia and lymphoma survivors (O’Connor et al., 2007; Zebrack, 2000). 
Although these studies only comprised small heterogeneous samples and cross-sectional 
designs, other research also supports these findings. Breast cancer research by Stanton, 
Danoffburg, and Huggins (2002) stated that high-hope women adopted problem-focused 
coping strategies and adjusted better one year following their cancer diagnosis. According to 
more recent research by Folkman (2010), hope was also an essential, practical support for 
participants’ motivations and corresponding actions, both in fighting cancer ‘medically’ for 
survival and maintaining psychosocial and spiritual wellbeing. In addition, research involving 
234 Chinese colorectal cancer patients, identified a sample of resilient individuals, who 
reported higher scores on hope and optimism scales and demonstrated less emotional distress 
(Hou, Law, Yin, & Fu, 2010).  
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Empowerment, Locus of Control & Fatalism 
An individual’s view of self is not only related to their sense of worth but also how 
they face challenges, such as a cancer diagnosis. This is composed of many inter-related 
factors, including one’s ability to feel empowered to overcome challenges, perceived internal 
or external locus of control, and fatalistic beliefs (Cartmell & Coles, 2000). These individual 
factors will each be outlined to explain how they function as protective factors to enhance 
resilience among those with chronic illness and cancer.  
First, a sense of empowerment is reported to assist the way people develop control 
over their circumstances (Cartmell & Coles, 2000; Stewart & Yuen, 2011). Empowerment is 
described by Rappaport (1984) as a means by which individuals gain control or mastery by 
initiating an active and participatory role in personal life events (cited by Bulsara, Ward & 
Joske, 2004). The role that empowerment plays as a protective factor is undisputed. 
Consequently, this has been a topic of interest among researchers including those investigating 
HC survivors.  
For example, a Western Australian qualitative study by Bulsara, Ward, and Joske 
(2004) sought to identify the common factors that HC patients believed enabled them to 
remain empowered while managing their cancer. Using a phenomenological approach, 
regardless of stage of illness or prognosis, seven HC patients (i.e., lymphoma and myeloma) 
including three spouses, took part in semi-structured interviews. The aim was to identify the 
coping strategies that patients and spouses felt assisted them to maintain control in managing 
HC. These patients were identified as having developed a high sense of empowerment during 
an earlier pilot study.  
Although generalisations about the findings of this study are limited, due to the small 
purposive sample, the results indicated that empowerment was influenced by three main 
factors. These included the patient’s determination to remain in control of the illness and 
treatment side-effects, the support of family and significant others, and, maintaining hope and 
having illness acceptance (Bulsara, Ward, & Joske, 2004). All factors were seen as inter-
related vital coping strategies. However, each were experienced by patients in varying degrees. 
It was evident from this study that these patients created ways of gaining mastery over their 
situation despite their prognoses. The authors concluded that the desired end result is not 
merely a case of increased survival, but rather empowering patients and their families through 
open communication, to have a degree of illness control through positivity and a readiness to 
accept their prognosis (Bulsara, Ward, & Joske, 2004). 
The second factor, locus of control, is a process that can affect resilience and is 
reported to be a major determinant in how cancer survivors manage their illness (Park, 
Edmondson, Fenster, & Blank, 2008). For example, a high external locus of control is linked 
with vulnerability, or the sense that an individual has little control over their life and is a risk 
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factor for negative health outcomes (Zimmerman, Ramirez-Valles, & Maton, 1999). Thus, as 
cancer is considered a life-threatening yet low-control condition (Thompson, Sobolew-Shubin, 
Galbruith, Schwankovsky, & Cruzen, 1993), those affected may be at greater risk of 
developing maladaptive coping strategies, such as avoidance behaviours (Turk & Okifuji, 
2002) and psychological distress.  
Conversely, an internal locus of control represents the confidence that a person can 
influence the events that occur in their life and is usually associated with effective adaptation 
following traumatic events (Luthar, 1991). A high internal locus of control has been found to 
have a positive relationship with other potential protective processes, including attachment, 
assertiveness, self-efficacy, increased feelings of competency and meaningful involvement 
(Luthar, 1991; Ungar, 2004). Hence, individuals with a high internal locus of control generally 
exhibit better psychological adjustment and enhanced resilience (Stewart & Yuen, 2011).  
This view is supported in quantitative research by Park et al. (2008) reporting that 
cancer survivors who have a higher perceived internal locus of control, implement more 
positive health behaviour, resulting in better physical and psychological outcomes. This cross-
sectional study involved 250 mixed cancer survivors (M age = 45.2) of which 172 were 
female, and 89 percent were Caucasian. Applying a stress and coping model, the authors 
aimed to examine positive and negative health behaviour changes among cancer survivors. 
Although it was difficult to establish causality and the results were suggestive rather than 
definitive, the findings indicated that sense of control over illness, social support, life meaning 
and approach coping were related to positive behaviour changes. Similarly, earlier research by 
Link, Robbins, Mancuso, and Charlson (2004) identified that survivors who made pro-active 
attempts to control their situation (i.e., sought treatment, re-prioritised life, and altered their 
diet) had less depressive symptoms. 
These results are supported by earlier Australian research by Xuereb and Dunlop 
(2003) who investigated the experience of leukaemia patients. This qualitative study in Sydney 
examined the experience of ten HC patients, of which six were male, who required a BMT. 
The focus of this study was on the meaning this adverse experience held for these individuals. 
However, all the participants belonged to a support group, and, consequently, the results may 
be biased. Nevertheless, the findings suggested that a capacity to control valued aspects of 
one’s life following cancer treatment was essential to HC survivor recovery. 
Despite the available research supporting an internal locus of control as a protective 
process, there is some evidence that an external locus of control is more protective following 
certain types of illness. For instance, an earlier study among those with rheumatoid arthritis 
(Schiaffino & Revenson, 1992) found external locus of control to be more adaptive, and 
another on individuals with chronic diseases in India (Dalal, 2000) found no significant 
difference between internal and external control. However, it is also important to note that both 
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of the previous studies have since been rated as methodologically ‘poor’ in a more recent 
systematic review (Stewart & Yuen, 2011).  
There have been other methodological issues worthy of consideration. For example, 
the majority of previous research has involved Caucasians. Therefore, the results may have 
varied if there was a more even cultural representation. The belief by an individual that they 
can control events is informed by cultural gender ideals (Martin, Ruble, & Szkrybalo, 2002) 
and shapes the perception of, and response to, a challenge (Dedovic, Wadiwalla, Engert, & 
Pruessner, 2009). Thus, cultural values will impact on locus of control and resilient capacities 
of individuals (Szanton, Gill, & Thorpe, 2010). For example, it has been suggested that 
Koreans and Mexican Americans are more likely to have an external locus of control due to 
belief systems involving luck or chance (Coolen, 2012).  
The third factor, referred to as fatalism, is defined by Straughan and Seow (1998) as 
the view that health issues are triggered by fate, luck or destiny, rather than an individual’s 
behaviour. According to Taylor, Lichtman, and Wood (1984), people with cancer not only 
ruminate about the causes of their disease, but may also create ideas about whether they can 
influence or control the cancer, both of which are impacted by an individual’s level of 
fatalism. Moreover, the extent to which survivors believe they can control their cancer may be 
directly linked with health behaviour change (Park et al., 2008). This is evident in previous 
research by Rabin and Pinto (2006) that investigated breast cancer survivors. Improved diet 
and increased exercise were related to less fatalism and higher beliefs by participants that their 
health behaviour was related to the cause of their cancer, or would avert recurrence. An earlier 
study, also involving breast cancer survivors, found that higher fatalism responses were 
associated with higher psychological distress when assessed at one and seven months 
following diagnosis (Ferrero, Barrento, & Toledo, 1994). 
In summary, the ability to cope with the management of HC requires patients to adopt 
specific strategies and coping mechanisms in the face of an unclear illness trajectory. The 
combination of optimism, confidence that the effects of cancer are controllable and 
determination to actively deal with the situation, has been labelled ‘fighting spirit’ (Wills & 
O’Carroll Bantum, 2012). This group of factors might serve to enhance resilience and result in 
better psychological adjustment. For example, positive outcome expectancies could reduce the 
impact of the diagnosis on fear and worry, active problem solving may assist in sustaining 
beneficial physical health status (i.e., through healthy diet, exercise & adherence to 
medication), and perceived control could trigger perseverance in dealing with setbacks. Thus, 
all of these individual protective factors may work together to reduce the impact of the risk 
following a cancer treatment (Wills & O’Carroll Bantum, 2012).  
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Coping Skills 
Lazarus and Folkman (1984) first identified the processes of cognitive appraisal and 
coping as central for adaptation to stressful events. Coping can be defined as “constantly 
changing cognitive and behavioural efforts to manage specific external and/or internal 
demands that are appraised as taxing or exceeding the resources of the person” (Lazarus & 
Folkman, 1984, p. 141). Thus, an individual diagnosed with HC will evaluate the situation by 
determining the threat or challenge the diagnosis represents, and will respond with certain 
cognitive or behavioural interventions in order to adapt and manage the associated stress. 
Although most HC survivors do not experience major psychopathology, negative cognitive 
appraisals due to the stressors of a HC diagnosis can result in psychological symptoms such as 
anger, depression, and anxiety.  
In the coping literature, various conceptual models have been described to explain 
responses to stress, each of which appear pertinent to cancer survivorship. These include: 
primary (enhance ones control over environmental situations) and secondary control strategies 
(efforts to adapt to the circumstances) (Rothbaum, Weisz & Snyder, 1982); problem-focused 
versus emotion-focused coping (Lazarus & Folkman, 1984); and, the approach versus 
avoidance model (Roth & Cohen, 1986).  
Research based on the traditional coping paradigm (Lazarus & Folkman, 1984) 
typically differentiates between problem-focused coping (PFC) and emotion-focused coping 
(EFC). First, PFC involves the efforts of an individual to alter the demands imposed upon 
them by defining the stress, generating ideas and then acting on a solution to change the threat. 
Alternatively, EFC entails attempts to appropriately express the emotions experienced by 
providing selective attention (i.e., lessen, avoid or minimize), in order to alter the way the 
individual thinks or feels (Lazarus & Folkman, 1984).  
In resilience research, it would seem that PFC or approach coping has been associated 
with higher functioning and more resilient outcomes. However, there is some speculation in 
the cancer-related literature that both coping styles may be beneficial when used concurrently. 
For example, Austenfeld and Stanton (2004) highlight that when individuals engage in both 
PFC and EFC, improvements in psychological well-being are evident, yet each may function 
differently. It is proposed that PFC may led to instrumental achievements such as scheduling 
necessary medical appointments, while EFC might lead to seeking emotional support, which 
could help reduce depression and anxiety (Wills & O’Carroll Bantum, 2012).  
Yet, researchers largely agree that PFC is more effective in managing the stress of 
cancer than negative styles. Positive coping styles include problem-solving, control, optimism, 
and seeking support as protective factors that assist people with cancer to adjust (Haase, 2004; 
Pieters, 2015). Previous evidence has also attested that optimism is one of the most important 
contributing factors in maintaining positive PFC strategies (Haase, 2004). In situations when 
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PFC is not possible for an individual, optimists are able to adapt and implement EFC by 
involving positive reframing, acceptance and humour (Rasmussen et al., 2006). 
Conversely, a negative or depressive coping style (i.e., impatience, ruminating) among 
breast cancer survivors has been reported to be associated with a greater fear of recurrence 
(Mehnert, Berg, Henrich, & Herschbach, 2009), including an adverse effect on health-related 
QOL (Shim et al., 2006). Similarly another study involving breast cancer survivors by 
Zwingmann, Wirtz, Müller, Körber, and Murken (2006) reported that a depressive coping style 
was positively and significantly linked to anxiety and depression, where-as an active or 
positive coping style was not significantly related to either disorder.  
In addition to the model described by Lazarus and Folkman, (1984), coping has also 
been discussed in the literature in terms of approach (e.g., problem-solving, reappraisal) 
versus avoidance (e.g., mental and behavioural disengagement) styles (Bellizzi & Blank, 
2006). Studies of individuals living with prostate cancer suggest that approach-focused coping 
is largely helpful, whereas avoidance coping strategies are inclined to be associated with 
poorer outcomes (Roesch et al., 2005). Research by Park (2008) confirm this standpoint, 
reporting that approach coping among cancer survivors is related to positive health behaviour 
changes, whereas avoidance coping is linked to negative changes. However, there is literature 
to suggest that the type of coping style may be influenced by situational factors, such as the 
stage of cancer survivorship. 
For example, a meta-analysis of studies that investigated coping during various stress 
encounters supports the hypothesis involving phase-specific adaptivity. Avoidance coping was 
associated with more positive adaptation in the short-term, but, over time, approach coping 
seemed more adaptive (Suls & Fletcher, 1985). Similarly, among cancer survivors, an avoidant 
cognitive coping style may be a more adaptive resilience factor in the acute phase, yet for 
long-term survivors it may be a risk factor and related to higher psychological distress 
(Wenninger et al., 2013).  
Moreover, avoidant coping or EFC has also been reported to be advantageous for 
uncontrollable stressors (i.e., invasive medical procedures) (Compas, Malcarne, & Fondacaro, 
1988, Weisz et al., 1994). This suggests avoidant or EFC may provide immediate or short-term 
benefits for cancer survivors by acting as a safeguard. However, persistent use of defensive 
coping may led to negative consequences. This perspective is shared by Di Gallo, Amsler, 
Gwerder, and Bürgin (2003), who concluded from their research of adult childhood cancer 
survivors that, “successful integration of the experience of cancer may be associated with the 
ability to accept painful feelings and to allow them to emerge (p. 666)”. Therefore, it may be 
imperative to consider time since diagnosis, when evaluating the coping and adaptive 
behaviour of individuals with cancer.  
In addition to PFC, approach coping and positive reframing, other strategies such as 
acceptance have been shown to foster better outcomes in dealing with a cancer diagnosis 
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(Carver, 1993; Lazarus & Folkman, 1984). For example, acceptance coping response at the 
time of diagnosis was described by Stanton, Danoff-burg, and Huggins (2002) to be associated 
with improved psychological adjustment twelve months later, leading the authors to suggest 
that earlier acceptance might be linked to better adaptability and a more active approach to 
treatment and recovery. Active coping and distraction have also been reported to be beneficial 
coping skills. Research by Lauver, Connolly-Nelson, and Vang (2007) aimed to determine the 
coping strategies that primary breast and gynaecologic cancers survivors used following 
treatment. The results of this study report that active coping strategies including distraction 
and problem-solving were found to be positively associated with improved mood and better 
psychological wellbeing (Lauver et al., 2007).  
In summary, coping is considered a significant area of research across the cancer 
trajectory. The stress-coping model (Lazarus & Folkman, 1984; Lazarus & DeLongis, 1983) 
proposes that the coping strategies one employs to manage stress are largely based on risk and 
the personal meaning that the individual has assigned to the situation. Thus, there is no 
universally effective or ineffective form of coping. Cognitive coping and positive problem-
oriented coping could be deemed as protective factors that foster recovery in cancer survivors 
in the long-term. However, the research remains unclear as to which coping strategies are most 
effective, when and in which circumstances (Wu et al., 2012).  
 
Finding Meaning and Benefit-Finding 
While the psycho-oncology literature has largely focused on negative and 
psychopathological outcomes of living with cancer, researchers have started to consider 
positive psychological outcomes. For example, cancer survivors often report finding meaning 
within the event, which been synonymously referred to as benefit-finding. Finding meaning in 
life has been shown to be related to many favourable outcomes in cancer survivors 
(Laubmeier, Zakowski, & Bair, 2004; Powell, Shahabi, & Thoresen, 2003; van der Spek et al., 
2013), an effect speculated to be mediated through the adoption of more adaptive coping 
(Breitbart, 2002).  
The conceptualization of ‘life meaning’ was detailed by Viktor Frankl (1959), a 
psychiatrist who survived a Nazi concentration camp (Szanton, Gill, & Thorpe, 2010). 
Adverse circumstances, Frankl (1963) stated, can have a positive impact on personal 
development by providing opportunities for “meaning-making,” which he believed to be a 
basic human need. Thus, a growing body of evidence has since reported that survivors of a 
variety of traumatic life events frequently describe finding a meaning or sense of purpose, and 
having benefitted from their experience. A sense of purpose is linked to resilience and reflects 
that the individual feels there is a benefit to belonging in society (Alim et al., 2008).  
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It has been suggested that, among those with serious illness, positive growth occurs as 
a result of cognitive restructuring which alter traumatic experiences into the acquisition of 
wisdom, personal growth, enhanced interpersonal interactions, and more meaningful and 
productive lives (Llewlyn, 2013; Thornton, 2002). Hence, finding something positive in a 
negative experience may render the experience less aversive overall by lessening the 
discrepancy between the meaning of the event and positive global beliefs (Thornton, 2002). 
Empirical studies, involving both quantitative and qualitative research methods, have 
been conducted to explore both meaning and benefit finding. For example, in a systematic 
review, Stewart and Yuen (2011) report several studies indicating that benefit-finders were 
better adjusted, had lower morbidity over time, and better mental well-being. Moreover, 
benefit-finding was shown to increase over the course of illness (Stewart & Yuen, 2011). In 
other research, Gotay, Isaacs and Pagano (2004) explored the qualities of cancer patients who 
had surpassed their life expectancies, in spite of a grim prognosis. The authors discovered that, 
with a cancer diagnosis where risk factors and outcomes are unpredictable, unexpected 
survival was attributed to the cancer patient’s capacity to foster resilience and a sense of 
meaning. Equally, Wenzel et al. (2002) discovered that a significant percentage of ovarian 
cancer survivors, described experiencing resilience and personal growth as a consequence of 
their experience that, in turn, enhanced a sense of wellbeing. Research has also stated that 
those who report higher levels of meaningfulness or purpose in life also tend to report lower 
levels of anxiety, hostility, depression and stress (Thornton, 2002). 
However, the results are not definitive, as other studies have reported no or negative 
outcomes from finding meaning or benefit. Research by Sherman, Cooke, and Grant (2005) 
stated that, after facing a life-threatening illness, many transplant patients expressed difficulty 
in finding meaning, including redefining themselves, their priorities and their values. In a 
study that investigated both psychosocial sequelae of BMT patients, Fromm, Andrykowski, 
and Hunt (1996) reported that finding benefits was not associated with improved QOL or 
psychological adjustment. In addition, Cordova et al. (2001) stated that, although breast cancer 
patients described personal growth, their growth did not have significant relationships to 
depression, relating to others, spiritual change, personal strength, or appreciation of life.  
Tomich and Helgeson (2004) also discovered that finding benefit predicted elevated 
distress three to nine months after breast cancer diagnosis. Thus, the association between 
benefit finding and reduced psychological distress is inconclusive (Tallman, Garcia, & 
Altmaier, 2007). The conflicting results may arise due to variability among cancer survivors as 
they attempt to restructure their expectations following traumatic events. Individual 
differences, such as in optimism, may influence how individuals view the world, during and 
following trauma (Tallman, Garcia, & Altmaier, 2007). This suggests that finding meaning and 
benefit may also be closely linked to other individual personality traits.  
 
RESILIENCE IN HC SURVIVORS 	 60	
Spirituality.  Finding meaning in life when faced with adversity is reported to 
enhance the consideration of an individual’s own spirituality and/or faith (Adejoh, Temilola, & 
Olayiwola, 2013; Walsh, 2003). While there is no agreed definition in the literature (McGrath, 
2004), several researchers have defined spirituality as broader than religion, involving the 
ability to look beyond oneself, in order to make greater sense of existence (Choumanova, 
Wanat, Barrett, & Koopman, 2006; Walsh, 2006). The main point highlighted in previous 
research is that religion and spirituality provide a framework within which individuals can 
positively appraise adverse experiences and attempt to manage psychological distress (Sears, 
Stanton, & Danoff-Burg, 2003).  
For example, a recent study by Adejoh, Temilola, and Olayiwola (2013) in Nigeria, 
involving HC survivors, reported that spirituality or religion was viewed as an escape from 
worrying about their health problems. This qualitative study that involved 20 leukaemia 
survivors is supported by previous studies suggesting that spirituality has an important role in 
helping individuals comprehend the cause of cancer and can help them maintain a sense of 
justice (Chaumanova et al., 2006; Strang & Strang, 2001).  
Another Australian study investigating HC survivors by McGrath and Clarke (2003) 
discussed the importance of creating space for spiritual communication. This research focused 
on investigating the concept of spirituality, while also proposing suitable ways to respond to 
spiritual issues in order to cope with serious illness. The results that emerged from this 
research partly affirm the notion of spirituality as 'meaning making'. Although for some, 
spirituality embraced religiosity (McGrath & Newell, 2001), for most participants spirituality 
referred to the meaning individuals make out of their life and illness experience. Moreover, the 
findings also proposed 'connection' as another vital dimension of spirituality (McGrath & 
Clarke, 2003). The indications were that HC survivors required a strong connection with life, 
through others, in order to make sense of the challenge of serious illness. However, this 
association can be threatened by dissatisfaction with life through physical and identity losses 
or the breakdown in expected relationships. Hence, if the disconnection is viewed as adverse, 
spiritual pain may occur, resulting in an emptiness that challenges the individual's ability to 
construct meaning from their existence (McGrath & Clarke, 2003). The findings of this study 
implied that survivors require the opportunity to discuss their experience and the meaning they 
are assigning to their lives through changes brought about by the experience of serious illness 
(McGrath & Clarke, 2003). 
Among breast cancer survivors, Choumanova et al. (2006) also explored the meaning 
of spirituality among 27 Chilean women. In this study, the women reported religion and 
spirituality as the primary resources for them during their cancer journey. The authors 
identified that a belief in God and spiritual faith assisted the women to recover. Similarly, 
interviews with 24 women, in a study by Taylor (2000), indicated that personal spirituality was 
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related to each woman’s ability to see her own transformation as a process of growth from the 
breast cancer. Although these studies were small qualitative studies, other researchers have 
expanded on different aspects of spirituality exploring variability in spiritual responses.  
For example, using spirituality seems to present the individual with a sense of 
empowerment associated with taking control of their life and recovery following treatment 
(Gall et al., 2005). Spiritual support is described as a group of coping strategies that a person 
applies both subconsciously (positive appraisal, believing in good outcomes) and actively 
(meditation, connection with nature, prayer) (Gall et al., 2005; Reynolds, 2006). The ability of 
the individual to use these strategies effectively to reduce stress assists them in the process of 
adjustment. 
In summary, while the diagnosis and treatment of cancer is both distressing and 
disruptive, inquiry among other cancer groups has established that there are some aspects of 
the experience that survivors describe as positive or beneficial (Llewllyn, 2013). Despite the 
multiplicity of problems faced by HC survivors, some report positive growth and increased 
appreciation of life since diagnosis (Bulsara, Ward, & Joske, 2004; McGrath, 2004a). This 
implies other HC survivors may be able to adapt following cancer, if provided with the 
appropriate support. In order to more clearly assess how meaning or spirituality interacts with 
other aspects of psychological adjustment, mixed-method studies with both qualitative and 
quantitative methodology are necessary (Dunn et al., 2011). 
 
Conclusion Individual Level Processes 
In conclusion, although mortality associated with HC remains high, the number of 
survivors is also increasing annually, and is likely to continue in the future (Aziz, 2009). Thus, 
it is important to understand more about the resilience and adaptability of these individuals. 
Research has identified that mobilising individual resources (i.e., coping skills) may be central 
in fostering resilience and reducing psychological distress, yet more research among the HC 
survivor population is necessary to fully understand these individual factors. In addition to the 
described internal processes that influence resilience, cancer survivors are also affected by risk 
and protective processes, within their home environment. Specifically, family resources are 
external resources that are provided by the family or peers to manage adversity, which will 
now be discussed.  
 
Family (External) Level Factors  
One of the most influential family resources is social support, which has been 
documented across several studies to have a major influence on an individual’s resilience 
(Hjemdal, Friborg, Stiles, Rosenvinge, & Martinussen, 2006; McCabe & Cronin, 2011; Ozbay 
et al., 2007). Yet, although the majority of research identifies that social support forms part of 
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the individual’s or family’s support system, researchers often fail to specify what is meant by 
social support (Black & Lobo, 2008). Thus, it is important to define social support and social 
networks, including the role of effective communication and how this impacts on the resilience 
of HC survivors. The social support specifically provided by communities and healthcare 
professionals will be addressed in the following section outlining community factors. 
 
Social Support 
Social support has been one the most extensively studied psychosocial constructs 
(Ozbay et al., 2007) and its relationship with psychological well-being has been widely 
reported (Cohen, 2004). Social support involves real or perceived resources, provided through 
social connections that empowers a person to feel part of a network of communication in 
which they are valued (Galván, Buki & Garcés, 2009).  
Theoretical models of social support stipulate two important features. The first is a 
‘structural’ element, which includes the frequency of social interactions and network size. The 
majority of research has established that quality of relationships is a better predictor of 
psychological health than quantity of relationships, yet both play an essential role (Ozbay et 
al., 2007).  
The second is a ‘functional’ element involving emotional, instrumental and 
informational characteristics (House, 1981). Emotional support relates to the perception of 
interpersonal help and allows for emotional expression and venting (Cohen, 2004). This is 
often influenced by the strengths of communication (i.e., love, trust, understanding and 
empathy) within the family (Teasdale & Bradley-Engen, 2010). Instrumental support refers to 
practical or tangible aid (i.e., meals, transport) that directly helps an individual in need, thus 
reducing the impact of negative events (House, 1981; Cohen, 2004). Finally, informational 
support relates to the delivery of advice, suggestions, and information (i.e., cancer treatment 
options) that an individual can draw upon, to manage ongoing challenges (Galván, Buki, & 
Garcés, 2009; Cohen, 2004).  
Social support has been recognized as being crucial in enabling individuals to cope 
with the challenges of illness (McCabe & Cronin, 2011; Yu, Lee, Kwong, Thompson, & Woo, 
2008). Most of the literature associates social support with a decrease in negative emotions, yet 
the relationship seems to be indirect, with social support having either a stress-buffering or 
stress-mobilising effect (McCabe & Cronin, 2011; Pieters et al., 2007). 
How social support mobilises coping resources is not fully understood (McCabe & 
Cronin, 2011). It has been proposed that social support assists individuals to: handle stress 
(Kynga ̈s et al. 2001); foster resilience (King, Willoughby, Specht, & Brown, 2006); prevent 
negative appraisals (Ozbay et al., 2007); provide relief from knowing that others care and are 
reliable (Lundman & Jansson 2007); improve self-care (Park et al., 2008; Yu et al., 2008); 
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enhance self-efficacy (Monsivais, 2005); foster emotional expression and confidence (Wills & 
O’Carroll Bantum, 2012); encourage illness caused adjustments to lifestyle (Nagelkerk, Reick, 
& Meengs, 2006); and, provide support in treatment decision making (Butow et al., 2011, 
2014; Sheppard, Kumar, Buckley, Shaw, & Raza, 2008) and treatment adherence (Magai et al., 
2007; McCabe & Cronin, 2011). 
In a systematic review involving those with physical illness, including cancer, Stewart 
and Yuen (2011) highlighted that social support was predictive of various aspects of resilience 
in several studies. This included better psychological health, successfully living with illness, 
benefit-finding, hardiness and self-esteem. In contrast, a lack of social support has been widely 
recognized as a risk factor for: psychological illness (Korszun et al., 2014; Parker, Baile, 
Moor, & Cohen 2003); poor QOL (Allart et al., 2013); and, increased mortality (Kroenke et 
al., 2012). 
Research by Parker et al. (2003) recommend that evaluating patients’ levels of social 
support is possibly the most accurate way to identify those patients most prone to anxiety, 
depression or distress following the diagnosis and treatment of cancer. Likewise, Frick 
Borasio, Zehentner, Fischer, & Bumeder (2004) reinforced this in research involving 126 HC 
patients, who explored their health values and coping styles preceding autologous stem cell 
transplantation. Participants completed several surveys addressing health-related control 
expectancies, causes of personal illness and coping with their illness. The results indicated that 
supportive relationships with others, including close family, are important for managing their 
disease (McCabe & Cronin, 2011). 
The beneficial effect of social support has been reported in several other studies 
investigating HC patients. For example, effective social support was positively correlated with: 
improved emotional and psychological QOL among HC patients (Santos, Kozasa, Chauffaille, 
Colleoni, & Leite, 2006; Smith et al., 2010); and, acceptable interactions with family and 
friends (Zebrack, 2000). In one study, fulfilment with social support predicted improved QOL 
in long-term survivors of leukaemia and lymphoma (Lim & Zebrack, 2006).  
A more recent systematic review reported on the negative factors impacting on social 
support and affecting QOL in HC patients (Allart et al., 2013). For example, conflicts with 
friends or family are reported to lower the satisfaction with support and may lead to feelings of 
uncertainty, impacting on ability to cope with cancer. This is supported by previous research 
highlighting that ineffective social support within interpersonal relationships can lead to 
negative outcomes, such as increasing a survivor’s feeling of isolation (Landmark, 
Strandmark, & Wahl, 2002). In addition, this review by Allart and colleagues also reported 
that one study found that the size of the social network was not related to QOL (Lim & 
Zebrack, 2006). This implies that relationship quality, and not just network size, matters to 
survivors (Allart et al., 2013). 
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In summary, the research highlights that naturally occurring social networks influence 
resilience among those with cancer. However, it remains uncertain as to how social support 
specifically functions to have a positive effect on adjustment to HC, and why some individuals 
employ more effective social support strategies than others. The idea that social support may 
have a positive effect on self-esteem and self-efficacy has been suggested (Robinson, 1997). 
The likelihood that a low level of social support is an outcome, rather than a cause, of poor 
adjustment has also been proposed (Moss, 1997). For example, a negative self-appraisal may 
result in social withdrawal that, in turn, reduces social support opportunities (Moss, 1997). It 
may also be that optimistic cancer survivors are more likely to seek support groups and be 
active in their communities (Korszun et al., 2014). The literature has not specifically identified 
what aspects of social support networks are most influential among HC survivors. It is, 
therefore, essential to investigate social support in more depth as it is clear that social support 
is a significant protective factor among those with cancer.  
 
Communication  
Communication between family members is another important factor influencing 
psychological outcomes (Knobf, 2011). Effective communication processes facilitate the 
understanding of not only the information provided, but also the central context of the message 
(Friedman, Bowden, & Jones, 2003; Friesen, Bowden, & Jones, 2003). Functional styles of 
communications are apparent when individuals communicate clearly and openly, while 
clarifying feelings and inviting feedback. Research has reported that functional communication 
among cancer survivors is associated with lower emotional distress and better marital 
satisfaction (Manne et al., 2006). Moreover, the capacity for couples to effectively 
communicate about the challenges associated with cancer is reported to enhance positive 
outcomes among cancer survivor (Morgan et al., 2005).  
Conversely, dysfunctional communication styles are less effective as the message 
tends to lack clarity, is more assuming and judgmental, and provides little opportunity for 
emotional expression and feedback (Friedman, Bowden, & Jones, 2003; Greenstein, 2006). In 
a study involving 58 couples, in which the female had a breast cancer diagnosis, adjustment 
and communication difficulties early in the survivorship trajectory predicted an increased risk 
for poorer adjustment one year following diagnosis (Northouse, Templin, & Mood, 2001). 
Likewise, in situations in which dysfunctional communication occurs, cancer survivors may 
perceive lack of interest and recognition in their cancer experience by significant others 
(Gatchel, Mayer, Kidner, & McGeary, 2005).  
Communication styles between cancer survivors and family members are also reported 
to change over time. For example, Lauver, Connolly-Nelson and Vang (2007) investigated the 
communication changes among HC survivors at different times following their diagnosis. The 
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frequency with which communicating with a partner was a stressor increased over time by 
approximately 13% to 23%. This pattern is consistent with other research maintaining that 
many couples place the communication issues in a relationship on hold during treatment 
(Gatchel et al., 2005). Hence, following treatment the attention shifts away from addressing 
immediate challenges, and relationship issues become more prominent.  
In summary, research has explored factors in relation to communication, identifying a 
positive influence of effective communication between family members (Forrest, Plumb, 
Ziebland, & Stein, 2009; Harris & Templeton, 2001). However, there are often several factors 
that affect communication styles within families. For example, the culture of the family will 
influence the styles of communication and the hierarchy of communication between family 
members (Fukui, Ogawa, Ohtsuka, & Fukui, 2009). There are several factors impacting on 
communication many of which are not yet fully understood among cancer survivor 
populations.  
 
Conclusion Family Level Processes 
In conclusion, there are processes within the home environment that can impact on 
both an individual’s risk or protective processes. In particular, social support, effective 
communication and cohesion offered by families and friends, are seen to create a positive 
climate that may facilitate resilience in HC survivors. Finally, while it is also apparent that risk 
and protective processes may be operating at the individual and family level, there is also some 
contribution from the community, which will now be discussed.  
 
Community Level Factors 
The community provides a context, which either promotes protective processes or 
increases risk. For example, a key risk factor among cancer survivors at the community level is 
low socioeconomic status. However, a protective factor may include the ability to return to 
work (Amir & Brocky, 2009; Feuerstein, 2005; Grunfeld et al., 2013) or access to community 
healthcare services (Gatchel et al., 2005). According to Hollingshaus and Utz (2013) 
community factors have a strong influence on the perception that cancer survivors hold of their 
experience, and how they cope with illness. Thus, although community-level factors have been 
less comprehensively studied than features of the individual and family, they are also 
important in cancer survivor outcomes (Vanderbilt-Adriance & Shaw, 2008). Those 
community factors particularly relevant in the survivor context will now be outlined.  
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Socio-economic Status  
A well-established risk factor that may exist in any community is low socioeconomic 
status (SES). It has been suggested that low SES among cancer survivors increases the risk of 
anxiety, partly due to their reduced capacity to communicate successfully with health 
professionals (Isaksen, Thuen, & Hanestad, 2003). According to Isaksen and colleagues 
(2003), those with lower education levels often experience increased problems in 
understanding medical terminology, which may result in feelings of disempowerment. 
Therefore, these individuals tend to withdraw from their healthcare communities thus 
receiving less support. Conversely, research by Butow etal. (2013), found that among 
immigrants, SES was not related to information/support and physical needs, which is in 
contrast to previous studies. However, it may be that the accessibility and uptake of support 
services among low SES communities is influenced by linguistic, financial and cultural factors 
(Butow et al., 2013; Galván, Buki, and Garcés, 2009). For example, Galván, Buki, and Garcés 
(2009) reported that there is often limited availability for social support among minority ethnic 
groups. This results in a decreased awareness and access to key information that can promote 
healthy adjustment to cancer, including the underutilization of mental health treatment 
(Galván, Buki & Garcés, 2009).  
Thus, SES is an important consideration, as research has established a direct link 
between the availability and access of community health services and an overall adjustment to 
cancer (Isaksen, Thuen, & Hanestad, 2003). In addition, more attention to multicultural factors 
could lead to more positive outcomes, such as compliance with treatment, empowerment and 
uptake of community health services (Butow et al., 2011, 2013). However, research in this 
area is limited (Galván, Buki, & Garcés, 2009). 
 
Healthcare Professional Support  
Support from HCP’s within the community has been identified as a significant 
protective factor among cancer survivors (Butow et al., 2007; Doyle, 2008; Roundtree, 
Giordano, Price, & Suarez-Almazor, 2011). Yet, notably missing from illness and resilience 
research is the influence and role of clinicians (Knott et al., 2012). There is no consistent 
definition for health professional support, primarily due to the range of services available in 
the community. However, health professional support is generally considered to include the 
aid provided by non-family members such as doctors, allied healthcare professionals, 
community groups and internet information (Friedman, Bowden, & Jones, 2003).  
In a recent study, Adejoh, Temilola, and Olayiwola (2013) stated that supportive 
interpersonal relationships with HCP’s enhanced the compliance to treatments and helped 
participants develop hope and self-efficacy in adjusting to living with HC. Twenty leukaemia 
survivors took part in this qualitative research reporting that emotional support characterised 
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by respect, understanding, listening, compassion and reassurance are particularly important in 
a cancer patient’s adjustment to their illness. Furthermore, this study reaffirmed previous 
research highlighting the importance of empathy and rapport (Knott et al., 2012), including a 
warm and trusting environment, in which the patient feels valued and is treated as an 
individual (Butow et al., 2011; Xuereb & Dunlop, 2003).  
However, several studies have identified that this is not always the reality experienced 
by cancer survivors (Knobf, 2011). The support is noted to lack continuity and participants in 
several studies have described a need for increased information and emotional support from 
the health professionals (Butow et al., 2013; Landmark, Strandmark, & Wahl, 2002; Roundtree 
et al., 2011; Swash, Hulbert-Williams, & Bramwell, 2014). For example, Lobb et al. (2009) 
stated that 59% of HC survivors in their study believed it would have been helpful to meet 
with a HCP at the end of treatment. This would have helped prepare the patients during this 
transition phase (Lobb et al., 2011).  
Research by Knott et al. (2012) concurs with this view, having identified that, for 
some cancer survivors, the dissatisfaction with the health care system becomes more apparent 
following the acute illness phase. Despite the practical support provided at the time of 
diagnosis, when treatment ends participants find that support and communication cease (Knott 
et al., 2012). In later survivorship phases, the patient’s focus generally shifts from merely 
getting through treatment, towards a more comprehensive view of QOL and ongoing survival. 
According to Knott and colleagues, it is during this phase of transition when patients often 
notice a sense of loss and failure by the healthcare system. There remains a focus on treating 
disease, rather than considering the survivor holistically. However, as reported in this study, 
participants highlighted the importance of follow-up communication and continuity in care 
following treatment (Knott et al., 2012). 
Research by Roundtree and colleagues (2011) also underscored the importance of 
physician communication. In this qualitative study involving eight focus groups (n = 33) of 
breast cancer survivors, several issues were identified. Many of these included barriers to 
screening, feeling in limbo in the healthcare system and difficulties in communication and 
relationships with physicians. This study concluded that the survivors’ experiences are fraught 
with challenges, especially in finding a doctor who can both address their individual needs and 
coordinate their care (Roundtree et al., 2011). 
Communication between clinicians, the cancer patient and their family is integral to 
the concept of social support. Limited communication with HCP’s about physical and 
psychological symptom distress, can result in adverse psychological morbidity (Knobf, 2007).  
Moreover, the communication in each context is dependent on the different needs of each 
individual and their interpretation of the relationship (Ungar et al., 2007), as not all individuals 
or clinicians will communicate in the same manner. The medical profession tends to have a 
different style of communication, which mainly focuses on treating the illness, thus patients 
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may perceive their doctors to be less concerned in their personal experience (Ofri, 2004). In 
addition, appointments with clinicians are typically short, with an extra minute only cited as 
being provided for patients with psychosocial issues (Howie et al., 1999). These time 
constraints can mean that patients’ concerns with mental health are not always dealt with 
appropriately (Swash, Hulbert-Williams, & Bramwell., 2014). 
Numerous studies have highlighted the importance of communication between 
clinicians and cancer patients, especially in regard to providing relevant cancer-related 
information. In a study by Rabin et al. (2011), 84% of cancer survivors expressed a need for 
information-based interventions. This view is supported in recent research stating that cancer 
patients and their family require informational and educational support, in order to cope 
effectively following diagnosis and treatment (Adejoh, Temilola, & Olayiwola, 2013).  
In addition, previous qualitative research among 73 migrants by Butow et al. (2011) reported 
that cultural isolation, language and communication difficulties with HCP’s and interpreter 
issues all contributed to making their recovery more difficult. A systematic review by Swash 
and colleagues (2014), which solely addressed HC survivors, agrees with these findings (Table 
2.1). As well as the fear of reoccurrence, information provided by HCP’s was the other key 
area of need identified (Swash, Hulbert-Williams, & Bramwell, 2014). 
In summary, the level of resilience exhibited by individuals with illness can be 
significantly affected by the level of support and communication with multidisciplinary teams 
of professionals responsible their care, contributing as either a risk or as a protective process 
(Deimling et al., 2005; Knobf, 2011; Mellon, Berry-Bobovski, Gold, Levin, & Tainsky 2006). 
The outlined literature highlights that adequate information and support from HCP’s across the 
trajectory are vital protective factors among cancer survivors. Describing how and when her 
cancer treatment ended, the support also ceased, Carr (2004) aptly described the feeling “the 
party, such as it was, was over” (p. 89).  
 
Community Services and Organisations  
The role of community organisations in the support of individuals facing a health 
adversity has been explored in several studies (Badger, Segrin, & Meek, 2004; Northouse, 
Kershaw, Mood, & Schafenacker, 2005; Zabalegui, Sanchez, Sanchez, & Juando, 2005). 
Individuals who participate in community groups are more likely to be resilient, have an 
increased sense of belonging and develop more adaptive skills (Laursen & Birmingham, 
2003). However, researchers have identified a general reluctance by clinicians and general 
practitioners (GP’s) to refer cancer survivors to community support organisations (Brennan et 
al., 2011; Gunn, Turnbull, McWha, Davies, & Olver 2013; Kam, Knott, Wilson, & Chambers 
2012).  
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Community services, such as internet information and counselling groups, all form a 
part of the oncology network that provides support for individuals with the cancer. In addition, 
there are several other community-level resources available to cancer survivors, designed to 
assist both emotional and physical recovery. These may involve: participating in music therapy 
(Docherty et al., 2013); use of complementary therapies (Beatty, Koczwara, Knott, & Wade, 
2011; Jones & Demark-Wahnefried, 2006); relaxation (i.e., yoga, meditation, mindfulness, 
deep breathing, massage, laughter) (Rabin et al., 2011; Sharplin et al., 2010); and, lifestyle 
programs, such as exercise (James et al., 2011) or nutrition groups (Rabin et al., 2011).  
The role of lifestyle interventions aimed at preventing recurrence, secondary cancers 
and psychological illness, is an emerging area of research (James et al., 2011). For example, 
physical activity in cancer survivors is linked with lower risk of disease recurrence and longer 
survival (Aziz, 2002; James et al., 2011). The benefits for cancer survivors include improved 
cardiovascular fitness, maintaining a healthy weight, assisting with recovery from treatment 
and reducing fatigue (James et al., 2011; Rabin et al., 2011). In addition, cancer survivors have 
identified an improvement in mental health, QOL, relaxation, sleep and self-esteem levels 
(James et al., 2011). Yet, despite the emerging evidence of the advantages of lifestyle 
behaviours in promoting improved health and recovery for cancer survivors, there are limited 
services specifically targeting cancer survivors following treatment (James et al., 2011).  
Nevertheless, research has identified that patients would like access to such support 
services (James et al., 2011). For example, several cancer survivors have noted that it was 
difficult to receive appropriate support from family or friends, as they often became distressed 
while discussing the cancer diagnosis and were unable to remain objective (Rabin et al., 2011). 
Cancer survivors have found benefit in community support groups that provided an 
environment in which they were more able to share their story and normalise their experience 
(Rabin et al., 2011).  
However, an important consideration in relation to community support is that the type 
of service provided should match the survivor’s needs (Butow et al., 2007; Steginga et al., 
2008). For example, the type of support group is known to influence the ongoing participation 
by the cancer patient. Butow et al. (2007) identified the main reasons for ongoing group 
attendance included feeling connected, having a sense of community, receiving current 
medical information and effective group leadership. This sample of 417 cancer survivors also 
reported that support services should be flexible and consider all survivors, as the requirements 
changed as the patients were further along their cancer trajectory.  
Rabin et al. (2011) confirmed these findings also reporting that participants described 
receiving more benefit if other program participants were comparable in age, cancer type, time 
since diagnosis, gender, treatment history and life situation. In many circumstances, HCPs who 
care for cancer survivors are already aware of the requirement for support and services. For 
example, Rankin, Butow, Price, & Evans (2011) canvassed the priorities of health 
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professionals in providing effective support to cancer patients. Among the twelve priority 
areas identified, participants noted that improving follow-up assessment, referral and patient 
management was important. In addition, support services and research that included specific 
populations including the elderly and less common cancers such as HC, were noted as a 
priority (Rankin et al., 2011).  
Kam et al. (2012) also reported that even those cancer survivors who experience 
significant distress fail to receive appropriate support services that might address mental health 
problems. This study identified the two key barriers preventing patients from attending 
community support services. They included the lack of referrals, recommendations and advice 
from clinicians (13%), and a lack of knowledge of the service (34%). Oncology clinicians 
stated that their main reason for non-referral was a lack of awareness of services (Kam et al., 
2012). Yet, of those clinicians who were aware, 70% had not advised patients on the 
availability of community groups, despite rating those services as being ‘useful’ or ‘extremely 
useful’ (Kam et al., 2012).  
Brennan et al. (2011) identified a lack of referral by GP’s in breast cancer survivors, 
despite them being ideally placed to manage these issues. Similarly, a lack of services, or 
knowledge about available services, particularly for males, was noted (Knott et al., 2012). 
Earlier research among ovarian cancer survivors also reported that 56% of participants 
reported that they would have joined a support program if it had been recommended (Wenzel 
et al., 2002). The literature has reported that other barriers to referral by clinicians include: 
work burnout (Alacacioglu, Yavuzsen, Dirioz, Oztop, & Yilmuz, 2009); the belief that issues 
related to psychosocial wellbeing are outside their professional responsibilities (Johnson, 
Girgis, Paul, & Currow, 2008); a lack of trust in the effectiveness of existing services (Snow et 
al., 2009); and, concerns about distance to services (Andrykowski & Birris, 2009).  
Gunn et al. (2013) investigated psycho-social service use from the perspective of rural 
Australian cancer patients.  Seventeen purposively sampled cancer survivors, who lived 
outside metropolitan Adelaide, participated in semi-structured, face-to-face interviews. The 
most dominant theme was that rural cancer patients who access psychosocial services valued 
them highly. The results identified that, despite their isolation, rural cancer patients believe 
there is a need for more transparent communication among HCPs and more defined referral 
pathways to psychosocial care. The authors concluded that more systematic screening of 
distress, and the involvement of appropriate services, may help address the communication and 
referral issues for rural patients (Gunn et al., 2013).  
The literature discussed has identified that there is a low referral rate by clinicians to 
many community support services, despite cancer survivor requests (Kam et al., 2012; Wenzel 
et al., 2002). However, research has highlighted that community support services are important 
and may be able to address many of the issues that matter most to cancer survivors (Brennan et 
al., 2011, Rankin et al., 2011; Swash, Hulbert-Williams, & Bramwell, 2014).  
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The community surrounding a cancer survivor can influence them through either the 
provision or lack of both human and material resources. However, it is important to note that 
the influence of the community as a risk or protective process is dependent on the 
characteristics of the community. As discussed, positive community influences among HC 
survivors include the accessibility of healthcare services, effective relationships with health 
professionals and community support (Galván, Buki & Garcés, 2009). Yet, there are cultural 
minority groups and those with low SES who are more at risk (Butow et al., 2013). According 
to the literature, supporting emotional needs can often be addressed at the community level, 
although it is not possible to suggest that all community services contribute to resilient 
outcomes, as each community varies and will have different risk and protective processes 
operating. It is, therefore, important to research community-level protective factors to further 
understand their role in promoting resilience (Gorman-Smith, Henry, & Tolan, 2004; 
Vanderbilt-Adriance & Shaw, 2008).  
The final section of this literature review will describe positive and negative mental 
health outcomes that may result as a consequence of HC. Based on the available literature, this 
will be followed by presenting a conceptual model of resilience among HC survivors.  
 
Positive and Negative Outcomes  
Most survivors of HC seem resilient and are able to adapt well (Schumacher et al., 
2014). However, there are a number of studies that also report significantly elevated levels of 
psychological distress among survivors on specific measures of anxiety, depression, and 
interpersonal problems (Wenninger et al., 2013). This is important to investigate as research 
has identified a significant correlation between low resilience and higher levels of depression 
and anxiety in several studies (Krebber et al., 2014; Mitchell et al., 2013; Walker et al., 2013). 
For example, research by Korszun et al. (2014) identified a distinct subgroup of cancer 
survivors that reported poor QOL. Several psychosocial factors were found to be associated 
with this finding, yet this study noted that the most consistent association was with high 
depression and anxiety scores (Korszun et al., 2014).  
However, understanding depression among cancer survivors can be a challenge, partly 
due to conflicting results. For example, a meta-analysis by Mitchell and colleagues (2011) 
found the prevalence of depression ranged immensely (1.0% – 77.5 %). This research 
reviewed 70 studies on mood disorder in haematological and oncological settings, involving 
10,071 individuals across 14 countries. Mitchell et al. (2011) also reported a significant 
variation in documented depression rates among cancer survivors over time. In studies 
published up to 1990, the reported prevalence of depression was 23.3 %, in those published 
from 1991 to 2000 it was 15.5%, and in those published since 2001 it was 13.4 %. This may 
suggest that rates of depression have reduced over time. An alternative explanation, according 
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to Mitchell and colleagues (2011), is that recent studies tend to be more methodologically 
sound (i.e., use more rigorous definitions of depression) and therefore report more realistic 
rates than older studies.  
As a result of this review, Mitchell et al. (2011) concluded that approximately 16.6 % 
patients with cancer have depression. These rates are notably higher than the prevalence of 
depression in general population, which is reported to be approximately six percent (ABS, 
2007). The results are not unexpected, given the trauma and uncertainty faced by those with 
serious illness. However, it has also been suggested that, in some situations, the rates are also 
higher in cancer patients when compared with individuals with other chronic illness (Härter et 
al., 2007). For example, in two separate studies, the relative risk of depression in patients with 
cancer exceeded that of patients who had diabetes, heart disease and those who had suffered a 
stroke (Patten et al., 2005; Polsky et al., 2005).  
Although the exact rates remain unclear, depression has been the most extensively 
investigated mood disorder among cancer patients (Mitchell et al., 2013). This may have 
limited our understanding of psychological distress among cancer survivors. According to 
more recent research by Mitchell et al. (2013), increased rates of anxiety were found following 
a cancer diagnosis and these tend to persist, whereas increased rates of depression were less 
enduring. Although depression was reported to be twice as common in the first two years 
following a cancer diagnosis, an increased risk of anxiety disorders were found to persist 
beyond ten years. This suggests that anxiety, rather than depression, may be the most common 
problem in long-term cancer survivors. This is not dissimilar to rates among populations 
without cancer, where anxiety levels are reported to have a 12-month prevalence of 18% that is 
approximately twice as common as depression. These results provide support for earlier 
research with similar findings (Alacacioglu et al., 2010; Brown, Kroenke, Theobald, Wu, & 
Tu, 2010). Therefore, it is important to also investigate anxiety, not only because the 
prevalence may be higher among cancer survivors, but also as screening for anxiety has often 
been overlooked in comparison to depression and distress (Mitchell et al., 2013).  
In general, according to many researchers, it is also important to recognize that 
psychological distress levels reported in long-term cancer survivors vary as rates may be 
influenced by the cancer type and the associated physical complications (Krebber et al., 2014; 
Mitchell et al., 2013; Walker et al., 2013). However, as HC remains relatively understudied, 
the extent to which HC survivors experience psychological distress and the factors that 
influence psychological wellbeing remain unclear. 
In summary, the literature has highlighted that both positive and negative outcomes 
may present as a result of being diagnosed and treated for HC cancer. In spite of experiencing 
the initial shock at diagnosis, including a potentially aggressive treatment regime, many long-
term survivors report positive outcomes (Schumacher et al., 2014), yet others report poor QOL 
and psychological distress (Allart et al., 2013; Korszun et al., 2014; Schumacher et al., 2014). 
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The key to improving positive outcomes may be resilience, which is described as a 
phenomenon that acts as an antidote to stress (Schumacher et al., 2014). However, as resilience 
is a dynamic concept, it can be influenced by life circumstances, the external environment, 
including situational and contextual factors. Therefore, stress and negative experiences can 
cause temporary disturbances even in the most resilient individuals (Schumacher et al., 2014). 
Thus, being resilient may not necessarily result in the absence of psychopathology. However, 
substantial research has found a significant correlation between resilience and mental health in 
those with physical illness (Schumacher et al., 2014). This is perhaps because resilient 
individuals are more able to maintain or restore their ability to function, despite adversity 
(Masten, 2007; Pooley & Cohen, 2010; Rutter, 1995; Ungar, 2008). 
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Conceptual Model  
A preliminary conceptual model of resilience among HC survivors (Figure 3.1) is 
presented below, which outlines the main factors identified in the literature, to be moderated 
by resilience. Moderators are referred to as variables that can influence the relationship 
strength between other variables (Baron & Kenny, 1986). Thus, resilience is understood to 
moderate interactions in regression by influencing the direction and/or strength of a 
relationship between other variables such as coping skills.  
The following modifiable variables have been identified as having a direct relationship 
with positive outcomes in HC survivors. First, within the individual: coping skills, a sense of 
control, global meaning and self-efficacy are four factors that are reliably correlated with 
either resilience and or QOL in numerous studies (Allart, 2013; Bulsara, Ward, & Joske, 2004; 
Denz-Penhey & Campbell Murdoch, 2008; Kelly & Dowling; 2011). Second, within the 
family, social support and effective communication are consistently referred to as important 
factors (Adejoh, Temilola, & Olayiwola, 2013; Allart et al., 2013; Dunn et al., 2011; Korszun 
et al., 2014; Rodin et al., 2013; Schumacher et al., 2014). Finally, there is an overall consensus 
that interpersonal relationships with healthcare professionals are significantly influential in 
improving psychological wellbeing (Lobb et al., 2009; Swash, Hulbert-Williams, & Bramwell, 
2014). Therefore, these are the factors that were included in this model.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
INDIVIDUAL 
FACTORS 
• Coping Skills 
• Life Meaning 
• Control 
• Self-efficacy 
FAMILY FACTORS 
• Social Support 
• Communication 
COMMUNITY 
FACTORS 
• Relationship 
with healthcare 
professionals 
RESILIENCE 
Haematological Cancer 
Diagnosis 
Psychological 
Outcomes 
Figure 3.1. Conceptual model of factors that influence the resilience process and 
moderate psychological outcomes in HC survivors. 
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Overview of Literature Review 
 
This review has highlighted that, although the HC experience brings significant 
challenges and stress before, during, and after treatment, there is very little research that 
specifically examines resilience and its relationship to the cancer experience among this 
patient population. Yet, the literature has reported that the ability to mobilise resources, either 
within the individual, family or community, does increase the likelihood of better 
psychological outcomes (Llewellyn et al., 2013). However, due to limited research, the process 
is still unclear as to how, when and to what extent these internal and external factors influence 
resilience among the HC survivor population (Llewellyn et al., 2013). This topic will become 
increasingly relevant as we witness an increasing number of HC survivors.  
The following chapter will outline the methodology selected for this study. Qualitative 
and quantitative approaches are considered complementary, thus both will inform this 
research. It is anticipated that this mixed-method research will gain the most comprehensive 
understanding of the HC survivor population. The literature review findings highlight the 
importance of seeking the views of HC survivors, as only they will have a true understanding 
of the risk and protective processes that are operating in their lives. In addition, the HC 
survivors’ perception and experience of relevant processes may be dissimilar from the views 
of current and previous research investigators. Therefore, it is important to hear the personal 
story from the perspective of HC survivors themselves. First, qualitative data will be collected 
in order to provide a glimpse into the participant’s narrative, which aims to be relatively 
untainted by researcher assumptions. This will then inform further instrument development for 
a second larger quantitative study. The specific details entailing this research methodology will 
be explained in the next chapter.  
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Chapter 4 
 
Research Design and Methodology 
 
 
 
 
Philosophical Framework  
Prior to selecting an appropriate methodology, it was essential to adopt a suitable 
research paradigm that provided a philosophical framework for this research. The research 
paradigm is a “basic set of beliefs that guides action” (Guba, 1990, p. 17). More explicitly, 
“paradigms are frameworks that function as maps or guides for scientific communities, 
determining important problems or issues for its members to address and defining acceptable 
theories or explanations, methods, and techniques to solve the defined problems” (Usher, 
1996, p. 15). There are several different paradigms that researchers may choose to include. In 
the current study, two paradigms, namely social constructionism and post positivism were 
selected, as each provided a framework for the research process that complemented both the 
qualitative and quantitative methodologies (mixed method) involved in this study.  
As mentioned earlier, the overarching question in this research was to identify the key 
factors and processes that contribute to, or impede, resilience in HC survivors. The aim of the 
first phase was to develop a conceptual model that explained how individual HC survivors 
exhibit and maintain resilience. The aim of the second phase was to test the developed model 
on a larger national sample of Australian HC survivors. In order to achieve both these aims 
and answer the research question, it was necessary to adopt a combination of both a qualitative 
and quantitative approaches.  
This framework also enabled both inductive and deductive reasoning to be applied, 
resulting in a more thorough understanding of the research problem (Johnstone, 2004). 
Inductive reasoning (bottom-up approach) is research that begins with a base of specific 
observations and slowly starts to look for broader patterns or generalisations in order to build 
Chapter Overview  
The purpose of this chapter is to explain the research design and methodology 
employed in each of the two phases included in this study. First the study’s 
philosophical framework and research approach are outlined. This includes a 
discussion of social constructionism and post positivism including the rationale for 
using a mixed method exploratory sequential design. Second, the research 
paradigms, methodology, data collection process and analyses of each phase are 
described. This includes the steps taken to ensure rigour and the process involved 
in developing the final questionnaire. Last, the ethical concerns and data analysis 
issues surrounding resilience research are presented.  
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on a theory or model that describes the phenomenon (Trochim, 2000). Inductive reasoning is 
generally more open-ended and exploratory. Conversely, deductive reasoning (top-down 
approach) functions in the opposite way, working from the more general observations to be 
more specific. Thus, a theory is first formulated, which is then narrowed down into more 
specific hypotheses that can be tested. Observations are then collected that ultimately result in 
a confirmation (or not) of initial theory (Trochim, 2000). Similar to this study, much of the 
social research investigating mixed-cancer survivors to date has involved a combination of 
both inductive and deductive reasoning processes. 
In Phase One (qualitative) when exploring the resilience experience among HC 
survivors, a social constructionism paradigm guided the phenomenological methodology. The 
methods of data collection involved semi-structured interviews that were interpreted using 
thematic analysis (Braun & Clarke, 2006). Yet, in the following phase (quantitative) when 
developing and implementing the questionnaire, a post positivist paradigm was employed. The 
methodology included survey sampling that was interpreted through statistical analyses. The 
research paradigms, methodology, data collection methods and analyses, relating to each 
phase, are discussed following an outline of the research approach.  
 
The Research Approach  
Once the philosophical framework was ascertained, it was important to identify and 
adopt the most appropriate research methodology to guide the study (Creswell, 2003; Mertens, 
2005). According to Johnson and Onwuegbuzie (2004), the only “correct” methodology is the 
one that provides the most effective data in order to answer the research question. A mixed 
method approach employing a sequential transformation strategy was considered the most 
appropriate methodology for this study, as it is a research methodology that was not restrictive, 
but rather supported, the use of multiple paradigms and offered freedom to shift from one 
paradigm to another. Mixed methods are defined as “the class of research where the researcher 
mixes or combines quantitative and qualitative research techniques, methods, approaches, 
concepts or language into a single study” (Johnson & Onwuegbuzie, 2004, p.17). Many 
researchers have described mixed method research as the “third wave” of research 
methodology (Creswell, 2003; Johnson & Onwuegbuzie, 2004; Patton, 2002; Tashakkori & 
Teddlie, 2003) and was the most appropriate for this study for a number of reasons. 
First, this approach suited the research objectives of this study by providing the 
flexibility to elicit and capture the resilience experiences and support needs of individual HC 
survivors, as well as testing the findings in a broader context. Within resilience research, 
Curtis and Cicchetti (2003) and Rutter (2006) have both claimed that a comprehensive 
research agenda is required, spanning biological, cognitive and social domains, utilizing 
qualitative and quantitative approaches (Davydov et al., 2010).  
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Second, mixed methods provided a practical way of addressing the research problem 
by allowing the use of multiple paradigms (Creswell & Plano Clark, 2011; Tashakkori & 
Teddlie, 2003). Hence, mixed methods allowed the collection of new data utilising a social 
constructionist paradigm and then using these data in a systemic post positivist paradigm to 
obtain a validated questionnaire. Further, following this process of development, whereby the 
results from one method helped develop and inform the other method, the validity of the 
results obtained would be strengthened (Creswell & Plano Clark, 2011).  
Third, mixed methods designs use the strengths of each methodology, which results in 
the disadvantages of each potentially being offset (Creswell & Plano Clark, 2011). For 
example, one limitation of a quantitative approach is the apparent lack of in-depth and rich 
knowledge about the individual being researched. To eliminate this disadvantage, qualitative 
data may be included to provide a deeper appreciation of the quantitative data. Thus, mixed 
methods offered a highly robust, realistic and flexible framework for undertaking this study, 
which was based on the need to explore a relatively unknown area.  
Just as there are valid arguments for employing mixed methods there are also 
limitations. As this study involved the collection of both qualitative and quantitative data the 
researcher had to be well versed in the different methodologies and have the necessary skills to 
be able to mix multiple methods appropriately (Johnson & Onwuegbuzie, 2004). There is also 
a longstanding view that research paradigms that are different in terms of beliefs, foundations 
and methods should not be combined due to the complexity involved (Greene & Caracelli, 
2003; Guba & Lincoln, 1989). Yet, several researchers now support the use of competing 
paradigms in a single study, in order to holistically comprehend the phenomena being 
researched (Creswell, 2013; Denzin & Lincoln, 2005; Hassard, 1993; Greene & Caracelli, 
2003; Patton, 1988). Within this perspective, including mixed methods provides differing, yet 
valuable, insights into the understanding of humans and their social world (Greene & 
Caracelli, 2003). As Patton (1988) pointed out, “there is no logical reason why qualitative and 
quantitative approaches cannot be used together” (p. 117). Combining results from both the 
qualitative and quantitative parts of any study are more likely to produce a richer account of 
the experiences. Therefore, a mixed methods approach was believed to be the most appropriate 
for this study.  
 
Exploratory Sequential Design.  
Once the methodology for the study was selected, the next stage involved formulating 
the research design. Research design refers to the plan of action that links philosophical 
assumptions to specific methods (Creswell, 2003; Crotty, 1998). The first step in planning the 
research design, in a mixed method study, is choosing whether the data should be collected in 
stages (sequentially) or at the same time (concurrently) (Creswell & Plano Clark, 2011). 
Taking the research objectives into consideration, a sequential approach was undertaken. 
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This approach involved collecting qualitative and quantitative data in succession 
where the findings identified following the first phase led to the formulation of questions, data 
collection, and data analysis in subsequent phases (Mertens, 2005). One of the most frequently 
used sequential mixed method designs involves a qualitative study followed by a quantitative 
research (Morgan, 1998). The exploratory sequential design is based on the idea that 
exploration of a phenomenon is required as there is either little theory that has been developed 
that can guide the research, important variables relating to the phenomenon are not yet widely 
recognised, or quantitative instruments are not available (Creswell & Plano Clarke, 2011). In 
sequential transformation strategies, the method that is first used for data collection depends 
upon the theoretical base that the researcher is addressing (Creswell, 2003). In the current 
thesis, as discussed in the literature review, little is known about the factors that influence 
resilience among individual HC survivors. This issue had not been previously explored within 
this context or within the wider HC survivor population. Therefore, Phase One involved a 
qualitative design, which comprised in-depth interviews with HC survivors. In conducting the 
qualitative stage first, greater exploration of the theory (resilience) and phenomenon (living 
with HC) was achieved. The objective was to provide new insights and lines of inquiry for 
theory development relating to the process of resilience in this population. The qualitative 
phase was then followed by a quantitative stage, involving a larger sample, where the issues 
identified were tested and confirmed using a survey. It was expected that this would result in a 
more complete picture of influential resilience factors that could be generalised in HC 
survivors across Australia and overseas. Such data would help enhance our understanding of 
the phenomena involved and strengthen any recommendations proposed at completion of the 
study (Newman & Benz, 1998).  
Adopting a sequential, mixed method design also has other advantages. According to 
Creswell (2003), this design is relatively straightforward to implement, describe and report. 
Sequential designs are also viewed as the most appropriate design when testing elements of an 
emerging theory that result from a qualitative phase. In addition, this model has been cited as 
being especially advantageous when developing a questionnaire. The initial qualitative phase 
assists in identifying the key areas that need to be addressed in the questionnaire, while the 
quantitative phase gives an opportunity to validate and test the questionnaire (Creswell, 1999). 
In summary, the aims and agenda outlined by the current study, fit with the procedure 
of the exploratory sequential design. Phase One was interested in exploring factors that 
influenced resilience, while subsequent phases developed a questionnaire to test these factors. 
The research design chart below (Figure 4.1) presents a visual representation of the two major 
phases of data collection and analysis to be conducted in this study.
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Figure 4.1 – Overview of mixed method research design and methodology.
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Phase One – Qualitative Study 
As discussed, a mixed methods research design was used for this study. The 
qualitative findings (Phase One) were used to guide the quantitative methodology (Phase Two) 
and to validate the interpretation and understanding of the quantitative data. The next section 
outlining the first qualitative study begins by providing an overview of social constructionism. 
Second, a description of phenomenology outlining the steps taken to maintain research quality 
and rigour are presented. Third, the data collection (interviews) instruments and recruitment 
procedures are discussed. Finally, the rationale for the analyses employed in Phase One 
(thematic analysis and Leximancer software analysis), are described.  
 
Paradigm - Social Constructionism   
The paradigm that guided the first qualitative phase was social constructionism, 
described as information formed through conversations (Talja, Tuominen, & Savolainen, 
2005). Social constructionism according to Holloway (1997) emphasises the interactive 
process that assists an individual in the construction of knowledge and understanding, as 
individuals engage with the world they are interpreting. Constructionism argues that multiple 
truths can exist within one reality, as reality itself is fluid and shaped by subjective 
experiences, which are impacted by personal history and social traditions (Guba, 1990). To put 
this more simply, constructionism is based on the premise that humans interpret their world 
according to their social and cultural perspectives (Creswell, 2011; Crotty, 2003). Social 
constructionism is most commonly used in exploratory research projects that attempt to 
understand individuals’ perceptions of their experiences (Schwartz, 2005). 
Social constructionism is often used interchangeably with the terms “constructivism” 
and/or “social constructivism”. As Raskin (2001) states, they “are employed so 
idiosyncratically and inconsistently that at times they seem to defy definition” (p. 1). Although 
these terms are similar, there are also subtle differences between each paradigm (Raskin, 2002; 
Talja, Tuominen, & Savolainen, 2005).  
Essentially, constructivism is the knowledge created by people as a result of their 
observations and experiences (Talja, Tuominen, & Savolainen, 2005). Social constructivism 
builds on this framework to also include the meaning individual’s construct through interaction 
with others that is also influenced by societal conventions, history and their interpretations of 
that world (Crotty, 1998). Social constructivism is analogous to the knowledge attained within 
a social constructionism framework, however social constructionism occurs more at a 
collectivist level, rather than an individual level (Crotty, 1998). Along similar lines, Daly 
(2007) suggests that constructivism is the individual cognitive process of making meaning 
while constructionism is the interactive construction of meaning. Illness recovery has been 
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likened to a social experience involving the collective interactions between patients, their 
families, clinicians and allied health professionals, and, as such, the meaning lends itself to 
research conducted from a social constructionist standpoint (Dewey, 1963).  
In support, Ungar (2004) reasoned that resilience is best understood in terms of a 
social constructionist perspective, suggesting that the relationship between risk and protective 
factors is a phenomenon that can only be comprehended within a context and is made 
meaningful by the individuals’ interaction with others. Thus, risk and protective factors are 
also created at a social level. Therefore, it is the individual’s interaction within a social context 
that governs the meaning and significance of risk and protective factors, including a sense of 
healthy well-being (Ungar, 2004).  
When considering the researcher, social constructionists maintain that research is a 
product of the values of the researchers and cannot be independent of them (Mertens, 2005). 
The researcher is viewed as a “passionate participant” who interacts with the respondents to 
construct the outcome of the inquiry (Guba & Lincoln, 1994). As such, the assumptions of the 
constructionist paradigm are subjective and the created knowledge is dependent on the 
interaction between the interviewer and the respondent. Hence, it is imperative for researchers 
to understand the complex world of lived experiences from the point of view of those who live 
in it (Guba & Lincoln, 1994; Schwandt, 2000). 
Therefore, when applied to the current study, social constructionism required the 
researcher to authentically engage with the research subjects, in order to more accurately 
understand their world. This allowed the research data to emerge through the interaction 
between the researcher and the researched (Holloway, 1997). The manner in which HC 
survivors consider themselves to be resilient emerged during this interaction between the 
researcher and participant, and through the meaning each attributes to their interpretation of 
events and processes that have influenced their cancer survivor experience. From this 
perspective, HC survivors may encounter their illness experiences in a variety of ways. For 
example, some cancer survivors may prefer to access social support services in order to cope 
following treatment. However, other HC survivors may turn to the support of family or find 
that they adjust better following the recommencement of activities (i.e., exercise) that were 
previously considered normal for them.  
With this premise, the goal of social constructionism, when investigating resilience 
was to focus on the individual’s account and interpretation of the situation, including the 
context in which that situation occurred (Creswell, 2013; Guba, 1990). Advocates of the social 
constructionism approach prefer using qualitative methods such as interviews and observations 
to comprehensively understand human experiences in context (Creswell, 2013; Mertens, 
2005). Hence, the designed questions tend to be broad and open-ended so as to enable the 
individual to best recount their experiences and to elicit rich information (Creswell, 2013). 
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Within this paradigm, the researcher interpreted the stories of individuals who experienced life 
following diagnosis and treatment for HC. The researcher strived to understand how these 
individuals constructed their meaning of being a HC survivor, including the resilience factors 
they perceive to be resilient or contribute to risk.  
In summary, from the social constructionist position, knowledge is created and 
modified through experiences and interactions with the world and other people (Talja 
Tuominen, & Savolainen, 2005). Thus, social constructionism was essential to this phase of 
the research. In this study, each HC survivor had their own unique story to tell, and social 
constructionism allowed the researcher to understand each individual’s exclusive experience, 
whilst allowing for the identification of overarching themes and generalisations. As 
highlighted by Sarantakos (2005) “what people perceive as reality is not ‘the reality’, but what 
they constructed through experiences and interpretations” (p. 37). 
 
Research Methodology - Qualitative (Phenomenology) 
Qualitative research aims to explore and describe individual experiences such as the 
interpretations, accounts and meanings that people ascribe to social phenomena (Hansen, 
2006). A comprehensive definition of qualitative research has been offered by Denzin and 
Lincoln (2005): 
 
Qualitative research is a situated activity that locates the observer in the world. It 
consists of a set of interpretive, material practices that make the world visible. These 
practices transform the world. They turn the world into a series of representations, 
including field notes, interviews, conversations, photographs, recordings, and memos 
to the self. At this level, qualitative research involves an interpretive, naturalistic 
setting, attempting to make sense of, or interpret, phenomena in terms of the meanings 
people bring to them (p. 3).  
 
Qualitative researchers support the belief that there are many realities and that 
individuals construct their reality as they interact with the environment. Therefore, 
methodologically, qualitative researchers predominantly interact with their participants in their 
natural setting (Denzin & Lincoln, 1998; Glesne & Peshkin, 1992). Research conducted within 
an individual’s own environment, such as their home or neutral territory, has been shown to 
help participants feel less anxious and more at ease, allowing for more open and candid 
responses (Glesne & Peshkin, 1992).  
Conversely, in quantitative research, it is not always possible for participants to 
articulate their feelings or point of view. This is because the participant’s involvement is 
limited by set choice responses or information sought through the completion of surveys and 
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psychometric tests. For example, quantitative data may specify participants’ reported levels of 
personal characteristics such as self-efficacy, but do not deliver an explanation of the levels 
and meaning of self-efficacy. Qualitative enquiry helps researchers to understand the “how and 
why” by canvassing the in-depth experiences of the participants, thereby examining 
phenomena holistically in context (Denzin & Lincoln, 1998; Liamputtong & Ezzy, 2009).  
Qualitative methodologies are distinguished by the collection and analysis of 
descriptive data that can be represented through observations, transcripts, interviews and other 
‘word enriched’ documents (Hansen, 2006; Patton, 2002). Only by this manner, according to 
qualitative researchers, can human behaviour begin to be understood (Hansen, 2006). There 
are many different qualitative methods that are employed to gather and explore social 
experiences. These include: phenomenology (i.e., study the lived experiences of people); 
ethnography (i.e., the study of culture) (Daly, 2007; Hansen, 2006); and, grounded theory 
(which explains how individuals generate theory and define reality) (Hansen, 2006). For the 
current study, phenomenology was the selected as the qualitative method, an outline is 
provided below. 
Phenomenology. 
According to Holstein and Miller (1993) social constructionism has its roots 
embedded within phenomenology (Holstein & Miller 1993), and, therefore the two 
perspectives are interrelated. Although there are similarities, it is valuable to include both 
perspectives, as social constructionism tends to advocate a paradigm in which all that occurs, 
exists within relationships, where as phenomenology is more individually focused. Creswell 
(1990) states that by adopting a phenomenological perspective, "researchers search for 
essentials, invariant structure (or essence) or the central underlying meaning of the experience 
and emphasize the intentionality of consciousness where experiences contain both the outward 
appearance and inward consciousness based on memory, image and meaning" (p. 52). Put 
more simply, the focus of phenomenology lies in the investigation of an individual’s lived 
experience, and how they experience it (Holloway, 1997; Liamputtong & Ezzy, 2009).  
The phenomenological method was first conceived by Edmund Husserl, who, in the 
1960’s, stated that only the individual themselves can know what they experience (Lincoln & 
Guba, 2000). Hence, it is not possible for all research inquiry to engage in “science of facts”, 
as there are no absolute facts, we are only able to establish “knowledge of essences” 
(Schwandt, 2000). Liamputtong (2009) concurs, suggesting that people must have lived an 
experience to be able to truly describe what it was like, or its essence (van Manen, 1990). 
Phenomenology’s methods of inquiry generally include in-depth interviews, life 
histories, and narrative techniques (Liamputtong, 2009). However, there are two perspectives 
involved in phenomenological analysis. The first is the individuals themselves who are living 
through the experience of a phenomenon. The second is that of the researcher, who generally 
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has great interest invested in the phenomenon. As phenomenological research is an 
interpretative methodology, it is imperative the researcher has awareness of their own 
experience, as this will influence both their engagement in the interviews and the analysis of 
data (van Manen, 1990). 
In order to fully understand an experience, the researcher is required to ‘bracket out’ 
(i.e., recognize personal bias by disregarding their own related experiences) (Creswell, 2011; 
Liamputtong, 2009; van Manen, 1990). However, it is often impossible to detach personal 
interpretations from the phenomenon that are personally interesting. One analysis principle 
was suggested by Rossman and Raliis (1998), who argued that "phenomenological analysis 
requires that the researcher approach the texts with an open mind, seeking what meaning and 
structures emerge” (p. 184).  
Phenomenological data analysis advances through the process of reduction, the 
analysis of explicit statements and themes, and an exploration of all possible meanings 
(Creswell, 1999). During this process, as much as possible, the researcher needs to set aside all 
prejudgments, bracketing his or her experiences (Creswell, 1999). This assists the researcher to 
discover the true essence of the reality in question, as it limits personal experience from 
influencing the interpretation of the examined lived experience. 
In summary, phenomenological methods are very effective at bringing to the fore the 
experiences of individuals from their own perception of events (Creswell, 1999). This study 
explored the experiences of individuals who had faced HC. Thus, the study sought to gain an 
in-depth description of these experiences and to capture the meaning, essence, and 
characteristics of resilience during this phase. In using a phenomenological approach, these 
outcomes could be achieved. In addition, the social constructionism paradigm focused on the 
meaning of the lived experience formed by the individual’s social context. The next section 
will outline the efforts taken during the qualitative phase of the thesis to ensure rigour and 
quality of inquiry, were maintained.  
Rigour. 
As discussed, qualitative research is based on the assumption that knowledge can be 
generated from narrative data that represents the participant’s experience (Liamputtong & 
Ezzy, 2009). Yet, as there is no concrete way to test for quality, it requires the research process 
to be rigorous (Robson, 2002). Rigour has been likened to the qualitative equivalent of 
quantitative reliability and validity, representing research accuracy and truth, including the 
degree to which research can be repeated (Martin, 2004; Robson, 2002).  
According to Nagy and Viney (1994), within a social constructionist philosophical 
approach, there are several realities that are expressed by the participants, including the 
interaction between the participants, researcher and the context, all of which result in the 
constructs of reliability and validity being less helpful. These dissimilarities create challenges 
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in repeating the research and obtaining similar results (Corbin & Strauss, 2008). 
Notwithstanding these issues, steps need to be taken to ensure that qualitative research is 
rigorous and denotes the participants’ views and is not simply the “idiosyncratic opinion” of 
the researcher (Johnson & Onwuegbuzie, 2004; Seale, 1999). While there is much controversy 
as to what specifically constitutes rigour, it is generally deemed to be a matter of 
trustworthiness (Martin, 2004; Robson, 2002). 
Trustworthiness is viewed as similar to the conventional concepts of internal validity, 
external validity, reliability and objectivity (Smith, 1990) and addresses the “methods that can 
ensure one has carried out the research process correctly” (Guba & Lincoln, 1989, p. 245). A 
set of criteria has been proposed for building and enhancing the trustworthiness of the 
qualitative research. These criteria can include credibility (comparable to internal validity), 
transferability (comparable to external validity), dependability (comparable to reliability) and 
confirmability (comparable to objectivity) (Guba & Lincoln, 1989). However, there remains 
much controversy within qualitative research as to the most effective methods for judging 
rigour, and no universal method has been established. Consequently, numerous attempts to 
define what constitutes a suitable, trustworthy qualitative study have been proposed (Rolfe, 
2006). For example, Sandelowski (1986) and Beck (1993) both further clarify dependability to 
be auditability, suggesting that another researcher can follow the decision trail employed by 
the investigator in the study. In addition, Maxwell (1992) discusses the descriptive, 
interpretive, theoretical, generalisability and evaluative validity of research rigour. More 
recently, Hansen (2006) advocate’s purposive sampling, respondent validation, transparency of 
methods and analysis, and reflexivity to enhance rigour. Many researchers have established 
their own criteria for ensuring rigour through appraising the events, influences and actions of 
the researcher (Koch, 2006). For the purpose of this study, the methods of rigour are adopted 
from the criteria outlined by both Lincoln and Guba (1985) and Hansen (2006). This allowed 
for an eclectic style that ensured each concern is comprehensively addressed. The following 
techniques are used: purposive sampling, credibility, dependability, confirmability, 
transferability and reflexivity. Each of which will be discussed in turn:  
Purposive sampling is the selection of participants founded on specific common 
characteristics, instead of random selection, to ensure that interpretations are established 
through a rich and comprehensive pool of data (Hansen, 2006). As such, sampling individuals 
can offer different and even conflicting viewpoints, which can greatly strengthen the 
description of the phenomenon (Polit & Beck, 2006). In this study, purposive sampling was 
implemented to ensure that there was a level of diversity in the participants recruited. The final 
sample consisted of participants with different characteristics such as: age, gender, time since 
diagnosis, type of HC, and geographical location. This diversity aided in assembling a wide 
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range of experiences by these HC survivors and provided a comprehensive account of their 
resilience experiences in the real world, thereby enhancing rigour.  
Credibility is one of the most important factors in establishing trustworthiness and 
refers to the extent to which the findings of the study represent the multiple realities of the 
participants involved (Shenton, 2004). Credibility can be affected if the researcher lets their 
prior expectations or beliefs affect how the data are analysed and interpreted instead of being 
directed by the data (Miles & Huberman, 1994). Several techniques have been suggested that 
can assist researchers in establishing credibility of the findings (Guba & Lincoln, 1989). For 
example, credibility can be enhanced by examining the meaning of common terms and 
clarifying ambiguous words or phrases to guarantee the communication of the participants is 
correctly interpreted (Miles & Huberman, 1994). This can be managed by providing credibility 
checks, involving multiple qualitative analysts to review the data for discrepancies or errors, 
thus comparing two or more varied perspectives. In the current study two researchers 
(supervisors) not involved in the data collection, viewed the transcripts and participated in the 
full analysis process to ensure an accurate representation of findings from the narrative data. 
Credibility was also enhanced through triangulation, a method of rigour advocated by 
many authors (Corbin & Strauss, 2008; Guba & Lincoln, 1994; Nagy & Viney, 1994). 
Triangulation arises when data are included from multiple sources (i.e., participants, methods) 
that help to validate the study (Corbin & Strauss, 2008). Investigator triangulation involves the 
use of several researchers from different perspectives partaking in the data analysis process 
(Denzin & Lincoln, 2005). In the current study, triangulation was also achieved by 
accumulating data through different methods (i.e., individual interviews and surveys) and by 
including different participants in each phase. As such, the model developed through Phase 
One interviews was presented to a different sample in Phase Two through a different 
methodology, achieving triangulation and thus enhancing credibility and validity.  
Finally, another technique to ensure credibility refers to prolonged engagement, which 
involves the researcher spending sufficient time in data collection activities to have an in-depth 
understanding of the views of the participants under study (Polit & Beck, 2006). This 
technique is used to build trust and rapport with the participants and establish credibility of the 
findings. In the first phase of this study, the researcher met the demands of prolonged 
engagement by:  
• attending relevant symposiums conducted on topics relating to cancer and resilience 
to gain a better understanding of the world of these survivors;  
• engaging with the participants at the time of recruitment in order to develop rapport 
with them;  
• conducting interviews in convenient locations and spending sufficient time with the 
participants at the commencement of the interviews to assist in building trust;  
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• ensuring familiarity with healthcare facilities and relevant social settings that become 
part of the cancer patients environment; 
• frequently listening to the interview tapes and re-reading the transcripts;  
• taking part in peer debriefing through discussions held with objective peers to review 
and explore various aspects of the inquiry assisted to maintain reflexivity (Polit & 
Beck, 2006). This allowed the researcher to broaden her views of the phenomenon 
and identify any flaws in the research (Shenton, 2004). Collaborating with the peers 
throughout the data collection and analysis stages, helped improve the credibility of 
the findings;  
• using the experience of being a nurse and a psychologist and having had prior 
exposure to caring for cancer patients. These experiences helped the researcher gain a 
better understanding of the reality of the situation for these survivors; and, 
• the ongoing observations that were carried out throughout the study, such as note 
taking which enabled the researcher to focus on relevant and important issues during 
the data collection, analysis stage and interpretation. 
Confirmability signifies the ability of the researcher to demonstrate that the findings 
and interpretations are clearly linked to the participants, rather than of the preferences of the 
researcher (Liamputtong, 2009). In the current study confirmability of the research findings 
were addressed by situating the sample. This means that the demographics of the sample are 
described along with the life circumstance or experience about which they are being 
interviewed, to allow the reader to comprehend who the findings of the research may be 
relevant to. In this study, all audio recordings were transcribed by the researcher shortly after 
the interview. This was to ensure that intricacies in each interview were easily identified and 
that the researcher accurately portrayed the meanings participants were attempting to express. 
Each interview was also replayed and checked against the corresponding transcript. In 
addition, five of the transcripts and identified themes/codes were sent for feedback to the 
interviewees, who all confirmed the accuracy of the findings.  
Transferability refers to the extent to which the findings from the data can be 
transferred to other settings or groups (Merriam, 1998; Polit & Beck, 2006). In order to 
demonstrate transferability of the findings, researchers are required to provide thick 
description in the study; that is, a rich, thorough description of the research process observed 
during the inquiry, for readers to evaluate the applicability of the data to other contexts 
(Erlandson, 1993). In the first phase of the study, sufficiently detailed descriptions of the 
settings, participants, data collection methods and analysis procedures are presented to the 
reader. In addition, direct quotations from the participants are used to allow the reader to have 
a better understanding of the context. This thick description will hopefully enable others 
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interested in applying the findings within their research context to reach a conclusion about the 
transferability of the findings. 
Last, reflexivity is concerned with the results during interviews or storytellings, which 
are constructed in the “joint enterprise between interviewer and interviewee” (Hyden, 1994, p. 
99). This refers to the researcher’s appreciation of their own beliefs, characteristics and how 
this may impact the research process (Hansen, 2006). To be reflexive, the researcher is 
required to critically evaluate their emotional investment and biases, in relation to the 
participants, and how these may act as potential influences on the results (Wilkinson, 1998). 
Reflexivity was maintained throughout the current project through two strategies. First, it was 
important to disclose relevant beliefs and assumptions in advance. This required the researcher 
to acknowledge her values, interests and the significance of these in understanding resilience. 
This enables the reader to interpret data more transparently and consider possible alternatives. 
Thus, as the main researcher, two related areas motivated my interest in this study. First, my 
curiosity about subjectivity and how individuals give voice to their experiences following 
health crises. In addition, my interest in understanding how some individuals living with 
chronic illness are able to develop and maintain resilience, while others find this more difficult 
provided a second motivation.  
Second, reflexivity was preserved through detailed records via a journal that showed 
evidence of all the planning and research interactions (Schatzman & Strauss, 1973). This 
journal was also a compilation of captured thoughts, ideas, feelings, emotions, and 
observations regarding data collection and analysis. This enabled a continual reassessment and 
self-appraisal process, with the acknowledgement that my own personal experiences could 
influence the analysis and interpretation of the data. For example, as the interviewer, a relevant 
difference between myself and participants particularly for a study of this nature was my status 
as a person that had not experienced cancer. However, 20 years of working within healthcare 
would have influenced my interpretation to some degree. To address reflexivity, during the 
interviews, the researcher openly explained to the participants that she was a nurse and a 
psychologist, but was currently in the role of researcher wishing to understand their 
perspective.  
In summary, to guarantee that the research was accurate, the methods of rigour used in 
the current study included: purposive sampling, credibility, dependability, confirmability, 
transferability and reflexivity. These became an essential feature of each phase of the research 
process, as the quality of the research was dependent on the trustworthiness with which it was 
conducted. In addition, the methods of rigour helped to ensure that the research was a genuine 
representation of the beliefs of the participants. This aspect of rigour was crucial, as the aim of 
this research was not to identify the researchers’ understanding of resilience, but rather that of 
each HC survivor.  
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Data Collection – In-depth Semi Structured Interviews 
Phase One aimed to identify those risk and protective factors which contribute to the 
process of resilience from the subjective viewpoint of individual HC survivor undertaking the 
experience. Hence, in this first phase, in-depth, flexible, semi-structured interviews were 
chosen as the preferred method to collect data. Interviews are known as “…conversations with 
a purpose…” (Holloway, 1997, p. 94) and fit appropriately within the social constructionism 
framework, including the phenomenological method of data collection.  As there was limited 
knowledge about resilience among HC survivors, face-to-face, in-depth interviews were 
necessary to further explore the experiences, views and needs of this population. This data 
collection method is supported by Osborne and colleagues (2012), who investigated the issues 
that matter most to HC survivors, specifically those with multiple myeloma. Their systematic 
review recommended more inductive qualitative research using in-depth interviews, in order to 
effectively identify the meaning and issues important from the patient’s perspective across the 
disease trajectory (Osborne et al., 2012). 
Conducting interviews served several purposes. First, there are limited methods 
available that can provide as much detailed information as in-depth interviews. Interviews are 
the best method to elicit participants’ experiences as they allow for the collection of thick and 
rich data (Liamputting, 2009; Erlandson, 1993). The interviews in this study explored and 
gathered each participant’s narrative that offered a broad understanding of the phenomenon 
being researched, namely resilience (van Manen, 1990). Each interview allowed for a 
conversation between the interviewer and interviewee about the meaning of this experience 
(van Manen, 1997). Hence, within the research process, the interpretation of, and meaning 
given to, the interview data was co-constructed between the researcher and the participant 
(Charmaz, 2000). In-depth interviews not only empower participants but also allow 
researchers to uncover the thoughts, perceptions and feelings experienced by these participants 
in the context of their daily lives (Minichiello, 1995). Finally, in-depth interviews generally 
provide a more relaxed atmosphere in which to collect information, especially in situations 
when the research involves sensitive topics (Boyce & Neale, 2006). 
The delivery of research interviews may present in varying formats (i.e., unstructured, 
semi-structure or structured). As such, interview methods can be identified along a continuum, 
with structured interviews and unstructured (in-depth) interviews being on opposite ends 
(Minichiello, 1995). Unlike structured interviews, semi-structured interviewing is mainly 
characterised by flexibility (Taylor & Bogdan, 1998). There are other differences between 
these methods that will be briefly highlighted. 
The structured interview technique usually involves asking the same pre-defined, 
closed-ended questions, in the same order to each new interviewee, that is delivered in a 
standardised and rigid style (Minichiello, 1995; Taylor & Bogdan, 1998). In this scenario, the 
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researcher tends to control the flow and direction of the interview. Thus, the researcher has a 
specific understanding of what is required and what questions to ask in order for this to be 
addressed. 
Conversely, the unstructured (in-depth) interview is open-ended, delivered one-on-
one, generally face-to-face, and involves much greater disclosure of the interviewee compared 
to other interviewing methods (Liamputtong, 2009; Taylor & Bogdan, 1998). During an in-
depth interview, the flow of the conversation tends to be controlled by both the participant and 
the interviewer. As a result, there is a more mutual stance on the share of power and influence 
between both individuals (Minichiello, 1995). In this circumstance, the content of what the 
interviewee is sharing is highly valued. Therefore, the interviewer will monitor the content of 
the interviewee and delicately re-direct conversation toward information that addresses the 
purpose of the interview (Minichiello, 1995). Thus, the participant’s view of the world and the 
language they use to express meaning, knowledge and understanding is considered central to 
in-depth interviewing (Minichiello, 1995). 
The in-depth, semi-structured interview sits between the structured and unstructured 
(in-depth) interviews. The researcher delivering a semi-structured interview has several pre-
determined areas that they wish to explore with open-ended questions (Ayres, 2008). Prior to 
the interviews, the researcher designs an interview schedule that contains topics that need to be 
included (Ayres, 2008). These topics are devised by the research questions pertinent to the 
study (Minichiello, 1995). The schedule is considered dynamic, as following each interview, 
new areas worthy of further investigation may be added to the interview schedule or questions 
may be revised or removed. This approach of interviewing was suitable to employ in the 
current study as there were specific areas investigated (i.e., cancer and resilience) that still 
necessitated an in-depth personal account so as to fully comprehend each participants’ 
experience of living with HC, including their resilience within that context. 
Finally as inductive, phenomenological, qualitative work, the reporting of the current 
findings is based on a commitment to the participants' point of view. In this stance, the 
researcher played the role of co-participant in the discovery and understanding of what the 
realities are of the phenomena studied (Holloway 1997). Therefore, in this study, as outlined 
by Grbich (1999), a narrative account dominates, with a clear distinction between the 
presentation of the exact words of each participant documented in the findings chapter and the 
interpretation in the following discussion chapter.  
In summary, as with any method, there are a few limitations of using in-depth 
interviews that need to be outlined. Delivering the interviews and analysing the data can be 
extremely intense and time-consuming (Tashakkorie & Teddlie, 2003). It is also difficult to 
preserve total anonymity of the respondents when conducting in-depth interviews 
(Tashakkorie & Teddlie, 2003). Finally, the interviewer must be proficient in interviewing 
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techniques in order to capture detailed, rich information from the respondents (Boyce & Neale, 
2006). Yet, despite these limitations, in-depth interviews are still deemed as the most suitable 
method for acquiring new knowledge about specific populations. 
Instruments. 
An information letter (Appendix C) was provided to the participants prior to the 
commencement of each interview. This informed each HC survivor of the nature of the study 
and how this may impact on them as participants. A consent form (Appendix D) was made 
available, which also outlined the participant’s rights and explained that the interviewer was 
not a qualified psychologist and that the interview was non-therapeutic. As survivorship is a 
complex phenomenon, the interviews had the potential to be upsetting, therefore each 
participant was also given a list of contacts for counselling and supportive services (Appendix 
E) to refer to if required. Prior to the interview, participants were asked to provide 
demographic details (i.e., age and cancer diagnosis) (Appendix F). A semi-structured schedule 
of open-ended questions was used to conduct each interview. Examples of questions included, 
“Please can you tell me about your experience following your HC diagnosis?” “Do you believe 
that you have coped well during this time?” and “What has helped you to adjust?” The 
interview schedule was altered after initial interviews to include new concepts raised, which 
therefore informed subsequent interviews. The final version of the interview schedule is 
provided in Appendix G). Following each participant’s written consent, the interviews were 
digitally recorded.  
The SPSS statistical analysis program (Version 22) was used to analyse the 
demographic data. To assist with a more valid explication of the data, a further qualitative 
analysis was also undertaken using Leximancer (4.0) a software program developed by Dr 
Andrew Smith at The University of Queensland’s Faculty of Social and Behavioural Sciences. 
Leximancer is a text analytic tool that identifies ‘meaning’ within large, unstructured, text 
based documents, by searching for key themes, concepts and ideas (to be discussed in more 
detail in the following analysis section) (Leximancer 4 Manual, 2011).  
 
Procedure 
 Recruitment.   
Purposive sampling was used to select the participants for the in-depth interviews. 
This type of sampling involved the researcher targeting subjects who, in their opinion, were 
pertinent to the research topic (Creswell, 2003). According to Creswell (2003), purposive 
sampling is usual in situations where the researcher wants to explore and identify particular 
types of cases for in-depth investigation. Further, this type of sampling is central to qualitative 
research, as it enhances the researcher’s ability to discover different patterns and problems that 
occur in the context of the study (Creswell, 2003; Patton, 2002). The participants were selected 
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on the basis of pre-determined criteria. These include the following: aged 18 years or above; 
had been diagnosed with HC at least twelve months prior; not currently an in-patient receiving 
chemotherapy or transplant; proficient in English; and, not suffering from a diagnosed mental 
illness. There were three stages taken in the recruitment of each participant for this study. 
The first stage comprised the assistance of support agencies including the Cancer 
Council of Western Australia (CCWA) and the Leukaemia Foundation of Western Australia 
who were approached to support this study. A Cancer Council representative was instrumental 
in providing the names and contact details of relevant healthcare professionals who were able 
to assist in brainstorming ideas for the recruitment of participants. Following this, the 
Leukaemia Foundation willingly disseminated the details of this study, among various key 
stakeholders (i.e., support group leaders) within their agency and to HC survivors on their 
email lists. This led to the recruitment of five participants. In addition, Edith Cowan University 
also distributed an email detailing this research to staff and students though out the Faculty of 
Health, Engineering and Science, resulting in a further three participants. 
The second stage in the recruitment process involved applying a modified chain 
referral technique (Watters & Biernacki, 1989).  This technique required the researcher to ask 
family, friends and associates if they knew of any HC survivors who might be willing to 
participate in the study. Implementing this technique had a number of advantages: it ensured 
that the recruitment was initially kept independent of the researcher, thus preventing 
respondents from being pressured into participating; the privacy of respondents who refused to 
participate was retained; and, there was a higher probability that the introduced respondents 
would qualify for the study. This was due to the fact that the researcher was able to first 
outline the selection criteria to associates/friends prior to them approaching any potential 
participants. The modified chain referral technique resulted in the recruitment of seven 
participants. 
The final step in recruitment involved snowball sampling, which is described as a 
method that uses current participants to identity other individuals of the population who meet 
the necessary criteria (Robson, 2002). This was particularly pertinent in this study, as the 
majority of HC survivors knew of others (i.e., they had met during treatment or through 
support groups) who had also been diagnosed and treated for HC. Snowball sampling 
accounted for the remaining eight participants. Despite the advantages of both the modified 
chain referral technique and snowball sampling, there was also the possibility that HC 
survivors might feel some pressure to participate. This was addressed by not making contact 
with the participants, until they had contacted the researcher. 
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Interviews.  
The same researcher conducted phase one data collection between December 2012 and 
April 2013. Each interview ranged in duration from 22 to 107 minutes (M = 48 min). The 
interviews were carried out until a point of information redundancy was reached (Lincoln & 
Guba, 1985), meaning that the interviews no longer offered any new insights into the 
experiences of these HC survivors.  
Participants who contacted the researcher were offered the information letter and 
consent form that outlined the details of the study, also highlighting specific requirements. 
Those that met the necessary criteria and were willing to be involved in the study were invited 
to participate in a face-to-face interview. A mutually acceptable time and place was arranged. 
This was either during the initial contact, or later, after the participants had read the research 
information letter and consent form. Before commencing each interview, interviewees were 
encouraged to ask any further questions, prior to collection of the signed consent forms. The 
consent included details such as permission to audio record the interviews and requesting 
permission to contact them, if necessary, at a later date for clarification or feedback in relation 
to the researcher’s interpretations of their interview. In addition, brief demographic details 
about the interviewee were also sought. The demographic information was deliberately 
obtained at the start of the interview, mainly as it provided a better understanding of the 
participant’s circumstances and allowed the framing of questions in a more relevant manner. In 
the interests of gaining the most ecologically valid1 account of HC survivor experience, the 
semi-structured interview remained flexible and the questions open-ended. The researcher 
guided the areas to be explored, based on current literature and clinical experience, whilst 
encouraging the participants to pursue their own thought processes and conversation. 
Attending through active listening, eye contact, a relaxed manner and using strategies such as 
clarification and paraphrasing enhanced rapport. This also assisted the flow of interviews, 
toward collecting richer data and facilitated a positive experience for interviewees. 
The interview process was not expected to cause distress. However, all participants 
were provided with a list of available supportive and counselling services in the event they 
experienced any stress or discomfort. Participants were also encouraged to contact the 
researcher by telephone or email if they had any further queries or information they wished to 
add following the interview. In addition, following the interview, the participants were sent a 
letter, once again reminding them of supportive services available to them and to thank each 
individual for their participation (Appendix H). Each interview was then transcribed verbatim 
to ensure an accurate representation of the conversation. Pseudonyms were used during the 
interview to ensure anonymity of each participant. 
 																																																								1	Ecological validity the ability to generalize findings to real-life settings 	
RESILIENCE IN HC SURVIVORS 95	
Analyses 
Thematic Analysis. 
Thematic analysis is a method for ascertaining themes, categories and concepts within 
qualitative data, which can be expanded into groups in order to develop more abstract concepts 
(Braun & Clarke, 2006; Liamputtong & Ezzy, 2009). The documented data are transcribed, 
coded and arranged into themes categorised by certain characteristics. According to Braun and 
Clarke (2006), a theme “captures something important about the data in relation to the research 
question, and represents some level of patterned response or meaning within the data set” (p. 
82). This analysis aimed to unravel the narrative data in order to reflect the deeper meaning of 
this personal journey with HC survivors. The six stages of thematic analysis are outlined in 
Figure 4.2. 
 
 
Figure 4.2. Six stages of thematic analysis outlined by Braun and Clarke (2006). 
 
Step 1: According to Braun and Clarke (2006), in order to completely familiarise the 
researcher with the data, the first stage in thematic analysis involves actively reading and re-
reading each transcript, whist generating ideas (i.e., by searching for meaning). In this study, 
the researcher transcribed all of the collected qualitative data and therefore had a solid 
understanding of the interview material prior to re-reading each interview transcript. 
Step 2: The recurring topics within each transcript were grouped and coded by the 
researcher. A cut and sort method (Miles & Huberman, 1994) was used by the researcher once 
key phrases were identified. For example, the different features and ideas were printed in 
various colour fonts to allow for easy identification by the researcher. These were then cut and 
printed on separate paper sheets according to their features. 
Step 3: The groups of phrases and initial codes were placed into broad themes so that 
an overarching theme or sub-theme was produced. 
Stage 1
Data transcribed 
verbatim (re-read, 
search for meaning & 
generate ideas)
Stage 2
Initial codes are 
generated (by noting 
interesting features & 
organising ideas)
Stage 3
Initial codes are collated 
into broader themes & 
relevant data combined
Stage 4
Themes reviewed, 
revised & thematic map 
of analysis generated 
Stage 5
Focus shifts to defining 
& naming themes
Stage 6
Themes are written up 
in a report, relative to 
research questions 
RESILIENCE IN HC SURVIVORS 96	
Step 4: A thematic map was created which linked initial themes and identified any 
overlapping features in the analysis. At this point of the thematic analysis, the variation 
between participants’ resilience in terms of protective and risk factors began to surface. An 
example of this was phrases relating to ‘challenges in dealing with uncertainty’, which most 
participants discussed in some detail. The themes were then defined as either important details 
of the data relating to the research question (i.e., coping strategies implemented) or those 
which represented a patterned response (i.e., those recurring across transcripts). The transcripts 
were also revisited as new themes emerged from the analysis to identify any missing phrases. 
Step 5:  Underlying assumptions began to emerge with each successive refinement of 
analysis of the data. This level of data analysis is referred to as latent thematic analysis (Braun 
& Clarke, 2006), where the researcher explores the material beyond the semantic content level 
to include underlying ideas shaping the data. Therefore, the researcher examined the 
transcripts for broader assumptions within the data that were not always clearly discussed by 
interviewees. For example, the exploration of the theme related to ‘employment’ was 
examined and found to reveal an extended theme including ‘loss’ that impacted on the 
participant’s ability to be resilient. Hence, this stage involved defining the essence of the 
theme and identifying what the narrative data represented. 
Step 6: The final step of this analysis was to produce a report that summarised the 
personal experience of each participant and determined relevant links between protective 
and/or risk factors that influenced the resilience process. 
In this analysis the researcher used an inductive approach, identifying themes 
convincingly related to the data, without trying to fit the data into pre-existing codes (Braun & 
Clarke, 2006). However, in this qualitative research, the initial instrument for analysis was the 
researcher. Therefore, it is recognised that this qualitative analysis is subjective in nature 
(Starks & Trinidad, 2007). Hence, as discussed earlier, several methods were incorporated in 
order to enhance the validity and reliability of the analysis methods, reduce bias and ensure 
theoretical and procedural rigour. For example, as discussed previously, to ensure researcher 
confidence in the objective approach to the data analyses, the transcripts and identified 
themes/codes were sent to five of the interviewees for feedback. The responses indicated that 
the transcripts correctly portrayed the participants experience and, therefore, no major changes 
were necessary. In addition, at various points in time throughout the coding process the 
researcher also met with her supervisors, who were able to assist in the verification and 
confirmation of code names and themes. Finally, as a validity test, this study also used the 
Leximancer analytic software to further analyse the interview data. 
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Leximancer software analysis. 
Leximancer analysis provides a platform for qualitative interpretation of concepts in 
interview transcripts (Smith & Humphreys, 2006). The Leximancer tool searches for concepts 
within multiple transcripts, visually represents these within the data and also provides a forum 
to view related concepts in one place (Cretchley, Rooney, & Gallois, 2010). Leximancer 
differentiates between concepts and words, with concepts being the most semantically 
important words. This information is then visually presented as a ‘concept map’ that provides 
a bird’s eye view of the analysis. As explained by Cretchley, Rooney and Gallois (2010), “this 
map visually represents the strength of association between concepts and provides a 
conceptual overview of the semantic structure of the data” (p. 319).  
In order to summarise the main idea in a particular cluster, each cluster of concepts, 
are also grouped by theme circles. The theme is labelled after the most significant concept in 
that group, which is also represented by the largest dot in the theme cluster (Cretchley, 
Rooney, & Gallois, 2010). In addition, Leximancer creates a list, referred to as a ‘thesaurus’, 
of closely associated words linked by proximity to a particular concept. This proved 
particularly useful for the researcher when making comparisons between different participants 
on one concept. 
There are several advantages in using Leximancer software. First, this program 
visually displayed the presence of defining concepts, identified the strength of connections 
between each concept and also provided links to the original text, thus assisting the researcher 
to identify specific concepts and their relationships (Leximancer 4 Manual, 2011). Second, this 
method varies from standard content analysis in that specific word strings are not needed. 
Rather, Leximancer recognises what concepts exist in a set of texts, enabling concepts to be 
automatically coded (Cretchley, Rooney, & Gallois, 2010). Another attribute of Leximancer’s 
analysis is its reliability, measured in two ways: stability (i.e., equivalent to intercoder 
reliability) and reproducibility (Smith & Humphreys, 2006). Leximancer is consistent in the 
manner it organises text and recognises relationships between concepts, hence the same result 
is produced, irrespective of how many times a data set is coded and recoded (Cretchley, 
Rooney, & Gallois, 2010; Smith & Humphreys, 2006). Finally, Leximancer’s automatic 
‘concept extraction’ ensures that the concepts emerge from the actual data, rather than the 
researcher instructing or directing the program (Smith & Humphreys, 2006). This enabled an 
unbiased, objective analysis and a second means of exploring the transcripts done by hand, 
thus further enhancing the reliability and validity of these results. 
 The next section outlines Phase Two (quantitative) and the methodological processes 
carried out in the development of an appropriate questionnaire for the final study. First, the 
pilot study undertaken to test the reliability and credibility of the developed scales (Stage I) is 
outlined, followed by the methodology involved in the final questionnaire (Stage II).   
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Phase Two – Quantitative Study 
 
Instrument Development and Pilot Study (Stage I) 
Stage I of the second phase of this research involved the development and testing of 
questionnaire items. Questionnaires are one of the most common types of measurement tools 
used when adopting a post positivist approach (Neuman, 2011) and are a useful component of 
mixed method studies (Creswell & Plano Clark, 2011). A pilot study was also implemented to 
test the developed questionnaire and ensure the final instrument was reliable, valid and simple 
to complete, prior to dissemination among a larger sample of HC survivors in Stage II.  
Various methods were included in the development of the questionnaire (Stage I). 
First, the resilience factors identified in Phase One of the study along with knowledge gained 
from current literature were included as relevant factors in the questionnaire. Once the 
measures had been selected, the next step was to develop relevant questions to use in the pilot 
survey in order to obtain the most accurate demographic and personal information. This was 
achieved by adhering to the fundamental issues in questionnaire design, specifically the 
wording type and sequence of questions (Boynton & Greenhalgh, 2004). The pilot 
questionnaire was then distributed to university experts (supervisors) to ensure that all areas of 
concern were comprehensively addressed. Throughout this stage, the content and design of the 
pilot questionnaire was refined. The combination of these methods, which will be discussed in 
more detail, helped to ensure face, construct and content validity of the final questionnaire. 
Finally, the draft questionnaire was then informally pre-tested for clarity and readability using 
a convenience sample of mixed cancer survivors.  
 
Questionnaire Development 
Questionnaires provide a simple way of sampling behaviours, attitudes, and beliefs, 
whilst providing anonymity and highlighting patterns among responses (Robson, 2002). One 
of the main strengths of questionnaires is their usefulness in obtaining data from a large 
number of participants quickly, easily and efficiently, especially if these are self-administered 
(De Vaus, 2002; Wadsworth, 1997). According to Angus and Katona (1953), “it is this 
capacity for wide application and broad coverage which gives the survey technique its great 
usefulness...” (p.16). Questionnaires can also be easily disseminated to varied locations, thus 
providing access to a geographically diverse sample (Nardi, 2006). This is a significant factor 
as it provides a better representation of the population and assists in enhancing the validity of 
the developed questionnaire and the interpretations derived from the responses (Nardi, 2006). 
Further, questionnaires are comparatively easy to create, code and interpret and are generally 
cost effective and less time consuming than other methods (Dillman, 1983). 
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Questionnaires are also a very reliable method as they include questions with uniform 
definitions that guarantee all participants are asked the same questions in the same way 
(Hagino, 2002). Another advantage of using a questionnaire, especially for this study, where 
the questions were personal in nature, was the high degree of anonymity it offered 
respondents. Participants could complete the questionnaire in their own time, respond in 
private and at a place convenient to them. In addition, as anonymity and confidentiality were 
ensured, participants could be more honest and accurate in their responses, that were free from 
interviewer bias (Bernard, 2000; Dillman, 1983). Finally, questionnaires can also measure 
variables that cannot be observed (i.e., opinions and feelings) and allow for numerous topics to 
be dealt with concurrently (De Vaus, 2002; Nardi, 2006). 
However, like any research method, there are limitations to using questionnaires. One 
of the key issues is that questionnaires are generally linked with lower response rates (Mertens, 
2005; Neuman, 2011). This can be credited to the impersonal nature of questionnaires where 
there is no occasion for the participants to build rapport with the researcher (Gliner & Morgan, 
2000). Another disadvantage is the structure of questionnaires, which limits the kind of 
questions researchers can include and makes it challenging for researchers to examine complex 
issues and opinions (Neuman, 2011). Hence, even when open-ended questions are included, 
researchers may find it difficult to obtain rich in-depth information, as most of the answers 
provided by respondents tend to lack complexity (Wadsworth, 1996). Lastly, researchers are 
unable to limit the situations under which the questionnaire is completed. For example, the 
researcher has no way of knowing who actually filled out the questionnaire or if the 
respondent has completely understood the questions. Yet, in spite of these limitations, in this 
study, questionnaires were still considered the most comprehensive and efficient way of 
gathering information. 
 
Pilot Study 
Instrument Development Data Collection. 
Based on the literature review a questionnaire was developed and piloted. The pilot 
questionnaire was tested on a convenience sample of mixed cancer survivors, all of whom 
spoke English and lived within the Perth metropolitan area of Western Australia. It was not 
necessary at this stage to only include HC survivors for the pilot study, as the purpose of this 
pre-test was to first investigate the reliability, validity and feasibility of the developed 
questionnaire. Qualtrics (by Smith, Smith, Smith, & Orgill in 2002) was used to develop and 
distribute the on-line, self-administered pilot questionnaire (Appendix IA through to IE). The 
participants all received an information flyer (Appendix J) that was attached to the emails and 
explained the purpose of the research, outlined participation criteria, discussed 
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privacy/confidentiality issues and requested participation. This information was also included 
in the first section of the Qualtrics survey to ensure all participants were informed.  
In order to establish the representativeness of the sample, a range of demographic 
details were obtained. Participants were asked information regarding their age, sex, cancer 
diagnosis, treatment type, time since diagnosis, cancer relapse details, ethnicity, educational 
level, religious affiliation, relationship status, and occupation. In addition, the inclusion of the 
participant’s postcode allowed for geographic categorisation. At the completion of this section 
of the survey, participants were asked to comment on any questions they had difficulty 
answering. The following sections outline the scales sourced for the pilot study. These were 
selected on the basis of their suitability and the majority had been validated in previous 
research efforts.  
The pilot survey contained 20 items measuring demographic variables and 5 scales 
comprising 103 items measuring 30 variables. Twenty-two of the 30 variable were examined 
due to the base of evidence that they measured the domains from both the literature on 
resilience and the findings identified during the interviews. These included family support, 
support from friends, healthcare professionals and significant others, self-distraction, active 
coping, denial, substance use, emotional support, instrumental support, behavioural 
disengagement, venting, positive reframing, planning, humour, acceptance, religion, self-
blame, exercise, diet modification, care in appearance and taking time out. Therefore, the final 
pre-test instrument contained all the relevant questions (including standardized instruments) 
designed to obtain the most accurate information about the factors of interest in this 
dissertation regarding resilience. These scales are discussed in more detail below. 
 
Instruments. 
Coping Strategies. The Brief-COPE is a validated, multidimensional inventory 
which assesses situational coping (Carver, 1997). The Brief-COPE is a shorter version of the 
original COPE Inventory (Carver, Scheier, & Weintraub, 1989), which Carver (1997) later 
refined. The 60-item inventory was reduced to 28 items by removing two scales proven to be 
less reliable and through reducing other redundant items from the remaining scales. The short-
form version of the COPE assesses coping strategies on 14 conceptually different subscales 
with internal consistency ratings for each ranging from .50 to .90 (Carver, 1997). Scores range 
from 1 (‘generally don’t) to 4 (‘generally a lot’), with higher scores indicating greater use of a 
particular coping style. Carver indicated that the Brief-COPE scale is not designed to have an 
overall coping score and that each item should be assessed individually.  
Social Support. The Multidimensional Scale of Perceived Social Support 
(MSPSS) is a self-report measure of subjective feeling towards degree of social support 
(Zimet, Dahlem, Zimet, & Farley, 1988). This 12-item scale measures perceived social support 
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received from family, friends and significant others. Examples of the items include: “My 
family really tries to help me”; “I can talk about my problems with my friends”; and “There is 
a special person in my life who cares about my feelings”. High internal consistency for the 
overall scale was reported (a = .88), and Cronbach’s coefficient for the significant other, 
family and friends subscales were .91, .87 and .85 respectively (Zimet et al., 1988). Test-retest 
reliability for the total scale was found to be high (r = .85). Similarly, subscale test-retest 
reliability were also shown to be high (i.e., significant other r  = .72; family r  = .85; friends r  
= .75) (Zimet et al., 1988).  
The literature maintains that it is important to investigate different sources of social 
support, rather than measure it as an overall construct (Mustanski & Liu, 2013; Mustanski et 
al., 2011). With this in mind, and as a result of the findings from Phase One, four additional 
items that importantly measured healthcare professional support were added to this scale. For 
example, “I get the emotional support I need from my healthcare provider”. Thus, all subscales 
contained four items each (in total 16 items) on a 7-point Likert scale (ranging from 1 = 
strongly disagree to 7 = strongly agree). Higher scores indicate greater social support from 
either family, friends, significant others or healthcare professionals.  
It was important to include the MSPPS in this pilot study as research suggests that 
adjustment and social support are not only key elements of coping and social well-being (Hahn 
et al., 2010, McCabe & Cronin, 2011), but are also associated with low levels of depression 
and anxiety (Zimet et al., 1988). The MSPSS was selected among others scales that assessed 
social support, as it presented in a manner that was self-explanatory and straightforward to 
complete. Moreover, the scale was also considered useful as a subjective assessment of social 
support from multiple sources. 
Resilience. The Resilience Scale for Adults (RSA) consists of 33 items with 
semantic differential response (bipolar) options (Friborg et al., 2005). This means that each 
item has a negative and a positive attribute at each end of the scale continuum. The RSA 
intended to measure protective resources that correspond accurately with the overarching 
classification of resilience (Friborg, Hjemdal, Rosenvinge, & Martinussen, 2003). According 
to previous literature these include: personal/dispositional attributes, family support and 
external/community support systems (Garmezy, 1993; Rutter, 1990; Werner, 1989; Werner, 
1993).  
Thus, the RSA comprises five factors measuring personal competence (personal 
strength, social competence and structured style), family cohesion and social resources. The 
first category, ‘personal strength’ contains two primary factors. The first factor, measures 
perception of self (i.e., views of current strengths and abilities, self-liking, hope, 
determination) and the second planned future (realising future plans and goals). ‘Social 
competence’ measures social adaptiveness, communication skills, mood, extraversion, 
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initiation of activities and social flexibility. The third factor in this category, structured style, 
measures the ability to plan, organise and adhere to daily routines. In the second category 
‘family cohesion’ was determined by family coherence, which measures cooperation, stability, 
family conflict and loyalty. The final category, external support systems included the factor 
social resources, measuring intimacy and access to external support from relatives and friends 
(Friborg et al., 2003; Friborg et al., 2005). An example of one item on the RSA is, “I feel that 
my future looks”, where the negative attribute is “uncertain” and the positive attribute is “very 
promising”. In response, the participant selects the attribute that best describes them. 
Cronbach’s alpha for these items resulted in high reliability (a = .89).  
The RSA is recognised as a valid and reliable measure in health and clinical 
psychology to assess the presence of protective factors essential for maintaining mental health 
and aiding recovery (Friborg et al., 2003; Friborg, Hjemdal, Martinussen, & Rosenvinge, 
(2009). Several previous reviews investigating resilience measures concur with these findings 
and further support the RSA as a scale to include (Ahern, Kiehl, Sole, & Byers, 2006; 
Davydov et al., 2010). A systematic review of resilience measures published by Windle, 
Bennett, and Noyes (2011) found the RSA to have the highest test-retest reliability. According 
to Windle and colleagues, this provides, “some indication of the measure's stability, and an 
early indication of the potential for it to be able to detect clinically important change, as 
opposed to measurement error” (p. 16). The RSA was also one of three scales developed for 
use with an adult population, which received the highest overall ratings. Windle, Bennett, and 
Noyes argued that, “whilst a strong sense of personal agency is important for negotiating 
adversity, the availability of resources from the level of family and community are also 
important” (p. 14). Ideally, one should include a measurement instrument capable of assessing 
a range of protective mechanisms within multiple domains. The RSA is one such measure that 
evaluates resilience as a dynamic process of adaptation to adversity, by examining resilience 
across multiple levels (Windle, Bennett, & Noyes, 2011). 
Similar reliability and validity results to those found by Windle and colleagues (2011) 
were also reported in earlier studies. Based on a review of instruments measuring resilience, 
the RSA was one of three instruments found to have acceptable internal reliability (Ahern et 
al., 2006). In addition, more recent results using a healthy sample supported the validity of the 
RSA, as it was identified that individuals scoring high on this scale were psychologically 
healthier, better adjusted, and thus more resilient  (Davydov et al., 2010). 
Depression and Anxiety. The Hospital Anxiety and Depression Scale (HADS; 
Zigmond & Snaith, 1983) is a 14-item questionnaire that assesses anxiety and depression. The 
HADS has been extensively used in various patient groups, including cancer survivors, and 
has proven to be a valid and reliable independent measure (Llewellyn et al., 2013; Mitchell et 
al, 2011; Vodermaier, Linden, & Siu, 2009). For example, an internal consistency of .93 for 
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the anxiety subscale and .90 for the depression subscale were reported when the HADS was 
administered to a group of cancer patients (Greer, Moorey, & Baruch, 1991). 
Each question included in the HADS has four possible answers rated from zero to 
three, thus scores can range from 0 – 21 for each subscale (anxiety and depression). Examples 
include: “I still enjoy the things I used to enjoy” and “Worrying thoughts go through my 
mind”. Higher scores (>15) are suggestive of a clinical depressive/anxiety disorder, scores 
between 11 and 21 suggest subclinical depression/anxiety, whereas lower scores (< 7) are 
considered normal.  
The HADS was considered appropriate for this study for several reasons. First, the 
scale was designed specifically to be a measure of psychological distress among those 
individuals living with physical illness such as cancer. The HADS focuses more on the 
cognitive (psychological) function rather than the somatic (physiological/physical) function of 
the individual. In addition, the HADS is a measure of recent episodes of anxiety and 
depression (i.e. patients’ experiences in the last seven days). Therefore, this will help assess 
how both short- and long-term survivors are currently managing with their mental health.  
Health Behaviour Change. The qualitative findings of this study, completed 
during Phase One (Chapter 5), indicated that many HC survivors maintained their resilience 
through proactive health behaviour reform. Many of these included, but were not limited to: 
partaking in a hobby, finding time for themselves, taking care of their appearance, complying 
with treatment recommendations, participating in complementary/alternative health practises, 
modifying their diet, increasing their level of exercise, planning and being more organised 
with their health appointments, researching cancer-related information and proactively seeking 
support (i.e., internet, clinician, community, family). 
In order to limit the length of this survey, seven Phase One participants were contacted 
and asked to rate the top four health or behavioural factors that they believed contributed the 
most in maintaining their resilience. The results suggested that exercise, dietary changes, care 
in self-appearance and taking time out for oneself were most influential. Consequently, 12 
items were developed to measure these four factors. For example, “When I take time out for 
myself I cope better” and “My concerns are less when I do some form of regular exercise”. 
The respondents were asked to rate each item on a 6-point Likert-type of rating scale ranging 
from ‘strongly disagree’ to ‘strongly agree’. After completing the scale participants were asked 
if there were any questions they found difficult or confusing to answer. In addition, a final 
open-ended question in this pilot study asked if there was anything important missed in how 
they had each coped and if so to provide further details.  
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Phase Two – Quantitative Study (Stage II) 
The next section outlines the final quantitative study, which begins by providing an 
overview of the paradigm employed (post positivism). The methodology including a 
description of survey development is then explained. Third, the data collection (questionnaire) 
final instrument and recruitment procedure are outlined, followed by the data collection 
process. Finally, the rationale for the statistical analyses employed in the second stage of Phase 
Two are explained. 
 
Paradigm - Post Positivism  
In comparison to social constructionism, the positivist paradigm believes that the 
social world occurs externally and should therefore be measured through objective 
methodologies rather than being understood subjectively (Easterby-Smith, Thorpe, & Lowe, 
1991). Positivism was the paradigm that informed early psychological literature and supported 
the implementation of scientific methods to discover objective truths (Lincoln & Guba, 2003).  
Positivists searched for the “truth” by using the most effective and unbiased methods 
in order to elicit information that was factual (De Laine, 1997). Such an approach required the 
research inquiry to be value free, with the investigator and the phenomenon being independent 
of each other (Guba & Lincoln, 1989). From this perspective, positivists used quantitative 
methods, such as surveys to measure and analyse causal relationships between variables and to 
test existing theories, thus providing results that were replicable and generalisable (Creswell, 
2003; Deshpande, 1983). The positivists believed in empiricism, which refers to the belief that 
observation and measurement was central to the scientific agenda and the goal of knowledge 
was to describe the phenomena that individual’s experience (Creswell, 2003).  
Despite comparable ideals to that of positivism, the post positivism paradigm 
identifies that knowledge can always be flawed (Creswell, 2009; Crotty, 1998; Daly, 2007). 
The positivists believed the goal of science was to uncover the truth. Yet, the post positivist 
believes that the goal of science is to hold true to the goal of getting reality correct, even 
though we can never entirely achieve that goal (Trochim, 2000). Post positivists rejected the 
idea that any person can see the world perfectly (as it really is) as our observations are “theory 
laden” and therefore biased by previous experience (Daly, 2007; Trochim, 2000).  
One of the most universal forms of post positivism is a philosophy referred to as 
critical realism (Trochim, 2000). According to Trochim (2006), a critical realist “believes that 
there is a reality that is independent of our thinking about it that science can study” (p. 2). 
Although positivists were considered realists, post positivists are also critical of the 
researcher’s ability to know reality with certainty. As such, the difference is that post 
positivists are critical realists in that they acknowledge that observation may be in error, is 
fallible and that all theory is revisable (Daly, 2007; Trochim, 2000). Thus, as theory and/or 
RESILIENCE IN HC SURVIVORS 105	
hypotheses can never be proven as true, instead evidence needs to be collated in order to reject 
it or prove it wrong (Crotty, 1998). Post positivism still considers objectivity and empiricism 
as important values, hence quantitative methods are well established within this paradigm.  
In the current study, post positivism was considered an appropriate paradigm for Phase 
Two, as it involved quantitative methods with the aim of further developing and validating the 
findings from Phase One. According to post positivists, our best prospect for realising 
objectivity is to triangulate across many fallible viewpoints, whilst acknowledging that each of 
these may still contain different types of error (Trochim, 2000).  
In summary, within the two paradigms discussed, first social constructionism provided 
a framework for understanding the context of the individual (i.e., their interpretations, cultural 
influence, meanings, and experience of what is was like to be a HC survivor). Second, post 
positivism ensured reliability, objectivity and empirical evidence so that variables identified in 
Phase One could be applied to a larger sample and tested for their relevance. The next section 
outlines the research methodology and the rationale for selecting a quantitative survey design 
and correlational research.  
 
Research Methodology – Quantitative Survey  
Quantitative research methods aim to explain phenomena by collecting numerical data 
that are analysed using mathematical methods often involving statistical techniques (Creswell, 
2003; Martin, 2004). In general, a study commences with the collection of data that is based on 
a theory or hypothesis, which is followed by the use of descriptive or inferential statistical 
methods (Muijs, 2004). The causal relationships are examined by manipulating factors 
considered to influence the phenomena of concern, while controlling other variables pertinent 
to the experimental outcomes (Creswell, 2003; Patton, 2002).  
Quantitative research is generally based on positivist/post positivist paradigms, 
objectivity, reliability and empiricism (Martin, 2004; Muijs, 2004). In addition, quantitative 
research is deductive, seeking to test theory/hypotheses or measure variables (Muijs, 2004; 
Neuman, 2011). A strength of quantitative research is that results are considered as factual, 
reliable and, thus, have the ability to be generalised to a larger population (Steckler, McLeroy, 
Goodman, Bird, & McCormick, 1992).  
This quantitative study involved a combination of descriptive and correlational 
research. It is descriptive, in that its rationale was to generalize variables to a larger sample of 
HC survivors. However, this research was also correlational, as it investigated the relationship 
between variables (Martin, 2004). The process of collecting data within Phase Two was via the 
use of survey research and so, for the purposes of the current study, the design used in Phase 
Two was considered as a survey. However, the aspects of the correlational design will also be 
outlined below. 
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Surveys. 
Quantitative surveys are widely used by psychologists, where statistics such as the 
proportion of respondents who display one or more psychological traits are reported. In such 
surveys, respondents are asked a set of structured questions and their responses are tabulated. 
There are several quantitative research designs that include: experimental studies, quasi-
experimental studies (i.e., cause and effect studies that involve variable manipulation); 
descriptive/survey research (i.e., to describe a particular sample); and, correlational 
research/survey research (i.e., used to explore associations between variables) (Martin, 2004; 
Mertens, 2003; Nardi, 2006). The process of gathering data within Phase Two was through the 
use of surveys.  
According to Goodwin (2008), a survey is a “structured set of questions or statements 
given to a group of people to measure their attitudes, beliefs, values, or tendencies to act” (p. 
435). Thus, surveys gather data in various formats including questionnaires, observations and 
interviews (individual, group, face-to-face, telephone) (De Vaus, 2002). The terms 
questionnaire and surveys are often referred to interchangeably (Giles, 2002). However, there 
is a subtle difference in that questionnaires are considered the tools that are used to collect the 
data, where as surveys relate more to the actual method of conducting research (Giles, 2002).  
In order to achieve generalisation, large, randomised samples are usually selected 
when conducting survey research (Neuman, 2011). There are two types of survey designs: 
longitudinal and cross-sectional. Longitudinal designs collect data from the same sample at 
different points in time. As a result, longitudinal designs enable patterns of change to emerge 
over a period of time (Neuman, 2011). Hence, comparisons are made between the different 
points of data collection. Conversely, in cross-sectional designs, surveys are collected at a 
single point in time and only administered once to a selected sample (Giles, 2002). Cross-
sectional designs are beneficial, in that they enable data to be collected from two or more 
different groups simultaneously, which can allow for comparisons and are therefore relatively 
cost and time efficient (Giles, 2002; Neuman, 2011).  
Correlational research. 
Correlational research enables the researcher to explore individual differences in the 
sample by observing variables in their natural state and also the relationships between them 
(Goodwin, 2008). However, without manipulation it is unknown which variable influenced the 
other, or whether a third extraneous variable explains the relationship. Therefore, only the 
associations between variables can be identified, and the reasons why these variables are 
related are often unable to be established (Mitchell & Jolly, 2010).  
Conversely, experimental research manipulates variables in an attempt to control and 
limit individual differences, with the intent of exploring cause-effect relationships (Goodwin, 
RESILIENCE IN HC SURVIVORS 107	
2008). Yet, it is not always possible to manipulate or control variables within the social 
sciences, thus correlational research provides a flexible option to test variables in a given 
context. Experimental research can stem from correlational research by further investigating 
relationships. However, in this study, correlational research is a useful starting point to 
examine the relationship of variables that have not been manipulated or controlled.  
 In summary, a cross-sectional survey design that employed correlational research was 
used in Phase Two (Stage II) of this research. This allowed for data collection of a large 
sample in a cost efficient manner to be completed in the limited timeframe available. The use 
of a survey design enabled the researcher to examine the generalisability of variables and to 
conduct correlational research within a single application. Therefore, this study enabled the 
researcher to explore and examine the relationship between variables (i.e., the contextualised 
model developed during Phase One) to a more generalised measure of protective processes 
related to resilience. 
 
Data Collection – Questionnaire 
 Final Instrument. 
As previously outlined in the description of the pilot study (Stage I), the validated 
measures included in the final questionnaire comprised the: Brief Cope (Carver, 1997); 
Multidimensional Scale of Perceived Social Support (MSPPS) (Zimet et al., 1988); Resilience 
Scale for Adults (RSA) (Friborg et al., 2005); and, the Hospital Anxiety and Depression Scale 
(HADS) (Zigmond & Snaith, 1983). In addition, several items developed to measure positive 
health behaviour change (HBC) (i.e., exercise, diet etc.) were also included.  
However, it is not yet known if additional research measures are required in the final 
questionnaire, as this will be guided by the findings of the pilot study. For example, there may 
be additional items relating to various coping strategies or health behaviour change that 
emerge though the pilot study findings. Therefore the final instrument tool will be outlined in 
detail in Chapter 7, following the pilot study results.  
 
Procedure  
 Recruitment. 
There were several recruitment methods implemented concurrently. First, purposive 
sampling (a deliberate process of choosing people to ensure representation of key 
characteristics) was used, in which an email with a hyperlink and an attached information 
letter with consent information (Appendix K) was disseminated. This requested that only 
individuals diagnosed with HC, who were over the age of 18 and English speaking 
participated. This was sent to friends, family, cancer and social communities, research 
institutes, including a database of interstate HC survivors (who contacted the researcher during 
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Phase One, but were unable to participate in the interviews). Several of these individuals then 
forwarded the study details onto other key stakeholders and potential participants. 
Social media was another medium used to advertise the study. A Facebook page was 
created with appropriate privacy settings that initially advertised the study and had a hyperlink 
on the home page. Permission was then sought from the administrator of 15 different national 
and international HC-related Facebook sites (i.e., Leukaemia Sucks, Delete Blood Cancer, 
Multiple Myeloma Awareness, The Lymphoma Club, CLL Society, Chronic Myeloid 
Leukaemia, etc.). In addition, the study was publicized on the Facebook pages of the Harry 
Perkins Institute of Medical Research, Ride to Conquer and the CML support group for 
Australia. The respective administrators went on to post the study information on other 
Facebook forums including CML survivors, Multiple Myeloma Awareness, and Lymphoma 
Club. The administrators also provided friend suggestions, which led to individual friend 
requests. Although over 300 friend suggestions were sent to this Facebook page, in order to 
maintain individual privacy, only those who sent friend requests were accepted. This resulted 
in 215 friends all of whom could view the study information and forward the hyperlink to 
other potential participants. In addition, an ‘event’ was also created on this Facebook site, 
which resulted in 25 individuals choosing to attend. However, this was not necessarily 
representative of participation, as some individuals may have elected not to participate or may 
not have met the study criteria. The created event not only provided a forum to advertise the 
study, but also enabled the invited guests to share the study hyperlink with other HC survivor 
Facebook friends. The study was not posted on any Facebook site by the researcher without 
administrator permission. The Facebook site was frequently monitored for posted messages, 
comments or queries.  
The third recruitment method comprised the assistance of support agencies and 
healthcare providers including the Leukaemia Foundation of Western Australia and The Perth 
Blood Institute. A representative of each agency was instrumental in disseminating both emails 
and hard copies of the survey details to potential participants, predominantly at support group 
meetings or social gatherings. Finally, assistance was sought from the NSW Cancer Council 
through their ‘Join a Research Group’ initiative. This research initiative involved previous 
cancer survivors volunteering to partake in future cancer-related research. An application was 
successful in granting permission for the researcher to access the contact details of 64 
individuals currently listed on this survivor database. In the event that individuals’ contact 
details may have changed, it was advised by the NSW Cancer Council to email and also post 
hard copies to each person. As part of the distributed email and mailed copy, each individual 
was asked to forward the study information to others they knew that met the study criteria.  
It is acknowledged that, in targeting agencies and volunteer participant databases, it 
could potentially skew results towards those with high social support, due to these individuals 
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active involvement in support and research communities. However, it was intended that by 
also recruiting through several avenues, including word of mouth, healthcare providers, 
research institutes and through the Facebook page, that sampling bias may have been reduced.  
 
Analyses - Statistical 
As this study is interested in answering several questions, a number of analyses were 
required to be performed among the sample. Prior to statistical testing, the data were first 
evaluated to test for normality (Kolmogorov-Smirnov and Shapiro-Wilks), linearity and 
homoscedasticity assumptions (inspecting the normal probability plot of standardised residuals 
and scatterplot of standardised residuals against standardised predicted values) (Tabachnick & 
Fidell, 2007).  
Second, independent t-tests, one-way ANOVAs and correlation analyses (i.e., Pearson’s r and 
Spearman’s ρ) were conducted to measure the significance of differences and the strengths of 
linear relationships between variables and to investigate the relative influence of selected 
demographics (gender, age and time since diagnosis). Last, as the main focus of this study was 
to assess the ability of the model to explain variance in resilience and to identify significant 
explanatory variables, a standard multiple regression analysis (MRA) was conducted. All 
explanatory variables were entered simultaneously into the regression model to explain 
variance in resilience. Zero-order correlations between these variables and the outcome 
measures were also reported. 
This section has detailed the quantitative methodologies that were employed, 
including the methods of data collection and analyses for each stage of this project. The 
following section discusses the ethical considerations concerned with this research followed by 
an outline of the data analysis issues involved in resilience research.  
 
Ethical Considerations and Approval 
The study was submitted to, and approved by, the Edith Cowan University Human 
Research Ethics Committee (project # 8481). Ethics is an integral part of research planning 
and implementation that helps to define the benefits of the research versus the risks to 
participants. For a research study to be considered ethical, it must satisfy the principles of 
research merit and integrity, justice, beneficence and respect (Mertens, 2005) and these 
principles will guide the ethical framework for this thesis. The following section explains how 
these four ethical principles were addressed in this study. 
Research merit and integrity. 
A study cannot be ethically justifiable unless the proposed research has merit and the 
researchers who are going to carry out the research have integrity (National Health and 
Medical Research Council (NHMRC), 2007) (Crowden, 2010). The research merit and 
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integrity of this study was satisfied in the following ways. First, the study provided a better 
understanding of the support needs of HC survivors in Australia. This is an important 
contribution as this area previously been under researched. Furthermore, the study provided 
valuable data that could assist healthcare professionals to deliver more proactive and 
responsive approaches to quality care. 
Justice. 
The notion of justice involves ensuring that those who assume the burden of the 
research should be the individuals who benefit. In addition, the procedures for the recruitment 
of participants should be fairly administered and reasonable (Mertens, 2005). Justice in this 
study was attended to in several ways. Although there was no direct benefit to the participants, 
the information gained in this study aimed to enhance our understanding of HC survivors. The 
information gained helped in developing a questionnaire that provided valuable data for the 
planning and delivery of better support services for survivors. The participants were also given 
the right to be informed about the results of this study on request. Further, the recruitment 
process was fair and there was no coercion of participants. Informed consent was obtained 
from all participants involved in the study. Last, the inclusion and exclusion criteria used in the  
recruitment process were clearly stated and justified. 
 Beneficence. 
Beneficence involves maximising the possible benefits for research participants and 
minimising or avoiding unnecessary harm or risk (Mertens, 2005). In this study, the concept of 
beneficence was addressed in the following ways. During the study there was a possibility of 
psychological distress for the participants. However, the care of cancer survivors was 
paramount, as most HC survivors have already been through significant trauma as a result of 
this illness. It was essential that this research did not cause participant’s further distress. Thus, 
a list was provided with the contact details of support including psychological and counselling 
services should participants wish to discuss any issues that arose as a result of the interviews. 
Moreover, as qualitative interviews are unpredictable in nature, it was not possible to 
know exactly how each participants will feel during and following their interview (Rosenblatt, 
1995). Therefore, all participants had the option of discontinuing the interview at any time and 
of being referred to counselling if required. Participants were also contacted within four weeks 
of their interview to remind informants of the supportive services agencies available and to 
thank them for their participation.  
In addition, all information obtained was treated confidentially and the privacy of the 
participants was maintained. During the interview and analysis phases each participant was 
assigned a pseudonym, and all identifying information was kept separate from the collected 
information.  In addition, all the study data including interview transcripts, questionnaires, 
computer discs and audiotapes were stored securely in a locked filing cabinet in the 
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researcher’s office. The tape recordings were also erased following the transcription and data 
will be stored for a period of five years according to NHMRC guidelines, after which time 
they will be destroyed.  
Respect. 
Of the four principles of ethics, respect is deemed to be the most central. Respect 
involves treating people with regard and courtesy as well as providing protection to those with 
reduced autonomy (Mertens, 2005). In this study, the concept of respect was addressed in the 
following ways. Participation was entirely voluntary and issues of confidentiality were 
reinforced. Participants were also assured prior to interviews that this research would not 
impact on any current services they may be receiving. Information sheets were sent out to all 
participants prior to each phase of the study to ensure they were fully informed. During the in-
depth interviews, written informed consent was obtained from all participants, while in the 
quantitative study consent was assumed on return of the completed questionnaires to the 
researcher. Finally, all participants were given the contact details for the primary researcher, 
supervisors and ethics officers at Edith Cowan University in case they had any concerns or 
complaints about the conduct of the research.  
This last section briefly highlights the methodological issues pertaining specifically to 
resilience research and how this study attempts to address these problems. 
 
Data Analysis Issues in Resilience Research  
Although theory and empirical data concerning resilience are growing, integrating the 
literature is complex. This is mainly due to definitional and methodological variability, limited 
breadth (i.e., most include individual factors only) and/or inadequate measurement tools 
(Gartland et al., 2011; Thornton, 2002; Windle; 2011). Thus, although the presence of 
resilience across a spectrum of specific crisis events confirms its salience, interpreting the 
findings obtained from different samples presents numerous problems (Thornton, 2002). 
For example, one of the methodological issues is that, until recently, resilience was 
conceptualized mainly in terms of mono-causal models (i.e., separately in biomedical, 
psychological, or sociocultural domains of resilience), with little attempt to integrate these 
within a general theoretical framework (Bonanno, 2004; Davydov et al., 2012). As such, 
Davydov and colleagues (2012) argue that the resilience concept in mental health research is 
currently hindered by poor definition and the lack of a unified methodology (Davydov et al., 
2010).  
According to Barton (2005), another relevant issue in current resilience research is the 
lack of qualitative inquiry and previous reliance on positivist paradigms involving quantitative 
methodologies (Barton, 2005). Quantitative methodology is valuable for analysing known 
variables and the associations among them, yet this method fails to explain the nature of the 
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known variables or unearth new processes (Ungar, 2004). Subsequently, quantitative designs 
add to our understanding of relationships between variables, but do not extend or broaden the 
interpretation of resilience. For example, coping strategies are often used as a measure of 
resilience, yet quantitative methods only show correlational relationships between coping 
strategies and other variables, but do not describe what comprises coping strategies. Therefore, 
solely including the quantitative approach to resilience research is problematic, as there may 
be a supposition that it is unnecessary to search for other factors, as all of the influential factors 
associated with resilience have been identified (Barton, 2005). In addition, the quality and the 
characteristics of the variables being examined can also be less obvious when the variables are 
only examined within statistical analyses. Thus, if the aim of resilience research is to advocate 
positive change in the lives of individuals who have experienced risk such as cancer, it is 
crucial to comprehend which processes led to positive change and how these processes 
function.  
Another important issue in resilience methodology is that context is rarely considered 
in research. This is an issue as risks, protective processes, and positive outcomes may vary 
between contexts because of the resources and constraints of each context. Presently, research 
in resilience is being developed across cultures and a number of discussion papers have 
contributed substantially to the study of resilience (Ungar et al., 2007). However, in most cases 
these papers have been mainly entrenched within the discipline of developmental psychology 
and derived from studies of children and adolescents (Windle, Bennett, & Noyes, 2011). 
Although this literature is rich and informative, a substantial majority has not originated from a 
clear methodological approach. For example, methods for obtaining the results are not 
comprehensively presented (Windle, Bennett, & Noyes, 2011). In addition, limited research 
exists among those suffering from mental health problems (Davydov et al., 2010) or among 
those with chronic illness (Windle, Bennett, & Noyes, 2011). Therefore, research should be 
considered within specific contexts so that the risk, protective processes and positive outcomes 
are relevant to that context. 
According to Windle, Bennett, and Noyes (2011) many of the methodological 
differences include the variables measured, the time after exposure to the risk and the selected 
assessment. Specifically, in most studies involving cancer survivors, the measures focus on 
resilience only at the individual level (Windle, Bennett, & Noyes, 2011). While a personal 
strength is an important component of negotiating adversity, so too is the availability of 
resources from the level of family and community. Yet, in the review by Windle and 
colleagues (2011), only five of the fifteen resilience scales that had been used to measure 
resilience examined this concept across multiple levels. As such, the selected scales can 
produce different results, as they measure different level factors. Other resilience measures 
have included some environmental factors, but these are limited in scope and detail (Windle, 
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Bennett, & Noyes, 2011). As there is no gold standard, researchers have little robust evidence 
to inform their selection of a resilience scale, which may lead to an inappropriate selection for 
the population and context of interest (Windle, Bennett, & Noyes, 2011). These differences do 
not invalidate the concept of resilience, rather they highlight that variable selection and 
instrument choice are important and can influence the measurement of resilience. 
Variations in resilience over time may also arise because of the various risks 
experienced by the participants in the studies. Rutter (2007) states that, “people can be resilient 
in relation to some kinds of environmental hazards but not others. Equally, they may be 
resilient with respect to some outcomes, but not all” (p. 205). Therefore, it is not that the 
individual is resilient at one point, and non-resilient at another, it is that they may be 
experiencing different forms of adversity or only showing positive outcomes in some areas 
(e.g., academic or social competence). 
Finally, it is necessary to establish if an individual needs to be resilient throughout 
their life to be labelled resilient. For example, can a person be deemed resilient if they have 
effectively recovered from the risk of abandonment during childhood and thrived during 
adolescence, yet experience periods of dysfunction such as severe anxiety/depression during 
adulthood? The stance taken in the current study is that the construct of resilience is not 
necessary during every phase in an individual’s life in order for long-term positive outcomes to 
be realised. Hence, resilience is about being positive in the foreseeable future, acknowledging 
that we may not sustain resilience at all times.  
 
Improving Future Research Methodology. 
As a result of the issues described, in order to broaden the interpretation of resilience, 
it is necessary for future methodology to utilize both quantitative and qualitative approaches 
and to position the experiences of individuals in varying contexts. These considerations will 
ensure that the conceptualisation of resilience is not restricted to factors identified in previous 
studies and that the contextual variances are understood. In the future, Luthar, Sawyer and 
Brown (2006) proposes that, in resilience research, the risk and protective processes need to be 
malleable, generative, enduring and salient. Therefore, they should have a lasting effect, be 
relevant to a large group of individuals, investigate a phenomenon that can be improved and, if 
possible, also create positive changes in other contexts. 
Many of these methodological issues were considered when developing the current 
study. The design is mixed methods and employs both quantitative and qualitative approaches 
to identify relationships between variables and to develop new theory. The qualitative data will 
also provide a rich description of the processes that occur from the risk experienced with a 
cancer diagnosis, to the experience of positive outcomes, such as psychological wellbeing. In 
addition, the perceptions of HC survivors from a specific context are included to ensure that 
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the risks, protective processes, and positive outcomes are applicable to their experiences. In 
this way the findings will be relevant to HC survivors within this context. 
In terms of the quantitative methodology, further considerations require addressing. As 
advised by Windle (2011), researchers performing cross-sectional surveys need to consider 
implementing resilience measures that exhibit good internal consistency and good content and 
construct validity. This may provide some assurance that the concept being measured is 
theoretically robust. Research findings indicate that resilience is a multi-dimensional construct, 
hence resilience in one context does not automatically confer resilience in other contexts. 
Thus, it is vital to examine resilience more broadly.  
 
Conclusion 
This chapter presented a discussion of the research design and methodology pertaining 
to this study. A two phase, sequential, mixed method design was chosen to help achieve the 
objectives of the study, which were to initially explore and then to validate the resilience 
process among HC survivors. First, the philosophical framework and two paradigms that 
underpinned the phases of this study were described, before providing an overview of the 
mixed method approach. Next, research methodology, data collection methods and analyses of 
each study were outlined in detail. Finally, relevant ethical considerations were presented 
along with a discussion of the methodological issues surrounding resilience research. The 
following chapter describes in detail the findings pertaining to the qualitative phase of this 
investigation.  
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Chapter 5 
Phase One – Interviews Exploring Resilience in HC Survivors 
 
 
 
Aim and Research Questions 
The aim of the first phase was to develop a conceptual model that explained how HC 
survivors exhibit and maintain resilience. This involved in-depth, semi-structured interviews. 
The questions addressed in Phase One were:  
1 As a result of their experience, what are the common individual, family and 
community level factors that the HC survivors identified as contributing to their 
positive or negative mental health outcomes? 
  
2 Which key factors made it easier or more difficult for HC survivors to achieve and 
maintain their resilience? and, 
 
3 Were there any factors mentioned during the interviews that were not previously 
identified in the proposed conceptual framework?  
 
Analysis – Phase One 
Profile of Participants 
A total of 23 participants were included in this study, all of which were English 
speaking and living in metropolitan (n = 21) and rural Western Australia (n = 2). The majority 
of those interviewed were Caucasian and of Australian or north-west European origin (n = 19; 
83%), however the sample also included Italian and Asian descendants. As outlined in Table 
5.1, slightly more females (n = 14; 61 %) than males were interviewed. The ages of 
interviewees ranged from 22 to 84 years (M = 52.87, SD = 16.72), ensuring the widest possible 
diversity among adult participants. The length of time since diagnosis ranged from 1 to 17 
years (M = 5.13, SD = 3.79). Fourteen participants in this sample (61%) were diagnosed within 
the last five years, with the remaining nine participants (39%) distributed among the 
permanent (> 5 years) survival phase. Five years following cancer treatment is considered an 
important milestone that often signals cure in terms of oncology and may provide a different 
perspective on resilience. It was, therefore, important to include HC survivors distributed 
Chapter Overview  
Chapter 5 describes the qualitative findings of the first phase of this project. First, 
the aims and research questions that led this qualitative study are highlighted. An 
analysis outlining the participant demographics is then presented. Following 
presentation of the profile of participants, the results are discussed and interpreted 
with reference to previous research. This chapter concludes by presenting a revised 
conceptual model of resilience in HC survivors.  
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between both the extended (1-5 years) and permanent (> 5 years) survivorship phases of 
cancer survival (Mullan, 1985).  As indicated in Table 5.1, the 23 survivors interviewed 
included seven different HC diagnoses. The majority of HC survivors reported undergoing a 
combination of treatments including oral medication, chemotherapy and radiotherapy. 
However, six participants also required either a BMT (bone marrow transplant) or SCT (stem 
cell transplant). In addition, since their initial diagnosis and treatment, three of the participants 
reported a relapse. 
 
 
Table 5.1 
 
Profile of the Participants in Phase One 
____________________________________________________________________________ 
Pseudonym Sex   Age       Diagnosed HC              Years Since Diagnosis 
____________________________________________________________________________ 
Natasha F    22       Non-Hodgkin Lymphoma (NHL)   3 
Travis  M    23       Acute Myeloid Leukaemia (AML)   4 
Sharon  F    31       Non-Hodgkin Lymphoma (NHL)   2 
Zac  M    34       Acute Myeloid Leukaemia (AML)   4 
Imogen  F    34       Chronic Myeloid Leukaemia (CML)   1 
Max  M    40       Acute Myeloid Leukaemia (AML)   6 
Megan  F    43       Acute Lymphoblastic Leukaemia (ALL)  2 
Karen  F    43       Chronic Myeloid Leukaemia (CML)   3 
Lara  F    44       Hodgkin Lymphoma (HL)    17 
Fiona  F    51       Chronic Myeloid Leukaemia (CML)   1 
Alyssa  F    57       Chronic Lymphocytic Leukaemia (CLL)  5 
Ellen  F    58       Chronic Myeloid Leukaemia (CML)   6 
John  M    60       Non-Hodgkin Lymphoma (NHL)   11 
Ben  M    60       Chronic Lymphocytic Leukaemia (CLL)  1 
Helen  F    62       Non-Hodgkin Lymphoma (NHL)   3 
Pete  M    63       Non-Hodgkin Lymphoma (NHL)   3 
Lily  F    64       Chronic Lymphocytic Leukaemia (CLL)  10 
Colin   M    66       Non-Hodgkin Lymphoma (NHL)   6 
Anna  F    68       Acute Promyelocytic Leukaemia (APML)  6 
Tess  F    69       Chronic Myeloid Leukaemia (CML)   3 
Jack  M    70       Non-Hodgkin Lymphoma (NHL)   5 
Maria  F    70       Burkitt’s Lymphoma    7 
Fred  M    84       Chronic Lymphocytic Leukaemia (CLL)  9 
           M = 52.87                        M = 5.13 
          SD = 16.72                      SD = 3.79 
____________________________________________________________________________ 
Note. Pseudonyms were used to protect the identities of participants. 
 
 
The findings and interpretations of Phase One will now be discussed. This will provide 
the links that connect previous literature and the current qualitative findings to the revised 
conceptual model, which will be presented following these results. 
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Findings and Interpretations  
The aim of Phase One was to explore the experience of individuals who had been 
diagnosed with HC. A particular focus was on how each survivor was, or was not, able to 
navigate their way to protective resources that facilitate resilience, therefore enhancing 
successful adaptation and psychological wellbeing. The collective findings from both the 
qualitative thematic analysis and Leximancer analytic software are discussed below as each 
research question is addressed concurrently. 
 
Together the thematic and Leximancer analyses produced data that highlighted four 
main themes that impacted on the positive and negative mental health outcomes of HC 
survivors. These are presented in Table 5.2, along with sub-themes that emerged through both 
qualitative data analyses. Each theme and sub-theme will be explained and interpreted with 
reference to previous research literature. Participant quotes are also referred to in order to 
substantiate the relevance of each theme and/or sub-theme. 
  
Table 5.2 
 
Themes and Sub-themes Common to HC survivors’ Experience 
____________________________________________________________________________  
 Core Themes     Sub-themes 
____________________________________________________________________________ 
The burden associated with a HC diagnosis  Physical impact 
      Psychological impact 
      Social impact 
      Unexpected loss 
 
Resilience: Coping with HC    Social support network   
      Personal coping strategies 
      Positive health behaviour change 
      Importance of time 
      Self-Education 
 
Pathways and barriers to resilience   Employment 
Relationships 
       Communication 
Information and Resources 
       Unmet needs 
        
Survivor outcomes     Transition: a new normal 
       Re-prioritisation and growth  
       Self-reflection 
________________________________________________________________________ 
Interview Research Question 1.  As a result of their experience, what are the 
common individual, family and community level factors that the HC 
survivors identified as contributing to their positive or negative mental health 
outcomes?  	
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The burden associated with a HC Diagnosis 
 There were four sub-themes that survivors in this study attributed to as factors 
associated with the burden of having being diagnosed and treated with HC. These included the 
physical impact, psychological impact, social impact and unexpected loss. 
Physical Impact. 
Research maintains that treatment regimens can be harrowing and physical side-effects 
are common (Bennett et al., 2007; Butow, Girgis, & Schofield, 2013; Deimling et al., 2005; 
Doyle, 2008; Jefford et al., 2008). All of the survivors discussed dealing with physical 
changes, which impacted on them daily. For example, fatigue, which participants highlighted 
as the most debilitating symptom, was a major physical limitation in their lives that continued 
well beyond treatment. As commented by interviewees: 
Just trying to recover all the time is tiring and it’s ongoing    (Pete, 63yr) 
 
I was so tired. Trying to do everything as normal was exhausting and frustrating, it all 
just becomes slower        (Ellen, 58yr)  
 
The participants also described numerous other physical challenges such as loss of 
taste sensation, skin problems and extreme nausea. Although some of these effects were not 
serious, they were annoying, and were a constant reminder to the participants of their cancer 
journey.  
At that time the anti-nausea medication was rubbish so I spent my time with my head 
in the toilet, it was like the movie Philadelphia where he was vomiting constantly. It 
was like that.                        (Lara, 44yr) 
 
The worst thing is trying to get back your normal body functions, like just cleaning 
your teeth you start gagging. All the things you like you can't taste. You get a reminder 
of the smell of that muck truck food trolley coming in the hospital and you know you 
can’t eat it.                    (Pete, 63yr) 
  
My weak point was my skin and it still is, I've lost probably three quarters of my skin 
colour, I've also lost eyelashes, toenails and fingernails.     (Ellen, 58yr) 
 
 
Although it was observed during the interviews that sexuality was an uncomfortable 
topic to discuss, a number of participants did share their experience with sexual dysfunction. 
For example, Colin spoke of his concerns about impotence, which had greatly impacted on his 
marriage stating, “My sexual function that's totally gone…. so yeah there's been some major 
changes like that.” In addition, according to Colin these issues were not openly discussed or 
explained by his medical team. However, Colin also acknowledged that he found the topic 
sensitive and had not raised the issues with his GP or medical team.  
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Many of the survivors continue to endure long-term physical issues, such as chronic 
graft versus host disease (GVHD)2, and complaints regarding the medication side-effects. 
Participants discussed issues with low immunity, insomnia and joint pain as other difficult 
physical side-effects: 
I also seem to get complications from colds or the flu very easily which can take 
longer to recover from. Like many others, it took ages to gain my taste for food. I get 
achy joints [and] I’m still fatigued and have trouble sleeping.    
(Max, 40yr)  
 
Another more long-term impediment mentioned by many participants was diminished 
memory and concentration. This was often met with humour and commentaries during the 
interview as they discussed their “chemo brain”. For example, Imogen stated, “You become 
vaguer than ten pregnant women. It’s like your brain doesn’t function properly.” This was also 
experienced by Colin:  
Other things that have changed that get little bit frustrating are the blanks of memory, 
big patches are just gone. There's about a four-year period, for example I can't 
remember a car we had for about four years. When my wife shows me pictures of it 
there’s nothing but snippets.  
 
As described in the literature, the physical impact of experiencing HC was clearly 
evident and highlighted by all participants. Many of these physical challenges were transient. 
For example, in support of previous literature (Kelly & Dowling, 2011), hair loss, referred to 
as alopecia, featured extensively as a challenge in this sample, yet this was short lived. 
However, other burdens associated with HC were described as more permanent. As Max 
summed it up, “Physically you put your body through hell. Some problems come and go, but 
others such as fatigue linger on for years.”  
Psychological impact. 
The psychological impact of HC has been well documented (Krebber et al., 2014; 
Lobb et al., 2009; Mosher et al., 2011; Xuereb & Dunlop, 2003). The majority of emotional 
reactions for the all participants were consistent with this literature and ranged from a sense of 
being overwhelmed and out of control to complete shock and fear.  
Most of the survivors were impacted by feelings of uncertainty. In general, this 
uncertainty was associated with the fear of recurrence of their illness and knowing that, for 
many, treatment offered no guarantees. This fear was evident in all of the participants’ 
interviews. For many of the survivors it governed their lives and each had to find a way to 
navigate this fear. Anna who had previously worked in the medical field shared: “I think you 
stop becoming a professional and you just become a scared patient” and Max commented: 																																																								2	GVHD is a possible complication following a bone marrow or stem cell transplant from another person that can 
last several months to years. GVHD occurs when donated white blood cells (T cells) attack the patients own body 
cells which they recognize as foreign. GVHD commonly affects the skin, digestive system and liver but may extend 
to complications involving the eyes, lungs and joints.  
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“Mentally you struggle with the fear of dying and overcoming the hurdles that come with 
having cancer.” Luke summed it up by commenting: “It just mucks with my head space 
daily… you know getting used to the whole thing…thinking what if it comes back… that sort 
of stuff.” There was also a strong emotional reaction to an unforeseen threat to life, which was 
common to many of the participants. The following narrative is an exemplar of this:  
Your life changes so much when you are told you have cancer. I clearly remember it 
felt like someone stabbed me; I went all hot in the face. My heart was pounding and I 
went blank. It’s all a bit of a blur. The hardest part is also not knowing the future: 
what’s next, what’s it going to involve and will I die?           (Natasha, 22yr) 
 
Many survivors experienced psychological trauma as a result of physical 
complications that resulted in urgent and unplanned hospital admissions. As Ellen shared: 
In one of my emergency admissions there was just blood everywhere coming out of my 
pores, my nose my eyes, everything, even my skin, there was a plasma it was like you 
can touch it. It was wet and was a bit weird.  
 
Lara also described two frightening events that led to emergency admissions as a 
result of physical trauma during and following treatment: 
On the second lot of chemo my oesophagus and the stomach lining got so burnt.  I was 
rushed back and stayed in hospital for several days, and I was in agony, I turned around to my 
husband…and it’s the only time I ever said that I just wanted to die. On another occasion I 
had a huge nosebleed and started choking on blood, I had no platelets, that was actually quite 
scary because I was literally drowning in my blood and I did not know what to do… the blood 
was all over...coming out my nose into my mouth down my throat, it just wouldn’t stop. 
 
Several participants also described being over-vigilant and almost obsessed by any 
health-related symptoms. For example Lara commented: “The next time you get sick, even just 
a flu or a cold or whatever you freak out because you like, oh God it’s an enlarged node.” 
Another fear disclosed during the interviews related specifically to living with HC. There was 
a sense of despair described by several participants with the realisation that surgery was not a 
treatment option and that their cancer was different in that respect to many solid tumours. Two 
participants shared an example of this: 
What's particularly difficult about leukaemia, it's scary to know it's running through 
your body and it's not like having a tumour which they can just cut out. I have 
previously had a mass removed from my ovary, which ended up being benign. But the 
fear is different even when I did not know the result it's much more easier to cope 
when you can have it cut out and think oh that’s a relief its gone.             (Fiona, 51yr) 
 
This type of cancer is difficult to process. I feel like I’ve got it running around my body 
all the time. It’s not like I can go and have an operation and have it chopped out. That 
may be easier because I could visualise in my mind the cancer being removed. 
                  (Megan, 43yr) 
 
Consistent with the literature (Wenninger et al., 2013), these findings support the idea 
that, although most survivors are well adjusted, several in this sample experienced elevated 
psychological distress. In face of a highly adverse event such as HC, a variety of recurrent 
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thoughts can help people to make sense and attempt to problem-solve. Conversely, recurrent 
thoughts that are unproductive may contribute to anxiety or depression (Tedeschi & Calhoun, 
2004). This was clearly evident in this study. For example, several interviewees spoke of 
experiencing anxiety at various times. Lara commented that, “At check-up time my thoughts 
were consuming, I used to keep a brown paper bag in a car because I’d hyperventilate and 
panic” and Anna shared, “I did in effect actually develop panic attacks… that was probably a 
low point.” Several participants also acknowledged they had suffered from depression with 
one survivor feeling exceptionally low and at times suicidal:  
You've got to be careful, you get suicidal, when I first got diagnosed I thought what’s 
the easiest way to top myself, I got a bit depressed.    (Pete, 63yr)  
 
Interestingly, for many participants, depression did not seem to occur until several 
months following treatment. As Megan commented on her experience after chemotherapy, “It 
was almost as though I was scared to be myself; it was very weird, I've never felt like that 
before.” Also, as reported by other participants: 
I struggled about 6 months after the transplant. I probably suffered depression. My 
GP didn’t really pick it, but to be fair I didn’t tell him much either. It may have helped 
if he had asked more about how I was coping mentally.      (Zac, 34yr)
       
Six months after treatment you have a big ‘what if” going on up in your head and I 
know that other patients I spoke to had the same thing, in your head you start thinking 
about what if I had died? I think that hit me quite strongly especially the second time 
because I’d look at my kids and I’d think I may not have been here and I still do that 
now all these years later.  So that was a big issue for me.    (Lara, 44yr) 
 
The survivor’s own expectations also added to their emotional instability. Max tells of 
his experience: “It was almost as though I had thrown everything at fighting this and I have 
nothing left to give. For the first time ever I experienced what it may be like to give up hope… 
perhaps I was unrealistic.” Even when expecting the feelings of emotional turmoil, Sharon 
illustrated: “I just remember feeling like my world would never be the same again… it felt a 
bit unsafe and unpredictable.” 
The diagnosis and treatment for HC is an emotionally turbulent time. The survivors in 
this study voiced a myriad of typically adverse emotions including fears, uncertainty and low 
mood. This was psychologically a very challenging, all-encompassing time to navigate. 
However, one survivor also provided an account that highlighted a more positive perspective 
resulting from her diagnosis and treatment. Ellen described her relief once diagnosed and 
treated by commenting: “At this stage I wasn't feeling too upset by the news I was more 
relieved that they had worked out what was wrong. So for me I had a name and I had a drug, 
which was a relief.” Ellen went on to say, “thank goodness if there's a name for it then there's 
some sort of history behind it, even if there is one other person I'll find them. I’ll make the 
most of this opportunity.”   
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Social Impact.  
The literature states that each cancer survivor’s experience is also impacted by social 
influences (Kelly & Dowling, 2011;Waldrop, O’Connor, & Trabold, 2011). In the current 
interviews, several participants illustrate how family, peers, co-workers, and others in the 
survivor’s social setting impacted their HC experience. In particular, participants shared the 
need to protect others close to them. This supports previous research stating that those 
diagnosed with cancer often try to protect significant people in their lives (Kelly & Dowling, 
2011; McGrath & Clarke, 2003). For example, Ellen mentioned: “The worst part was telling 
my parents, I had to set them up with other people who could support them” and Ben 
commented: “I think about it sometimes being the type of person I am, I keep a lot to myself 
on the basis of not wanting to worry others.” This concern for significant others was confirmed 
by Fiona:  
Your thinking how are you going tell your kids? When am I going to die? How am I 
going to die? and, What this can look like? I didn't want to give them the impression 
that this is a huge disaster that we couldn't deal with.  
 
Other participants felt it was important to put on a brave face at the expense of sharing their 
true feelings:  
It’s uncomfortable when they’re telling me I’m looking much better even 
though that’s not how I’m feeling inside because I feel as though I need to 
pretend so as not to upset them.                          (Megan, 43yr) 
 
I guess sometimes it's just difficult when others say you looked great or 
look really well but on the inside you’re like screaming out well actually 
I feel like crap.                        (Lily, 64yr) 
 
Family-related concerns were expressed as worries and/or guilt about how the illness 
was impacting on loved ones. Participants described a heightened awareness of how their 
cancer treatment caused changes that affected their families. For example, Zac, who was self-
employed, grappled with voicing his concerns for his wife and son: 
This was a very difficult time because I was not able to see my son, at the time no 
children were allowed to visit because of the infection risk. This must have also been 
so hard on my wife. Having a baby and sick husband… she also got stuck with 
managing a lot of the books for the business.  
 
Colin also explained:  
What I understand is that my wife just took over really with all the decision-making, 
but I never felt as though I was missing anything I never even realised. There are still 
times when I know that that's a burden. I think the biggest thing once you come out of 
the chemo world some of the residual effects like a chemo brain when I can't 
remember everything, but it's sort of like a guilt, in terms of what I've put all the others 
through.  
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Participants who were mothers expressed concerns for how their children were being 
affected by their treatment-related symptoms. Lara, who was diagnosed with Hodgkin’s 
lymphoma while she was pregnant, spoke of having to leave her newborn son for prolonged 
periods during her chemotherapy: 
When my son was born early, he went into special care for two weeks and literally the 
day after I had him they sent me for another scan, which showed the cancer had taken 
off. They gave me one week and then I started chemotherapy. It was really hard 
because I couldn’t hold my son, I was radioactive. 
 
A number of participants also described how this experience impacted on their social 
lives. Colin commented, “socially it took its toll… you had plans but then you just feel 
bombed out and it got a bit embarrassing cause you’re not doing things with people you wanna 
do.” Several participants also commented on the impact on international travel. As Fiona 
shared, “I got that sting of oh, now I’m one of those, a liability, so I had a bit of a ‘pity party’ 
about that” and Pete commented, “Everything changes even with flying, either they don't 
insure you or you pay a premium price. These are things that have made it more difficult.” 
Lily, who was diagnosed with CCL the year following the death of her husband who 
also fought leukaemia for ten years, highlighted another social perspective. Lily was 
particularly concerned that she would drive friends away. Lily summed up how determined she 
was not to follow in her late husband’s footsteps: 
All my husband talked about was his illness, it started to affect our social  
life he couldn't understand why people stopped coming over, but it was like an 
overload for them all the time. It's really hard to know what the balance is but I don't 
want anyone to think I'm whinging and push my friends away like my husband had and 
I am aware of what they dealt with when my husband was so sick.  
 
Unexpected loss.  
Analysis of the transcripts exposed diverse emotional responses to loss during and 
following treatment. In addition to the functional loss (i.e., sexual, cognitive impairment) 
previously discussed, several other areas of reoccurring and unexpected loss were prevalent. 
For example, many interviewees revealed the added strain as a result of financial loss. Travis 
highlighted: “I know this has been really hard on my parents financially” and Max reiterated 
“you also suffer financial strain because you are unable to work fulltime.” 
Pete not only raised the issue of time off work but also lost time, stating: “You've got 
those waits in hospital, time off work attending clinics and all that. When you go for a blood 
test you sit there looking at the goldfish, but it’s half a day gone.” Other participants shared 
Pete’s view commenting that, “It had a massive effect, I was tired all the time and spent a lot 
of time alone because of my infection risk” (Travis) and, “I often waited hours for my clinic 
appointment and I spent the whole time looking at all the other patients thinking, they look 
sick” (Imogen). 
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As many of the survivors began to realise that their treatment journey was ongoing, 
they identified with the loss of a perceived planned future. These results support previous 
literature by Grunfeld et al. (2013) who reported that cancer survivors frequently convey 
sorrow and regret about being unable to accomplish ambitions and perceive missed 
opportunities. During these interviews, Imogen became teary as she conveyed details about her 
lost pregnancy:  
I accidently got pregnant…I was having a moral dilemma because of the treatment, 
being on Gleevec3 and I was told there would be all of these birth defects and taking 
into account my health. I made a hard decision for a termination.  
 
Anna also detailed the loss of opportunity related to her career: 
I do miss the people and the camaraderie and having a skill that’s acknowledged. I 
was doing on-call 24/7 so I was working a lot. Especially, when you don't have a 
family, your profession is a big part of who you are. I miss that.   
 
The most significant loss expressed by the participants involved their identity. The 
loss of identity and altered self-concept has also been widely discussed in the cancer survivor 
literature (Aziz, 2002; Kelly & Dowling, 2011; McGaughan, Prue, Parahoo, McIlfatrick, & 
McKenna, 2012). For most participants, the perception of who they were previously had 
changed. The survivors commented that they no longer felt connected to their bodies, which 
contributed to an altered body image. For Imogen, there was an abrupt realisation that her 
body had changed: “Suddenly I was ten kilograms heavier and nothing fitted. That was hard.” 
The physical changes and the altered body image impacted on the self-esteem of several 
survivors. Their bodies now felt alien, and, for some, the transformation in body image was so 
apparent that it left them devastated. The following account by Lara illustrates this: 
 My self-esteem was at its lowest when my hair come out, the steroids had caused my 
face to blow out, I had a grey green colour to my skin and I was really skinny because 
I’d been vomiting for nine months. I was gutted and just wanted my old self back.              
     
In addition, interviewees discussed their reluctance to identify as the “sick person with 
cancer” (Natasha). This supports previous research by Wallace, Harcourt, Rumsey, and Foot 
(2007), who reported the importance to cancer survivors to appear ‘normal’ and unchanged in 
the eyes of others.  
However, for the majority of survivors an altered appearance following treatment 
resulted in difficulty in them being perceived as ‘normal’. For example, appearance changes 
such as hair loss were an indication of illness that allowed others to identify them as different. 
There were also frequent instances where participants communicated how their identity, self-
image and self-esteem had been transformed in some way. As shared by two participants:  
 																																																								3	The drug imatinib mesylate (Gleevec) was one of the early success stories in the search for targeted therapies. 
This oral medication that directly inhibits the activity of cancer causing protein was approved as a first-line 
treatment for CML in 2001.	
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When my mum is telling friends what happened to me, it's almost as though she's 
talking about someone else. It's surreal. It's like my body has been a battlefield. I'm 
trying to get back into the way I used to think, but I’ve changed, you think differently. 
              (Megan, 43yr) 
 
I was still modelling the day before I had my son even when I had cancer. Part of my 
identity were my looks, my self-esteem absolutely plummeted because everything I had 
always done had been on looks, then all of a sudden you’re like who the hell am I 
now?                              (Lara, 44yr) 
 
Appearance issues were a significant part of the illness experience and of extreme 
concern. However, even when participants spoke of discontent in their current appearance, 
some demonstrated the ability to reinterpret this in a more optimistic manner. For example, 
Natasha used the opportunity to explore different hairstyles she would not normally have tried 
before her hair fell out, as she stated: “there is always a positive.” 
In addition, hospitalisation is often associated with loss of autonomy and control 
(Xuereb & Dunlop, 2003). Several of the HC survivors expressed the importance of trying to 
preserve some personal control while in hospital. However, Anna described how challenging 
this was during her admission. 
Just watching people walk out back into the real world, that was really hard, knowing 
I couldn't. People are just leaving and you're thinking I'm stuck here. Also exercise 
was a big thing because I exercised six times a week. And suddenly it stopped and I 
felt lost. They probably thought I was just too weak but I wasn't. 
 
The interviewees also wanted to be able to trust in their physical health and plan their 
future. However, all interviewees shared experiences through stories relating how their lives 
had been altered through loss of control especially in terms of their independence. This was 
particularly evident in Megan’s interview:  
Well it's really changed my life. I used to live in the hills and I was on a quarter acre 
block, I was very independent I used to do a lot of gardening and then I had to sell my 
house, my mum and friends had to help pack it up. I tried to do a few bits and pieces 
but they pretty much moved everything while I was in and out of hospital.  I don't have 
that freedom anymore and I am relying on others and that is so hard.  
   
In summary, the burden associated with a HC diagnosis was filled with experiences of 
loss in physical, psychological and social domains. As Max stated: “Well, when you hear the 
big ‘C’, your life changes and is never the same.” The physical changes were widespread 
among survivors. However, fatigue and cognitive impairment were common and long-lasting. 
Psychologically, the participants experienced an array of negative emotions comprising shock, 
vulnerability, isolation, fear and uncertainty. Social domains predominantly included the loss 
of perceived opportunities, time, identity, self-perception, independence and control. However, 
despite this adversity, many interviewees also demonstrated evidence of resilience and of 
positive emotional outcomes. This supports recent research in which participants referred to 
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their diagnosis as a “two-edged sword” and an “eye-opener” allowing each an opportunity to 
also re-evaluate the focus of their lives (Grunfeld et al., 2013).  
 
Resilience: Coping with HC 
The emphasis on resilience in this study involved investigating risk and protective 
factors, including successful adaptation, as a result of experiencing adversity, namely living 
with HC. Risk factors are conditions or situations that have been linked to negative 
psychosocial outcomes and have the potential to decrease the chances of resilience (i.e., lack 
of social support) (Masten, 2007; Ungar, 2008). Alternatively, protective factors promote 
resilience (i.e., personal coping strategies) and, therefore, decrease the negative influence of 
being at risk (Garmezy & Masten, 1991). 
The literature has shown that resilient individuals are more likely to successfully 
adjust after facing adversity (Richardson et al., 1990; Wagnild, 2009). This is supported by the 
findings of this research highlighting that personal resiliency provided a vehicle for HC 
survivors that assisted them to navigate their world following HC. As will be outlined, 
resilience enabled their illness to become secondary to their connection with life. The majority 
of participants in this study maintained resilience through available social support, personal 
coping strategies, self-education, self-care, and by taking timeout. This also supports previous 
research, as many of these factors are commonly discussed in the cancer-related literature 
(Allart et al., 2014; Lau & van Niekerk, 2011; Llewellyn et al., 2013; McGaughan et al., 2012 
Stewart & Yuen, 2011; Swash, Hulbert-Williams, Bramwell, 2014; Wenzel et al., 2002).  
For many participants, remaining resilient was a challenge, as Sharon commented: 
I definitely went through a difficult patch about six to twelve months following my 
treatment. A lot of negative thoughts. Why me? What would my future look like? How 
am I going to live the best way I can to give myself the best opportunity? All of those 
sort of questions consumed me and at times it all seemed overwhelming. 
 
However, as the physical and psychological strength of the participants started to 
improve, their personal resilience also began to rally. In most instances, the interviewees drew 
strength from their experience of overcoming previous adversity. For example, Fred 
commented: “When I was a kid castor oil was the medicine for everything and I think it was 
like poison and it made me sick. We had no fresh water, no money, but all this helped me learn 
how to be a survivor.” Similarly, others agreed:   
About 6 years before my diagnosis our family went through a really traumatic 
experience. It wasn't health-related but it was very painful and public. Even though it 
was a very different scenario I felt as though I'd overcome those feelings of not being 
in control. So it was like, you know what, you've done this before if we keep calm and 
were honest with each other we can get through this and I know we could all get 
through difficult things not because of what I'd read but because of what we've been 
through previously.                 (Fiona, 51yr) 
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I lost both my parents tragically in separate circumstances, one as a teenager and one 
in my early 20s. I definitely think that experience has helped prepare me for coping 
with cancer and has a lot to do with how well I've managed so far.         (Sharon, 31yr) 
 
This belief is consistent with previous research regarding resilience. Wagnild (2009) 
depicted a resilient individual as being able to conquer, learn, and flourish from adversity. In 
addition, as the resiliency model proposed by Richardson et al. (1990) highlights, resilience is 
developed through facing challenges, risks, and stressors. This process begins early in life, as 
individuals attempt to adapt to any challenge or disruption in an attempt to successfully cope.  
As discussed earlier, some participants became depressed, anxious and considered 
suicide. Such findings may suggest a lack of resilience, as depression, anxiety and suicidal 
ideation may be perceived as unsuccessfully coping with adversity (Richardson et al., 1990). 
However, these participants managed to overcome these problems and went on to achieve 
psychological wellbeing. For this reason, it is preferable to evaluate resilience over time, rather 
than on one occasion. These results support the view that resilience is a dynamic process and 
successful adaptation to adversity may take time (Richardson et al., 1990). 
 In addition to overcoming previous adversity, the resilience factors that emerged 
within this study broadly relate to social support, education and coping strategies (i.e., 
perceived control, purpose, attitude, hope, etc.). These have been viewed as protective factors 
within previous literature (e.g., Herman et al., 2011; Masten & Powell, 2003; Raphael & 
Wilson, 1993; Stewart & Yuen, 2011). However, the findings of this study have also identified 
additional factors (i.e., self-care and time-out) that are reported by this sample of HC survivors 
to combat adversity.  
Social support networks.  
Much has been written about social support contributing to personal resilience (Kelly 
& Dowling, 2011; Lau & van Niekerk, 2011; McGaughan et al., 2012). Moreover, the 
literature reports that seeking social support has been highly endorsed as an important coping 
strategy that is directly related to improved physical wellbeing (Bloom, Kang, Petersen, & 
Stewart, 2001; Northouse et al., 2007). There is evidence that cancer survivors who have more 
social support experience less distress (Waldrop O’Connor, & Trabold, 2011). The results of 
the current study further illuminates the importance of support offered by family, peers, 
neighbours, medical staff, the community (including strangers), and how this plays a key role 
in the HC survivor experience. Participants of all ages also referred to the Internet as a means 
of support. The following statements provide exemplars of the valued support received, in one 
instance from strangers. 
I didn't realise until later how amazing my wife was. You could not have possibly have 
survived in that way without that support.              (Colin, 66yr) 
 
My mates would come and annoy me whenever they could. They also brought in junk 
food and watched movies stuff like that.                                (Travis, 23yr) 
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One of my really good friends would always email me an inspirational text or picture 
every day. What a commitment.                  (Natasha, 22yr) 
 
More importantly strangers like here at the shop the cleaners they will call me by my 
name and talk to me and this helps me more. It is not so much those who you think are 
your friends who help you. It has surprised me that a lot of support has come from 
strangers. Strangers can be very helpful, especially when you don't expect this.  
                     (Maria, 70yr)
  
Additionally, according to Wills and O’Carroll Bantum (2012) available support from 
others enhances aspects of self-control involving behavioural action (i.e., adherence to 
treatment). The current findings are consistent with this research, as highlighted by Fiona: 
I remember ringing a girlfriend who is a nurse, as I really didn't want to  
take this medication because I'd figured it must be pretty potent and I remember my 
friend saying to me “take the bloody tablet and put it in your mouth with a glass of 
water and thank God that you live in a country where this medication is available, just 
swallow the fucking tablet, and that was it, that’s what I needed and it got me back on 
track. 
 
 
Previous research also indicates that a crucial factor in preserving a positive outlook is 
the support that patients are provided by their health professionals (McGrath, 2004). However, 
like many types of cancer, one complication of a HC diagnosis is the need to involve several 
different specialists. Despite some exceptions, participants in this study were largely satisfied 
with the health care support they received, with some instances of unexpected support. As 
Anna reported: “One doctor used to send me a picture on my phone every morning like a rose 
or the view from Bethesda4. Things like that to show you that we're thinking of you and there 
is a world outside.” In other circumstances, participants actively pursued professional support 
to facilitate self-control of their relationships, emotional wellbeing, and their personal goals. 
Seven interviewees received psychological interventions and commented on the contribution 
this support provided, as Lily remarked: 
My psychologist is amazing. I get a lot out of it because there are things you don't 
want to tell your family and friends she's totally neutral and I can tell her anything 
and she is someone I can trust and I think that's really important.  
 
Of particular interest was the number of interviewees (n = 20) who deliberately sought 
ways to interact and assist others with similar problems. This was particularly common in 
survivors living alone. Participants expressed the advantages of conversing with other patients 
who had similar cancers. These participants appreciated any opportunity to talk about their 
illness, primarily because they did not always want to burden their family and friends. The 
participants also suggested that hearing about the experiences of other HC cancer survivors 
																																																								4	A private hospital located in Perth, Western Australia	
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assisted them to better understand their illness, the experience of others and further educate 
themselves. As mentioned by Megan, who had a rare type of leukaemia: 
It was very important for me to meet someone with the same cancer as me because 
they will be able to relate more to what I’ve been through, but apparently there may 
only be five/or six in my circumstance in Perth. I've had extremely intensive 
treatment…I've nearly died three times so I felt it was important to meet a survivor 
who had been through the same journey as me.     
Interestingly, the interviewees who elected not to be involved in support groups stated 
that they either found it a negative experience, preferred the company of significant others, or 
did not want to be constantly reminded of their cancer. However, this group of HC survivors (n 
= 3) each stated that they considered themselves to be resilient individuals and on observation 
each demonstrated resilient traits (i.e., optimism). Therefore, one could conclude, that the type 
of social support accessible is not as influential to cancer survivors as the perception that social 
support is available, which remains an important factor. 
Spiritual support was another important source highlighted by the participants. 
However, there was great variety among the interviewees. Similar results have been reported 
in the literature (McGrath, 2004a; McGrath & Clarke, 2003; Tedeschi & Calhoun, 2004). Over 
half the sample considered themselves to be raised as Christians, but were not affiliated with 
any particular church. Yet, there were others, for whom religion was already a central factor in 
their life, and continued to be a key source of strength throughout diagnosis and treatment. As 
shared by Colin, “We belong to a church and our faith is an enormous part of dealing with 
stuff.” Fiona similarly shared, “I consider myself a Christian…God has helped me in the past 
so I just embrace that love.” In contrast, other participants described themselves as more 
spiritual and provided examples of meditation, walking, yoga and music in an attempt to cope 
with their cancer. These activities provided support by allowing participants a break from 
thinking about their cancer. For example, Alyssa remarked: 
I learnt transcendental meditation in my early 20’s and I had always done it on and 
off, now however I do this daily I find that this keeps me balanced and helps get rid of 
stress. Music too has kept me sane all my life. I couldn't imagine my life without it.
        
Whether religious or not, all of these avenues provided support and personal direction, 
allowing time to refocus. This supports research by McGrath (2004a) who stated that there are 
several cognitive or spiritual frameworks that people implement to assist them maintain and 
develop positive orientations.  
The social support received in this sample was found to have both positive and 
negative influences on the participants. The results of this study agree with other research, 
which acknowledged social issues and a lack of understanding from the participant’s families 
and friends as having a detrimental effect on their recovery (Kelly & Dowling, 2011). For 
example, Fiona’s mother who is in her 80s says to her, “Oh just get over it, it's just anaemia” 
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as her mother calls it. In addition, the lack of a supportive partner was also clearly evident in 
Karen and Imogen’s interviews, which impacted negatively on their ability to cope. 
My ex-husband was the worst because he walked away completely he didn't want to 
know about it, it was like he didn't believe that I had leukaemia and it was almost like 
‘here we go again’ she's done this to get me to come back.                       (Karen, 43yr) 
 
My ex-partner was really unsupportive, we'd only split last year and I was diagnosed 
in the March. When I was in hospital he was trying to take custody of my children and 
I had to get out a restraining order. I don't think I've dealt with having the CML 
because I've had all that other stuff to deal with. My ex-partner is my major issue at 
the moment, having cancer is more fun than dealing with him.                (Imogen, 34yr) 
 
However, this was the minority. Most interviewees received tremendous support in 
numerous ways ranging from practical support, as was the case for Imogen, who had friends  
who would just say “I am coming to cook dinner”, without giving her a chance to refuse, or in 
the form of emotional support: 
It was very helpful. Two of my nursing friends, midwives, would come in and stay the 
night on a most uncomfortable little bunk bed. For about four to five nights they did 
that. One of them worked all day and had a family of her own and would leave them at 
home with her partner and would come in and sleep the night with me.    (Anna, 68yrs) 
 
According to Kelly and Dowling (2011), support networks are central to cancer 
survivors and their ability to cope. This study not only supports these findings, but also 
established that participants were proficient at finding emotional support that matched their 
specific needs. For example, they exhibited self-awareness in terms of whom they would elect 
to share their inner feelings with, often judiciously protecting their family. In addition, each 
interviewee stressed the importance of at least one other individual who offered constant and 
ongoing emotional support. However, this is an area that requires further investigation as 
research is still not clear as to which methods of social support are deemed the most beneficial 
to those with HC, or, indeed, if this is dependent on the individual in question.  
Personal coping strategies. 
Coping is defined as “constantly changing cognitive and behavioural efforts to manage 
specific external and/or internal demands that are appraised as taxing or exceeding the 
resources of the person” (Lazarus & Folkman, 1984, p. 141). The literature generally refers to 
two types of coping within the resilience research. The first, emotion-focused coping (EFC), 
involves avoidant behaviour, ignoring the problem, worry, and/or wishful thinking. 
Conversely, problem-focused coping (PFC) is recognised as being proactive in identifying the 
problem then creating and acting on solutions (Lazarus & Folkman, 1984).  
The participants in this study demonstrated a combination of both EFC and PFC. For 
example, the coping strategies discussed by interviewees ranged from blocking or avoidance to 
the active management of their illness. However, the general trend appeared from the data to 
be predominantly EFC in the early post-treatment phase, with participants transitioning 
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towards a PFC approach later in the survivorship trajectory. According to research, this 
demonstrates an effective way of coping.  Previous literature suggests that in the earlier cancer 
phase, EFC (i.e., avoidance) may be an adaptive aspect of resilience, with PFC more effective 
in the long-term (Wenninger et al., 2013). However, if PFC strategies are not executed there is 
more chance of psychological distress (Wenninger et al., 2013). Thus, if negative maladaptive 
cognitions continue to be suppressed, or not attended to, they may persist. As Di Gallo et al. 
(2003) argue, “successful integration of the experience of cancer may be associated with the 
ability to accept painful feelings and to allow them to emerge” (p. 666). The interviewees’ 
employment of both PFC and EFC strategies are illustrated below. 
Emotion-Focused Coping. 
According to the literature when cancer survivors implement EFC they are attempting 
to control the feelings associated with having cancer rather than attempting in a practical 
manner to solve every problem associated with their diagnosis (McGrath, 2004;Waldrop, 
O’Connor, & Trabold, 2011). The findings in this study supports this perspective, as many 
participants described ways in which they attended to their emotions through activity-focused 
strategies, creativity, pursuing relaxing diversions as well as denial, avoidance and distancing. 
Two examples of avoidance, were described by Lily, involving herself and her late husband: 
One thing with my husband’s cancer, he handed his care over to me, he didn't ask 
questions he asked me to do everything for him, he didn’t want to know. It was 
consuming it took over our lives and I didn't want to go down that path. 
 
The relaxing diversions served to distance many survivors for periods of time in order 
to give themselves a break from thinking about their cancer. Taking this ‘rest time’ was well 
illustrated by Lara, who had experienced a relapse. She said, “I take time-out every single day 
whether it’s sitting at the beach for half an hour or just do something for myself…me time” 
This coping strategy was not exclusive to Lara; rather this was a common theme among 
participants. Many felt it important to ‘take a break from cancer’ and enjoy activities that 
served as effective distractions. For example, Lily did a lot of jigsaws, stating, “That does 
sound queer but that's my quiet time, my meditation time; when I'm doing jigsaws I think of 
nothing else.” 
According to research, taking part in activity-focused coping strategies assists cancer 
survivors to manage physical and psychosocial stressors (McGrath, 2004;Waldrop, O’Connor, 
& Trabold, 2011). For these participants, activity-focused strategies were often considered a 
way of remaining focused on something other than cancer. These activities provide a welcome 
distraction by grounding participants and assisting them to maintaining normality. As Colin 
mentioned, “Keeping busy was important, even though the busyness was not very busy in the 
first twelve months, it got me out of bed.” The majority of participants also described how 
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scheduling helped. Alyssa commented, “I tend to book Pilates classes into my diary and work 
around them.” Likewise, Tess described ongoing projects that continue to keep her busy: 
 
I have got so many hobbies, I sew, and I keep up with a lot of Medscape and read all 
the journals. I research my large extended family through genealogy. I keep up with 
my friends and we often have family here on a weekend. We are also so busy with the 
kids and grandkids I don’t have time to think about my cancer. I have a very busy life, 
but we go with the flow. 
 
While EFC was highlighted as an essential coping strategy by these interviewees, 
earlier resilience research also suggests that EFC is linked with the absence of resilience 
(Olsson et al., 2003). However, EFC (i.e., diversion) did prove beneficial to these interviewees 
as it assisted them to ease their stress (Lazarus & Folkman, 1984). In addition, by engaging in 
EFC strategies early in the cancer trajectory, the participants were more equipped at a later 
date to engage in PFC strategies to identify solutions. Sharon’s excerpt highlighted this:  
There were days when I just didn’t feel like being strong and I think I've learnt when 
that happens to just let it be, move on to something that can take my mind off cancer. I 
have now got to the point where I have more good days than bad and this is when I’m 
more productive. 
 
As the initial shock of having cancer subsided, there was a notable shift towards a part 
of life that was, importantly, not related to their cancer. For example, Helen went on a holiday 
with her husband stating: “We also planned a holiday to Queensland at Christmas and that was 
really good because it gave my husband the chance to spend time with me.” Others like Ben, 
preferred to get back to work: “I also kept myself busy I think from the first treatment I was 
back at work and I was not sitting around.” 
Problem-Focused Coping. 
As mentioned in this study, PFC generally surfaced among participants following the 
use of EFC. PFC involved critically processing and reasoning about their experience and 
addressing ongoing challenges. Participants in this study achieved this in four ways: 
implementing cognitive strategies, taking action to deal with problems, discussing openly how 
they felt with others, and/or diarising their feelings. For example, Ellen commented how in 
some instances, she was proactive in accepting help from others: “Some woman sat with me 
all night just rubbing my back, I have learnt to allow people to engage.” Colin, on the other 
hand preferred to process his experience in writing, commenting: “I used to keep a 
diary…from day one and I would write something each day. That, in itself, was very 
therapeutic.” 
Cognitive strategies referred to ways that participants dealt with their thoughts, fears, 
and responses to the physical and psychosocial challenges they experienced. In this study, the 
attitudes (i.e., acceptance, determination, persistence, hope, optimism, perceived control, 
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ownership and mental flexibility) of each participant aided in their ability to implement 
successful cognitive strategies. 
First, in terms of positive attitude, all the interviewees demonstrated a strong sense of 
acceptance. Several comments included: “I sucked it up…put one foot in front of the other and 
didn’t dwell on it” (Tess) and “I quickly learned that this was an illness that I would need to 
manage” (Alyssa). They also accepted the need for medication: “I beat to my own drum…it 
required me coming to terms with life-long treatment” (Ellen). Similarly, Fiona made the 
following statement: “Face your fears and grapple with them… because I think until you 
finally confront and accept the reality of death you can't really enjoyed the abundance of life.”  
However, being accepting did not always mean that the participants were happy about it. 
Rather, they came to the realisation that they didn’t have a choice. As Ben stated: “It's 
important to accept the situation and deal with it. You don't have to like it, but it's fact” and 
“think positive and accept it, if it is meant to be, it is meant to be. No matter how you feel the 
thing is there” (Maria). The participants’ stories went on to demonstrate sheer determination, 
assertiveness, persistence, and occasionally stubbornness, all of which reflected qualities 
beneficial to maintaining resilience. This is evident in following statements: 
A lot of being able to cope has been my personality I am very determined and maybe 
even being stubborn at times is important.                             (Lara, 44yr) 
 
I wanted to survive so much, to continue to be there and witness the many joys that 
come with life.                                           (Helen, 62yr) 
 
My determination, I don't like to give up on anything. It's like I say to myself ‘Yay me 
I'm a single mum with two kids who works three days a week and is building a house… 
oh and I've got leukaemia.                  (Imogen, 34yr) 
 
In addition, maintaining hope and optimism tended to redistribute the focus away from 
disease and toward oneself and the confidence in one’s ability to reach an obtainable goal. This 
supports a number of previous studies proposing that hope facilitates belief among cancer 
survivors and assists in maintaining the motivation necessary for them to pursue their goals 
(Bulsara, Ward, & Joske, 2004; Denz-Penhey & Campbell Murdoch, 2008; Folkman, 2010). 
For all participants, it was vital to maintain realistic hope while also acknowledging the 
actuality of their circumstances.  
Although many interviewees accepted the gravity of HC cancer, they were also 
focused on maintaining a positive outlook. As Pete shared: “I suppose I've got a positive frame 
of mind. I don't fixate on why me.” In order to achieve optimism participants frequently 
avoided negative environments by distancing themselves from situations that they believed 
impeded their recovery. For example, participants strongly protected their optimism by 
rejecting anyone who they perceived did not support them. In part, this might be helped them 
maintain a sense of control or this could be understood as a way to conserve personal resources 
to accomplish their goals (Hobfoll, 2002). As mentioned by Anna: 
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I have always felt that you should make the most of your life, I don’t waste my time 
with people who bring me down.                   (Anna, 68yr) 
 
However, participants commented about the ongoing challenge associated with 
continuing to remain positive and hopeful. Similar results have been discussed in previous 
research (Folkman, 2010; McGrath, 2004). Indeed, positivity is not a given, but rather a 
process dependent on the changing situation of the individual. This can be appreciated by the 
following statements provided first by Lily and subsequently Fiona: 
At the beginning when I was diagnosed I was very negative. I had been through ten 
years of watching my husband deal with leukaemia. Even though your intellect tells 
you that they are two separate leukaemia’s, whenever something happens you think 
here we go again.  
 
In general the relentlessness of life’s demands made it more difficult to stay positive. 
 
In addition to the positive attitudes discussed above, individual personality 
characteristics, including mental flexibility, assertiveness, and taking ownership, also 
contributed to facilitating resilience. Those participants who exhibited mental flexibility 
demonstrated an ability to operate whole-heartedly in order to attain what they considered of 
significant importance to them. According to research by Denz-Penhey and Campbell 
Murdoch (2008), mental agility also enables those with cancer to alter direction. Therefore, 
mental flexibility suggests individuals can adapt their lifestyle or change their minds in 
response to further treatment or managing their recovery (Denz-Penhey & Campbell Murdoch, 
2008). As stated by Lara:  
My doctor said “What do you want to do? If you don’t do anything you’ve got 
approximately 3 years”and I just looked at him and said “I have got two children, do 
what you have to do. I just want to live. Get rid of it” and that was my attitude, just do 
what you have to do to get rid of it.   
   
Further research has also established the relationships between perceived control, 
taking ownership, remaining active in decision-making and less stress, fewer depressive 
symptoms, and greater self-efficacy (Denz-Penhey & Campbell Murdoch, 2008; Roundtree et 
al., 2011;Waldrop, O’Connor, & Trabold, 2011; Wenninger et al. 2012). Behavioural 
strategies, such as taking control or ownership and decision-making, were discussed by several 
interviewees. This is highlighted by John who witnessed his brother endure intensive treatment 
for the same cancer: “I asked my specialist if we could go the soft option first, because I 
wanted to leave the big guns for later.” These results highlight a process by which participants 
assertively consider the stressors of illness and treatment and actively engage in decision-
making about how to manage their distress. Similar results were noted in this sample. As Ellen 
remarked: 
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I have project-led my own condition. So I changed on all my sheets from patient to 
cancer client. I am not a patient I am ‘cancer client’. Are you going to manage this or 
aren't you? That's your choice. Sometimes you need to stand true to yourself to begin 
with and I stand solid, that's important.  
 
Ellen went on to add the discussion she had with her specialist:  
I will look after myself if you look after me” I said to my doctor “This is how we are 
going to do this, you go to every conference you can, do all the things you need to 
do…but I'll also do my part and we will care share me.  
 
Similarly other participants commented:  
I learnt very quickly that if I needed to get anywhere it was only me that was going to 
do it.                      (Lara, 44yr) 
 
From my point of view I was running the ship. I live by the motto that has basically 
helped me. It’s to “deal with the things that I can change, accept the things I can’t 
change and the wisdom to know the difference” and I acknowledge that it’s a prayer, 
but it’s also my philosophy.      (Colin, 66yr)  
 
Serious illness is a catastrophic scenario in which the predictable world of a healthy 
and self-reliant individual unexpectedly transforms into one where the control is in the hands 
of strangers. As patients, the ability to plan or predict their future is taken by others, and this 
can be an isolating and disempowering experience (Xuereb &Dunlop, 2003). Previous 
research has reported that, in order to remain in control, those with chronic illness such as 
cancer may rebel against the normal expected care by refusing to attend check-ups, take 
recommended treatment, or, alternatively, will participate in risk-taking behaviour (Denz-
Penhey & Campbell Murdoch, 2008; McGrath & Clarke, 2003). However, this issue was not 
apparent among the current participants. Rather, the majority were vigilant in conforming to 
medical advice and took active steps to improve their health and wellbeing. Ben stated: “I’m 
trying my hardest to exercise and go for walks, I’m trying to do things to help with my weight 
and take some control over what I can.” As part of PFC, other cognitive strategies included 
‘self-talk’. Lily in recalling her husband cancer journey, shared how she had learned to 
effectively manage her thoughts, “I have to say stop! It's not the same. Stop panicking. It's silly 
but I guess it's natural because I went through so much trauma with my husband.”  
Similarly, PFC behavioural strategies were equally effective in assisting participants to 
plan, organise and document their treatment regime. Ellen illustrated how she charted her 
progress: “I keep a diary and documented everything, all my results and side-effects and I use 
a USB that's encrypted so I don't have to remember everything.” This supports previous 
research identifying that intentional cognitive and behavioural strategies can be effective when 
coping with health-related life changes (Waldrop, O’Connor, & Trabold, 2011). 
Finally, an important behavioural strategy that built resilience and was emphasised by 
all participants was the benefit of finding purpose or meaning in their life or “a reason to get 
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up each day.” As Zac reiterated, “It’s important to find your passion and don’t wait… go for 
it.” As discussed in the literature review, the concept of man’s search for meaning was first 
introduced by Viktor Frankl. Since then, several themes denoting the search for meaning have 
emulated beliefs in triumph over adversity in numerous qualitative studies involving chronic 
illness and traumatic injury (Denz-Penhey & Campbell Murdoch, 2008; Lau & van Niekerk, 
2011; Moi & Gjengedal, 2008; Park et al., 2008; Williams et al., 2004). First Ellen and then 
Colin also echoed the importance of maintaining a sense of meaning in life:  
One of the big things is when you're very ill and your life becomes smaller it becomes 
quite content. It might be just sitting, so it becomes smaller it organically happens.  
You don't necessarily become happier but your life means more and you become more 
content. 
 
I'm involved in the church a fair bit, and I love gardening and seeing friends.  
In terms of my personality, bit of a doer and is probably part of my 
spiritual dimension, meditation has always been part of my life. I like to  
be involved in things socially, that is very important. We have two  
or three different groups of friends that are very close. I'm involved in  
volunteer work and reading for the Blind. I've been involved in basketball, and that 
still keeps me busy this all helps to give meaning to my life. 
 
The following participants received their sense of purpose by either giving back to the 
community or by being an advocate: “I became part of a buddy system, people would phone 
up and talk me about stem cell transplants which helped those who were very frightened” 
(Lara). Walsh (2003, p. 56) defined this “transcendence from personal tragedy and suffering to 
concern and action on behalf of others” as a central feature of resilience. This is also nicely 
demonstrated first by Ellen and then Fiona who fittingly shared: 
People say giving back to the community I think that is a terrible word, you give 
forward. If you give back then that stops the negotiation, you give forward to the 
community, that gives you the opportunities in life. Those sorts of things are the 
cornerstones of coping better. Don't ever just receive. I think with the political 
situation the one who screams the loudest get acknowledged. I've always said you live 
with cancer you don't live it. I've never lived my condition except I voice it. You can’t 
take things personally when people don’t understand.  I believe it is important to show 
people you can live well with CML.             
 
I have a personal mission in that I'd like to live my life and in some way make a 
contribution. If I can do my little bit too allay fears that cancer is not the end of life, if 
you get a cancer diagnosis it isn’t the worst thing that can happen.  
 
The results of this study indicate that both EFC and PFC strategies can be helpful at 
different stages in the coping process. A previous meta-analysis of studies on coping with 
various stress experiences supports the hypothesis of a phase-specific adaptivity (Suls & 
Fletcher, 1985). As the current study identified, avoidance was associated with more positive 
adaptation in the short-term, but, over time, attending to the experience seemed more adaptive 
(Suls & Fletcher, 1985; Wenninger, 2012). It seems that coping is dependent on the individual 
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concerned, the adversity, available resources, and the time following diagnosis. Regardless, the 
participants in the current study highlighted the effectiveness of both EFC and PFC strategies 
in maintaining resilience. However, further research is necessary to explore how different 
coping strategies are used collectively over time to accomplish positive outcomes in cancer 
survivors. 
Positive Health and Behavioural Change  
The benefits of positive health and behavioural modifications (e.g., lifestyle and self-
care behaviours) have been discussed within the cancer-related literature. For example, several 
studies maintain that exercise, diet, and relaxation have a positive influence on those living 
with cancer (James et al., 2011; Rabin et al., 2011; Schwartz, 2004). The results of this 
research concurs with several common themes discussed by the majority of interviewees (n = 
20), who emphasized these benefits, including a new respect for their inner health. These 
benefits comprised helping with recovery from treatment, improving mental health, facilitating 
weight loss, promoting relaxation, and feeling stronger physically.  
First, lifestyle changes appeared to be even more important for the participants 
following their cancer diagnosis and were effective in reducing the risks associated with 
treatment. As Lara explained: “I definitely watch my diet, and try to keep fit by exercising. I 
have noticed since having cancer that if I slip up and get slack, I feel more tired and sluggish.” 
In addition, the participants reiterated the importance of maintaining the lifestyle that they 
were accustomed to prior to their diagnosis, even during their hospital treatment. This was 
beneficial to Pete’s recovery as he commented:  
I was also training in the hospital, I took dumbbells in, and I walked up and down the 
ward and found a stationary pushbike. It was like I wanted to keep my routine and to 
prove that it wasn't getting the better of me. Basically when I do my exercises it 
definitely helps me psychologically. I have always been fit and exercised and for me 
this is back to the normal me and I am much more able to cope.  
 
The majority of interviewees also participated in some form of relaxation, such as 
music, art, yoga, and meditation or additional complementary approaches including 
reflexology, tapping therapy, acupuncture and massage. As mentioned by Maria:  
Every now and then I will go for yoga but this is funny to watch because I am old and 
I'm not an exercise person or I might go for meditation. I'm not too sure if this works 
because you know my mind wanders but I feel so good afterwards. 
 
Another area of self-care identified by participants as paramount to their overall 
psychological wellbeing involved taking care of their appearance. The main benefits included: 
feeling in control, being treated more normally by others, improving their self-esteem, 
increasing their energy levels and generally enhancing their mood. For example, Maria, who 
was going through a difficult time, shared: “I'm finding it hard getting up, but when I make an 
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effort and dress nicely, I do feel better.” Pete stated: “Yeah if I bother to shave, I do feel half 
alive.” Further examples are first described by Helen and then Sharon:   
Most days, whenever I could, making the effort to get up out of bed and 
get dressed, wear a pretty scarf put a bit of lipstick on all helped my state of mind and 
get on with things.  
 
I would always put my lippy on in hospital before the doctors came in. That was like 
my mantra and helped me feel less crappy and more in control.  
 
Several comments related to remaining vigilant in other areas of their physical health. 
Ellen stated: “I always have regular check-ups with my GP for my ongoing health…dental 
visits, the optometrist…. things like that.” Finally, self-care encompassed several areas, but 
importantly there was an awareness of the need to be kind to themselves. As commented by 
Sharon: “I treat myself gently and I give myself lots of rewards…I make sure I have lots of 
things to look forward to and I always listen to my body.” Although some participants did 
highlight at least one practical barrier, such as limited time available for maintaining self-care 
because of work and family commitments, the majority of participants considered self-care a 
priority.  
Influence of time. 
Previous literature has highlighted the importance for cancer survivors to take ‘time-
out’ (Kelly & Dowling, 2011; McGrath, 2004; McGrath & Clarke, 2003). However, with the 
exception of one article by Gartland et al. (2011), no other study could be found that has 
directly related this to resilience. This research by Gartland and colleagues involved adolescent 
cancer survivors and identified the importance of having the ‘time and space to think’ (i.e., to 
work through the meaning behind the cancer event and why) as an important factor in 
maintaining resilience. This was also found to be necessary for the participants within this 
study. It was observed that interviewees acquired self-confidence in their ability to face 
cancer-related challenges if they were able to take the time necessary, and, importantly, 
process this at their own pace. At times, this allowed the participants a break from the 
expectation to remain positive. In some circumstances, the opportunity to attend to their own 
feelings in their own time was of more value than talking to or being with others. As stated by 
these participants: 
I was glad to have some space and time when I was first diagnosed and not to have to 
put on a public face because I had to get my head around the fact that it was going to 
affect me for the rest of my life. I was very self-conscious about my appearance, my 
round face.                              (Fiona, 51yr) 
 
I needed the space from people and importantly time to accept the diagnosis. It takes a 
long time for your body to recover; it’s not like a broken leg that everybody can see. 
                                  (Lara, 44yr) 
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I find it’s helpful to spend time by myself, switch off the phone, not talk to anyone. 
Give myself the chance to deal with it on my own.                      (Megan, 43yr) 
 
The participants also discussed the importance of getting help at the right time. 
However this varied between individuals. This supports research by McGrath and Clarke 
(2003) who identified that timing was the most important factor reported by cancer survivors, 
in effectively providing the opportunity to ‘talk’ about their illness experience. This research 
highlighted that there are times during the survivorship trajectory when talking with others is 
ineffectual, conversely there are other moments where getting help and sharing experiences is 
beneficial. Likewise, many participants in this study expressed a specific need for help at 
particular stages in their survivorship trajectory. For example, Lara referred to a definite phase 
during her cancer journey when she felt vulnerable and the support provided at that time was 
not only ineffective but created more stress: 
I didn’t really get any help until several months after my treatment at which point they 
gave me a whole lot of information and reading about my cancer. This was also when 
I just hit that “what if phase” so it actually made me really sad and wasn’t helpful.  So 
I think it is crucial to be given the information about your cancer at the right time 
which is probably when you’re at your most positive and this may be different for 
everyone but definitely not six months following treatment.   
 
In addition, illness often compels patients to consider many factors, such as the time it 
will take to be treated, quality time remaining and, potentially, time left until death. The 
literature reports that, as a consequence of focusing on their own mortality, some patients cope 
by making significant changes to their lifestyle and reassessing how they prioritise spending 
their time (Grunfeld et al., 2013). This was also apparent in the results of this study. 
Participants reported that they now considered their time to be more precious. For example, 
Helen stated: “I just need to make the most of every minute.” 
Previous research reports that perspective on time may also change for individuals 
who have faced a life threatening illness (Sherman, Cooke, & Grant, 2005). As Colin 
remarked: “It is very surreal as the chemo progresses. It’s like you are living in a parallel place 
in time.” However, a key point that surfaced was also the ability to accept that recovery would 
take time and that health challenges were transient. As Karen commented: “It's all 
circumstantial depending on what's happening at the time, some days are better than others, 
but I guess this is no different to my life before cancer.” In addition, Anna remarked on the 
change in her anxiety as time went by: 
I mean when you’re first having the blood tests every two weeks you sort of worry…as 
soon as I heard the fax machine even if it was 2 o'clock in the morning, I'd be out of 
bed running down the stairs to look at it, but now I sort of think I'll look at them in the 
morning, I'm not getting out of bed. This sort of thing so confidence increases as time 
goes by. 
 
  
RESILIENCE IN HC SURVIVORS 140	
Self-Education. 
The final sub-theme described by participants as contributing to their resilience was 
their ability to proactively self-educate or become self-informed. This supports previous 
research reporting that cancer patients who remain informed are more likely to experience 
positive outcomes, and that lack of adequate information can be a source of substantial stress 
(McGrath, 2004; Rabin et al., 2011; Xuereb & Dunlop, 2003). 
The gathering of information predominantly helped the participants to have some 
control over decisions regarding their future. As Max commented, “I learnt as much as I could 
so that I felt more informed about the decisions regarding my therapy.” Likewise: “I wanted as 
much information as I could get. That way I could make choices and feel in control, in an 
uncontrolled situation” (Colin). Participants would actively seek a second medical opinion, if 
deemed appropriate, and, at times, the information provided was not always taken for granted. 
As Fred explained: 
If a GP gives me a prescription I don't just take it. I study it and get the book. I never 
believe everything just because they give it to me, we have to be responsible to look 
after our health and check it out yourself. 
 
In circumstances when information wasn’t easily accessible, the interviewees were 
incredibly effective at self-educating. The participants gathered information from several 
sources, some of which included the Leukaemia Foundation, their specialist, the library, the 
Internet and social media. Two participants summed up the benefits of being self-educated in 
these words: 
My doctor apart from the verbal, he didn't give me anything. So got the phone 
directory out and looked under the Leukaemia Foundation and rang them. I'm a book 
type of person so I wanted something visual to read… they sent me a package and in 
that was one particular booklet on CML. After this I went online but I was very careful 
because of some of the information was not always correct. So I've got a CML section 
in my filing cabinet and it’s there for my kids if they want.                         (Fiona, 51yr) 
 
First of all is the acceptance of it and then being able to go and research it, If you're 
not educating yourself enough speak to someone else about it I believe that resilient 
people have a wider grasp and understanding of the world they live in.     (Ellen, 58yr) 	 	
In summary, the analysis of the interviews has identified a personal resolve that each 
HC survivor demonstrated to maintain resilience. The experience of living through HC led 
many of the interviewees to reassess their lives, be less focused on material goals, and 
strengthened relationships. It is clear from the results of this study that personal resilience is a 
complex multifaceted web of attitudes and values that are facilitated through: self-awareness 
(i.e., through acceptance, self-education and personal attributes); self-protection (i.e., through 
coping strategies, available resources and social support); and, self-management (i.e., through 
decision making, self-care, and utilisation of resources). As Ben concluded: “Lots of things 
together not just one big thing has helped me be resilient.”  
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Pathways and barriers to resilience 
Although participants in this study identified themselves as resilient, many 
acknowledged situations in which their resilience was challenged. The next major theme 
identified by the analyses was the various pathways and barriers to resilience. Five sub-themes 
were highlighted by the participants, as factors that either assisted or impeded their ability to 
maintain resilience. These included factors related to employment, relationships, 
communication, information and resources and unmet needs.  
Employment. 
Research evidence indicates that resuming work after illness is associated with 
improved physical and psychological functioning (Grunfeld et al., 2013; Hara & Blum, 2009). 
Conversely, being out of work is thought to contribute to adverse health outcomes (van Dijk, 
Ojajärvi, Taskila, de Boer, & Verbeek, 2009). This has been widely reported among males 
(Grunfeld et al., 2013), however the current study also found that employment was equally 
pertinent to females.  
A variety of benefits were described by those participants who returned work 
including social interaction, financial reward, a sense of purpose, routine and a sense of 
normality. As shared by Pete: “I missed my work, it is a big part of who I am, and they were 
excellent, absolutely brilliant. I was able to go back part-time which was really helpful, it gave 
me reason to keep going” and also Zac: “I am self-employed, so it has been a relief to be back 
at work doing something useful for a change.” According to the literature, work is a vital 
component of an individual’s self-identity (Grunfeld et al., 2013) with approximately 63% of 
cancer survivors returning to work following treatment (Hara & Blum, 2009). The figures in 
this study are similar, however many of the participants who returned to work were no longer 
able to work full-time, in addition their focus shifted to finding a work-life balance. As shared 
by Ellen:  
When I was extremely unwell they changed my job description which was fantastic 
because I didn't have to make many decisions. I've reduced my hours. At 2 o’clock I’m 
done. So I think this is the best job for me so, that I can also do all my community 
work. It’s not the main focus of my life.  
 
However, there were also negative consequences associated with returning to work. 
Several participants discussed as a sense of uneasiness and identified a lack of confidence in 
their ability to carry out their work role effectively. This was due in part to the survivor’s time 
away from the workplace and concerns over treatment side-effects, such as fatigue and 
memory loss. Another concern for some participants was the disclosure of their cancer 
diagnosis to their employer. Several reasons for this included: feelings of embarrassment; the 
culture or ‘sigma’ of cancer; to avoid unwelcome attention; and, wanting to appear normal and 
capable in their ability to do the job. As commented by Max:  
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How much do you tell them all about your cancer or do you play it down? I was 
having lots of days off work, I felt like I had no choice. It’s definitely harder. I will 
perhaps always have to disclose my leukaemia as I often travel in my job, which 
impacts on health insurance but others can be quick to discriminate or prejudge and 
that’s hard to cope with. 
However, the majority agreed that by disclosing their cancer diagnosis they had 
received advice and support from not only their managers, but also from colleagues they least 
expected. This supports previous research highlighting that the self-disclosure of a cancer 
diagnosis in the workplace is associated with positive outcomes including better adjustment 
(Hagedoorn et al., 2011). This is most often due to the provision of role adaptations and/or 
practical support offered by employers (Hagedoorn et al., 2011). As Colin confirmed: 
My manager told me to take as much time off as I needed to get my head around it and 
my body used to the medication, so it was good to have that breathing space. 
 
Relationships. 
According to all participants, their interpersonal relationships also impacted on the 
resilience process, both inside and outside the home. However, this varied within the group as 
both positive and negative interactions were encountered involving partners, family and peers, 
and/or relationships with physicians and other allied health professionals.  
Several interviewees referred to their partners and immediate family as being their 
main source of strength.  However, the positive effects of other close relationships were 
equally important. For example, Alyssa commented: “My children were incredible, but I also 
have special friends with whom I now have a deeper connection.” For other survivors, the 
focus was on repairing relationships and resolving any conflicts, to reduce ongoing negativity. 
However, either way, it was clear from the interviews that close relationships mattered. As 
Helen explained: 
I just had a new granddaughter who was five days old so I wasn't going anywhere. 
Having all of my grandchildren, daughters and my husband keeps me resilient, 
motivated, and alive. 
Nevertheless, there were also situations in which the relationships created stress and 
impeded resilience. For example, many participants found it difficult to cope with others’ 
expectations, especially in relation to how they should behave. As Ellen shared: “People have 
an expectation of what they think you should be and how you should act” and Megan said: 
“It’s hard work to keep pretending to others that you are feeling well, which is what my family 
wants to see.”  
There was a general consensus that the HC experience could only be understood by 
others who had been through this experience. Several participants recognised that many of 
their friends were unable to appreciate what they had endured. Specifically, the ignorance of 
others was challenging for many survivors. For example, Ellen commented that a colleague, 
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after finding out she had leukaemia, said to her: “That’s not good my dad died of leukaemia” 
and likewise Colin pointed out that: “It's not helpful to hear about what happened to aunt 
Martha.” Similarly, Megan found it very upsetting after losing 20 kilograms, as a result of 
severe nausea, when her friend stated: “I hope you are not trying to stay thin by not eating?” 
These results support previous literature affirming that comments and presumptions by others 
who had not been through a similar illness are perceived negatively (McGrath & Clarke, 
2003). 
As a consequence of HC, participants also shared stories about long-term friends, 
family and even partners who had distanced themselves. For example, Helen commented: “My 
relationship changed with my husband and became a bit distant because he couldn’t cope with 
it…he didn't talk about it.” Other participants also sensed that intimate relationships were 
affected because they had personally changed. As Lara remarked: “I have noticed a change in 
the relationship with my husband, when I started my chemo he was great at looking after me, 
but now that’s over, I’ve moved on and I don’t want that anymore…I’m a different person.” 
Travis too summed up his post-cancer relationship dilemmas by sharing:  
Chicks too, who wants a guy who has had cancer. I know that it shouldn’t matter, but 
that is just another thing you think about. I don’t have a girlfriend at the moment but 
it’s that whole part of having to tell a girl you like. When do you do this? How much to 
say? All that crap. 
 
 In addition to friends and family, participants highlighted that a trusting and positive 
relationship with healthcare professionals was regarded as essential in fostering resilience. 
This supports previous research reporting that many cancer patients have faith in their health 
care providers (Bulsara, Ward, & Joske, 2004; Knott et al., 2012; Roundtree et al., 2011). In 
this study, there were numerous examples of positive relationships with healthcare 
professionals. For example: “They are genuinely interested and I'm not just another patient and 
another number” (Pete). Lily also confirmed this: “My specialist is incredible. He's like a 
friend. I trust him one hundred percent and I know that I can call him at any time.” Anna too 
believed that her relationship was paramount to her recovery stating: 
The positivity of my specialist is one of the huge parts of getting me through. I would 
have to almost put that at the top of the things that helped me.  
 
However, as with family and friends, negative relationships were also mentioned by a 
number of interviewees. Imogen found the interaction with her physician challenging, 
especially in relation to issues regarding her appearance. The lack of empathy was highlighted 
when her specialist stated: “Well, it’s a bit of weight gain or you die… what’s the better 
option?” In response, during the interview, Imogen commented: “I’m a single mum with two 
kids and I've also got to have some quality of life. I get what he's saying, but it's hard that my 
specialist can't acknowledge some of what's important to me.”  
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Finally, in addition to the relationship with the immediate treatment team, participants 
also referred to several influential relationships, often transient, that had an impact on their 
resilience process. Many of these included: psychologists, pharmacists, phlebotomists, drug 
company representatives and the hospital ancillary staff (i.e., cooks, cleaners and clerks) who 
were all mentioned in a positive light. As Jack commented: “The medical receptionist was 
amazing we knew what was happening 12 months ahead with appointment bookings, so that 
we were able to plan our lives.” Anna too was very moved by an unexpected relationship that 
assisted her recovery:  
There is a delightful old nun at the hospital, she is well into her 80’s and she tries to 
see every patient in the morning and before they go to bed at night. She comes around 
and tucks you in, she is amazing. She would bring you a little prayer which I still have 
by the bed, and knowing how old she was and you are thinking “You're the one that 
should be in bed.” So things like that all helped to get me through. 
 
In essence, these participants believed that healthcare relationships were influential 
and either contributed to, or hampered, their resilience. This experience was often reliant on 
how satisfactory the survivors believed their needs were met and whether interviewees felt 
they could express their feelings in a supportive environment. However, as McGrath (2004) 
highlights: “In short, the health professional can nourish the patient with support, honesty, 
compassion, and a realistic appreciation of their situation, but the hard work of maintaining a 
positive attitude must come from and be sustained by the patient themselves” (p. 32). 
Communication. 
Probably the most important factor in the relationships of each participant was 
effective communication. This supports the literature stating that open, honest, sensitive and 
transparent communication styles can empower survivors and thus facilitate a more trusting 
relationship (Bulsara, Ward, & Joske, 2004; Butow et al., 2011; McGrath, 2004; Parry et al., 
2011). Most participants felt the need to have their concerns acknowledged and taken seriously 
in all relationships. However, for the participants in this study, the communication between 
family, friends and healthcare professionals varied considerably, with both positive and 
negative experiences encountered. 
First, the communication styles used by the participants ranged immensely. Many 
interviewees considered an open communication style to be essential. This was particularly 
pertinent within their interpersonal relationships, stating that open communication resulted in a 
sense of support, transparency and closeness, which was paramount to their recovery. As 
Karen was advised by a friend: “Tell everybody that you have cancer then people are aware 
and you can get the support and you know where you stand.”  Likewise, when Fiona was first 
diagnosed, when telling her children it was particularly important to her that she was honest:  
I tended to focus on the positives when I was talking to them and minimise the 
negatives, but I never ever lied to them and said that I would be cured.  
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However, on the other end of the spectrum, several participants elected to be more 
guarded in their communication. This was described as an attempt to maintain control, reduce 
distress and also to protect others. However, according to McGrath and Clarke (2003), a more 
closed communication style can impact on the support offered and may also be misinterpreted. 
This is evident in Lara’s situation:  
I tended to keep it all to myself. So you know I remember somebody saying that I was 
in denial, but I don't think that’s denial, I just didn’t want to worry them. It was on a 
need to know basis.  
 
Second, participants’ attitudes regarding their communication style with healthcare 
providers played an important factor in their ability to maintain resilience. Although these HC 
survivors generally expressed trust in their physician’s advice, they also disclosed much 
trepidation. The main concern related to communication issues such as: questions left 
unanswered; a lack of attention; contradicting information; a lack of empathy; and, the use 
medical jargon. This supports the literature stating that communication between cancer 
patients and their specialist has been identified as an area of potential stress (Butow et al., 
2011; Roundtree et al., 2011; Xuereb & Dunlop, 2003). For example, Pete described the 
communication provided by a doctor and a nurse while he was in hospital: 
The doc said to me: “We will just put a line in” what does a line mean? Is that a line 
with a pen? What does that entail? It's a whole new world of language you feel like 
you're travelling blind. Then the nurses have got their protective stuff on, aprons and 
masks, and they have got syringes with what looks like red cordial. I asked them once: 
“why are you dolled up like that?” and the nurse said: “it's dangerous stuff it can kill 
you this stuff” while she's busy pumping it into me. 
 
Imogen and Lara also both experienced specialists to lack empathy and to be 
inappropriate and not forthcoming with correct information:  
When I saw my doctor he said: “So you have got CML. Good news, ten years ago you 
would have died… take this pill and you’ll be fine.” I just remember thinking, 
seriously are you for real but that's just him.                    (Imogen, 34yr) 
 
They never told me pregnancy wasn’t a good idea they just said I would never fall 
pregnant again. Well I fell pregnant and then my specialist just put a whole dampener 
on the situation and said you can’t have it.                                           (Lara, 44yr) 
 
Lara also found herself in a situation where the disclosure of her personal information 
was mismanaged:  
I was at the hospital the first time on my own and l needed to see another doctor so the 
hospital staff gave me my medical report with my whole history…they just gave it to 
me…and of course what did I do? What would anyone do? You look at it and the first 
thing I saw was ‘poor prognosis’ written right there smack in front of me basically 
saying my days were numbered. That was probably one of the first times I actually 
completely broke down. 
 
However, the majority of participants were complimentary about most healthcare 
professionals who were sensitive to their communication needs. The most positive scenarios 
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involved physicians who identified a way of relating to the participants and who met their 
needs in terms of providing an empathic response. The following excerpts are examples of 
this:   
My haematologist told me upfront it's incurable, it won't go, it will pop up again and 
we’ll deal with it if it does. That's why I liked my doctor he was straight with me.  
                                (Colin, 66yr) 
I told my specialist: “All I want of you is to be there if we get into the trenches and 
that you can walk away and say I did all I could do.” That surgeon…I remember him 
kissing me on the forehead and saying: “Just remember if you die tonight don't ever 
forget you have been loved and cared about.” It was just him communicating those 
things and the kindness of somebody giving you that. To know that you may die and 
they were his last words.                               (Ellen, 58yr) 
 
My specialist didn't try to talk me out of it he just said: “You do whatever you feel you 
need to do, I know what you went through with your husband’s cancer.” He was 
trying every avenue to be helpful.                                 (Lily, 64yr) 
 
However, getting the balance and timing of information correct is not an easy feat. 
This is particularly the case in haematology where treatments are aggressive and invasive 
(McGrath & Clarke, 2003). Consequently, some of the literature has queried the need to cause 
further worry by overloading patients with information, decisions or through excessive 
explanations (McGrath & Clarke, 2003). This was discussed by some participants. As Ellen 
stated: “You've got all these decisions to make, it’s overwhelming and there becomes a 
frustration.” Knott et al. (2012) found, in their study of cancer patients, that when participants 
were asked if they were content with the treatment options provided, many implied that they 
were not provided with options. However, those interviewed were not dissatisfied, as they 
presumed that it was the specialist’s role to communicate appropriate advice on treatment 
recommendations. Similar results were found in this research, as is evident in Pete’s comment:  
I'm a great believer in research and drugs, partly because of the job that I do. I trust 
the medical system I don't question it at all, I just wanted to know what they would do 
in the same situation. Whatever was good for him was good for me. 
 
Nevertheless, there were other participants who clearly communicated their need for 
control over treatment decisions that impacted on their lives. As Lily highlighted:  
I think when the disease took off and I had to make that decision “Do I  
have treatment or not?” and it was my decision to make because I always said after 
my husband’s cancer journey that if I ever had anything like that I would never go 
there.  
 
Finally, the use of humour across all age groups invited a lighter perspective on the 
HC experience. For example, Maria’s interview was particularly humorous and it was evident 
that her sense of humour had contributed toward her resilience. As Maria shared: “I also used 
to embarrass the doctor, I would tease him all the time and say he was good looking. I think 
that made him blush but it also made me laugh.” Humour was mainly used to actively distract 
RESILIENCE IN HC SURVIVORS 147	
participants, make others feel more at ease and in attempts to down play the seriousness of 
their illness. As other participants highlighted:  
Probably one thing that was significant was that my close mates mucked around. You 
know they still gave me shit and kept that sense humour. I really appreciated that at 
the time.                           (Travis, 23y) 
 
One day the priest came round and I’m not very religious and I gave him cheek every 
time but he saw the funny side of it. I think humour is important.   (Pete, 63yr) 
 
Our kids now have a thing where they say ‘first world problem’ meaning it is not a big 
issue and we have a laugh about that.                              (Fiona, 51yr) 	
Information and Resources. 
The anecdotes provided by these interviewees highlighted that the knowledge gained 
through the delivery of information and available resources allowed the survivors to have a 
sense of control and to set realistic expectations. The literature confirms the importance of 
offering the right amount of quality information that is also appropriately timed. However, it 
can be difficult to achieve the right balance (McGaughan et al., 2012; McGrath, 2004b; Rabin 
et al., 2011; Xuereb &Dunlop, 2003). The results of this study support the literature, with 
many participants finding that, although they were eager to understand their HC, they also felt 
overwhelmed by the information provided.  
First, several participants believed that the ‘timing’ of information delivery was 
essential. Many felt that they were given important facts at times when they were unable to 
process the information. For example, Jack commented: “I was in shock, I did not remember 
everything they told me in the beginning” and this was reiterated by Megan: “My sisters came 
with me a few times when I've met with doctors, because I haven't always found it easy to take 
in the information.” Lara’s excerpt also provided another perspective:  
The timing is important, l think it’s helpful to get small amounts of information more 
often and I don’t think you need to know absolutely everything, but it’s different for 
everyone.  I actually stopped at one point and thought I’ve dealt with it…I don’t need 
to know any more.  
 
Karen shared this opinion and found the information confronting, especially when first 
diagnosed. Karen was adamant that she did not want the survival statistics or intricate medical 
facts. When Karen’s mother asked her specialist: “What are her chances?” Karen replied: 
“Don't ask that, I don't need or want to know all that stuff.” As is reported in previous research 
(Xuereb & Dunlop, 2003), for many participants receiving less information in the initial 
diagnosis phase, helped to reduce their anxiety. Anna highlighted this:  
I didn't want people to bring me information about five-year survival and things like 
that. I was happy with the haematologist and what he told me. I didn't want to go into 
all those details at this stage.   
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 Other participants like Lily and Pete just felt completely overloaded and at times this 
was stifling. 
I felt totally overloaded by information so I shut a lot of that out. I just did not want to 
travel that road again.          (Lily, 64yr) 
 
I was flooded with information. Someone gives you one bit of information and then 
someone else gives you other information. The information scares the pants off you… 
You learn all the new words like ‘neutropenia’ but some of the information is too 
involved. They tell you about all the things that can go wrong…and I thought my God 
it's a bit overwhelming.        (Pete, 63yr) 
 
Another important factor was the quality of information provided. Having a lack of 
adequate information was expressed as a source of significant stress by many interviewees. For 
example, many participants were predominantly interested in the tangible way that HC would 
impact on their life, rather than the statistical details. As Lara shared:  
The statistics are really bad and when they tell you these it’s a shock, but these don’t 
take into account your personal situation… your age and how fit you are? The type of 
person you are? It doesn’t take into account any of that. I just wanted to know how it 
was going to affect my quality of life. 
Many of those interviewed were able to recognise deficits in their knowledge and 
areas in which they needed more information. Research reports that when patients ask for 
more information it is often in an attempt to gain some control and hope in their current 
circumstances (Xuereb &Dunlop, 2003). Like Lara, in order to take care of their health, 
several other participants wanted to know the impact that treatment would have on their short-
and long-term QOL and wellbeing. As these participants commented: 
I also wish I was told more about the long-term side-effects of treatment. I was not 
prepared for that at all. I did not know that the fatigue would continue, my fingers 
would go numb, that it may send me into early menopause, I would get lots of ulcers 
and sores and also depression that was initially a big one for me.           (Sharon, 31yr) 
 
I would have liked to be more prepared for medical tests. I had never been in 
hospital…then suddenly you’re getting pricked with needles.                 (Natasha, 22yr) 
 
I think it was really important just to know what the treatments going to do. If you 
know there's nothing unusual about it then you don’t react to it. There was a certain 
calmness because I knew what to expect. Although I wouldn't have taken it all in I 
wanted as much information as I could get. That way l could make choices and feel in 
control.         (Colin, 66yr) 
 
To compensate for the information gaps, the participants became more pro-active in 
finding their own resources. Some interviewees wanted to fully understand their condition and 
be up to date on the most recent literature. As Ellen explained to her specialist: “One of these 
days we're going to have a conversation about this cancer and I want it to be an equal 
conversation.” Zac provided another example: 
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Even through this, l still managed to seek out more positive information from various 
resources and focus my energy on educating myself. I wanted to learn all about my 
leukaemia.           (Zac, 34yr) 
 
Several participants also discussed effective strategies they employed to retain 
information.  For example, many interviewees went with family members to appointments, 
they took the initiative to ask questions, employed note taking, used recording devices, read 
various resources, watched DVD’s, joined support agencies and, in some circumstances, 
sought out a second opinion. The majority of participants in this study also articulated the use 
and importance of the Internet. The Internet, including social media, acted as a vehicle that 
enabled independence, reduced feelings of isolation, provided cancer-related information, and, 
connected participants with other cancer survivors. This is highlighted in the following 
examples:  
The Internet and Facebook can be helpful to people, for example if someone says:“ I 
get these side-effects” and fifty other people respond and say: “yes I do too”, it can be 
quite supportive and reassuring and this response can be instantaneous and from all 
over the world. This can be quite comforting and less isolating.                 (Tess, 69yr) 
 
I was ill for weeks until I got onto the Internet and contacted someone in America who 
said: “I think you're taking the drugs the wrong way”.                               (Ellen, 58yr) 
 
One of the things that helped me cope was chatting to others online, who I could talk 
with anytime. Sometimes I would post stuff asking about my cancer, I would almost 
instantly get a response from someone in the world.  I would often log on at night 
when I couldn’t sleep especially when I felt lonely. I also used the Internet and my 
phone, so they helped me feel less alone and I was able to search a lot of information. 
                                 (Natasha, 22yr) 
 
In this study, the benefits of social media and the Internet were clearly apparent. 
However, two participants also commented on the negative aspects of using the Internet such 
as the quality and reliability of the information available. First, Karen described a scenario 
involving her parents who received inaccurate information about her type of leukaemia. 
Both mom and dad came in wearing dark sunglasses. They had been on the Internet 
all night of course and had discovered on some site that said I had two years to live. 
Luckily, my specialist came in and said: “No if she takes a pill and responds well she 
should be fine.”                   (Karen, 43yr) 
 
Sharon too confirmed the benefits of using the Internet but was also realistic about the 
use of social media:  
I had regular contact on the Internet with friends and would read various blogs from 
other survivors. This was encouraging but some of the posts were also very 
confronting. It did help me feel less isolated but I take social media with a grain of salt 
as not everything you read will relate to your journey.                      (Sharon, 31yr) 
 
In this study, the information gained through various avenues was clearly an important 
commodity for HC survivors. However, the amount, delivery method and timing of 
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information proved to be a double-edged sword, as the knowledge gained was not always 
beneficial (McGrath, 2004b). As outlined in this study, there was diversity in how information 
and resources were required by participants. Thus, in order to form the basis for a positive 
coping experience, the main challenge is to ascertain the individual patient needs and match 
information delivery accordingly (Xuereb & Dunlop, 2003). 
Unmet needs. 
The final sub-theme impacting on the resilience process for participants involved 
unmet needs, particularly following treatment. This supports the literature highlighting that 
numerous stressors often accompany the completion of treatment and/or transition to 
survivorship (Knott et al., 2012; Roundtree et al., 2011; Waldrop, O’Connor, & Trabold, 
2011). For example, several triggers evoked by particular events and/or surroundings can bring 
back painful memories and intensify feelings of uncertainty among survivors. In addition, 
Stanton et al. (2005) have identified four myths that may be experienced by cancer survivors 
following treatment. These include the belief that, as a survivor: I should feel well; I should be 
the pre-cancer me; I should be celebrating; and, I should be able to cope with minimal support. 
However, as expressed in this study, although this was how many participants wanted to feel, 
it was not their reality. A number of those interviewed struggled to maintain resilience as a 
result of unmet needs.  
The most common unmet need occurred at the completion of treatment when the 
participants described feeling: ‘in limbo’, ‘uneasy’, ‘lost’, ‘dismissed’ and in ‘unknown 
territory’, mainly due to the lack of support following treatment. For example, Zac noticed the 
support from family and friends fell away stating: “I think people thought, he’s OK now… so 
we won’t talk about it anymore…while really, I was still struggling with everything. So this 
was a difficult time for me.” The same feelings were shared by Helen:  
I'd say the first few months after treatment were the hardest. My family went back to 
Queensland and I think I felt really lost after this. I think they thought: “it's all right 
now the treatment is finished.” Whereas you have so many people ringing and visiting 
during the earlier stages worried about you and you’re seeing people every few weeks, 
but all of a sudden it stops and you feel very isolated and lonely. It may have helped to 
have somebody call once a month even up to 8 months after treatment because that 
was a difficult time. You do get a bit lonely after being so fussed over in hospital.  
 
Research maintains that additional support is particularly valuable, not only at the time 
of diagnosis, but also when patients are transitioning at treatment completion (Knott et al., 
2012; Rabin et al., 2011). Yet, this is also a point in time when assistance and support from 
health care professionals is being withdrawn (Rabin et al., 2011). This was also a time that 
many interviewees stated that they would have most benefitted from the offer of counselling or 
support groups. As these participants stressed:   
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It would have helped to have a support group contact me at home after my treatment. I 
was given a lot of information and I really wanted to contact them but I just didn't get 
round to it. I know if someone had phoned me and said: “We hear that you have just 
completed treatment and we are available for support.” I would have signed up for 
some help, but I just never took that extra step myself to contact them which I regret.  
           (Sharon, 31yr) 
 
Possibly help with the sexual function and I know there is information at the Cancer 
Council I probably should have pursued that. Like the Leukaemia Foundation, if one 
of their sessions had been on sexual dysfunction I would have probably attended but at 
the time they were more general topics.                                                       (Colin, 66yr)
           
Although the majority of participants indicated benefits in hearing ‘success stories’ by 
talking to other survivors, such connections were not always available following treatment. In 
some circumstances the interviewees had lost contact with other patients who had left the 
hospital or they had since passed away. Another downside was mentioned by Megan, who 
attempted to join a support group only to find that the other patients did not understand her 
aggressive leukaemia. As Megan commented:  
This one lady went on about me not cleaning my house, she didn’t understand that I 
couldn’t as it was a huge infection risk to me. She had a chronic cancer not an acute 
leukaemia like mine but she went on about a ‘don't feel sorry for yourself attitude’. I 
would come away thinking there was something wrong with me. I felt as though they 
thought I was imagining it and I thought to myself that isn't what I came here for. 
 
Many participants also referred to the lack of time with their specialists. As Max 
stated, “It takes time to talk about uncomfortable issues, I couldn’t just blurt it out in a few 
minutes…but l was well aware of the queue outside in the waiting room.” This is concerning 
for cancer survivors, as many important issues remain unanswered due to the lack of time 
available during medical appointments (Kelly & Dowling, 2011; McGrath, 2004b). Pete also 
summarised his perspective and shared what he believed would have been beneficial to him: 
What would really help is if someone could come into your environment with 
pamphlets that are easy to follow, and sit with you one-on-one to answer your 
questions. When you go to the haematology department you’ve got one million 
questions, the interns been briefed by the doctors, lots of people are waiting and 
you've only got 5 to 10 minutes and they speak code, so it's very hard to get the 
information you need. It would be really beneficial to have someone come your own 
home just before you are due to go to hospital and once you've had a few weeks to let 
the diagnosis sink in to have a coffee with you and explain anything you don't 
understand. That would be the best thing. 
 
Participants were also discouraged by what they perceived were barriers to care. For 
example, some felt unsure about the follow-up process and screening they would receive. 
Others referred to the lack of resources, ongoing costs and the ‘black tape’ surrounding the 
availability of medications through the public benefit scheme (PBS). For example, Ellen 
discussed in depth her frustration in getting her prescribed medication through the PBS:  
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Issues with PBS made it very difficult. I spend lots of time on the phone, it absolutely 
does my head in. If only I could get into their office and tell them how their stupidity 
and incompetence impacts on the health and care of cancer patients. They need an 
overhaul, they only let you have minimal repeats so there are no spares and they take 
too long getting new scripts, so you run out. They also change the coding but they 
forget to tell the pharmacist. I say to them: “Do you want me to not take drugs for four 
months, so your computer system marries together.” They don't understand sometimes 
they say, “Can you have another drug instead?” It's a nightmare for me, my specialist 
and my pharmacist and it happens all the time. I know patients who have borrowed 
drugs from other patients to keep them going until they get a script. It becomes an 
administration nightmare…these people seem to have no medical background or 
knowledge yet their decision to change to the drugs and the codes makes a big 
difference to my life.  
 
The final unmet need described by the majority of participants referred to feelings of 
loneliness and vulnerability, mainly due to isolation. The interviewees felt that the lack of 
normal contact with others made it difficult to remain resilient. This was particularly the case 
when friends and family were unable to visit due to their low immunity and when admitted to 
hospital isolation rooms. As Ben stated: “You are locked away alone in a room feeling pretty 
awful” and Luke confirmed: “Another thing that was crap was that shit isolation room… for a 
guy you just want like a set of weights or something.” Colin and then Anna also described this 
experience in more detail:   
It's like a darkness, not a depression darkness but you feel like you're in your own 
world and isolated and not connected and you don't realise how much other people 
are actually doing to allow you to maintain your health. 
 
There are two isolation rooms in the hospital that look out on a boring courtyard. On 
the other side is the road, St Joseph's, the football and other things happening and 
okay there are funerals at St Joseph's but that's not so bad as you can actually see 
there's a world out there. But instead you get this window and it just looks out on a 
little walkway and nothing much else and you can't go out anyway as you’re in 
isolation. It would be much better if it were reversed. 
 
In order to cope with this sense of isolation and loneliness while in hospital, 
participants employed several strategies. For example, Zac would do his best to stay in contact 
with friends and family even if he couldn’t see them face-to-face. Natasha commented that she 
would log on to the Internet when she felt lonely and was unable to sleep. Lara too shared 
another strategy that helped her cope:  
My husband had set up a video thing for me and I went through all our camcorder 
stuff and put it on to tapes so while I was in hospital I could watch old videos of happy 
times so that was really good.   
 
However, several participants also discussed how difficult and lonely the nights were 
at home, suggesting that this experience goes beyond the hospital. This was particularly 
relevant among the single female participants who commented that they found it hard to sleep 
and spent hours lying awake feeling alone. As shared by two participants:  
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I literally cried every night. I felt really lonely and quite isolated in the evening 
especially. When the kids have gone to bed or they were not at home I found it very 
difficult.                                                      (Imogen, 34yr) 
 
The most difficult time for me is being alone especially at night. My sleep patterns 
have been disrupted and I wake up in the middle of the night feeling isolated and 
anxious wondering round the house until eventually l might take a sleeping tablet or 
an anti-histamine to help me sleep.                                                             (Karen, 43yr) 
 
During these interviews, various factors that either assisted or made it more difficult 
for participants to maintain resilience were identified. The influential topics discussed 
included: employment, relationships, communication, information and resources and unmet 
needs. Although the analyses highlighted factors contributing to resilience (i.e., open 
communication), several other factors created barriers (i.e., lack of time with specialists). This 
supports several studies indicating that the survivorship needs of distressed cancer patients 
have not previously been sufficiently met by the Australian healthcare system (Girgis & 
Butow, 2009; Jefford et al., 2008; Knott et al., 2012; Lobb et al., 2009). However, the 
resilience process could be improved by addressing many of the modifiable factors identified 
by these participants (i.e., offering counselling following treatment; improving 
communication, information and resources, providing regular contact; addressing isolation 
issues etc.).  
 
Survivor Outcomes 
The final theme identified in this study relates to survivor outcomes. As a result of 
living with HC, there were three main sub-themes that participants attributed to as factors 
associated with personal outcomes. These included, transition - finding a new normal; re-
prioritisation and growth; and, self-reflection.  According to Roundtree et al. (2011), cancer 
survivors usually define survivorship in terms of what it means to experience cancer. 
Likewise, the participants in this study sought to find meaning in order to explain and cope 
with their HC experience.  
The interviewees reflected on this journey from two time frames; prior to and post 
cancer. Life before cancer involved the participants’ sense of who they were, which was 
largely based on external roles, responsibilities and tangible material gains. Conversely, life 
following cancer comprised shifting away from outward (external) thinking, to involve more 
inward (internal) thoughts. For example, many participants described issues pertaining to 
‘personal achievement’ and ‘self-development’, such as fully embracing life, discovering the 
purpose of their existence and wanting to make a difference in the world. For all participants 
this journey resulted in a significant transformation and a term that several referred to as ‘a 
new normal’. This supports previous research reporting that the need to find a ‘new normal’ is 
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a common phenomenon among cancer survivors (McGaughan et al., 2012; Wallace et al., 
2007). 
Transition: Finding a new normal. 
In this study, the participants highlighted that once the main crisis of HC cancer had 
subsided, their distress levels lowered. At this point, several participants recognised that they 
then began to focus their attention on positively adapting and moving on in their personal 
lives. However, the majority of participants found themselves lost in transition between their 
pre- and post-cancer lives. For example, Colin stated: “I suppose post-treatment you begin to 
get on with life again, but it’s like you live in that parallel universe, like you are just in a dream 
world for a while I guess.”  
Following treatment, this sense of being ‘adrift’ and in ‘no man’s land’ was described 
by Little, Jordens, Paul, and Sayers (2001), who referred to this phenomenon as ‘liminality’. 
According to Little and colleagues, survivors’ transition through the space of illness, but do 
not return to their world as it was prior to illness. Rather they experience disorientation, which 
is then followed by an adaptive phase, in which the survivor constructs meaning from their 
experience. Other researchers have also implied that surviving is a process, involving several 
phases of change without an endpoint and is, therefore, a lifelong journey (Deimling et al., 
2005; Dow, 1991; Pelusi, 1997).  
Similarly, after treatment, many participant anecdotes alluded to persistent physical, 
psychological and social changes. As Ellen commented, “I'm far less tolerant …it becomes the 
new normal, it becomes part of you and you can't change it.” Moreover, this ‘new normal’ was 
viewed as something that set these HC survivors apart from others in society who had not 
experienced cancer. For example, Ellen went on to say:  
Unlike most of my friends who haven’t had cancer, I don't go out at night much 
anymore, I'm usually asleep early. So now my new normal is going out for breakfast 
and lunch instead.  
 
Likewise Imogen had adjusted to changes in her routine:  
I need to set my alarm at 4:30 in the morning to have my tablets because you've got to 
fast before you can have them. So this is normal now and these are the things that I 
have had to adjust to.      
 
Re-prioritisation and Growth. 
In addition to establishing a new normal, all participants discussed re-prioritising their 
lives and the subsequent outcome of personal growth following this experience. According to 
research, as is common after facing a life-threatening illness, cancer survivors often develop a 
more realistic and positive outlook on life and are not as easily upset by everyday stress 
(Bulsara, Ward, & Joske, 2004; McGrath & Clarke, 2003; Wallace et al., 2007). Similarly, in 
this study strength, optimism, acceptance, appreciation, determination, and the ability to 
process everyday stress in perspective were amongst many qualities that were reflected in the 
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interviews. As stated by Zac: “I now know how strong I can be, nothing has ever challenged 
me like this. It’s comforting to know if it does come back again I can cope, I have already 
done it.” Likewise several other participants shared the same view:  
It's not all tragic or bad or sad. There are still all the good things in life that are 
happening…we still holiday, and I don't sweat the small stuff. I think that stands you 
in good stead, otherwise you're fighting and that can only give you ulcers and anxiety.
                                                                    (Colin, 66yr) 
 
That’s another thing I don’t judge people at all any more. Not that I used to very 
much, but now I definitely don’t, knowing that you have no clue what they’ve been 
through.                                               (Lara, 44yr)  
 
The way I positively interact with my diagnosis is more helpful definitely for myself as 
the first beneficiary and then also for others that can then witness me.     (Fiona, 51yr) 
   
These participants were acutely aware of life’s fragility, believing they had been given 
a second chance. This provided the momentum for participants to re-assess and re-prioritise 
their lives. As Fiona stated: “So for me it's like, well I have got it, it doesn't define me, I’m 
going to live a very full life, in fact it’s going to inform me in a better way.” Similarly, Alyssa 
commented: “Generally speaking I'm getting on with my life without letting leukaemia define 
who I am, I live with the disease not against the disease.” For other participants, their 
perspective on time had changed. This awareness empowered many to ‘seize the moment’. 
This was pivotal to their recovery and highlighted a quality that many believed was not present 
prior to their cancer diagnosis. As these participants explained: 
It has been so beneficial for me to not stress about the future. We now take more 
holidays and enjoy the present. I guess I live much more day-to-day. I used to be too 
serious, a planner and saver! So much is different.         (Zac, 34yr) 
 
I probably cope by living more in the moment. I know my future is important but that 
is unknown so I try to enjoy stuff now.                (Jack, 70Yr) 
 
I've decided to live life and really enjoy myself, I don’t worry about what's happening 
in six months time or in a year.                                          (Helen, 62yr) 
 
In several circumstances participants also sought to optimistically re-appraise their 
lives. As the following participants remarked: 
Sometimes I feel I'm in front because I'm in remission and they are keeping an eye on 
me. It's not as though I am walking around on the street without knowing I have got 
cancer. Even if they find something it's likely to be in the early stages so I guess that's 
a good position to be in.                             (Pete, 63y) 
It was kind of like a gift because it pulls you up and you never take life for granted. 
You think okay today is a beautiful sunny day and I want to make the most of it. So you 
live more in the moment and thinking about positive and less of the past. I have more 
trust in the goodness of humanity and the world generally. In some ways I feel more 
connected. The cancer experience has just given me another opportunity to step up.     
                     (Fiona, 51yr) 
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Equally, other participants also commented that they had experienced personal growth 
and felt more liberated. Research in the area of post-traumatic growth (PTG) maintains that 
there can be signs of positive growth following cancer treatment (Tedeschi & Calhoun, 2004; 
Wenzel et al., 2002). According to Tedeschi and Calhoun (2004), PTG is “positive 
psychological change experienced as a result of the struggle with highly challenging life 
circumstances” (p.1). One of the excerpts by Lara highlighted this: 
I have grown as a person. Having cancer has definitely made me stronger mentally.  
You do go through the anger and all that and then you go through a stage where 
you’re very carefree and then all these years later you come to a plateau. The little 
things don’t matter, I am more at peace and I surround myself with people who are 
positive. I’m a better person for this experience. 
 
Although PTG is achievable, it is not necessarily inevitable (Tedeschi & Calhoun, 
2004). This is demonstrated in the current study in which a minority group (n =3) were 
undecided about whether they had experienced personal growth. However, these three 
participants who also maintained that they were coping well were all early in the survivorship 
trajectory (under 2 years). As Sharon stated:  
It’s early days and I feel like I am going ok, but I haven’t had the chance to see the 
positives yet, you know properly take it all in. 
 
Therefore, one could speculate that ‘time’ is an important factor in processing the 
cancer experience and that the absence of PTG does not necessarily denote a lack of resilience. 
Although this is beyond the scope of this study, future research into the relationship between 
PTG research and resilience would be beneficial in enhancing our understanding of personal 
growth and psychological well-being following cancer.  
Self-reflection.  
The final sub-theme, that was apparent in the majority of participant’s interview 
transcripts, involved self-reflection. Each participant contemplated many aspects of this cancer 
journey and shared several areas in which they questioned not only personal choices but also 
highlighted several regrets. For example, several participants commented that they regret not 
expressing their emotions, taking time-out for themselves and/or keeping written anecdotes. 
This is highlighted in the following excerpts:  
I wish had written down or recorded more information. I have forgotten a lot of stuff. I 
wish that I had gone out more for short walks or done gentle exercise that sort of 
thing. I think allocating that time may have helped my headspace.  (Jack, 70Yr) 
 
I wish I had allowed myself to vent more and not bottle up my feelings and keep a 
diary, as there is a lot I simply can’t remember.                                         (Helen, 62yr) 
 
Others participants reflected on situations that left them feeling frustrated in areas they 
believed others were accountable. For example Anna stated: “I wish that I was offered the 
opportunity to exercise, it is probably the only thing that really could have made a difference 
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to my recovery.” Likewise Ellen remarked: “I wish I had been offered more thorough tests 
then I may have been diagnosed earlier.” In contrast, other participants reflected on their own 
need to take ownership. For example, some discussed the importance of prioritising and 
acknowledging their own limitations. As Alyssa stated: “I have come to realise my health 
comes first” and Ellen said: “Without burning the candle at both ends I still do what I can.” 
Similarly, Lily reflected on her part in being responsible for her health: 
I used to fight it but one thing I've learnt through my psychologist is to listen to my 
body, when it tells me it's enough it's enough, and I do now. I gain courage from the 
easy days and take the difficult days one day at a time. When I think back, I used to 
feel guilty, but now I will actually lie on the couch. So I'm listening to my body now. 
 
In summary, the previous discussion has outlined four main themes (and sub-themes) 
that the HC survivors in this study identified as contributing to their positive or negative 
mental health outcomes. These included: the burden associated with a HC diagnosis; resilience 
- coping with HC; pathways and barriers to resilience; and, survivor outcomes. This qualitative 
analysis has confirmed that over time many factors contributed to the process of resilience 
among these HC survivors. Thus, there is no unanimously effective or ineffective form of 
coping. Equally, Compas (1987) maintains that, in order to comprehend the coping response, 
one must consider the resources accessible within various individual, family and community 
levels. Therefore, if the resources alter or vary, the response to coping may also change. 
Ultimately, it is likely that the most beneficial coping response is shaped by one’s ability to 
adapt to an eclectic coping style that is not only influenced by available resources, but also the 
individual themselves (Moss, 1997). The following statements highlight such examples:   
In terms of my personality, my friend thinks I'm like a dog with a bone. I won’t give up 
on anything and I tend to stick with things. So I suppose resilience is just the same as 
that, you just stick at it and just get on with it and do the best you can. So I think that's 
my character to keep on keeping on, I won’t give in. So I probably don't think about it 
consciously but I would say this attitude probably kept me going and helped me cope.           
                                 (Anna, 68yr) 
 
I guess it's my mental approach to it all and remaining positive that helped 
me to be resilient. But if I'd got too many knocks at once, if too many other difficult 
things had occurred at the same time I could certainly see that would sooner or later 
impact on how resilient I would be. But having cancer has made me stronger and 
more determined.                                   (Ben, 60yr) 
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Leximancer Results 
As previously mentioned, the collective findings of both qualitative thematic analysis 
and Leximancer analytic software contributed to the above results. There was an overlap of 
approximately 80% of the concepts/factors identified between the thematic and Leximancer 
analysis. For example social support, friends, family, work, remaining positive, treatment side-
effects and the relationship with doctors/specialists were all commonly highlighted equally 
throughout both analyses. However, one advantage of including the Leximancer analysis was 
that it further highlighted ‘time’ as the most significant concept shared among the participants, 
further adding to the accuracy of data interpretation. Therefore, both the thematic analysis and 
use of Leximancer software had advantages, each of which contributed to a more valid 
analysis of the data.  
A visual concept map produced by Leximancer is presented to further highlight the 
main themes and word concepts of the qualitative data provided by interviewees (Figure 5.1). 
Themes are ‘heat mapped’ to reflect importance. Thus, the hottest or more important themes 
appear in red (i.e., thought) then orange (i.e., work) and so on, followed by the colder colours, 
denoting less relevance (according to the colour wheel). This outlines the overlap of several 
concepts/factors identified between the thematic and Leximancer analysis. For example, 
remaining positive, social support, friends, family, work, treatment side-effects, the hospital 
experience and the relationship with doctors/specialists were all commonly highlighted. 
However, interestingly the individual factors such as positive thinking (red), work (orange), 
and down-time (yellow) were ranked as more important than the support from friends and 
family (blue). In addition to the themes, the ranked word concepts are also identified by the 
size of the black circles. As shown in Figure 5.1, the largest black dot representing the most 
frequently referred to word by interviewees was ‘time’ in the yellow circle (with 179 statement 
hits), the second was ‘people’ (with 145 statement hits) followed by the word ‘treatment’ (with 
128 statement hits). Statement hits refer to the number of times these words appeared in 
separate statements within the data. 
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     Note:  ⁬ Red ⁬ Orange (warmer colours indicate most important themes)  
     ⁬ Green ⁬ Blue (cooler colours indicate less important themes) 
  ¢ Larger size black dots represents most frequently referred to words 
 
  Figure 5.1 Concept map.  
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In order to answer this question, participants were asked to list the top three protective 
factors that either helped or hindered their resilience. In the first instance, interviewees 
identified what they believed facilitated their resilience. As can be seen from Table 5.3, the 
majority of participants (n = 19; 82%) referred to social support as one of their top three 
factors. This is not unexpected given the proliferation of literature confirming the significance 
of providing support to cancer survivors (Girgis & Butow, 2009; Jefford et al., 2008; Knott et 
al., 2012; Lobb et al., 2009; Stewart & Yuen, 2011). 
However, what is of relevance is the imbalance between individual, family and 
community level factors. For example, when analysing all responses (i.e., three responses by 
each participant), 57% identified individual factors. This suggests that over half of participants 
believed (as opposed to their family or the community) most factors that facilitated their 
resilience were individually influenced (e.g., self-care, positive attitude, finding purpose, etc.). 
Of the eleven participants who listed community factors, the majority referred to their medical 
team (n = 7; 64%) followed by support agencies (n = 2; 18%) or medical accessibility (n = 1; 
9%), with one participant also highlighting their workplace as being paramount. 
Variations among participants also appeared to be related to demographic factors. For 
example, both participants under 30 years of age identified social media as the second most 
important factor. In addition, there are differences noted between short-and long-term 
survivors. The importance of finding purpose or life meaning was listed by 78% of long-term 
survivors, as opposed to only 28% of short-term survivors. However, self-care was more 
paramount in the early survivorship trajectory, particularly among the younger cohort. The 
difference in these cohort results are worthy of future consideration in terms of the both 
promoting individual protective level factors and providing beneficial methods of support 
across age and survivorship trajectory. 
 
 
 
 
 
 
 
 
 
 
 
 
Interview Research Question 2.   Which key factors made it easier or more 
difficult for HC survivors to achieve and maintain their resilience?  	
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Table 5.3 
 
The Most Influential Individual, Family or Community Related Protective Factors that 
Foster Resilience as Identified by HC Survivors 
____________________________________________________________________________ 
Participant  Age     Factors 1        2                   3 
____________________________________________________________________________ 
Natasha  22 Social support           Social Media                  Support groups       
Travis  23 Social support          Social Media                  Self-care         
Sharon  31 Positivity/Focus         Social support          Self-care  
Zac  34 Social support         Self-care                          HC Professionals          
Imogen  34 Social support         Workplace support          Accepting help      
Max  40 Social support         Self-care            Purpose/Meaning      
Megan  43 Genuine doctors        Purpose           Self-care        
Karen  43 Social support         Faith            Remaining Positive 
Lara  44 Social support         Personal outlook          Purpose 
Fiona  51 Faith           Treatment accessibility   Financial stability      
Alyssa  57 Social support         Purpose/meaning          Music       
Ellen  58 Understanding self    Financial backing            Purpose - engagement       
John  60 Acceptance            Positive attitude               Purpose - keeping busy 
Ben  60 Social support         Positive attitude               HC Professionals      
Helen  62 Social support         General Practitioner         Self-care        
Pete  63 Social support         Self-care            Belief in self       
Lily  64 Social support         Medical Specialist           Time alone/meditate 
Colin   66 Social support           Purpose/keep busy           Trusting treatment plan  
Anna  68 Doctors optimism     Social support           Trusting health regime 
Tess  69 Social support/pets   Purpose/keep busy            Competent specialist 
Jack  70 Social support         Positive attitude           Enjoying each day      
Maria  70 Purpose/Meaning      Leukaemia Foundation    Sense of humour      
Fred  84 Hope          Social support           Purpose - Learning  
____________________________________________________________________________       
Note:  ⁬ Individual level            ⁬ Family/combined level             ⁬ Community level 
           ⁬ 1-5yrs post treatment   ⁬ >5 years post treatment 
 
 
The second part of question two aimed to highlight the top three risk factors that each 
participants found prevented, or made it more difficult for them to maintain their resilience 
(Table 5.4). As can be seen in Table 5.4, the individual factors were separated into either 
physical, psychological or social/community. In addition, several responses fell into more than 
one category, so these were labelled as combined level factors.  
Many of the participants (16/23; 70%) listed individual factors as impacting on their 
resilience. Of the total individual factors identified (26/69), the majority of participants 
believed that psychological (n = 18; 70%), rather than physical (n = 8; 30%), effects impacted 
on their resilience the most. There were no specific family-related factors identified by this 
sample (in the top three). However, community/social factors (e.g., issues with specialists or 
employers) were selected by 43% interviewees and accounted for 17% of the total responses.  
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The majority of participants (18/24; 75%) considered that combined factors largely 
impacted on their ability to maintain resilience. For example, social isolation and/or loneliness 
(identified particularly among the female and younger survivors) that may lead to 
psychological issues can have implications for the individual, family and community.  
Likewise, the inability to work or forced early retirement can impact on the individual 
(physical, social, psychological), family and the community. The concerns over finances and 
forced retirement were particularly pertinent among long-term survivors. This result suggests 
that the risk factors impeding resilience are multi-layered (i.e., involve all levels). Therefore, 
supporting these individuals will likely require a broad, interdisciplinary approach that 
holistically addresses several facets of the HC survivor’s world.  
 
 
Table 5.4 
 
The most Influential Individual, Family or Community Related Risk Factors that 
Impede Resilience as identified by HC Survivors 
____________________________________________________________________________ 
Participant  Age       Factors 1    2     3 
____________________________________________________________________________ 
Natasha      22 Social isolation    Loss of normality            Altered appearance  
Travis       23 Isolation/Loneliness   Tx side-effects                Fear of reoccurrence       
Sharon       31 Fear of future                Tx side-effects                 Not offered counselling        
Zac       34 Inability to work              Fear of death     Mental challenges      
Imogen       34 Lack ex partner support   Unhelpful specialist        Unknown future  
Max       40 Inability to work              Guilt family sacrifices     Financial impact           
Megan       43 Fatigue/Nausea                Inability to plan future    Psychological impact      
Karen       43 Being alone                Expectations of others     Lack of recognition       
Lara       44 Physical/nausea                Lack of social support     Information timing  
Fiona       51 Fear future health             Life’s other demands      Recent previous trauma      
Alyssa       57 Unknown future               Earlier isolation               Lack of control  
Ellen       58 GP not listening                Ignorance of others         Issues with PBS Tx regime  
John       60 Challenges/recurrence      Tx inconsistency             Impact on work    
Ben       60 Medical incompetence     HC accessibility              Inability to work    
Helen       62 Physical/ulcers                Fear of reoccurrence       Tx side-effects       
Pete       63 Fear of reoccurrence        Issues with hospital     Loss of normality        
Lily       64 Fear                    Loneliness at night          Inability to work   
Colin        66 Fatigue       Early retirement/ $ loss   Tx side-effects  
Anna       68 Panic attacks                Early retirement               Lack exercise opportunity       
Tess       69 Physical side-effects        Adhering to Tx     Lack of Acceptance  
Jack       70 Check-up anxiety             Fear of reoccurrence        Difficult to plan future    
Maria       70 Unsupportive employer   Unexpected fear               HC Communication  
Fred       84 Language barrier              Dealing with doctors       Fatigue 
____________________________________________________________________________       
Note: ⁬ Physical             ⁬ Psychological             ⁬ Community/Social           ⁬ Combined           
             ⁬ 1-5yrs post Tx   ⁬ >5 years post Tx 
Tx = Treatment; PBS = Pharmaceutical Benefit Scheme; HC =Healthcare; $ = financial. 
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Several of the individual factors reported to be predictive of resilience in this study 
support those previously identified in the resilience literature. Many of these include, but are 
not limited to: perceived control, optimism, mastery, social support, self-efficacy, self-esteem, 
hope, empowerment, acceptance, determination, social support, coping strategies, spirituality, 
cognitive appraisal, and a sense of coherence. According to a meta-analysis by Stewart and 
Yuen (2011), this is not unexpected, given that past experiences, coping factors, genetics and 
the environment all influence resilience, regardless of the type of adversity faced. 
However, this research also unearthed several factors directly salient to this population 
of HC survivors that were not identified as major contributing factors in the proposed 
conceptual model. These included aspects of positive health behaviours (such as making an 
effort with one’s appearance, sustaining a healthy diet, and adherence to treatment). In 
addition, a sense of feeling connected to the physical environment was another unexpected 
factor that was not widely emphasised in the cancer-related literature. This was, however 
discussed in one study by Denz-Penhey and Campbell Murdoch (2008), who proposed that 
connectedness to the physical environment was important, as this provided the means for those 
with illness to achieve access to their inner wisdom. As they stated, “we would suggest that 
inner wisdom is the experiential source of knowing, energy and motivation for becoming a 
more whole and resilient person and that this inner wisdom has been shown to be often 
accessed through their positive relationship with self-selected aspects of their physical 
environment” (Denz-Penhey & Campbell Murdoch, 2008, p. 402). Many of the participants 
shared stories of how their sense of connectedness within their physical environment 
facilitated an inner peace impacting positively on their psychological wellbeing. For example, 
Helen discussed in depth, how moving to bush land had facilitated her recovery. Similarly, 
Anna and Fred both expressed the importance for them of living near the coast and having a 
view of the ocean. 
The final relevant factor regarding the HC experience that had not been anticipated to 
such an extent in the analysis was the impact of time. The Leximancer software supported this 
finding and identified ‘time’ to be the most frequently referred to word expressed by 
participants. This is illustrated in Figure 5.2, which provides a visual representation of the 
significant links between the word concept ‘time’ and other relevant core concepts. 
 
 
 
Interview Research Question 3.  Were there any factors mentioned during the 
interviews that were not previously identified in the proposed conceptual 
framework?  	
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Note:  ⁬ Red ⁬ Orange (warmer colours indicate most important themes)  
  ⁬ Green ⁬ Blue (cooler colours indicate less important themes) 
 -  Solid lines indicate significant relationships between concepts  
 
Figure 5.2 Time-related concept map with core concepts indicated by a solid line. 
As can be seen in Figure 5.2, ‘time’ was linked to many concepts (i.e., time in 
hospital, with people, at work, getting treatment, etc.). However, the most significant link 
identified in this study by interviewees was the need to take time (i.e., time-out, down-time, 
alone-time etc.). In doing so, the resilience process was nurtured, as time enabled the 
participants the ‘space’ necessary to process this adverse experience. As remarked by Fiona 
who believed she did not have time on her side: 
 
I guess the fact that my cancer diagnosis came so soon after our other trauma and I 
really didn't have time to grieve. I have probably got unresolved grief that has carried 
over which has affected my resilience. 
 
The impact and importance of time is also aptly expressed in this analogy by Alyssa: 
If you imagine a hurdler running in a race. If the hurdles were too close together the 
runner wouldn't be able to get over them, but by giving space between them the runner 
is able to recover and is ready for the next hurdle. This is what I believe resilience 
looks like in some respects. So I guess if you have too many traumatic experiences 
without the time in between to recover this would be difficult. 
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The majority of factors identified as influencing resilience in this study support those 
discussed among previous literature investigating other cancer survivors (including other types 
of cancer). As can be seen from Table 5.5, the majority of factors are similar to those that 
emerged as a result of this study.  
 
Table 5.5 
 
Summary of the Factors Identified as Influencing Resilience among Cancer Survivors 
_____________________________________________________________________ 
Factors Identified in the Literature                        Factors Identified in this Study            
(All types of cancer)     (Haematological Cancer) 
____________________________________________________________________________ 
Personal Coping Strategies    Personal Coping Strategies  
     - Denial/Self-Blame         - 
     - Emotion-focused                  - Emotion-focused   
     - Problem-focused                  - Problem-focused    
     - Hope/Humour             - Hope/Humour        
     - Optimism                  - Optimism    
     - Acceptance                 - Acceptance   
     - Mental flexibility                  - Mental Flexibility 
     - Determination             - Determination 
     - Risk-taking behaviours       Adherence to treatment 
o Alcohol/drugs      Empowerment 
Adherence to treatment            - Decision making control 
   (Non-compliant or     Communication 
Compliant)     Relationships 
Empowerment           - Family/friends/community 
     - Decision-making control               - Healthcare professionals 
Social support      Social Support 
Relationships      Self-care specifically: 
     - Family/friends/community             - Health behaviour change  
     - Healthcare professionals                        (care with appearance) 
Communication      (diet, exercise) 
Self-care       (taking time-out for oneself) 
Self-education      Self-education 
Treatment options     Treatment options 
Information/Resources     Information/Resources  
Purpose/Life Meaning    Purpose/Life Meaning   
     - Employment               - Employment 
     - Community Spirit               - Community spirit  
     - Hobbies            - Hobbies 
     - Spirituality               - Spirituality       
____________________________________________________________________________
Note: ⁬ Factors not identified in this sample of HC survivors              
          ⁬ Relatively unique factors highlighted in this HC survivor sample       
 
The only relatively unique factor in this research influencing resilience, related to 
certain areas of positive health behaviour change (i.e., taking time-out). Although aspects of 
health behaviour change (i.e., diet and exercise) have been discussed in several studies (James, 
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et al., 2011; Murphy, 2013; Park et al., 2008) involving cancer survivors, these factors have 
not been linked to maintaining resilience among this population. In addition, several studies 
discuss self-blame, denial, non-adherence to treatment and risk taking behaviour as a negative 
coping strategy (Block, Drafter, & Greenwalk, 2006; Friedman et al., 2010; Lynagh et al., 
2015; Marjerrison, Hendershot, & Nathan, 2014; Phelan et al., 2013). This was not apparent 
among the HC survivors involved in this study. Table 5.5 provides a summary of the 
protective factors not only common to those identified among previous research but also those 
unique to this study. 
 
Modified Conceptual Model 
Many of the factors influencing resilience in this study are reliant on personal qualities 
(i.e., values and beliefs), trait characteristics (e.g., optimism, flexibility, and determination, and 
persistence), environmental factors (i.e., family and community social support) and can be 
considered part of a process (keeping busy, taking charge and contributing in the community). 
As stated by Denz-Penhey and Campbell Murdoch (2008), “resiliency can be thought of as 
starting with the inner-most depth of individual being, moving through social relationships to 
the person’s relationship with their physical environment” (p. 400).  
Therefore, these results support resilience research that is based on an ecological 
framework (Masten, 2007; Richardson, 2002; Ungar, 2008; Ungar et al., 2007), in which risks 
and protective processes are understood through either the individual, family, and community 
levels.  However, the model in the current research deviates slightly from this context, as many 
of the significant resilience processes for participants are also interconnected within these 
levels. For example, effective communication, finding meaning and self-care were all 
protective process identified by participants. However, these transpired across all levels 
through individual, family, and community processes.  
  With these results in mind, the modified model of resilience shown in Figure 5.3 
visually represents the three levels (individual, family and community) as circles. Resilience 
has been identified as a process that is not stagnant or stationary. The circles, therefore, reflect 
the continual movement (like a wheel) of each level over time. In addition, the levels intersect 
each other to highlight that resilience is multi-layered, thus not solely reliant on individual, 
family or community factors, but rather the integration of each.  This conceptual framework 
enables us to gain a deeper understanding into each key process of resilience, and can be used 
by healthcare providers in advising the patient, family members and the wider community on 
what to expect during the initial and extended stages following a HC diagnosis.  
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Figure 5.3 Modified conceptual model of resilience factors influencing psychological 
outcomes among HC survivors that is best reflected by the ecological approach to 
resilience.  
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Conclusion: Phase One 
The findings suggest that the psychological response to cancer is multi-dimensional 
and that resilience is not a static concept. The interviewees all discussed the distressing 
physical, psychological and social impact of HC, including areas of immense loss. However, 
importantly, this analysis also highlighted several protective processes that may contribute to 
the resilient strength of individuals when faced with HC. This analysis exposed the varying 
level of support provided by family, peers, healthcare professionals and the extended 
community and how this impacted on their overall functioning. In addition, individual personal 
coping strategies (i.e., attitude), self-care, time and being self-informed, were among many 
modifiable factors that facilitated resilience in this population. For example, many participants 
reported the positive influence of effective health behaviour change (i.e., exercise, diet, etc.) 
and how taking time-out (i.e., relaxation) to process this experience assisted their recovery. 
Moreover, the results not only illustrated the significance of the emotional impact of 
cancer on the survivors, but also highlighted individual differences. For example, the 
interviewees varied greatly in their need for information. Although the timing, quality and 
quantity were important, some survivors were more keen than others to be fully armed with 
informational resources. These participants spoke of sourcing extra information from the 
Internet to supplement the resources from healthcare providers and support groups. 
Conversely, there were others who felt overwhelmed and inundated by large amounts of 
information, preferring to focus on the essential facts. Therefore, the transcripts support the 
observation that individuals can exhibit resilience in different ways, and in ways that others 
find challenging. Resilience factors were also exhibited differently depending on demographic 
factors, such as the age of the survivor during diagnosis, employment status, time since 
diagnosis, financial circumstances and previous experience. 
While most participants managed their day-to-day lives, they also acknowledged 
situations they found challenging. Therefore, delving beyond factors that enhance resilience, 
the findings also discussed barriers/risks to resilience such as fear (future uncertainty), lack of 
support, inadequate resources, unmet needs and ongoing challenges related to the healthcare 
system. Many of these barriers were cultivated by physical, psychological and social reminders 
of the disease. For example, several survivors were reminded of their HC experience each time 
they attended medical check-ups or felt unwell. However, given appropriate support and 
resources, the majority of HC survivors were able to identify, implement and maintain 
personal strategies to enhance their resilience. 
Finally, in order to successfully navigate a ‘new normal’, the results highlighted the 
way in which many participants, reflected and re-prioritised their current and future lives. For 
the majority of participants, the HC experience offered them the opportunity to learn, adapt 
and grow as individuals. For example, survivors became more aware of their vulnerability, 
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and, as a consequence, previous priorities such as material gains became less important. The 
HC survivor outcomes reflect a deeper appreciation of life, largely based upon their current 
environment and individual core beliefs and values.   
 
Summary of Qualitative Analyses  
Chapter 5 began with an outline of the main aim and research questions. The overall 
objective of Phase One was to examine factors that facilitate the resilience process among HC 
survivors. Phase One also aimed to identify particular risk factors related to chronic illness that 
negatively affect mental well-being. Although resilience has been extensively studied among 
healthy individuals (Min et al., 2013), to date, less is known about the factors associated with 
resilience in cancer survivors, including patients with HC.   
Following outlining the study objectives, the profile of the participants and the 
findings were then presented. To enable a valid and rich account, the current study explicated 
these experiences using rigorous qualitative methodology, by including both thematic analysis 
and Leximancer analytic software. The results of this qualitative inquiry, involving 23 in-depth 
interviews, were then presented through the classification of major and sub-themes that 
emerged from the transcripts. To comprehensively explain this resilience process, exemplars 
were presented and interpreted in conjunction with reference to previous research. The results 
suggest that, although there was great diversity among participants, the majority shared a 
similar journey.  
This chapter presented the participants’ experiences as they described their response to 
HC. As stated by Lau and van Niekerk (2011, p. 1177), “rather than imposing expert judgment 
on experiences…survivors are offered the space to draw on their own strengths and contextual 
realities as defined by their gender, culture, history, and social location.” Moreover, this 
information supports, and yet expands on, the available literature addressing chronic illness 
and personal resilience. The findings from the interviews provide the reader with an in-depth 
description of the challenges and support needs among this population. It seems that the key 
processes of resilience (i.e., coping strategies, social support, attitude etc.) are constantly 
evolving, with each dimension affecting the outcome of the other. This dynamic process was 
visually captured in a revised conceptual model of resilience in HC survivors. 
The next chapter (Phase Two) outlines the item development and a pilot study (Stage 
I) that aimed to collate relevant measures to be included in a larger questionnaire (Stage II). 
The purpose of the pilot study was not only to test the findings of the qualitative interviews, 
but also to examine the reliability and validity of the measures included. 
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contributing to resilience. However, what is less understood is who, when and how social 
support impacts on the resilience process, or indeed, if this is dependent on other external 
factors (i.e., time since diagnosis).  Consequently, the Multidimensional Scale of Perceived 
Social Support (MSPSS) was also included as a measure of social support. Moreover, the 
interview data also revealed several factors salient to this population of HC survivors that were 
not identified as major contributing factors in the proposed conceptual model developed from 
the literature review. These new factors included the implementation of diet modification, 
exercise, taking care of one’s appearance and taking time out for oneself. Therefore, in order to 
identify the effect on various types of health behaviours on resilience, a final scale with these 
four factors was created to reflect each HC survivor’s positive health behaviour strategies.  
Several outcome measures that assessed mental health (i.e., anxiety and depression) 
and resilience were also included. It was important to measure anxiety and depression, as both 
the literature and the interview results indicated that many HC survivors experience negative 
mental health outcomes as a result of their diagnosis. Resilience is reported to buffer against 
depression and anxiety. It was, therefore, essential to include a validated resilience scale. By 
including both of these outcome measures, the relationship between mental health and 
resilience will be better understood. In total, the questionnaire used in this pilot study consisted 
of 5 scales with 30 items. 
It is acknowledged that many other individual factors reported to be predictive of 
resilience in this study, are consistent with those previously identified in the cancer resilience 
literature. Several of these include, but are not limited to: meaning/purpose in life, perceived 
control, mastery, self-efficacy, self-esteem, hope, connectedness and empowerment (Alim et 
al., 2008; Bulsara, Ward, & Joske, 2004; Denz-Penhey & Campbell Murdoch, 2008; Folkman, 
2010; Groopman, 2004; Hou, Law, Yin, & Fu, 2010; Llewlyn et al., 2013; McGrath, 2004a; 
Rodin et al., 2013; Schumacher et al., 2014; Stewart & Yuen, 2011). However, these factors 
have not been included as specific measures in this pilot study for two reasons. First, it is not 
possible to include every factor in the survey. Second, the majority of reports concur that these 
individual factors are indeed influential. Therefore, as we would not be contributing new 
findings, the above-mentioned factors have been omitted to ensure that the pilot survey is 
succinct.  
 
Pilot Study Focus and Preliminary Considerations 
The main focus of Phase Two (Stage I) of this thesis is to use the findings from the 
qualitative enquiry, including evidence from the literature, to inform and guide an appropriate 
survey for the final quantitative study (Stage II). While the majority of findings between 
previous literature and interviews represented an overlap, there were notable differences. For 
example, the interview findings suggest that the majority of HC survivors actively seek the 
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opportunity for positive health behaviour change. Although aspects of self-care (e.g., diet, 
exercise) are highlighted in the literature as factors that assist coping, additional factors, such 
as care in appearance and taking time out for oneself, were not widely discussed. In addition, 
among some cancer survivor populations (i.e., liver, cancer etc.), self-blame is commonly 
reported, in which substance abuse may present as a risk factor. Yet these factors were not 
identified during the interview results or reported in literature specifically investigating HC 
survivors. It is not clear whether these differences are due to the small sample size or if indeed 
there are variations between HC and other cancer types. Therefore, these results need further 
verification among a larger sample, in order to substantiate the findings. 
However, prior to conducting this survey involving a larger sample of HC survivors, 
various preliminary considerations concerning the survey required addressing. The majority of 
items used in this study are valid and reliable published scales. Nonetheless, based on the 
interview findings, there are additional items included that have not been psychometrically 
tested. It was, therefore, important to assess the validity, reliability and feasibility of the 
proposed questionnaire items. Reliability (repeatability and consistency) refers to whether the 
results are more than a one-off finding and can be replicated (Babbie, 2010). Test validity is an 
indicator of how much meaning can be placed on the results. This includes face validity (at 
face value, whether the instrument appears to be representative and of high-quality); criterion 
validity (whether a measure reflects a certain set of abilities); construct validity (whether the 
test actually measures what is intended); and, content validity (whether a measure represents 
every element of a construct). Last, feasibility is an evaluation and analysis of the proposed 
tool (Gatewood, Field, & Barrick, 2008; Tabachnick & Fidell, 2007).  
 
Aims of the Pilot Study  
The first aim of the pilot study was to identify and/or create appropriate measures. It is 
essential that these measures either reflect significant factors that emerged from the qualitative 
interviews conducted in Phase One (i.e., taking time out, diet modifications) or have been 
referred to, within cancer resilience research, as having a considerable effect on health-related 
outcomes (i.e., types of coping strategies, social support).  
The second aim of this pilot study involved reviewing the statistical properties of the 
scales included in the questionnaire. This included the mean, range, skewness, and kurtosis of 
the measures used within the questionnaire. In addition, the reliability (i.e., both internal 
consistency and stability) over a 2-week interval were assessed. 
The final aim was to acquire feedback from participants concerning their experience of 
completing the survey. In particular, it was important to ensure the survey instructions were 
clear to understand and that items were easy to read and complete. In receiving participant 
feedback, it is also essential to establish that the content of items is accurate and if any 
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additional measures needed to be included. Research indicates that developing a questionnaire 
that includes issues that are pertinent to respondents, may promote higher response rates, 
potentially reduce non-response error and help in data coding and analysis (Bernard, 2000; 
Dillman, Smyth, & Christian, 2009; Williams, 2003). Importantly, the questionnaire design 
literature offered beneficial advice, regarding the various ways of organising the current 
survey to best obtain relevant information that would address the research question (Hagino, 
2002). 
 
Pilot Study Data Collection 
Materials  
Qualtrics was used to develop and distribute the on-line, self-administered pilot 
questionnaire (Appendix IA through to IE). The participants all received an information flyer 
(Appendix J) that was attached to the emails and explained the purpose of the research, 
outlined participation criteria, discussed privacy/confidentiality issues and requested 
participation. The pilot questionnaire contained a total of 5 scales (30 items), as well as 20 
items that assessed demographic characteristics. The scales included in the pilot study were 
previously outlined in detail in Chapter 4 (Methodology).  
Twenty-two of the 30 items were examined due to the base of evidence that they 
measured the domains from both the literature on resilience and the findings identified during 
the interviews. These included family support, support from friends, healthcare professionals 
and significant others, self-distraction, active coping, denial, substance use, emotional support, 
instrumental support, behavioural disengagement, venting, positive reframing, planning, 
humour, acceptance, religion, self-blame, exercise, diet modification, care in appearance and 
taking time out. Therefore, the final pre-test instrument contained all the relevant questions 
(including standardized instruments) designed to obtain the most accurate information about 
the factors of interest in this dissertation regarding resilience. 
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Findings and Discussion 
Profile of Participants  
The pilot questionnaire was tested on a convenience sample of 17 mixed cancer 
survivors, all of whom spoke English and lived within the Perth metropolitan area of Western 
Australia. As this pilot study was investigating reliability and face, content and construct 
validity, it was not necessary to only include HC survivors. The questionnaire took 
approximately 20-30 minutes to complete. The majority of those interviewed were Australian 
(n = 8; 47%). However, the sample also included participants from the United Kingdom (n = 
6; 35%), Europe (n = 2) and one from South Africa. As outlined in Table 6.1, one more female 
(n = 9; 53 %) than male (n = 8; 47%) was interviewed. The ages of interviewees varied from 
28 to 74 years (M = 55.35, SD = 12.05) and the years since diagnosis ranged from one to nine 
years (M = 4.53; SD = 3.28).  As indicated in Table 6.1, the 17 survivors interviewed 
represented seven different cancer diagnoses. The majority of cancer survivors reported 
undergoing a combination of treatments including: chemotherapy, radiotherapy, surgery, 
immunotherapy, oral medication, brachytherapy5 and hormonal implants. In addition, since 
their initial diagnosis and treatment, one of the participants reported experiencing a relapse.  
The majority (71%) of the sample was either employed full-time (n = 6), or part-time 
(n = 6); the remainder were either retired (n = 4) with one participant on a pension, and another 
a stay-at-home mother. There were 68% of participants with either a tertiary diploma/trade 
(35%), tertiary undergraduate (42%) or postgraduate (6%) degree; 12% had completed Year 
12/HSC; while 18% had completed Year 10/11, with one participant finishing prior to Year 10 
level. Although the relationship status of participants varied, the majority were married (n = 
11; 65%), the other participants were either de facto/partnered (n = 2), separated (n = 2) and, of 
the remainder, one was single and the other a widow. Slightly more than half the participants 
did not consider themselves religious (n = 10; 59%). In this sample, the majority of 
participants had children (n = 13; 76%).  
 
  
																																																								
5 Brachytherapy is a procedure that involves implanting 'radioactive seeds' in the prostate which emit small amounts 
of radiation to prevent cancerous cells from growing. 
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Table 6.1 
 
Profile of the Pilot Study Participants  
____________________________________________________________________________ 
Participant Sex   Age    Cancer  Treatment Type           Years Since Diagnosis 
____________________________________________________________________________ 
1  M    28    Testicular         C, S    4  
2  F    36    Breast         S     2 
3  F    43    Breast         R, C, O, S    1  
4  M    48    Bowel                     C, S                6 
5  M    49    Skin          R, S     6 
6  F    52    Ovarian         C, S    4 
7  F    54    Breast         S        10      
8  F    56    Breast         R, C, S               10 
9  M    57    Prostate                  S     1  
10  F    58    Melanoma              I                             1 
11  M    59    Prostate         S                                         1 
12  F    60    Breast                     C, S               10 
13  M    63    Bowel                     S                 2 
14  F    66    Breast            S, O    6 
15  F    68    Bowel                     S     7 
16  M    70    Prostate         B                                         2 
17  M    74    Prostate         R, H                                      4 
           M = 55.35                M = 4.53 
        (SD = 12.05)                       (SD = 3.28) 
____________________________________________________________________________ 
Note: C = Chemotherapy; R = Radiotherapy; S = Surgery; I = Immunotherapy; H = Hormonal implant; 
B = Brachytherapy; O = Oral medication 
 
Instrument Development 
The first aim of the pilot study was to identify and create appropriate measures to meet 
face and construct validity. This was accomplished by ensuring that the measures included 
either reflect significant factors that surfaced from the qualitative interviews conducted in 
Phase One or have been referred to within cancer resilience research. In addition, the majority 
of measures included well-validated published tests. A total of 5 scales (30 items) were 
selected for this pilot study, as previously discussed in detail in Chapter 4 (methodology).  
 
Psychometric Properties  
The second aim of the pilot study was to assess for reliability including criterion and 
content validity by statistically assessing the psychometric properties of each measure (see 
Table 6.2). Significant deviations from normality were calculated using the following formula 
(Field, 2009), where S = the skewness value and K = the kurtosis value.  
 
           S – 0                                                       K – 0        
Zskewness =   SEskewness             Zkurtosis  =   SEkurtosis	
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A Z-score above ±1.96 within small samples indicates a significant deviation from 
normality. Using this criterion, approximately half the measures within this study were not 
normally distributed. Those factors that were normally distributed included: planning, 
acceptance, religion, support from healthcare professionals, exercise, including all resilience, 
depression and anxiety factors.  
To assess the internal consistency reliability, Cronbach’s Alpha (α) was calculated. 
Denial (α = .33); venting (α = .10); planning (α = .55); acceptance (α = .31); family support (a 
= .66) and diet (α = .56) initially produced a poor internal consistency score. It may be that the 
low participant numbers (n = 17) contributed to these results. However, two outliers were 
identified and when these were removed all internal reliability scores reached acceptable levels 
(>.70). Therefore, all published items remained in the final questionnaire, except for one of the 
created items measuring ‘diet’ which was subsequently deleted as it demonstrated a poor 
internal consistency reliability.    
In testing the reliability of measures over a 2-week time period (test-retest reliability), 
either Spearman’s correlation coefficient (ρ) or Pearson’s correlation coefficient (r) was 
calculated, depending on the measure’s normality (see Table 6.2). Active coping (ρ = .52), fell 
below an acceptable test-retest correlation. However, the internal consistency reliability was 
high (α = .84). A closer inspection of responses on this measure indicated a significant outlier. 
This case was excluded from the test-retest reliability analysis and subsequently produced an 
acceptable correlation coefficient (ρ = .71). The HADS results also fell below an acceptable 
level (r = .54). However, the HADS which is considered a reliable and valid scale, is time-
specific, in that it requires participants to respond to items for the previous week, and therefore 
scores may differ between the initial and the follow-up survey. All other measures produced 
acceptable test-retest reliabilities. 
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Table 6.2 
Psychometric Properties of the Measures within the Pilot Questionnaire  
_____________________________________________________________________________________________________________ 
        Pearson’s (r)        _______Range_____ 
Scale    N       M  SD  α     Spearman’s (ρ)  Potential Actual  Skewness Kurtosis 
_____________________________________________________________________________________________________________ 
Self Distraction   17     5.88  2.29 .81 .81a     2-8  2-8  -1.38  -0.83  
Active coping   17     6.12  1.73 .84 .52a     2-8  2-8  -1.72   0.87 
Denial    17     2.76  0.97 .33 .68a     2-8  2-5   1.81  -0.81 
Substance use   17     2.24  0.66 1.00 .70a     2-8  2-4   7.74   5.18 
Emotional support  17     6.71  1.57 .90 .87a     2-8  2-8  -3.17   3.86  
Instrumental support  17     6.00  1.94 .84 .90a     2-8  2-8  -1.81   0.22 
Behavioural disengagement 17     2.35  1.00 .78 .99a     2-8  2-5   4.75   5.12 
Venting   17     4.65  1.32 .10 .86a     2-8  2-6  -2.00   0.13 
Positive Reframing  17     5.94  2.01 .80 .80a     2-8  2-8  -1.44  -0.34  
Planning   17     6.29  1.45 .55 .87b     2-8  3-8  -1.32   0.19 
Humour   17     5.24  2.46 .98 .90a     2-8  2-8  -0.51  -1.45 
Acceptance   17     6.60  1.23 .31 .82b     2-8  4-8  -0.84  -0.50 
Religion   17     4.47  1.84 .89 .92b     2-8  2-8   0.41  -0.87 
Self Blame   17     3.06  1.30 .79 .93a     2-8  2-6   1.90   0.03  
BRIEF COPE (Total)  17     68.29 12.02 .87 .95a  28-112            34-87  -2.66   3.27 
 
Family support   17     25.06 2.38 .66 .73a   4-28            20-28  -0.83  0.10 
Friends support   17     25.76 2.80 .94 .71a   4-28            20-28  -1.94  0.06  
Significant others  17     25.00 5.82 .99 .66a   4-28              4-28  -5.93  11.15 
Healthcare professionals 17     23.18 3.54 .85 .79b   4-28            16-28  -0.81  0.40 
MSPSS (Total)   17     99.00 9.54 .85 .61a             16-112           77-109  -2.06  0.54 
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Table 6.2 
(continued) 
_____________________________________________________________________________________________________________ 
                Pearson’s (r)        _______Range_____ 
Scale    N       M  SD  α     Spearman’s (ρ)  Potential Actual  Skewness Kurtosis 
_____________________________________________________________________________________________________________ 
Time out   17 14.29  3.74 .93 .98a    3-18     3-18  -3.29   4.26  
Exercise   17 14.82  2.06 .92 .87b    3-18    10-18  -0.64  -1.02 
Diet    17 14.82  2.81 .56 .94b    3-18    10-18  -1.35   1.18 
Appearance   17 13.24  3.65 .80 .94a    3-18      7-18  -0.88  -0.84 
HBC (Total)    17 57.18  9.96 .90 .97a   12-72    38-69  -1.38  -0.74 
 
RSA (Total)   17 195.24  17.5 .89 .90b  33-231  157-224 -0.61  -0.07  
     
HADS (Total)   17 9.29  4.02 .68 .54b    0-42     2-17   0.08   0.31 
________________________________________________________________________________________________________________________ 
Note.  MSPSS = Multidimensional Scale of Perceived Social Support; HBC = Health Behaviour Change; RSA = Resilience Scale for Adults; 
HADS = Hospital Anxiety and Depression Scale. 
a = Test-retest for normally distributed data using Pearson’s correlation (r).  
b = Test-retest for data that is not normally distributed using Spearman’s correlation (ρ). 
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Qualitative Results 
A final aim was to acquire feedback from participants concerning their experience of 
completing the survey in order to evaluate face validity (personal judgement) and feasibility 
(evaluation of the tool). This qualitative information was designed to refine the instrument 
content in terms of ease of completion and comprehension. All participants understood the 
instructions and found the questionnaire easy to complete. However, there were several items 
in which the participants either responded to differently or provided feedback suggesting that 
improvements could be implemented.  
First, there was feedback in relation to the item asking about when participants last 
had treatment. For example, one participant queried this, as she was required to take lifetime 
treatment in the form of oral medication and therefore found this question difficult to answer. 
This question was subsequently changed to ask, “Which scenario best describes your current 
treatment regime?” The participants could choose from the following options: “N/A I did not 
require active treatment”; “I am currently undergoing treatment which will NOT continue 
indefinitely”; “My treatment is ongoing (i.e., I will always need to take medication)”; “I have 
completed treatment for my cancer (if so how many years ago)?” or “Other – please specify” 
where participants could write their own response. Additionally, in the same section of the 
pilot survey, when entering data the researcher realised that when she asked participants, 
“Your age at onset of cancer?” it required her to manually calculate how many years since the 
participant was diagnosed, based on their current age. Consequently, this item was altered to 
instead ask, “How long ago were you diagnosed with cancer (in years)?”  
Second, many participants seemed confused by the question relating to their ethnicity. 
This was identified through the range of responses offered by several participants detailing 
various descriptions of the same ethnicity. For example, the range of responses for one 
particular ethnicity was White European, Irish, Caucasian, White South African, Aussie, Born 
in England and Australian. This item was consequently altered from a qualitative response to 
categorical, where participants chose from one of the following responses: “White  (including 
Caucasian, Anglo, European; not Hispanic)”; “Hispanic or Latino (including Mexican 
American, Central American, and others)”; “Asian (including Chinese, Japanese, Korean and 
others)”; “Middle Eastern”; “Black (including African, African American, African Australian, 
African-European)”; “Aboriginal”; “Torres Strait Islander”; and “Other” where participants 
could write a response.  
A similar scenario occurred with the question asking if participants belonged to any 
religion. Like ethnicity, there was a range of responses offered by several participants detailing 
various descriptions of the same religion. For example Christian, Anglican, Christian-
Anglican, Catholic and Buddhist were some of the responses. Consequently, this item was 
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reworded to ask, “Which best describes your religious beliefs?” The participants could select 
from the following categorical options: “Non-practising”; “Christian (including Uniting, 
Anglican, Baptist, Catholic and others)”;  “Buddhist”; “Islamic”; “Hindu”; “Jewish”; and 
“Other” where participants could add their own response.  
 Third, in relation to relationship status, two of the participants added ‘separated’ in 
the “Other” option with the provided text box. In response, ‘separated’ was added as a 
categorical option. Likewise, on the item asking about employment status, one participant 
added home duties to the “Other” text box and another self-employed in the section asking for 
feedback. For the purposes of the current study the categories of home duties and self-
employed were also included to more accurately reflect the activities of those who care for 
children full-time or run their own business.  
 Fourth, there were issues identified in section of the survey asking about social support 
(MSPPS scale). In this pilot questionnaire, healthcare providers (HCP) were referred to as a 
group not as individuals. Consequently, one participant found this difficult to answer as she 
had diverse experiences stating that, “I have an alternative medicine general practitioner who 
is awesome but have found conventional doctors are closed to alternative treatment and thus I 
have little support from them. When I pursue those treatments in conjunction with 
conventional treatment I have experienced some awful treatment from some specialists”. 
Subsequently, the wording in the instructions was changed to ask participant to consider the 
HCP who was most helpful to them when answering the following questions. In addition, an 
open-ended section was added to the end of the final survey, which allowed participants the 
opportunity to explain in more detail who in their clinical team was least and most helpful 
following their cancer diagnosis. It is hoped that this may provide further insight into the 
support, or lack of, offered by clinicians. 
Fifth, at the completion of the pilot survey there was an open-ended section asking “Is 
there anything that is missed in how you have coped?” Several participants contributed 
feedback that suggested two other factors influence resilient outcomes. Two participants felt 
very strongly about the value of receiving alternative/complementary therapies. Another two 
commented that staying informed and proactively searching for cancer related information was 
vital to them. As one participant stated, “I feel more able to cope when I actively source the 
latest treatment and information about my cancer”. In relation to alternative therapies and 
seeking cancer-related information, the earlier interviews indicated mixed results, which are 
important to highlight.  
The results from the earlier qualitative study not only illustrated the significance of 
HC survivors being informed and offered treatment options, but also highlighted individual 
differences. The interviewees varied greatly in their need for cancer-related information and 
their use of alternative/complimentary therapies. For example, as mentioned previously, 
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although the timing, quality and quantity were important, some survivors were eager to be 
fully armed with informational resources. Conversely, there were others that felt overwhelmed 
and inundated by large amounts of information, preferring to focus on the essential facts. 
Likewise, some HC survivors sought out various alternative treatments, while others preferred 
to follow conventional treatment. Therefore, it was considered important to include 
information seeking and alternative/complementary therapies as factors in the final 
questionnaire, as it is still unclear how, and to what extent, these influence resilience.  
The results on the dietary items also proved to be less reliable (α = .56) when 
compared to the other items on this scale. Cronbach’s alpha highlighted potential issues with 
the reliability of the item asking, “I worry more when I don’t eat properly” and this question 
was subsequently reworded to, “taking care of my dietary needs is important to me”. In 
addition, negatively worded items were included in an attempt to encourage participants to be 
more focused on each individual question and reduce bias. Finally, due to the high response 
rate on the last item that asked if any influential factors had been missed, a similar open-ended 
question was also included in the final questionnaire. This final question asks, “Based on your 
personal experience is there anything else you would like to share that may assist others to 
cope when facing a similar situation?”  
 
Overview - Final Questionnaire  
In terms of the final instrument, the pilot study indicated strong internal consistency 
among the majority of scales including high test-retest reliability over 2-week period. 
However, as a result of feedback from the pilot study participants, there were several 
amendments made to improve the items in the final questionnaire. For example, various 
responses that related to ethnicity, relationship status, religion, employment position, treatment 
regime, time since cancer diagnosis and HCP support, were modified either to reduce the 
necessity for qualitative responses and/or to provide more clarification. In addition, as a result 
of the feedback offered by several participants, two additional factors were added to the final 
questionnaire. These included items investigating ‘information seeking’ and the use of 
‘alternative/complementary therapies’ as each of these were considered influential factors by 
several participants. Finally, three additional questions were added at the end of the 
questionnaire that provided participants a further opportunity to share their experience through 
open-ended responses. In conclusion, the earlier qualitative enquiry (interview data) including 
findings from the literature together with the results of this pilot study, all contributed in 
guiding an appropriate survey design for the final quantitative phase.  
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Summary of Questionnaire Development and Pilot Study 
 
This chapter has detailed the development and implementation of a pilot questionnaire 
(Phase Two – Stage I) for the purpose of guiding a larger quantitative study (Stage II). Overall, 
the preliminary assessment of validity, reliability, and feasibility was successfully achieved in 
keeping with the original purpose of this research study. Initially, the rationale and aims were 
highlighted. The first aim of the pilot study was to identify and/or create appropriate measures. 
The second aim of this pilot study involved reviewing the statistical properties of the 
questionnaire. A final aim was to acquire feedback from participants concerning their 
experience of completing the survey. Following the aims, a description of the cancer survivors 
who participated was discussed. Information and results relating to the reliability and validity 
of the questionnaire was then presented. The chapter concluded with an overview of the 
developed questionnaire. The next chapter outlines the results of the final quantitative study 
(Phase Two – Stage II) in which the modified final questionnaire (see Appendix K) is 
distributed to a larger sample of HC survivors.  
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considered to be inversely associated with depression, anxiety and perceived stress, whilst 
being linked with greater life satisfaction (Wagnild, 2009; Windle, Bennett, & Noyes, 2011). 
The few studies that have specifically investigated resilience among cancer survivors, have 
reported resilience to be associated with a greater sense of adaptation, psychological wellbeing 
(Wenzel et al., 2002) and improved QOL (Denz-Penhey & Campbell Murdoch, 2008; Stewart 
& Yuen, 2011; Wu et al., 2012). In particular, there are limited publications investigating 
resilience within the context of HC survivors. It is, therefore, unknown how resilience 
contributes to positive mental health for those who have been diagnosed with HC.  
Several possible risk and protective factors that could influence the resilience of HC 
survivors were discovered through the findings of Phase One as well as a review of the 
literature. These factors included: active coping, denial, behavioural disengagement, emotional 
support, instrumental support, positive reframing, planning, time-out, acceptance, religion, 
self-distraction, substance abuse, venting, humour, self blame, social support (significant 
others, HCP, family, and friends), exercise, appearance, researching information, alternative 
treatments and diet. However, these factors have yet to be examined within the larger context 
of HC survivors and so their influence on resilience is relatively unknown. A key question is 
whether the factors that lead to resilience among adult survivors of HC follow a similar profile 
to those found in other cancer populations (Windle, Bennett, & Noyes, 2011). The current 
study will use the final questionnaire, including all these factors, to explore resilience and 
mental health outcomes among a larger sample of HC survivors.  
 
Aims and Research Questions 
The aim of Phase Two (Stage II) was to test the validity of the model of resilience in 
HC survivors. As Robson (2002) stated, questionnaires can provide insight into patterns and 
responses and is an effective method of sampling attitudes, beliefs and behaviours. This will be 
useful in the current study, as the interrelationships of variables measured in the questionnaires 
can be compared to responses provided during the qualitative phase of the research. The main 
focus was to investigate if the identified risk and protective factors influenced resilience 
among HC survivors. Guided by previous research, Phase Two (Stage II) focused on 
addressing the following questions: 
1) What is the relationship between resilience and depression and anxiety?  
2) What are the significant factors that contribute to resilience 
     among HC survivors?  
3) Who in the clinical team provides the most and least support and relevant 
                  information? and,  
4) As a result of personal experience, what advice can current HC survivors provide to 
    those who are newly-diagnosed that may help them to cope?   
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Data Collection - Final Instrument 
The final instrument (Appendix L) was systematically compiled as a result of a 
thorough literature search, the interview findings (Phase One) and the results of the previous 
pilot study. The information, consent, demographic questions and research measures included 
in the final questionnaire, as presented in the online Qualtrics format, are outlined below in 
Table 7.1. 
 
Table 7.1 
Design and Measures of Final Questionnaire 
____________________________________________________________________ 
Section  Content/Factors Scale   Author    Items (n) 
____________________________________________________________________ 
1 Research background n/a  n/a    n/a 
 Ethics 
 Contact Details 
 Informed consent 
 
2 Personal Data   n/a  n/a    18 
 Demographic Details 
 
3 Coping Strategies Brief-COPE (Carver, 1997)   14 
 
4 Social Support  MSPSS  (Zimet et al., 1988)  4 
 
5 Resilience  RSA   (Friborg et al., 2005)  6 
 
6 Mental Health  HADS  (Zigmond & Snaith, 1983) 2 
 
7 HBC   created   n/a    6 
 
8 Opened-ended  created  n/a    n/a 
 
___________________________________________________________________________ 
Note. n/a = not applicable; MSPSS = Multidimensional Scale of Perceived Social Support;  
RSA = Resilience Scale for Adults; HBC = Health behaviour change; HADS = Hospital 
Anxiety and Depression Scale.  
 
Quantitative Findings 
Survey Questionnaire 
 The item development and content of each scale included in this questionnaire were 
described in detail in Chapter 6. To assess internal consistency, Cronbach’s Alpha (α) was 
again calculated among the entire sample (N = 222) and, as reported in Table 7.2, most scales 
indicated high internal consistency. The items measuring denial (α = .56) and venting (α = .58) 
initially produced a poor internal consistency score. According to Field (2009), this suggests 
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that the items were poor at measuring their respective constructs. However, denial and venting 
were kept in final analyses for two reasons. First, they are part of the Brief Cope Inventory, 
which is a well-validated scale, and, second, when these variables were removed they made no 
difference to the results of the final model. 
 
Table 7.2 
Internal Consistency Reliability of the Final Questionnaire Scales (N = 222) 
________________________________________________________ 
Scale       α 
________________________________________________________ 
Self distraction      .94  
Active coping      .74  
Denial       .56  
Substance use      .94  
Emotional support     .87  
Instrumental support     .81  
Behavioural disengagement    .69  
Venting      .58  
Positive Reframing     .79  
Planning      .75  
Humour      .87  
Acceptance      .74  
Religion      .91  
Self Blame      .65  
BRIEF COPE (Total)     .76  
Family support      .88  
Friends support      .93  
Significant others     .93  
Healthcare professionals    .84  
MSPSS (Total)      .86  
Time out      .72  
Exercise      .71  
Diet       .80  
Appearance      .71  
Researching       .67  
Alternative Tx      .83  
HBC (Total)       .77  
HADS Anxiety Scale     .86  
HADS Depression Scale    .81  
HADS (Total)      .76  
RSA (Total)      .89  
______________________________________________________________ 
Note. MSPSS = Multidimensional Scale of Perceived Social Support; 
HBC = Health Behaviour Change; RSA = Resilience Scale for Adults;  
HADS = Hospital Anxiety and Depression Scale; Tx = Treatment. 
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Questionnaire Completion. 
 Questionnaires were completed between May and August 2015. The majority of 
completed surveys were submitted electronically (n = 170). However, several were also mailed 
hard copies (n = 52). The electronic survey required respondents to click on a hyperlink, which 
initially presented the information and informed consent details (described earlier; see 
(Appendix J). Once respondents had nominated their consent to continue, they were presented 
with the questionnaire, which took approximately 30 minutes to compete. The hard copy 
questionnaires that were distributed through The Perth Blood Institute, Leukaemia Foundation 
and those mailed to respondents involved in the NSW Cancer Council research database, all 
included reply-paid, self-addressed envelopes.  
An overall response rate could not be calculated accurately as the survey was designed 
to remove responses that were not complete, although at one point 52 surveys were noted on 
Qualtrics as incomplete. Likewise, it was not possible to identify social media participation 
rates, yet, as can be seen from Table 7.3, approximately 42% of respondents were recruited 
through social media. However, it was possible to match participant details with the 42 
returned responses from the NSW Cancer Council database, which indicated a participation 
rate of 66%. Details of the final participant recruitment process are presented in Table 7.3.  
 
Table 7.3 
 
Participant Recruitment Setting 
___________________________________________________________________ 
 
Recruitment       Total sample (N = 222) 
___________________________________________________________________ 
Word of Mouth       11.3% (n = 25) 
Social Media (Facebook)     42.3% (n = 94) 
Email         19.4% (n = 43) 
Mailed letter       12.2% (n = 27) 
NSW Cancer Council (via mail)     11.3% (n = 25) 
Leukaemia Foundation      0.9% (n = 2) 
Cancer Council (unspecified)     0.9% (n = 2) 
Perth Blood Institute       1.8% (n = 4) 
___________________________________________________________________ 
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Data Screening 
 Prior to analysis, data were first examined for accuracy of data entry and missing 
values. There were no missing values and all participant data entry was complete. The 
Qualtrics online survey was set up to include forced responses, meaning that respondents had 
to respond to each question before continuing with the survey, this assisted in reducing 
missing values. However, as previously discussed, one mailed survey and 52 online surveys 
were incomplete, and these had already been excluded prior to data screening. All cases were 
also checked for systematic responses (i.e., the same answer was given to all of the questions). 
No systematic responses were evident.  
 
Profile of Respondents 
A total of 293 HC survivors completed the on-line survey, of which 222 were included 
in the data analysis after data screening. This represented a 79% completion rate (179 online 
and 52 hardcopies). Sixty-one online surveys and one mailed survey were not included due to 
incomplete information. In addition, a further nine surveys were removed from the analysis as 
the respondents were either too recently diagnosed (n = 8) or had been diagnosed with a blood 
disease (n = 1), not a blood cancer. One of the inclusion criteria was diagnosis with cancer at 
least 12 months prior, however it was decided to also include HC survivors over ten months 
post-diagnosis.  
The majority of respondents were female HC survivors (62.2%, n = 138) who spoke 
English as their main language (n = 219; 98.6%) and were of Caucasian/European decent (n = 
207; 93.2%) (See Table 7.4). The age of interviewees varied from 19 to 86 years (M = 54.35, 
SD = 14.31) and the years since diagnosis ranged from 1 to 34 years (M = 7.73; SD = 6.14). 
The respondents were equally divided between permanent (1-5 years) and extended 
survivorship (6+ years) phases. The majority of survey respondents lived in Australia (n = 151; 
68%). However, the sample also included respondents from the United Kingdom/Europe (n = 
32; 14.4%), USA/Canada (n = 35; 15.8%), and, Africa/Asia/New Zealand (n = 4; 1.8%). The 
sample comprised mainly urban residents (n = 176, 75%).  
As indicated in Table 7.1, the 222 survivors surveyed represented 12 different HC 
cancer diagnoses comprising various leukamias (n = 131; 59%), lymphomas (n = 83; 37.4%), 
and myeloma (n = 8; 3.6%). There was also a representation of both acute and chronic blood 
cancers. The term “acute” means that the abnormal cells are immature and continue to build 
up. The cancer can progress quickly and can be fatal within a few months, thus patients require 
urgent treatment. Conversely, in “chronic” HC’s, the cells can mature partly, but not 
completely. These cells may appear normal, however, they do not function properly and tend 
to live longer and crowd out normal cells. Therefore, chronic blood cancers may develop 
slowly over a period of years, but can be more complex in the long-term to treat. The diversity 
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in this sample of HC’s meant that there were several different cancer trajectories experienced. 
Most of the respondents were currently undergoing some form of treatment (n = 128; 
57.7%). The majority of cancer survivors reported undergoing chemotherapy (n = 117; 
52.7%). However, in addition to chemotherapy, several respondents also required a 
combination of treatments including many of the following: radiotherapy, surgery, transplants 
(BMT/SCT), and immunotherapy/oral medication (n = 86; 38.5%). Of this sample, 47 
respondents experienced a HC relapse (21.2%). In addition, 30 respondents (13.5%) required a 
transplant and 18 respondents (8%) were diagnosed with a secondary cancer.  
Over half (56.4%) of the sample was employed either full-time (n = 68), part-time (n = 
39), or were self-employed (n = 18); the remainder were either retired (n = 48), on a pension (n 
= 25), a homemaker/carer (n = 11), a student (n = 8), or unemployed (n =5).  
Respondents were well educated, with 26.1% (n = 58) completing a tertiary 
diploma/trade; 23.9% (n = 53) completing a tertiary undergraduate or postgraduate (n = 39; 
17.6%) degree, while 47 respondents (21.2%) had completed Year 12/HSC and 25 (11.3%) 
respondents completed Year 10/11. Although the relationship status of respondents varied, 
over half the respondents were married (n = 122; 55%). The other respondents were either 
single (n = 44; 19.8%), de facto/partnered (n = 22; 9.9%), separated/divorced (n = 15; 6.8%), 
widowed (n = 18; 8.1%) and one respondent described himself as polyamorous. Slightly less 
than half the respondents considered themselves Christian (Uniting Church, Anglican, Baptist, 
Catholic, etc.) (n = 106; 47.7%), a further 21 (9.6%) comprised other religions (Buddhist, 
Hindu, Islamic, Jewish and Druid), and the remainder described themselves as either non-
practicing (n = 86; 38.2%) or non-believers (n = 9; 4.1%). In this sample, the majority of 
respondents had children (n = 167; 75.2%). The respondents were not asked to provide further 
information on their children’s ages or whether they still lived at home. 
Based on analysis of the demographic data, in general, this population is representative 
of the HC survivors required to answer the research questions. It would have been ideal to 
capture a more ethnically diverse representation, which is one limitation of this research. Of 
note too, is that a large percentage of the respondents were diagnosed with CML (n = 107; 
48%). It is likely that this occurred as a result of active social media promotion through the 
CML Facebook site. However, the contribution from CML survivors is considered 
advantageous to this study, as CML is a particularly rare form of leukaemia, for which there is 
currently no cure. Thus, the input from CML survivors is important, as these individuals are 
required to manage their cancer and treatment side-effects on a daily basis for the rest of their 
lives.  
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Table 7.4 
 
Demographic Profile of Total Sample (N = 222) 
___________________________________________________________________ 
 
Variable        Total (N = 222) 
___________________________________________________________________ 
Mean age at time of study (years)     54.40 (SD = 14.31) 
 
Distribution of Age (years) 
 18 – 40        16.2% (n = 36) 
 41 – 60        47.7% (n = 106) 
 61+         36.0% (n = 80)  
Males         37.8% (n = 84) 
Females        62.2% (n = 138) 
 
HC Cancer Diagnoses 
Non-Hodgkin’s Lymphoma (NHL)     29.7% (n = 66)  
Hodgkin’s Lymphoma (HL)     7.2% (n = 16) 
 Small Lymphocytic Lymphoma (SLL)    0.5% (n = 1) 
 Acute Lymphoblastic Leukaemia (ALL)    0.9% (n = 2) 
 Acute Promyelocytic Leukaemia (APML)     0.5% (n = 1) 
 Acute Myeloid Leukaemia (AML)      2.3% (n = 5) 
  Chronic Lymphocytic Leukaemia (CLL)    5.4% (n = 12) 
 Chronic Myeloid Leukaemia (CML)    48.2% (n = 107) 
 Chronic Myelomonocytic Leukaemia (CMML)   0.5% (n = 1) 
 Hairy Cell Leukaemia (HCL)     0.9% (n = 2) 
 Biphenotypic Leukaemia (AML & ALL)    0.5% (n = 1) 
Multiple Myeloma (MM)      3.6% (n = 8)  
 
Mean time since diagnosis (years)     7.73 (SD = 6.14) 
 
Years Since Diagnosis  
 1 – 5        50% (n = 111) 
 6+         50% (n = 111) 
 
Initial Treatment Required 
 Radiotherapy only      3.2% (n = 7) 
 Chemotherapy only      15.5% (n = 34) 
 IV/Oral/Immunotherapy      38.3% (n = 85) 
 Combination (R,C,I,BMT,SCT)     38.7% (n = 86) 
No treatment required       4.5% (n = 10) 
        
Current Treatment Regime 
 Require ongoing treatment      48.6% (n = 108) 
 Completed treatment       43.7% (n = 97) 
 Treatment was not required     5.0% (n = 11) 
 Currently on treatment cycle (which is temporary)   1.8% (n = 4) 
 Undergoing treatment trial      0.9% (n =2) 
 
Required BMT/SCT 
 No        86.5% (n = 192) 
 Yes        13.5% (n = 30)  
 
Experienced HC Relapse  
 No        78.8% (n = 175) 
 Yes        21.2% (n = 47) 
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Table 7.4  
(continued) 
__________________________________________________________________________ 
Variable        Total (N = 222) 
__________________________________________________________________________ 
Diagnosed with Secondary Cancer  
 No         91.9% (n = 204) 
 Yes (Type):   Breast      1.4% (n = 3)  
           Bowel      0.9% (n = 2) 
    Prostate      1.4% (n = 3) 
    Lymphoma      0.9% (n = 2) 
    Skin Cancers (Melanoma, etc.)   2.7% (n = 6)  
    Thyroid      0.5% (n = 1) 
    Chronic Myeloid Leukaemia    0.5% (n = 1)  
 
Relationship Status 
 Married         55.0% (n = 122) 
 Single         19.8% (n = 44) 
 Divorced        1.8% (n = 4) 
 De facto/Partnered      9.9% (n = 22) 
 Widowed        8.1% (n = 18) 
 Separated        5.0% (n = 11) 
 Polyamorous        0.5% (n = 1) 
 
Dependents 
 0        24.8% (n = 55) 
1        14.0% (n = 31) 
2        36.0% (n = 80) 
3        16.2% (n = 36) 
4        6.8% (n = 15) 
5        2.3% (n = 5) 
 
Employment 
 Full-time       30.6% (n = 68) 
 Part-time       17.6% (n = 39) 
 Retired         21.6% (n = 48) 
 Unemployed (including redundancy)    2.3% (n = 5) 
 Pensioner        11.3% (n = 25) 
 Student         3.6% (n = 8) 
 Self-employed (Full-time or Part-time)    8.1% (n = 18) 
 Homemaker        4.1% (n = 9) 
 Carer         0.9% (n = 2) 
 
Education  
 Year 10-11 High school level     11.3% (n = 25) 
 High school graduate      21.2% (n = 47) 
 Tertiary diploma/Trade or TAFE certificate    26.1% (n = 58) 
 Tertiary degree       23.9% (n = 53) 
 Postgraduate degree      17.6% (n = 39) 
 
Main language spoken at home       
 English         98.6% (n = 219) 
 Chinese          0.5% (n = 1) 
 Japanese          0.5% (n = 1) 
 Urdu           0.5% (n =1) 
 
 
 
RESILIENCE IN HC SURVIVORS 192	
 
 
Table 7.4  
(continued) 
__________________________________________________________________________ 
Variable        Total (N = 222) 
__________________________________________________________________________ 
Ethnicity        
 White/Caucasian/European      93.2% (n = 207) 
 Asian (Chinese, Japanese, Korean)     3.2% (n = 7)  
 Hispanic or Latino       0.9% (n = 2) 
 Middle Eastern        2.3% (n = 5) 
 Aboriginal        0.5% (n = 1) 
 
Residence 
 Australia         68.0% (n = 151) 
 United Kingdom and Europe      14.4% (n = 32) 
 North America (USA and Canada)     15.8% (n = 35) 
 Other (i.e., Africa, Asia, New Zealand)    1.8% (n = 4) 
 
Area of residence  
 Urban         75.2% (n = 167) 
 Rural/country       24.8% (n = 55)  
 
Religious Beliefs 
 Christian (i.e., Uniting Church, Anglican, Catholic, etc.)  47.7% (n = 106) 
 Non-practising        38.2% (n = 55) 
 Buddhist       4.5% (n = 10) 
 Hindu        0.5% (n = 1) 
 Islamic        1.4% (n = 3) 
 Jewish        2.7% (n = 6) 
 Druid         0.5% (n = 1) 
 Non-believer (i.e., Agnostic or Atheist)    4.1% (n = 9) 
_____________________________________________________________________ 
 
 
Quality of the Data and Data Analysis Assumptions 
 Prior to statistical testing of relationships among variables in the data set the data were 
evaluated to determine if the data met normality, linearity and homoscedasticity assumptions.  
Normality, linearity and homoscedasticity – Analysis of the statistical tests of 
normality (Kolmogorov-Smirnov and Shapiro-Wilks) indicated that the data were not normally 
distributed (p < .05) as would be expected with a large sample size, when even small deviation 
from normality will be shown to be statistically significant. However, in regard to these 
statistical tests, Tabachnick and Fidell (2007) state that “they are very sensitive and often 
signal departures from normality that do not really matter” (p. 46). Consequently, it is 
recommended that more visual graphical results also be developed and analysed in addition to 
statistical tests. These graphical tests (e.g., normal Q-Q plots, detrended normal Q-Q plots) 
indicated that the majority of variables data were approximately normally distributed 
(Appendix M). 
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In addition, the assumptions of linearity and homoscedasticity of residuals were met. This was 
achieved by inspecting the normal probability plot of standardised residuals (Appendix N) and 
the scatterplot of standardised residuals against standardised predicted values (Appendix O). 
This suggests a linear relationship between the variables and the variability in one variable 
should be similar across all values of the other variable (Tabachnick & Fidell, 2007).  
 
Independent t-tests and One way ANOVA Analyses Assumptions 
 Analyses were used to identify what influence resilience may have on depression and 
anxiety in this sample of respondents. Independent t-tests, one-way ANOVAs and correlation 
analyses were conducted to measure the significance of differences and the strengths of linear 
relationships between these variables and to investigate the influence of selected demographics 
(gender, age and time since diagnosis).  
As normality was not consistently found, both parametric (i.e., Pearson’s r) and 
nonparametric (i.e., Spearman’s ρ) tests were conducted when testing the correlation among 
relationships. Likewise, the assumption of normality may have been violated for other analyses 
that compare means (i.e., t-test, ANOVA), thus equivalent non-parametric tests (Mann-
Whitney U, Kruskall-Wallis ANOVA by ranks) were also performed to ensure accuracy. 
Parametric tests were reported unless the results of the parametric and non-parametric tests 
differed (See Appendix P for comparisons between tests).  
Standard Multiple Regression Analyses Assumptions 
 The main focus of this study was to conduct a standard multiple regression analysis 
(MRA) to assess the ability of the model to predict resilience and to identify significant 
predictor variables (Research Question 2). According to Tabachnick and Fidell (2007), there 
are several additional assumptions, outlined below, that require testing prior to conducting the 
analysis and interpreting the results.  
Ratio of cases to the independent variable - In order to produce a reliable regression 
model, a reasonable ratio of cases to predictors is required. Tabachnick and Fidell (2007) 
suggest that the number of respondents should ideally be 50 + 8m (where m = number of 
independent variables). Investigating 24 predictor variables required a sample size of 240 
respondents). Although the present sample size fell slightly short, one of the principal research 
supervisors (an experienced statistician), deemed the sample size to be adequate. 
In addition, what is considered a ‘reasonable’ sample size tends to vary between experts, with 
other researchers such as Guadognoti and Velicer (1988) maintaining that a sample size > 200 
is a reasonable and fair sample.  
Absence of univariate and multivariate outliers - MRA is sensitive to univariate and 
multivariate outliers (Tabachnick & Fidell, 2007). It was, therefore, important to screen for 
these. First univariate outliers were screened for: 1) incorrect data entry; 2) incorrectly coded 
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missing-values; and, 3) cases that were not members of the intended sample population, but 
resulted in extreme scores outside the normal distribution (Tabachnick & Fidell, 2007). All 
outliers within the data were cases from the intended population, but contained extreme values 
outside the normal distribution, i.e., those that exceeded Z scores of ± 3.3 (Tabachnick & 
Fidell 2007). Fifteen of the 24 variables contained either extreme score or outliers. In addition, 
two outliers were detected among the dependent variable of resilience. Following 
recommendations, the values of these scores were altered so that they became less problematic 
and fell within the Z score range of ±3.3 (Tabachnick & Fidell, 2007).  
Second, six multivariate outliers were detected using Mahalanobis’ distance, using α = 
.001. Mahalanobis’ distance exceeded the critical χ2 (24) of 51.18 in the six influential cases in 
the data file. These cases were not deleted because, after re-running the analysis without them, 
they had no impact upon the regression model.  
Absence of multicollinearity - According to Tabachnick and Fidell (2007), high 
correlations (e.g., r ≥ .85) between predictors can render a regression analysis difficult to 
interpret and unstable. Multicollinearity was assessed by inspecting tolerance and VIF 
(variance inflation factor) levels. This assumption was met, as: there were no VIF scores 
greater than 10; the average VIF (current sample = 2.05) did not substantially differ from 1; 
and, there were no tolerance levels below 0.2 or 0.1.  
 In summary it can be presumed from the preliminary assumption analyses discussed, 
that the data are a good enough fit to be used to answer the research questions.  
 
Results 
Frequency Analysis 
 Descriptive analyses were conducted on all variables. As noted in Table 7.5, 
inspection of the mean scores indicated that respondents scored high relative to total possible 
scores, across several measures: self distraction, active coping, emotional support, instrumental 
support, positive reframing, planning, acceptance, social support (friends, family, significant 
others and HCP), time out, diet, exercise, appearance and researching information. Lower 
mean scores were noted for denial, substance use, behavioural disengagement, venting and 
self-blame. In addition, the mean score for anxiety was higher (M = 6.72) than depression (M = 
3.94). However, both anxiety and depression mean scores were low when compared to a 
maximum score for each of 21.  
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Table 7.5 
Descriptive Statistics of Variables within the Final Questionnaire  
________________________________________________________________________________________________________ 
_______Range______ 
Scale     N M SD  Potential Actual  Skewness Kurtosis 
________________________________________________________________________________________________________ 
Self distraction    222 5.42 1.85  2-8  2-8  -0.39   -0.91 
Active coping    222 6.18 1.61  2-8  2-8  -0.78  -0.04 
Denial     222 2.55 1.10  2-8  2-8  2.46  6.81 
Substance use    222 2.61 1.29  2-8  2-8  2.50  6.33 
Emotional support   222 5.77 1.85  2-8  2-8  -0.45  -0.78 
Instrumental support   222 5.26 1.89  2-8  2-8  -0.14  -1.03 
Behavioural disengagement  222 2.49 1.08  2-8  2-8  2.62  7.53 
Venting    222 3.65 1.42  2-8  2-8  0.84  0.67 
Positive reframing   222 5.90 1.81  2-8  2-8  -6.20  -0.48 
Planning    222 5.66 1.81  2-8  2-8  -0.41  -0.70 
Humour    222 4.96 2.25  2-8  2-8  -0.03  -1.42 
Acceptance    222 7.09 1.24  2-8  2-8  -1.42  2.10 
Religion    222 4.34 2.30  2-8  2-8  0.42  -1.34 
Self blame    222 3.03 1.36  2-8  2-8  1.60  2.48 
BRIEF COPE (Total)   222 64.91 11.52  28-112  35-100  0-.12  -0.15 
 
Family support    222 21.73 6.34  4-28  4-28  -1.33  1.15 
Friends support    222 21.54 6.14  4-28  4-28  -1.15  0.66 
Significant others   222 22.96 6.36  4-28  4-28  -1.54  1.73 
Healthcare professionals  222 19.90 5.38  4-28  4-28  -0.95  0.73 
MSPSS (Total)    222 86.13 20.26  16-112  19-112  -1.35  1.41 
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Table 7.5 
(continued) 
________________________________________________________________________________________________________ 
          _______Range______ 
Scale     N M SD  Potential Actual  Skewness Kurtosis 
________________________________________________________________________________________________________ 
Time out    222 14.72 3.14  3-18  3-18  -0.65  0.07  
Exercise    222 13.02 3.52  3-18  3-18  -0.46  -0.54 
Diet     222 14.39 2.86  3-18  3-18  -0.86  0.98 
Appearance    222 13.74 2.59  3-18  3-18  -0.42  -0.04 
Researching information  222 13.15 3.17  3-18  4-18  -0.36  -0.27  
Alternative Tx    222 10.04 4.07  3-18  3-18  -0.02  -0.80 
HBC (Total)     222 78.72 13.63  12-108  34-106  -0.41  -0.15 
 
Depression    222 3.94 3.27  1-21  0-17  1.01  0.89 
Anxiety    222 6.72 3.88  1-21  0-19  0.66  0.09 
HADS (Total)    222 10.65 6.44   0-42  0-33  0.82  0.11 
 
RSA (Total)    222 169.20 27.13  33-231  76-221  -0.65  0.19 
_________________________________________________________________________________________________________________ 
Note. MSPSS = Multidimensional Scale of Perceived Social Support; HBC = Health Behaviour Change; RSA = Resilience Scale for Adults;  
HADS = Hospital Anxiety and Depression Scale; Tx = Treatment 
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Resilience. The RSA does not classify specific levels of resilience (i.e., low, moderate, 
high, etc.). However, inspection of the mean scores and standard deviations revealed that, 
overall, respondents scored above average (M = 169.20), of a maximum possible score of 231, 
when compared to normative populations on measures of resilience. The distribution of the six 
mean factor scores comprising the RSA are shown in Table 7.6, ranging from a low 16.33 to a 
high of 40.18. The results indicate relatively high mean scores across most factors, in 
particular, social resources, family cohesion and perception of self. However, there was 
variability between the resilience measures. For example, the highest resilience measure 
reported was social resources (M = 40.18), which was above average when compared with 
normative populations. Yet for structured style (M = 16,33) a lower score was observed. In 
addition, some of the standard deviations seem large, indicating that there is more variability in 
the group of scores on those measures of resilience.  
Several previous studies support the use of the RSA instrument as a resilience 
predictor, for example among those with psychiatric illness following stressful events 
(Hjemdal et al., 2006), in relation to Extraversion-Intraversion, Psychoticism and Neuroticism 
(Annalakshmi, 2007), as a predictor of hopelessness (Hjemdal, Friborg, & Stiles, 2012), and 
more recently among HIV-positive South Africans (Dageid & Grønlie, 2015). 
 
Table 7.6 
Distribution of Mean Scores across RSA Factors 
____________________________________________________________________ 
 
RSA factors     M   SD Maximum Score Possible 
____________________________________________________________________ 
Perception of self (6 items)  31.46  6.72  42 
Planned future (4 items)   19.62  5.22  28 
Social competence (6 items)  29.72  6.48  42 
Family cohesion (6 items)  31.89  7.58  42 
Social resources (7 items)  40.18  7.06  49 
Structured style (4 items)  16.33  3.83  28 
__________________________________________________________________ 
Note. RSA = Resilience Scale for Adults (Friborg et al., 2003) 
 
  
Mental Health. The mean scores on negative mental health outcomes were low when 
compared to other cancer population (Table 7.4). As presented in Table 7.7, the majority of 
respondents’ scores were classified as being ‘normal’ in severity across both depression (83%) 
and anxiety (65%). However, the results presented indicate that a higher proportion of HC 
survivors experience anxiety than depression. For example, when comparing both the 
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moderate and severe ranges combined, more respondents reported anxiety (n = 37; 17%) as 
compared to depression (n = 8; 4%). 
 
Table 7.7 
Distribution of Severity Levels of Depression and Anxiety Measured by the HADS (N = 222) 
____________________________________________________________________ 
Outcome measure and   Score    Frequency (%)  
severity level 
____________________________________________________________________ 
Depression 
Normal    0 – 7    185 (83) 
 Mild    8 – 10    29 (13) 
 Moderate   11 – 14    7 (3) 
 Severe    15 – 21    1 (1) 
Anxiety  
 Normal    0 – 7    145 (65) 
Mild    8 – 10    40 (18) 
Moderate   11 – 14    26 (12) 
Severe    15 – 21    11 (5)  
____________________________________________________________________ 
Note. HADS = The Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983) 
 
  
Age, Gender, Time Since Diagnosis. Descriptive statistics on resilience were also 
explored across several demographic variables including age, gender and years since diagnosis 
(Table 7.8). 
 
Table 7.8 
Mean Resilience, Depression and Anxiety Scores According to Age, Gender and Time since 
Diagnosis  
_____________________________________________________________________ 
Demographic  Depression  Anxiety  Resilience 
Variable  M  (SD)  M (SD)  M (SD) 
____________________________________________________________________________ 
Gender  
Male  3.68 (3.28)  6.11 (3.31)  170.36 (25.41) 
Female  4.09  (3.26)  7.09 (4.16)   168.50 (28.19) 
 
Age 
YA (18 – 40) 3.86 (4.21)  8.03 (3.99)  170.25 (30.48) 
MA (41 – 60) 4.19 (3.27)  6.88 (3.91)  167.63 (26.15) 
 OA (61+) 3.64 (2.76)  5.91 (3.65)  170.81 (27.06) 
 
Years Since Diagnosis  
(1 – 5)  4.41 (3.16)  7.21 (4.02)  166.32 (26.18) 
(6+)  3.47 (3.31)  6.23 (3.69)  172.09 (27.87) 
____________________________________________________________________________ 
Note. TSM = Total Sample Mean; YA = Young Adult; MA = Middle Age Adult; OA = Older 
Adult. 
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Therefore, higher scores among these variables were related to greater resilience scores. 
Conversely, denial, behavioural disengagement and self-blame were negatively associated 
with resilience such that higher scores on these variables were related to lower resilience 
scores. 
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Table 7.9 
Zero-Order Correlations between Variables  
____________________________________________________________________________________________________ 
Variable   1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 
____________________________________________________________________________________________________________ 
Resilience  -.007 .384** -.170* -.115 .477** .253** -.391** -.070 .323** .318** .314* .263** 
1. SD    .276** .260** .178** .143* .272** .061 .235** .280**.303** .391** -.094   
2. AC     -.008  .047 .343** .424** -.307** .190** .578** .700** .275** .244** 
3. DE      -.219** -.080 .020 .288** .166* .058 .019 .168* -.191** 
4.  SA       .053 .076 .129 .167* .057 .000 .253** -.141* 
5. ES        .595** -.364** .153*  .314** .381** .364** .145* 
6. IS         -.213** .240** .355** .531** .380** .068 
7. BD          .041 -.301** .273**-.135* -.196** 
8. VE           .120 .215** .178** -.068 
9. PO            .575** .467** .301** 
10. PL             .350** .261** 
11. HU              .080 
12. ACC  - - - - - - - - - - - -   
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Table 7.9 
(continued) 
___________________________________________________________________________________________________ 
Variable   13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24.
 _____________________________________________________________________________________________________________ 
Resilience  .161* -.357** .443** .359** .591** .536** .200** .263** .300** .150* .189** .249** 
1. SD   .174** .205** -.002 .012 .137* .082 .181** .197** .198** .169* .078 .029 
2. AC   .326** -.061 .213** .245** .272** .297** .298** .248** .222** .154* .282** .234  
3. DE   -.042 -.130 -.152*  .124 -.075  -.087 -.204** .139* .184** -.073 -.164* -.102 
4. SA   .028 .273** .070 -.062  -.043 -.042 -.005 .060 .014 .051 .105 -.019 
5. ES   .207** .083 .547** .401** .615** .597** .278** .232** .394** .201**  .216** .196** 
6. IS   .277** .074 .293**  .231** .418** .456** .312** .176** .350** .335** .339** .081  
7. BD   -.034 .249** -.287** -.276** -.333** -.349** -.239** -.117 -.245** -.188** -.147* -.168* 
8. VE    .222** .144* .087 .050 .054 -.002 .221** .151* .063 .109 .126 .134* 
9. PO   .311** -.011 .126 249** .230** .376** .283** .206**.240** -.017 .265** .216** 
10. PL   .369** .033 .291** .294** .347** .303** .458** .395** .328** .260** .294** .289** 
11. HU   .194** .113 .084 .121 .248** .369** .219 ** .157*  .148* .166* .180** -.019 
12. ACC  .038 -.229** .141* .248**  .217** .254** .085 .108 .060 -.017 -.103 .132 
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Table 7.9 
(continued) 
________________________________________________________________________________________________________________________ 
Variable   13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24.   
______________________________________________________________________________________________________________ 
13. REL  - -.049 .138* .238** .209** .198**  .328**.200** .162* .272** .394** .199* 
14. SB   - - -.156* -.145* -.151* -.134* .000 -.011 .064 .037  -.015 -.148* 
15. SO   - - - -.451** .623** .392** .196** .183** .185** .217** .149* .180** 
16 HCP  - - - - .509** .467** .275** .145* .136* .148* .190** .220** 
17. FAM  - - - - - .644** .260** .153* .301**.222** .206** .137* 
18. FRI   - - - - - - .253** .155* .334** .145*  .256** .181** 
19. TO   - - - - - - - -.433** .465** .400** .417** .502** 
20. EX   - - - - - - - - .431** .265** .279** .514** 
21. APP  - - - - - - - - - .284** .292** .346** 
22. RES  - - - - - - - - - - .328** .245** 
23. ATx  - - - - - - - - - - - .259** 
24. DIET  - - - - - - - - - - - -
 _______________________________________________________________________________________________________________ 
Note. SD = Self-distraction; AC = Active coping; DE = Denial; SA = Substance abuse; ES = Emotional support; IS = Instrumental support;  
BD = Behavioural disengagement; VE = Venting; P0 = Positive reframing; PL = Planning; HU = Humour; ACC = Acceptance;  
REL = Religion; SB = Self-blame; SO = Significant other support; HCP = Healthcare Professional support; FAM = Family support;  
FRI = Friends support; TO = Time out; EX = Exercise; APP = Appearance; RES = Researching information; ATx = Alternative Treatment.  
* p <0.5,  ** p < .01, *** p <.001 
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Predictor Variables and Resilience. In addition to identifying factors that are 
correlated with resilience (See Table 7.9), MRA also reported on the specific factors that made 
a unique and significant contribution to the regression model. As can be seen in Table 7.10, the 
model significantly accounted for 61% of the variance in resilience scores, R2 = .609, adjusted 
R2 = .526, F (24, 197) = 12.80, p < .001. As observed in Table 7.10, predictors that made a 
unique and significant contribution to the regression model were: active coping, positive 
reframing, self-blame, family support, friend support and exercise. With the exception of self-
blame, these predictor variables were significantly and positively related to resilience. Only, 
self-blame was negatively associated with resilience. The majority of these results support the 
proposed model. The exception is self-blame, which was not discussed widely among previous 
research exploring HC survivors and did not emerge during the interviews as a significant 
factor.  
 
Table 7.10 
 
Summary of Standard Regression Analyses for Variables Predicting Resilience  
____________________________________________________________________________ 
 
Variable   B [95% CI]  SE  β  
_____________________________________________________________________
Constant   100.48 [72.11, 128.85]  14.38  - 
Self-distraction   -1.42 [-3.07, 0.22]  0.83  -.09 
Active coping   3.69 [1.34, 6.04]  1.19  .21**  
Denial    -0.44 [-3.11, 2.23]  1.35  -.01 
Substance use   -0.13 [-2.33, 2.06]  1.11  -.00  
Emotional support  1.15 [-1.08, 3.39]  1.13  .07  
Instrumental support  -1.10 [-3.06, 0.86]  0.99  -.07  
Behavioural Disengagement 0.81 [-2.20, 3.82]  1.52  .03  
Venting   -0.79 [-2.72, 1.13]  0.98  -04 
Positive reframing  2.28 [0.23, 4.34]  1.04  .15*  
Planning   -0.31 [-2.64, 2.03]  1.18  -.02  
Humour   -0.49 [-.91, 0.92]  0.72  -.04  
Acceptance   -0.07 [-2.33, 2.19]  1.14  -.00 
Religion   -0.11 [-1.32, 1.09]  0.61  -.01 
Self-blame   -4.41 [-6.61, -2.20]  1.11  -.22** 
SO support   0.20 [-0.42, 0.83]  0.32  .04 
HCP support   -0.22 [-0.83, 0.37]  0.30  -.04 
Family support   1.43 [0.71, 2.14]  0.36  .33***  
Friends support   0.98 [0.36, 1.60]  0.31  .22** 
Timeout   -0.35 [-1.45, 0.75]  0.56  -.04 
Exercise   1.15 [0.23, 2.07]  0.46  .15* 
Appearance   0.29 [-0.77, 1.37]  0.54  .03 
Research information  0.56 [-0.36, 1.50]  0.47  .06 
Alternative Treatment  -0.42 [-1.18, 0.34]  0.38  -.06 
Diet    -0.67 [-1.84, 0.49]  0.59  -.07 
____________________________________________________________________________ 
Note. B = unstandardized regression coefficient; CI = confidence interval; SE = standard error; 
β = standardised regression coefficient; SO = significant other; HCP = healthcare 
professional* p < .05, **p < .01, ***p < .001  
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treatment. For example, many respondents referred to the importance of: implementing life-
long, positive, health behaviour choices (e.g., yoga, meditation, exercise, diet, etc.); 
proactively researching information; taking control in decision-making; and, remaining 
positive, hopeful and realistic. Many also discussed the mental health benefits of: being a 
cancer survivor advocate; seeking and accepting all support; taking one day at time; trusting 
the clinical team; and, realising personal limitations.  
A full excerpt of the advice and recommendations provided by current survey 
respondents is transcribed verbatim (Appendix Q). The following quote offered by one 
respondent accurately summarises the coping experience of the majority of HC survivors in 
this survey study:  
 
“Accept your diagnosis. Ask as many questions as possible. If you are unhappy with 
your specialist or their treatment plan ask for a second opinion. Be honest and open 
with your family, tell them when you get the diagnosis, obviously there will be tears 
and despair but this passes and their support is invaluable. Tell people that you deal 
with regularly e.g. friends or work colleagues. I found it much easier if they knew and 
I didn't have to pretend if I was having a bad time. Accept help! Don't try and answer 
every message of goodwill, accept them for the expressions of care that they are. Love 
your family and confide in them - they go on this journey with you and will love you 
regardless of what happens. Indulge yourself buy that dress that you like, have that 
decadent piece of cake. Stop and smell the roses, give yourself time, dream, listen to 
music, sing, pray, meditate, cuddle the dog or cat, go for a walk, cry, shout or scream 
- it is your disease and your journey - own it! Believe in yourself and all those caring 
for you. Try not to listen to those who will try and give you negative advice.  It is a 
tough journey but one you have a good chance of surviving, a positive attitude makes 
the world of difference. Realise you and your life may never be the same, accept any 
deficiencies or any ongoing side-effects… you are alive to enjoy the things you thought 
you would never be able to do”. 
                     (Participant No. 96) 
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Table 8.1 
 
Review of the Themes and Sub-themes Common to HC survivors’ Experience 
____________________________________________________________________________  
 Core Themes     Sub-themes 
____________________________________________________________________________ 
The burden associated with a HC diagnosis  Physical impact 
      Psychological impact 
      Social impact 
      Unexpected loss 
 
Resilience: Coping with HC    Social support network   
      Personal coping strategies 
      Positive health behaviour change 
      Importance of time 
      Self-Education 
 
Pathways and barriers to resilience   Employment 
Relationships 
       Communication 
Information and Resources 
       Unmet needs 
        
Survivor outcomes     Transition: a new normal 
       Re-prioritisation and growth  
       Self-reflection 
________________________________________________________________________ 
 
The Burden Associated with a HC Diagnosis 
There were four sub-themes that survivors in this study identified as factors associated 
with the burden of having being diagnosed and treated with HC. These included the physical, 
psychological, and social impact, including unexpected loss. 
Physical impact.     First, the majority of cancer survivors in this study reported a 
number of ongoing physical complaints such as: bone, joint and nerve pain; memory loss; 
digestive, heart, lung and hormonal problems; lymphoedema; early menopause; infertility and 
sexual dysfunction. However, the most commonly experienced physical effect was fatigue, 
resulting in decreased physical functioning and QOL. The participants commented that many 
physical effects began during treatment and often lingered on for years. These results support 
recent research stating that, up to 5 years following a stem cell transplant, patients continue to 
experience side-effects and being out of shape, fatigue, reduced muscle strength and tingling 
extremities were most frequently reported among HC patients (Braamse et al., 2015). 
Participants were also unprepared for the side-effects that took years following treatment to 
develop, and, for some, this included secondary cancers. Turcotte et al. (2015) supports this 
finding in the US among a cohort of 3,171 ageing childhood survivors. Compared with the 
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general population, survivors in this study were found to have a twofold risk of developing a 
second cancer after age 40, and this risk remains into the fifth and sixth decade of life. 
Psychological impact.     As physical recovery progressed, the unexpected 
psychological effects took many participants by surprise. The range of negative emotions 
experienced by this sample included anger, guilt, depression, general distress, anxiety, and 
isolation. Getting life back to normal with its predictability and control was reassuring for 
those who completed treatment. Yet, many participants worried about their future health, with 
the ‘fear of recurrence’ being the most commonly discussed concern. Most survivors 
maintained that, although their bodies were potentially cancer free, their minds were consumed 
with worry. Chapman (2015), a cancer survivor who recently published his personal 
experience, supported this perspective stating that “…the psychological issues of a near death 
experience begin to find a place in my thoughts as the physical issues abate…suffice to say, 
facing one’s own ‘use by date’ is confronting and there is not always appropriate help 
available in the community” (p.74). The findings in this study also confirm recent research 
reporting that fear of cancer recurrence continues to be one of the most common, persistent 
and unmet supportive care need among cancer survivors (Butow, Fardell, & Smith, 2015; 
Marker, 2015). 
Social impact.     The third sub-theme associated with the burden of a HC diagnosis 
was the social impact. Many participants explained how family, peers, co-workers, and others 
in the survivor’s social setting impacted their HC experience. Many of the interviewee’s 
described a degree of insecurity, lack of intimacy and social isolation within their interpersonal 
relationships. In addition, several participants discovered that many of their friends were 
unable to relate what they had been through. In some cases, this reflected how much the 
participants perceived they had changed since their HC diagnosis. These finding concur with 
other studies suggesting that an appreciation of one’s cancer journey is often more genuinely 
accepted from those who have undergone a similar experience (Aziz, 2002; Kelly & Dowling, 
2011; McGaughan et al., 2012). A number of participants also felt guilty about the impact of 
their cancer on their loved ones. As a result, several participants put on a brave face at the 
expense of sharing their true feelings in order to protect others close to them. This supports 
previous research stating that those diagnosed with cancer often try to shelter significant 
people in their lives (Kelly & Dowling, 2011; McGrath & Clarke, 2003). 
Unexpected loss.     The final sub-theme expressed by current participants as 
contributing to the burden of their HC diagnosis was unexpected loss. The loss of control, 
especially in terms of their independence and autonomy, was the main theme highlighted by 
this sample of HC survivors. Several participants expressed the importance of trying to 
preserve some personal control while in hospital. While for others, this occurred following 
treatment when they began to contemplate their futures or reminisce about the life that they 
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once had, which seemed predictable. Many participants also grieved the loss of: life roles; 
career opportunities and finances; physical (i.e., infertility) and mental (i.e., lost memory) 
functioning; and, identity. Once survivors began to realise that their cancer journey was 
ongoing, they also identified with the loss of time, a perceived planned future and meaning in 
their lives. These findings on the losses experienced by this cohort of HC survivors support 
previous research (Aziz, 2002; Bulsara, Ward, & Joske, 2004; Grunfeld et al. 2013; Kelly & 
Dowling, 2011; McGaughan et al., 2012; Norris et al., 2011; van der Spek et al., 2013; Xuereb 
& Dunlop, 2003).  
 
Resilience: Coping with HC 
The second major theme to emerge from the interviews was resilience and coping with 
HC that highlighted the way in which individuals cope with the burden of cancer. The majority 
of participants in this study maintained resilience through available social support, personal 
coping strategies, self-education, health behaviour change and by taking time out, each of 
which will be briefly summarized. These findings support previous research, as many of these 
factors are commonly discussed in the cancer-related literature (Allart et al., 2014; Llewellyn 
et al., 2013; Stewart & Yuen, 2011; Swash, Hulbert-Williams, & Bramwell, 2014; Wenzel et 
al., 2002). The interviewees also drew strength from their experience of overcoming previous 
adversity, which is well documented (Molina et al., 2014; Pieters, 2015; Richardson et al., 
1990). 
Social support network.     The social support from family, friends and significant 
others was the first sub-theme contributing to the resilience among the interviewees. 
According to Kelly and Dowling (2011), support networks are central to cancer survivors and 
their ability to cope. In addition, the amount and quality of social support has been found to 
improve psychological outcomes, including growth (Molina et al., 2014). The results of this 
study concur with these findings. However, the social support received in this sample was also 
found to have both positive and negative influences on the participants. For example, a lack of 
understanding from the participant’s families and friends led to detrimental effects on their 
recovery. The results of this study agree with previous research, which also acknowledged the 
potential negative impact of social support (Kelly & Dowling, 2011). Thus, it was important to 
the majority of interviewees to also receive social support from others with similar diagnoses. 
The results of this study and previous research also identified that a crucial factor in preserving 
a positive outlook is the support that patients are provided by their HCP’s (McGrath, 2004b).  
Personal coping strategies.     The second sub-theme to influence resilience involved 
personal coping strategies. In this study, the participants used both emotion-focused coping 
(EFC) and problem-focused coping (PFC). First, EFC involved pursuing creative activities and 
relaxing diversions that were considered a way of remaining focused on something other than 
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cancer. Conversely, PFC involved critically processing, reasoning and planning their cancer 
experience and actively addressing ongoing challenges. Previous research has identified 
similar findings, however, there are mixed opinions among the experts. For example, earlier 
resilience research suggests that EFC is linked with the absence of resilience (Olsson et al., 
2003), yet other researchers maintain that EFC benefits cancer survivor assisting them to 
process feelings prior to attempting, in a practical manner, to problem solve cancer-related 
issues (McGrath, 2004b; Lazarus & Folkman, 1984;Waldrop, O’Connor, & Trabold, 2011; 
Wenninger et al., 2013). The findings in this study concur, as many participants described 
ways in which EFC provided a welcome distraction, allowing them to take a break from cancer 
and maintain normality.  
In addition, positive attitudes such as acceptance, determination, persistence, hope, 
optimism, perceived control, ownership and mental flexibility also aided in the participants’ 
ability to implement successful cognitive strategies. Similar findings are reported in several 
studies (Bulsara, Ward, & Joske, 2004; Denz-Penhey & Campbell Murdoch, 2008; Folkman, 
2010; Griffiths, 2014; McGrath, 2004a; Pieters, 2015; Wenninger et al., 2012). However, these 
participants also discussed the challenges associated with the perceived pressure placed by 
significant others associated with remaining positive and/or hopeful. Likewise, McGrath 
(2004b) reported that, at various times (i.e., cancer relapse), it was vital for patients to cycle 
through and acknowledge the process of despair or negativity and then readjust in their own 
time, before it was possible to maintain positivity. McGrath suggested that a hopeful position 
cannot be imposed, but rather requires time and nurturing by others, including clinicians, to 
allow the expression of a full range of emotions in a supportive environment. It was, however, 
acknowledged that the work of remaining optimistic must also be initiated and sustained by the 
patients themselves (McGrath, 2004b).  
Similarly, the literature warns against the potential harm of creating ‘false hope’ 
(Groopman, 2004). For example, Dr. Jerome Groopman, a haematologist who published a 
book titled Anatomy of Hope: How People Prevail in the Face of Illness, asserts that it is only 
‘true hope’ that results in courage and resilience. Groopman, who practiced medicine for 
several decades, was himself a patient suffering from a chronic back condition for nearly 20 
years. During this time, Groopman discovered that hope was a mechanism that optimized his 
ability to function. Groopman determined that hope is perhaps the difference between wanting 
to achieve goals versus having to. As a consequence of his personal experience and research 
on HC survivors (CCL), Groopman came to realise that false hope only served to temporarily 
protect patients. As, once the inevitable reality of the patient’s circumstances becomes 
apparent to them, patients are often left with a sense of uncertainty potentially resulting in 
more distress, than would otherwise be the case, if the hope provided were more accurate 
and/or truthful. Yet the focus of true hope, Groopman highlighted, is not to completely 
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eliminate emotions, such as fear or anxiety that are often hope’s greatest obstacles. Rather, a 
balance needs to be reached by integrating the genuine threats that exist (i.e., fear of 
recurrence) and proposing strategies to manage them. In summary, what is clear from 
Groopman’s findings is that hope is an active process in which cancer survivors are required to 
create, and at times reinvent, a positive future which can be emotionally challenging. 
Finally, another important personal coping strategy emphasized by participants was 
the benefit of finding purpose or meaning in their life. Numerous qualitative studies of chronic 
illness have identified meaning in life as an important factor that is strongly correlated with 
psychological well-being (Denz-Penhey & Campbell Murdoch, 2008; Lau & van Niekerk, 
2011; Miller & Tang, 2015; Park et al., 2008; van der Spek et al., 2013). Spirituality was one 
way of finding meaning highlighted by the participants, which supports previous research 
(Gall, 2004; Min et al., 2013; Wenzel et al., 2002). However, there was also great variation 
among the interviewees, as several did not affiliate with any specific religion or claim 
spirituality as a way of coping. It appeared from the results in this study that coping is 
dependent on the individual, the adversity experienced, available resources, and time since 
diagnosis.  
Positive health behaviour modification.     The third sub-theme that contributed to 
resilience in the majority of HC survivors interviewed was health behaviour modification. The 
benefits of self-care have been discussed within the cancer-related literature, yet research in 
this area is relatively recent. For example, several studies maintain that exercising, consuming 
a healthy diet and relaxation techniques have a positive influence on those living with cancer 
(Gouzman et al., 2015; James et al., 2011; Rabin et al., 2011). However, the direct influence 
on health behaviour modification in enhancing resilience is not widely documented in the 
literature. Therefore, health behaviour modification was not initially included as a major 
contributing factor in the proposed conceptual model. However, the interview results found 
that the transition to survivorship provided a strong motivation for the participants to modify 
their health behaviours. For example, the interviewees asserted that making positive lifestyle 
changes assisted with their long-term recovery, improved mental and physical health, 
facilitated weight loss and promoted relaxation.  
Importance of time.     The significance of time was another sub-theme that 
participants acknowledged as contributing to their resilience. Research shows that illness often 
compels patients to reassess and consider many factors such as: getting help at the right time; 
the time it will take to be treated; quality time remaining; taking time out; and, potentially, 
time left until death (Gartland et al., 2011; Kelly & Dowling, 2011; McGrath & Clarke, 2003). 
These factors were discussed by several of the participants in this study. The interviewees also 
outlined the importance of prioritizing their time. This supports research showing that 
perspectives of time may also change for individuals who have faced a life threatening illness 
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as their time becomes more precious (Charmaz, 1983; Grunfeld et al., 2013; Sherman, Cooke, 
& Grant, 2005). However, initially ‘time’  was not included as part of the proposed conceptual 
model, as there was little evidence in the literature of influence of time on resilience. Yet, 
surprisingly time as a theme was not only identified through thematic analysis, but, also was 
the most frequently referred to word spoken by interviewees, identified by the Leximancer 
software analysis, underscoring its importance to participant survivors.  
Self–education.     The final sub-theme that facilitated resilience was self-education. 
The participants required information to: help them understand the cancer experience; locate 
supportive resources; and, provide them with some control over decisions regarding their 
future. The participants pro-actively collected information from several sources, some of 
which included the Leukaemia Foundation, their specialist, the library, the Internet and social 
media. The results support previous research findings that cancer patients who remain 
informed are more likely to experience positive outcomes, and that the lack of satisfactory 
information can be a source of considerable stress (Butow et al., 2011; McGrath, 2004a; 
Murphy, 2013; Rabin et al., 2011; Xuereb & Dunlop, 2003). 
 
Pathways and Barriers to Resilience 
The next major theme identified by the analyses was the various pathways that 
assisted, or barriers that hindered, resilience. Five sub-themes were highlighted by the 
participants as factors that either assisted or impeded their ability to maintain resilience. The 
main conclusions of each will be briefly discussed. 
Employment.     First, according to this sample, employment was a major factor that 
positively influenced resilience. A variety of benefits were described by those participants who 
returned work, including, a sense of routine and normality, social interaction, financial reward, 
and a sense of purpose. This supports the majority of studies reporting that resuming work 
after illness is a vital component of an individual’s self-identity and is associated with 
improved physical and psychological functioning (van Dijk et al., 2009; Grunfeld et al., 2013; 
Hara & Blum, 2009; Marker, 2015). However, there were also negative consequences 
associated with returning to work. Some participants found the transition back into the 
workforce overwhelming, due, in part, to a lack of confidence in their ability to carry out their 
work role effectively. Another concern for participants was the disclosure of their cancer 
diagnosis to their employer. However, the majority agreed that by disclosing their cancer 
diagnosis they received valuable support. The results concur with previous research 
highlighting that the self-disclosure of a cancer diagnosis in the workplace is generally 
associated with positive consequences (Hagedoorn et al., 2011).  
Relationships.     According to all participants, their interpersonal relationships also 
impacted on the resilience process. However, this varied within the group as both positive and 
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negative interactions were encountered involving partners, family and peers, and/or 
relationships with physicians and other allied health professionals. Several interviewees 
referred to their partners and immediate family as being their main source of strength. Close 
relationships with others, especially those who have been through a similar experience, are 
also identified among previous research as one of the most important sources of meaning 
(McGrath & Clark, 2003; van der Spek et al., 2013). In addition, a trusting and positive 
relationship with HCP’s was regarded as essential in fostering resilience. This supports 
previous research reporting that many cancer patients have depended on effective relationships 
with HCP’s (Bulsara, Ward, & Joske, 2004; Knott et al., 2012; Roundtree et al., 2011). 
Conversely, there were also situations in which close relationships caused stress and impeded 
resilience. The participants shared stories in which friends, family and even partners had 
distanced themselves. These changes impacted on their self-confidence, sense of attractiveness 
and self-image. Several participants stated that their intimate relationships were also affected 
due in part to sexual dysfunction, and these findings concur with previous research (Jefford et 
al., 2008; Lobb et al., 2009; Mosher et al., 2011; Ussher, Wong, & Perz, 2011; Zebrack, 2011). 
Communication.     The third sub-theme that either impeded or enhanced resilience 
was interpersonal communication. For the participants in this study, the communication 
between family, friends and HCP’s varied considerably, with both positive and negative 
experiences encountered. First, by establishing an open communication style the participants 
were better able to adapt to the changes HC had caused within their relationships. This 
supports the literature stating that an open and transparent communication styles can empower 
survivors and thus facilitate a more trusting relationship (Bulsara, Ward, & Joske, 2004; 
Butow et al., 2011; McGrath, 2004b; Parry et al., 2011). However, at the other end of the 
spectrum, several participants elected to be more guarded in their communication. This was 
described as an attempt to maintain control, reduce distress and also to protect others. The 
communication style with HCP’s also played an important factor in the participant’s ability to 
maintain resilience. The majority of participants were complimentary about HCP’s who were 
sensitive to their communication needs, yet several shared concerns related to communication 
issues (i.e., unanswered questions; the use of medical jargon; contradicting information; a lack 
of empathy, etc.). This validates previous literature stating that communication between cancer 
patients and their specialist is an area of potential stress (Butow et al., 2013; Roundtree et al., 
2011; Xuereb & Dunlop, 2003). 
 Information and resources.     Fourth, interviewees highlighted that, for the majority, 
available information and resources enhanced their resilience. Several important factors were 
discussed in relation to the appropriate amount, timing and delivery of cancer-related 
information. This facilitated resilience by enabling participants the opportunity to process vital 
information, set realistic expectations and by providing them with a sense of control. The 
RESILIENCE IN HC SURVIVORS 217	
literature confirms the importance of offering the right amount of quality information that is 
also appropriately timed. However, research states that it can be difficult to achieve the right 
balance (Carey et al., 2012; McGaughan et al., 2012; Rabin et al., 2011; Xuereb & Dunlop, 
2003). The results of this study support the literature, with many participants reporting that, 
although they were keen to understand their HC, they also felt overwhelmed and found it 
difficult to retain the information provided. To overcome this issue, participants used effective 
strategies to remember information (i.e., taking family members to appointments, note-taking, 
using recording devices etc.) 
Another important consideration highlighted by participants is that the community 
resources offered should match their unique needs. For example, for one cancer survivor an 
active exercise program may be considered protective, however this may present a risk for 
another. Thus, one of the main challenges identified in this study is the ability for HCP’s and 
the community to ascertain the individual patient needs and match resources and information 
delivery accordingly.  
Unmet needs.     The final sub-theme identified by the participants that impeded their 
resilience were their unmet needs. The most common unmet need occurred at the completion 
of treatment when the participants faced unknown territory feeling lost, lonely, isolated and 
dismissed, mainly due to the lack of support following treatment. This was also a time that 
many interviewees stated that they would have most benefitted from the offer of counselling or 
support groups. These results concur with previous research highlighting that numerous 
stressors often accompany the completion of treatment and when additional support is 
particularly valuable (Knott et al., 2012; Rabin et al., 2011; Roundtree et al., 2011; Stanton et 
al., 2005; Waldrop, O’Connor, & Trabold, 2011). Many participants also felt rushed during 
their specialist appointments. Research reports that this is concerning for cancer survivors, as 
important issues remain unanswered due to the lack of time available during medical 
appointments (Kelly & Dowling, 2011; O’Leary, 2013). 
 
Survivor outcomes  
The final theme identified by participants in this study was survivor outcomes, which 
occurred as a result of being diagnosed with HC. In line with previous research (McGaughan 
et al., 2012; Roundtree et al., 2011; Wallace et al., 2007), all participants expressed the need to 
re-establish their lives following their HC experience, which resulted in a diverse range of 
survivor outcomes. Despite the negative impact of living with HC, there were also many 
positive outcomes also shared by the participants. For example, there were several examples of 
healthy, well-adjusted survivors who described their determination in achieving optimal health 
outcomes. There were three main sub-themes that participants attributed as factors associated 
with personal outcomes.  
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Transition: a new normal.     The first sub-theme identified as an outcome involved 
each HC survivor’s transition to a new normal. In this study, the majority of participants 
experienced as sense of disorientation between their pre- and post-cancer lives. This supports 
the work of Little and colleagues (2001), who describe this phase of ‘liminality’, in which 
survivors progress through the space of illness, but do not return to their pre-illness world. 
Other researchers agree suggesting that surviving cancer is a lifelong journey involving several 
phases of change (Deimling et al., 2005; Dow, 1991; Pelusi, 1997). In line with recent research 
(Pieters, 2015), the current interviewees highlighted that resilience did not simply occur 
instinctively. Rather, resilience required conscious dedication, persistence and effective self-
management skills on their behalf, to move toward establishing a new normal. These results 
also appropriately reflect the experience described by Chapman (2015), a ten-year cancer 
survivor, who recently published an article detailing his personal journey.  Chapman agreed, 
stating “I found it beneficial to be my own advocate and my own case manager as I navigated 
both the treatment and the survivorship space. By self-managing where possible, and then 
seeking good quality professional help when your need exceeds your own capabilities, it is 
possible to rebuild your new normal in a positive and useful way” (p. 75.). 
Re-prioritisation and growth.     In addition to establishing a new normal, most 
participants discussed their re-prioritisation and growth in relation to survivor outcomes. First, 
in terms of re-prioritization, the ability to process everyday stress in perspective and not ‘sweat 
the small stuff’ were amongst many qualities that were reflected in the interviews. An example 
of re-prioritizing was also highlighted by 25 year-old former Olympian and Hockeyroo’s 
player Fiona Boyce, a Hodgkin’s lymphoma survivor. Boyce stated that “having cancer has 
changed me and stopped me being such a perfectionist and I know now that doing your best is 
all you can ask. It’s made me grateful for all the good things I have” (O’Leary, 2014, p.5).  
Second, in relation to personal growth, this study supports previous research 
suggesting that, following cancer, survivors often develop new life perspectives and priorities 
(Bulsara, Ward, & Joske, 2004; McGrath & Clarke, 2003; Wallace et al., 2007). For example, 
the majority of participants described their search for meaning and purpose, which allowed 
them to optimistically re-appraise their lives and begin the healing process. In line with 
previous research (Connerty & Knott, 2013; Miller & Tang, 2015), several interviewees also 
found that assisting others in similar situations (i.e., through volunteer work) helped them to 
create value and meaning from their cancer experience.  However, the findings of this study 
identified that meaning making among cancer survivors is usually a multifaceted process. For 
example, in areas such as personal relationships many participants attributed more importance, 
yet, in other facets of their life, such as their careers, meaning tended to diminish. This 
inconsistency has also been reported in previous research (van der Spek et al., 2013).  
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Conclusion –Interview Discussion 
The 23 HC survivors interviewed offered significant insights that highlighted 
resilience as a natural and dynamic process within each individual, that connects their past, 
present, and their anticipated future. The majority of factors identified as influencing resilience 
in this qualitative study support those discussed among previous literature investigating other 
cancer survivors (including other types of cancer). The only relatively unique factor in this 
research influencing resilience, related to time out and certain areas of positive health 
behaviour change (i.e., diet). Although aspects of health behaviour change (i.e., exercise) have 
been discussed in several studies (Gouzman et al., 2015; James et al., 2011; Levin, 
Greenwood, Singh, Tsoi, & Newton, 2015; Rabin et al., 2011) involving cancer survivors, 
these factors have not been linked to maintaining resilience among this population. Phase One 
(Qualitative) provided new insight into the experience of living with HC. 
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to Mitchell et al. (2011), the variation in rates may be due, in part, to variations in research 
methodology. More recent studies tend to be more methodologically sound and, therefore, 
report more accurate rates than the older studies that report higher rates of depression. As a 
result of this review, Mitchell and colleagues (2011) concluded that approximately 16% of 
patients with cancer are depressed, substantially more than found in the survey sample 
included in this study. The survey results are also substantially lower than the rates (6.2%) in 
the general population (ABS, 2007). These survey results are surprising, as one would expect 
the rates to be higher than in the general population, given the trauma and uncertainty faced by 
those with serious illness. However, this indicates that the survey sample was potentially 
biased towards those who were coping better. It is possible that more of the depressed HC 
survivors were among those individuals who elected not to participant. As with all research it 
is difficult not to obtain a biased sample, and this is discussed later as a limitation of this 
research. Yet, it is not expected that potential sampling bias has undermined all the findings of 
this mixed method study, as the sample included in both studies still comprised a varied 
demographic. However, in the future, different research designs (i.e., targeting hospital 
settings via follow up appointments) may be more effective at recruiting a broader cohort of 
individuals, and, therefore, improve potential sampling bias.  
Anxiety.     The focus in the literature on assessing depression in cancer survivors may 
have illuminated our understanding of the impact depression may have on resilience; however, 
this singular focus may have also limited our understanding of other of psychological distress 
among cancer survivors. According to recent research, in addition to increased rates of 
depression, increased rates of anxiety have also been found in patients following a cancer 
diagnosis. More importantly, these high rates of anxiety tend to persist over time, whereas 
increased rates of depression were less enduring (Mitchell et al., 2013). This implies that 
anxiety, rather than depression, may be more problematic in long-term cancer survivors. This 
is not unlike rates among populations without cancer, where anxiety levels are reported to have 
a 12-month prevalence of 18% that is approximately twice as common as depression.  
 The results of the survey showed that four times more respondents reported either 
moderate or high levels of anxiety (17%) than those reporting depression (4%). These results 
concur with earlier research, which found higher levels of anxiety versus depression in both 
adult colorectal and mixed-cancer patients (Alacacioglu et al., 2010; Brown et al., 2010). 
Therefore, it is important to investigate anxiety, not only because the prevalence may be higher 
among cancer survivors, but also because screening for anxiety has often been overlooked in 
clinical care in comparison to depression and distress (unpleasant feelings or emotions) 
(Mitchell et al., 2013).  
Demographic variables.     Demographic variables were examined to further explore 
their influence on mental health and resilience. It was beyond the scope of this study to 
RESILIENCE IN HC SURVIVORS 224	
investigate all demographic factors. However, gender, age and time since diagnosis were 
selected, given that there are well-documented relationships, yet conflicting results, in the 
literature, as to how these demographic factors influence coping, adaptation and QOL among 
cancer survivors (Knobf, 2011). Demographic factors are also important, as certain cohorts 
may be at higher risk of negative mental health outcomes, which would be of significance to 
clinical practice (Avis & Deimling, 2008; Bennett et al., 2010; Foster et al., 2009; Pudrovaska, 
2010; Rabin et al., 2011; Zebrack, 2011).  
Survey results showed that there was no significant difference on either depression or 
anxiety levels according to gender. However, Mann-Whitney U tests indicated that resilience 
levels of long-term survivors (6+ years) were significantly higher than for those of short-term 
survivors (< 5 years). Conversely, depression and anxiety levels were significantly lower 
among long-term survivors. These findings obtained during Phase One (Qualitative 
Interviews), were consistent with previous literature (Ganz, 2011; Knobf, 2011; Maher & 
Fenlon, 2010) and suggest that psychological interventions would be best targeted to 
individuals earlier in the survivorship trajectory, as this is a time when HC survivors report 
lower levels of resilience and higher levels of depression and anxiety.  
Finally, analyses also identified a significant difference between the young (<40 years) 
and older (61+ years) survey respondents, with the younger adults reporting higher anxiety 
levels. Earlier research has revealed extensive differences in distress among cancer survivors 
according to age, suggesting that younger adults may be more vulnerable to negative mental 
health outcomes than older survivors (Constanzo, Ryff, & Singer, 2009). Developmental 
theorists propose that “off-time” life events occurring outside of typical age ranges are more 
likely to cause distress (Neugarten & Hagestad, 1976), and this may also be the case with a 
cancer diagnosis. The higher anxiety levels among the young adults found in this study 
concurs with previous research. For example, Wu et al. (2012) investigated the relationships 
among coping, anxiety and resilience in adolescents and young adults undergoing cancer 
treatment. This cross-sectional design, involving 131 adolescent and young adult respondents, 
reported that over 20% had high scores on worry. Wu et al. (2012) concluded that anxiety is 
the main psychological disturbance in adolescents with cancer. In addition, Zebrack (2011) 
proposed that younger cancer survivors face several age-related issues associated with their 
developmental stage, such as issues with self-esteem, confidence, identity and uncertainty 
about acceptance by others (Zebrack, 2011). Another related issue for young adults is the 
decision regarding the sharing of cancer-related information with their friends and peers, 
including new acquaintances and employers (Zebrack, 2011), which may lead to increased 
levels of anxiety.  
In summary, higher anxiety levels were identified among young adults. The overall 
results also indicated that those with higher levels of resilience reported decreased levels of 
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Six of the 21 variables, that significantly contributed to the model of resilience when 
combined with all the other 24 variables, included active coping, positive reframing, self-
blame, family support, friend support and exercise. One variable, self-blame, was a negative 
predictor of resilience; meaning that higher scores were related to lower resilience scores. 
Consistent with the results of the qualitative interviews and previous research, the majority of 
the predictor variables significantly correlated with resilience.  However, there were some 
exceptions.  
Active Coping.     Confirming previous research, this survey found that active coping 
(β = .21) contributed positively to enhance resilience and reduce negative mental health 
outcomes (Haase, 2004; Lauver, Connolly-Nelson, & Vang, 2007; Pieters, 2015; Roesch et al., 
2005; Wu et al., 2012). Active coping or problem-focused coping (PFC) involves the efforts of 
an individual to persevere in altering the demands imposed upon them by defining the stress, 
generating ideas and, then, in acting on a solution to change the threat (Lazarus & Folkman, 
1984; Pieters, 2015). Thus, active coping engages problem-solving, control, optimism, and 
seeking support as protective factors that assist people with cancer to adjust (Haase, 2004; 
Pieters, 2015).  
There is speculation in the cancer-related literature that emotion-focused coping (EFC) 
when used concurrently with PFC is also beneficial (Austenfeld & Stanton, 2004; Wills & 
O’Carroll Bantum, 2012). Rather than PFC/active coping, EFC entails attempts to 
appropriately deal with the emotions experienced by providing selective attention (i.e., lessen, 
avoid or minimize) in order to alter the way the individual thinks or feels (Lazarus & Folkman, 
1984). However, the results of this survey study suggest that, of the two styles of coping, PFC 
or active coping is associated with more resilient outcomes. This concurs with earlier research 
by Frick et al. (2004) that involved 126 HC patients, and explored coping styles prior to 
autologous stem cell transplantation. Respondents completed several surveys addressing 
health-related control expectancies and coping with their illness, in which active coping 
proved to be the most effective coping style. A more recent study by Wu and colleagues 
(2012), involving 131 cancer survivors, half of whom had leukaemia, also found resilience to 
be positively correlated with cognitive coping and active/problem-oriented coping. Similar 
results have recently been reported among other cancer populations. For example, active 
coping was identified among mixed cancer survivors in Nigeria to be associated with better 
social and functional wellbeing (Asuzu & Elumelu, 2013) and psychological wellbeing in the 
Netherlands (Aarts et al., 2015).  It has also been associated with: improved QOL among those 
with gastrointestinal cancer in Singapore (Cheng et al., 2012); and, in enhancing the coping 
abilities among Egyptian women with breast cancer (Elsheshtawy, Abo-Elez, Ashour, Farouk, 
& El Zaafarany, 2014).  
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Positive Reframing.     In the survey study, positive reframing (β = .15) also 
significantly contributed to the model of resilience. Positivity, which is reported in the 
literature to foster resilience (Dunn et al., 2011; Gartland et al., 2011; Ho et al., 2011), refers to 
a stable personality trait where an individual has a generalized expectation that the future will 
be positive, even when negative events occur (Pieters, 2015; Scheier & Carver, 1985). 
However, these results are not fully consistent with the earlier interview findings during Phase 
One, or concur conclusively with previous research, which has produced mixed findings. For 
example, the results of the survey study differ from earlier research carried out by Bowen, 
Morasca, and Meischke (2003), who stated that optimism was not correlated to any of the 
variables they used to compose their resilience scale.  
According to McGrath et al. (2006), research on positive reframing in cancer focuses 
on two broad hypotheses. First, ‘medical research’ proposes that positivity increases the 
likelihood of a better outcome. Yet, there is no clinical evidence that positive thinking affects 
the progress or outcome of illness by preventing or curing cancer. However, positivity may 
assist to maintain hope and protect cancer survivors from emotional pain and negativity (Youll 
& Meekosha, 2015). For example, an earlier study involving breast cancer survivors, who 
were on average cancer-free for nine years, reported that 60% of women credited their lack of 
recurrence to positive reframing, yet only 4% attributed this the use of tamoxifen6 (Stewart et 
al., 2001). Second, ‘social research’ maintains that a positive attitude enables cancer survivors 
to cope better with treatment and the illness experience (Youll & Meekosha, 2015). The results 
of this study generally support this perspective, which is shared among other researchers. For 
example, Lepore and Revenson (2006) report that optimists are more likely to demonstrate 
positive outcomes following adversity by positively reframing negative life events, adopting 
new and more adaptive world-views and by more readily eliciting social support resources. 
Likewise, in more recent research involving gynaecological cancer survivors in the USA (n = 
281), it was found that positive reframing functioned as a mediator in the association between 
resilience and QOL (Manne et al., 2015).  
However, although the survey respondents reported positive reframing as influential in 
building resilience, the interview results do not fully support these findings. Although the 
participants involved in the interviews discussed their optimism, several also commented about 
the ongoing challenge associated with the expectations of others to consistently remain 
positive. Similar results have been discussed in previous research in which the burden 
associated with maintaining ‘fighting spirit’ (Knott et al., 2012), or remaining positive can lead 
to further stress and anxiety (Folkman, 2010; McGrath, 2004). Therefore, although positive 
reframing was significantly related to resilience in Phase Two (quantitative), this was not as 																																																								6		Tamoxifen is a medication prescribed to women for the prevention and treatment of breast cancer 
which blocks the actions of estrogen  
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apparent during Phase One (qualitative). Rather, the earlier interview data analyses suggest 
that, although positive reframing is widely advocated and encouraged among those with 
serious illness (Youll & Meekosha, 2015), it is also important to be aware of the moral 
pressure societies place on individuals to maintain positivity. As Ehrenreich (2009) 
emphasizes “failure to think positively can weigh on cancer patients like a second disease” (p. 
43). Thus, as a community we need to consider that positivity is not a given, but rather a 
process dependent on the changing circumstances of the person.  
Social Support.     One of the most influential resources available to cancer survivors 
is social support, which has been documented across several studies to have a major influence 
on an individual’s resilience and psychological well-being (Hjemdal, et al., 2006; McCabe & 
Cronin, 2011; Ozbay et al., 2007). Social support refers to the real or perceived resources 
received through social interactions with others that enable an individual to feel valued and 
respected (Galván, Buki, & Garcés, 2009). Confirming previous research, social support in 
both phases of this study was found to contribute positively to resilience. More specifically, 
within the survey study results, family support was the most influential variable within the 
model (β = .33), followed closely by friend support (β = .22). Zebrack (2011) similarly 
identified family support and cohesiveness as the most central contributors to positive 
adjustment among adolescents and young adults. Family and friends are viewed as also a 
major source of support for cancer patients in other age cohorts (Gatchel et al., 2007; Hjemdal, 
et al., 2006; McCabe & Cronin, 2011).  
In a systematic review involving those with physical illness, including cancer, Stewart 
and Yuen (2011) highlighted that social support was predictive of various aspects of resilience 
in several studies. In addition, the support from family and friends has been recognized as 
being crucial in: enabling individuals to cope with the challenges of illness (McCabe & 
Cronin, 2011; Yu et al., 2008); improving self-care (Park et al., 2008); encouraging treatment 
adherence (Magai, Consedine, Neugut, & Hershman, 2007; McCabe & Cronin, 2011); 
enhancing emotional expression, self-control and confidence (Wills & O’Carroll Bantum, 
2012); and, boosting self-efficacy (Monsivais, 2005). The beneficial effect of social support 
has also been reported in several other studies to positively correlate with improved emotional 
and psychological QOL among HC patients (Lim & Zebrack, 2006; Korszun et al., 2014; 
Santos et al., 2006).  
Conversely, a lack of social support has been widely recognized as a risk factor for 
psychological illness (Korszun et al., 2014; Parker et al., 2003) and increased mortality 
(Kroenke et al., 2012). In addition, a recent systematic review reported that a lack of social 
support affected QOL in HC patients (Allart et al., 2013). This is supported by previous 
research highlighting that ineffective social support within interpersonal relationships can lead 
to negative outcomes, such as increasing a survivor’s feeling of isolation (Landmark, 
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Strandmark, & Wahl, 2002). As mentioned previously, research by Parker et al. (2003) 
recommend that assessing patients’ levels of social support is possibly the most accurate way 
to identify those patients most prone to anxiety, depression or distress following the diagnosis 
and treatment of cancer. 
It has been reported that some cancer survivors find it difficult to receive appropriate 
support from family or friends, as significant people in their lives often became distressed 
while discussing their cancer diagnosis and are unable to remain objective (Rabin et al., 2011). 
In such situations, cancer survivors rely on support from their clinical team and community 
support groups that provide an environment in which they are more able to normalize their 
experience (Rabin et al., 2011). Although support from HCP’s did not appear in the model, it 
did show a positive relationship with resilience in this study, suggesting that HCP’s also play 
an important role. Therefore, it is critical that clinicians not only consider the social resources 
that cancer patients have available when exploring differential responses to disease 
management but also recognize their responsibility in providing support.  
Exercise.     Another factor in this study that significantly predicted resilience is 
exercise (β = .15). This supports the results from Phase One and previous research asserting 
that engaging in physical exercise is one of the best prescriptions to reduce the side-effects of 
cancer treatment (Cormie et al., 2015; Singh et al., 2015). Decades of research have pointed to 
the benefits of exercise in: improving QOL, relaxation, sleep and self-esteem levels (James et 
al., 2011); reducing cancer re-occurrence (Aziz, 2002; James et al., 2011); and, improving 
psychological distress, fatigue, sexual dysfunction and pain (Cormie et al., 2015; Midtgaard et 
al., 2011; Murphy, 2013). For example, research by Min et al. (2013) proposes that physical 
exercise, especially aerobic exercise, is also helpful in enhancing resilience among patients 
with depression and/or anxiety disorders. In addition, recent research has reported on the 
benefits of exercise among adolescents and young adult cancer survivors (Murnane, Gough, 
Thompson, Holland, & Conyers, 2015) and in two exploratory case studies involving female 
patients with brain cancer (Levin et al., 2015).  
However, despite the benefits of exercise, studies suggest that physical activity usually 
decreases significantly after a cancer diagnosis and rarely returns to pre-diagnosis levels (Love 
et al., 2013; Murphy, 2013). In addition, research indicates that more than one-third of 
survivors, considered to be of normal weight prior to diagnosis, tend to be overweight by the 
time treatment ends (Love & Sabiston, 2011). Yet, many cancer survivors are eager to initiate 
changes in their health behaviours when faced with cancer (Gouzman et al., 2015). Thus, 
clinicians have a responsibility to use this as a ‘teachable moment’ to encourage healthy 
lifestyle practices. In situations in which a patient is unable to exercise (i.e., due to treatment 
side-effects or co-morbidities), other positive health behaviour changes should be promoted.  
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The results of this study also identified a significant correlation with other positive 
self-care behaviours, including improving dietary intake, taking care of appearance, taking 
time-out, and seeking alternative/complementary treatments. Cancer survivors would benefit 
from being educated on the importance of lifestyle behaviour changes, not only to assist their 
recovery, but also to potentially reduce the risk of cancer recurring (Murphy & Girot, 2013). 
The results of this study have confirmed that a healthy lifestyle contributes significantly to 
personal resilience, which, in turn, reduces psychological illness. 
Self-blame.     The final factor, and the only negative predictor of resilience, was self-
blame (β = -.22). Respondents who blamed themselves for their cancer diagnosis reported 
significantly lower levels of resilience. Although self-blame was not a factor that emerged 
during Phase One interviews, self-blame has been reported in previous cancer-related literature 
since the 1970’s. Among those with cancer, several factors allegedly contribute to the 
manifestation of self-blame. These may include the type and severity of the diagnosis, whether 
addictive behaviours such as smoking or alcohol use are involved, perceived lifestyle stress, 
the personality style of the individual and whether there is a history of psychological illness 
(Block, Drafter, & Greenwald, 2006). Consequently, self-blame rates vary significantly among 
the cancer survivor population. For example, earlier research among those with head and neck 
cancers has identified that approximately 50% blame themselves for their diagnosis (Block, 
Drafter, & Greenwald, 2006) as opposed to 25% of colorectal survivors (Phelan et al., 2013).  
Self-blame can be either behavioural which is the guilt about one’s behaviour (i.e., 
smoking) or characterological which involves blame about oneself (i.e., belief that you are the 
type who just gets sick) (Janoff-Bulman, 1979). Self-blame is an important issue to address, as 
reportedly both types are highly correlated with depression and anxiety (Block et al., 2006).  
Research in the USA among lung, breast and prostate cancer survivors found that 
respondents who hold internal causal attributions for their cancer report poorer psychological 
outcomes (Else-Quest, Hyde, Schiller, & LoConte, 2009). Likewise, research reports that 
breast cancer survivors (Friedman et al., 2010) and men with colorectal cancer (Phelan et al., 
2013) who blame themselves report poorer QOL and more mood disturbance. A significant 
inverse relationship between self-blame and physical wellbeing is also identified among 237 
mixed-cancer survivors in Nigeria (Asuzu & Elumelu, 2013). 
The survey study highlights that it is imperative that clinicians not only identify those 
cancer survivors who are at risk of experiencing self-blame, but also assist them to normalise 
their psychological distress. A common myth cancer patients adopt is that they must maintain 
a positive outlook in order to cure their cancer. Consequently, this can lead to self-blame when 
their own (normal) shock, anger or fear reactions occur during difficult times. As a society we 
also need to challenge the myth that all negative emotions are harmful. Negative emotions can 
assist to mobilise health behaviour change to lower cancer risks, and to comply with medical 
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patient’s focus shifts from merely getting through treatment, towards a more comprehensive 
view of recovery. It is during this phase of transition that patients often notice a withdrawal of 
support by the healthcare system (Knott et al., 2013). 
Clinical Information. A third question for survey respondents was aimed at 
identifying where the majority of cancer-related information was obtained. A recent study in 
the USA by Goldfarb and Casillas (2014) reported on the unmet information and support needs 
of newly diagnosed young adults with thyroid cancer. Of the 1,113 respondents, more than 
80% rated receiving information about medical or physical matters as very or extremely 
important with 70% also rating emotional/psychological information issues to be very or 
extremely important. Yet, the results suggested that very few recalled receiving any 
information besides that surrounding surgery and treatment. In addition, according to Boyle 
(2006), patients are often consumed with getting through treatment. Therefore, their ability to 
process new information about life following treatment may be limited. Thus, important 
information needs regarding survivorship concerns are largely unmet. However, Marker 
(2015) asserts that cancer survivors wish to understand the complex challenges they could face 
throughout their cancer journey and appreciate effective clinician communication involving 
authenticity and honesty. Numerous other studies have stressed the importance of providing 
relevant cancer-related information. In a study by Rabin et al. (2011), 84% of cancer survivors 
expressed a need for information-based interventions. This view is supported in other research 
stating that cancer patients and their family require informational and educational support, in 
order to cope effectively following diagnosis and treatment (Butow et al., 2011; Adejoh, 
Temilola, & Olayiwola, 2013). A recent systematic review by Swash and colleagues (2014), 
which solely addressed HC survivors, agreed with these findings. 
The majority of survey respondents reported that they sourced most of the necessary 
cancer-related information through specialists. These survey results concur with recent 
research that also emphasized the importance of the clinical team in the delivery of cancer-
related information. A literature review by Rood et al. (2014), found that HC patients 
expressed a high need for medical information and they preferred to receive this 
predominantly from doctors, followed by nurses. In addition, the perceived need for 
information differed strongly between patients. Therefore, in clinical practice more attention is 
required in tailoring the information delivery to the patient by taking into account their coping 
style, support networks, age, sex, diagnosis severity and time since diagnosis (Rood et al., 
2014). 
Several respondents also stated that community support groups, other cancer survivors 
and social media/internet were instrumental in information delivery. Similar findings were 
reported in a large-scale cross-sectional study involving rehabilitating breast cancer survivors 
(n = 465) in Belgium. The most popular sources of cancer-related information and support 
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coping and maintaining resilience. The advice provided by survey respondents was to seek 
support and accept help. The survey respondents shared that processes within the home 
environment, in particular social support, effective communication and cohesion, could 
facilitate resilience in HC survivors.  
Finally, while it was evident that risk and protective processes operated at the 
individual and family level, there were also contributions from community levels.  
Current survey respondents acknowledged that the community surrounding a cancer survivor 
impacts greatly on their survivorship experience. This supports research suggesting that the 
wider community can influence individuals, through either the provision or lack of both human 
and material resources (Gorman-Smith, Henry, & Tolan, 2004; Vanderbilt-Adriance & Shaw, 
2008).  
As previously discussed, positive community influences among HC survivors include 
the accessibility of healthcare services, effective relationships with HCP’s and community 
support (Galván, Buki, & Garcés, 2009). The influence of HCP’s was emphasized by the 
majority of these respondents, who highlighted the importance of effective communication and 
trust in the medical team. In addition, respondents suggested that proactively case managing 
their treatment by being actively involved in the decision-making and seeking second opinions 
when deemed necessary was also valuable. This population of HC survivors also credited 
religious communities, support groups such as the Leukaemia Foundation and the 
internet/social media as assisting their journey following diagnosis. The role of community 
organisations in the support of individuals facing a health adversity has been explored in 
several studies (Badger, Sergrin, & Meek, 2004; Northouse et al., 2005; Zabalegui et al., 
2005). Individuals who participate in community groups are more likely to be resilient, have 
an increased sense of belonging and develop more adaptive skills (Laursen & Birmingham, 
2003). It is apparent from the survey results that community services, including Internet 
information and counselling groups, all form a part of the oncology network that provides 
support for individuals with the cancer. As highlighted, the feedback provided by current 
respondents supports the factors previously identified during the interview phase and previous 
cancer-related literature.  
 
Conclusion – Survey Discussion 
 The main objective of Phase Two was to examine the impact of 24 variables that were 
sourced from the results of Phase One and previous literature on resilience between HC and 
other cancer survivors. These variables included self-distraction, active coping, denial, 
substance use, emotional support, instrumental support, behavioural disengagement, venting, 
positive reframing, planning, humour, acceptance, religion, self blame, social support 
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(significant others, HCP, family and friends), time out, exercise, self-appearance, researching 
information, alternative treatment and diet.  
The results of this survey study indicated that the 24 variables, when combined, 
predicted a substantial amount of variance in resilience among HC survivors. Consistent with 
previous research, active coping, positive reframing, support from family and friends as well 
as exercise were shown to positively impact resilience. Self-blame, a factor that is widely 
discussed in the cancer-related literature, yet not identified in the results of Phase One, was 
found to inhibit a person’s ability to cope and adapt.  
Second, the survey results indicated that higher levels of resilience were associated 
with decreased scores on depression and anxiety. Although, the majority of scores for both 
depression and anxiety fell within the normal range, consistent with recent research, anxiety 
levels were higher than depression levels among this population of HC survivors, and this was 
particularly evident among young adults.  
This study was also interested in understanding which individuals in the clinical team 
provided the most effective support, or lack of, including cancer-related information. The 
results indicate that a collaborative team of HCP’s contribute to supporting cancer survivor. 
However, at times the clinical team were also responsible for a lack of support. The majority 
of cancer-related information was received through specialists, community support groups, 
other cancer survivors and social media/internet.  
This survey study concluded with an open-ended question asking respondents if they 
had any words of advice for newly diagnosed HC patients. The feedback and 
recommendations are consistent with the themes previously discussed in the literature and 
throughout both Phases of this study (Appendix Q).   
 
Study Limitations 
Whilst the current study contributes to the literature concerning psychological 
resilience and HC survivorship, there are also several noteworthy limitations. First, although 
an advantage of this research is that the findings are relevant to a specific context involving 
HC survivors; this also limits the generalizability of the results to other cancer populations. 
The majority of participants were also well-educated, English-speaking, white Australians, 
therefore, generalizations to ethnically diverse cancer survivor populations cannot be assumed. 
The number of non-English speaking, culturally diverse populations are increasing in 
Australia, and, there is evidence to suggest that social class and ethnicity influences health 
outcomes (Butow et al., 2013; Denz-Penhey & Campbell Murdoch, 2008; O’Callaghan et al., 
2016; Ussher, Tim Wong, & Perz, 2011). In addition, the concept of resilience may have 
cultural ramifications as ethnic factors are reported to influence reactions to illness (Denz-
Penhey & Campbell Murdoch, 2008; Stewart & Yuen, 2011). Therefore, it would be 
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advantageous to evaluate personal resiliency among a diverse range of cultures across the 
lifespan in order to understand their unique need. 
In addition, the subjective experiences of these participants may not reflect the 
experiences of other HC survivors who had elected not to participate. In this study, HC 
survivors were either asked to contact the researcher to express their interest in being 
interviewed or asked to complete a survey. Each scenario required a level of motivation, which 
may have deterred many potential participants. Due to the nature of this study, many HC 
survivors may not have felt comfortable discussing their experience. For example, it is 
possible that long-term survivors did not wish to revisit their encounter with cancer. 
Conversely, HC survivors who were actively engaged in the community may have been more 
willingly to share their experience. The low depression and anxiety scores, relative to other 
groups, indicate that the survey sample is likely not particularly representative of all 
individuals with HC.  
Third, many participants were accessed via email, thus the study was to a large extent, 
limited to individuals who had access to the Internet and computer skills. Although 
information letters and survey hard copies were also posted, this was not the preferred 
sampling method and, therefore, those with no computer access were less likely to be informed 
of the study. In addition, participants that were sourced solely from community support 
settings (i.e., the Leukaemia Foundation, Cancer Council) were already in contact with support 
services and may differ as compared to those who are not engaged with community support. 
However, this study attempted to reduce potential sampling bias through recruitment of 
participants from alternative settings such as the Blood Institute and the Harry Perkins 
Research Centre, as well as social media through the use of Facebook. Moreover, an additional 
52 surveys were not included in the total sample of (n =222) as Qualtrics reported these as 
incomplete. A decision was made not to include any incomplete questionnaires, which has 
resulted in a smaller sample of participants.  
This study was also cross-sectional as each participant in this study took part on one 
occasion (at least ten months following their diagnosis). This is a useful starting point, 
however, it means that causal relationships should be cautiously inferred. For example, 
participants may feel differently if their HC relapses. Therefore, how each HC survivor 
interprets their situation may change over time. Longitudinal research involving participants at 
different stages during their survivorship trajectories would enhance our understanding of HC 
survivor adjustment. 
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Study Strengths 
Despite these limitations, this study has provided valuable information, through 
triangulation of data, in an area previously unexplored in great detail. A key strength of this 
research is that it has focused specifically on HC survivors, forming a homogeneous 
population that is understudied (Swash, Hulbert-Williams, & Bramwell, 2014). This research 
used mixed methods to generate both qualitative and quantitative data about the factors 
influencing resilience among both male and female HC survivors of varying ages and stages of 
survivorship. These attributes have allowed the findings of this study to be more generalizable.  
First, the interviews resulted in a wealth of information about the experience of having 
cancer. The value of researching a patient’s personal experience is becoming more widely 
understood in health-related studies. The same researcher undertook all the interviews and 
analyses; this ensured that a uniform approach to interpretation across all 23 interviews. 
Although the coding of study data relied, to some degree, upon subjective interpretation, the 
use of Leximancer data analysis software reduced the potential for subjectivity and/or bias in 
the qualitative study outcomes. 
Second, in order to elaborate findings the questionnaire included a broader spectrum 
of HC survivors from a larger sample of Australian and overseas HC communities. This 
research was conducted through several avenues and resulted in a relatively high participation 
rate. In addition, there was an equal representation of short- and long-term survivors (ranging 
from 1 – 34 years). This gap in the literature needed to be addressed as most previous psycho-
oncology studies have focused on those who have been recently diagnosed (Gouzman et al., 
2015; Swash, Hulbert-Williams, & Bramwell, 2014). Thus, a more definitive conclusion about 
resilience and psychological adjustment of short and long-term survivors was achieved. 
Previous research also reports little mention of the HCP’s roles in enhancing resilience among 
those with chronic illness (Stewart & Yuen, 2011). Consequently, this study attended to this 
gap by including the influence of HCP’s in this study.  
Finally, survivors of rare cancers have reported difficulty in having their voice heard. 
This research attempted to address this limitation by targeting those individuals diagnosed with 
less common types of HC. For example, this study was further enriched by the inclusion of a 
large sample of CML survivors, which is a rare subgroup of HC’s that have been understudied 
in prior survivorship research. 
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findings and previous research were then used in the second phase (Stage 1) to develop and 
pilot a survey instrument.  
Subsequently, in Stage 11, a final questionnaire was used to validate the earlier 
findings among a larger sample of HC survivors. The objective of Phase Two was also to 
examine the relationship between resilience, depression and anxiety. A summation of the key 
findings will now be presented, followed by the implications for theory, policy and clinical 
practice.  
 
Summation of Key Findings 
There are four valuable outcomes that were identified as a result of this study. 
Previous research concurs with the majority of these findings.  However, there are some 
exceptions, which will be highlighted. First, importantly this study has identified that that HC 
survivor population seem to cope remarkably well. Although there are limitations in this study, 
which have been discussed, this result was relatively unexpected, given the challenges 
associated with a HC diagnosis. However, although the majority of depression and anxiety 
scores reported were in the normal range, relative to depression scores, anxiety was found to be 
four times higher among this sample of HC survivors. Previously, depression has dominated in 
the literature, however more recent research (Marker, 2015; Mitchell et al., 2013) has also 
highlighted anxiety as a concern among cancer patients. Therefore, future interventions may 
need to consider targeting anxiety-related issues (i.e., fear of recurrence) among cancer 
survivors.  
 Another key finding relates to the demographic outcomes among this sample of HC 
survivors. These results identified that younger HC survivors (18-39 years) are more 
vulnerable to negative mental health outcomes than older HC survivors (60+ years). In 
addition, those survivors more recently diagnosed (< 5 years) were found to have significantly 
lower resilience scores and higher negative mental health outcomes than long-term survivors 
(+5 years). This suggests that individuals under the age of 40 years, who are within 5 years of 
being diagnosed with HC, may be an ‘at risk’ cohort that is more susceptible to anxiety or 
depression. Similar findings have been reported in the literature. 
 The third important outcome relates to the factors found to influence resilience. 
Twenty-four variables were examined for their influence on resilience among HC survivors. 
The results indicated that the model was successful in predicting resilience, as the combined 
effect of the 24 variables was able to account for a significant 61% of variability in resilience 
scores. The factors that made a unique and significant contribution to the model were active 
coping, positive reframing, self-blame, family support, friend support and exercise. With the 
exception of self-blame, these significant predictor variables were all positively related to 
resilience. In addition, it was found, among this population of HC survivors, that only three of 
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the twenty-four variables (self-distraction, substance abuse and venting), did not significantly 
influence resilience. These factors are comparable to those identified in other cancer 
populations. 
However, there were also mixed results. For example, self-blame is a factor that did 
not emerge during the interviews in Phase One, yet significantly contributed to the model in 
Phase Two as impeding resilience. Previous literature has reported on self-blame as a factor 
influencing cancer survivors. However, this has tended to dominate among other cancer 
populations (i.e., lung and head and neck cancers) in which there has been a higher possibility 
that the individual’s health behaviour may have contributed (i.e., by smoking). There is little 
research discussing self-blame among HC survivors. Nevertheless, the findings in Phase Two, 
reported that self-blame is an influential factor. Therefore, it would be reasonable to propose 
that those HC survivors who blame themselves for their diagnosis, demonstrate reduced 
resilience. Conversely, substance abuse is a factor that was not identified in either phase of this 
study. This implies that, in general, HC survivors do not rely on substances in order to cope, 
which supports previous research among HC survivors. However, this differs from the findings 
among other cancer populations (i.e., liver and lung cancer patients) who report otherwise. 
This is likely due to the fact that substance abuse is not generally referred to in the literature as 
a cause for HC, whereas substance abuse has been identified as a potential cause among many 
other types of cancer.  
The last key finding is that several additional factors identified among other chronic 
illness and cancer populations, but not well identified in HC population research, also 
significantly influenced resilience. The other factors that enhanced resilience, but did not 
make a unique contribution to the model included: emotional support, instrumental support, 
planning, humour, time-out, acceptance, religion, social support (significant others and 
HCP’s), self-care/appearance, researching information, alternative treatments and diet. In 
addition, denial and behavioural disengagement were negatively associated with resilience, 
such that higher scores on these variables were related to lower resilience scores. This has 
important implications for clinicians, because it highlights the flexibility in fostering other 
protective factors. For example, exercise was reported to make a unique contribution to the 
model. However, in situations in which exercise is not possible, other health behaviours (i.e., 
maintaining a healthy diet, alternative therapies and taking time out) may also be helpful in 
enhancing resilience. In addition, many of the existing interventions known to assist other 
cancer populations will likely also be effective among HC survivors, as the majority of factors 
known to influence resilience are similar. These important findings have significant 
implications each of which are outlined below. 
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Significance and Implications for Research, Policy and Practice 
It is becoming clear that the impact of cancer does not end with active therapy. As 
more individuals are surviving cancer, a patient’s longevity is no longer the only focus. 
Therefore, understanding how survivors cope following treatment is also increasingly 
important. This has significant implications for theory, policy and practice.  
 
Theory 
Research that is theoretically informed is vital in order to drive the innovation within 
the survivorship agenda and enhance patient outcomes across the entire journey. Although HC 
patients are living longer, we continue to have a limited understanding of how time influences 
their psychological health status (Aziz, 2009) and resilience (Hall et al., 2013; Schumacher et 
al., 2013). However, if we are to develop effective research priorities related to cancer 
survivorship, there are a number of key considerations that need to be taken into account. For 
example, cancer survivors consist of individuals with varying needs at different points along 
the survivorship trajectory. Thus, in order to acquire a comprehensive understanding, it is 
essential to identify a broader spectrum of psychosocial factors influencing patient’s well-
being that better matches this variability and longitudinality of survivorship. Some of the key 
findings are: the high percentage of survivors identified with anxiety across the survivor 
samples; that younger survivors appeared to experience more distress than older survivors; that 
the research to date appears to encompass the survivor experience fairly well, irrespective of 
cancer type, albeit with some notable exceptions (e.g., self-blame); and, that survivor research 
in other illness populations may have valuable contributions to cancer survivor research. This 
study has contributed to theoretical progress in this area, as detailed in the following 
discussion.  
Resilience. 
First, this study contributed to resilience theory by highlighting the importance of 
modifiable factors that contribute to resilient outcomes and by confirming a number of 
exploratory conclusions about resilience including: a) that resilience involves maintaining 
well-being under adversity including recovery; b) that resilience can be developed and is 
therefore not solely a fixed a trait; c) resilience is impacted by previous experience and 
underlying psychological make-up, yet modifiable factors, such as health behaviour change, 
can facilitate resilience; d) that several multi-level individual, family and community factors 
contribute to personal resiliency; and, e) that in order to be effective, clinical interventions 
need to reflect these dynamic interactions across these different levels, and not merely focus 
on fostering individual strengths. 
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Age-Related Differences. 
Another important finding in this study related to resilience theory was the significant 
difference in resilience and mental health outcomes between younger and older respondents. 
Age-related factors are an important variable to consider, as the literature suggests that the 
impact of cancer and cancer treatment is strongly associated with the patient’s age at the time 
of diagnosis (Aziz, 2003; Northouse, 1994; Zebrack, 2011). However, exactly how age 
impacts on resilience and mental health is still largely unexplained and, therefore, 
interventions are not able to appropriately address this factors influence. Although an 
extensive body of literature exists among young adult survivors of childhood cancer, few 
empirical studies have identified the unique psychosocial issues of those who were diagnosed 
and treated for cancer as young adults (Zebrack, 2011). For several reasons, this age group has 
been described as the "orphaned cohort" in cancer survivorship literature (Hara & Blum, 
2009). In general, young adults are the least represented in clinical trials, and are the cohort 
least likely to be referred to a tertiary care centre (Hara & Blum). Moreover, follow-up care for 
young adults tends to be the most neglected of all cohorts, partly as they are often combined 
with other age groups as part of larger studies (Hara & Blum, 2009). For example, Haase and 
Phillips (2004) refer to a common practice of combining young adults (i.e., 18 - 35 years) with 
either paediatric or older adult populations. This has resulted in a lack of knowledge of the 
cancer experience among young individuals diagnosed in their late teens or early adult years 
(Zebrack, 2011). 
Likewise, age-related factors may also be particularly relevant among older adults, as 
in the future we will observe a significant increase in the number of individuals over 65 years 
of age living with cancer (Bellizzi et al., 2008). Many of these older adults will be in the short-
or long-term survivorship phase following treatment, whilst potentially managing several co- 
morbidities and treatment side-effects. Surprisingly, despite the probability of having more co-
morbidities, the findings of this research suggest that older HC survivors (60+ years) cope 
well. In this study, older survivors reported higher resilience and lower anxiety and depression 
scores when compared with those between 18 - 39 years of age. This may be partly due to the 
experience of overcoming previous adversity during their lifetime, however there are likely to 
be other reasons. Thus, the study of age-related factors among HC survivors provides a fertile 
area of research that may highlight how adults of all ages, perceive and process information in 
order to effectively adjusting to life following treatment.  
Long-term effects. 
In addition, this study incorporated long-term survivors, a neglected aspect of 
resilience theory and research, as the majority of what we understand about cancer 
survivorship to date still centres largely on the time between diagnosis and just 2 years 
following treatment (Aziz, 2003). The long-term psychosocial consequences and adaptability 
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of less common, adult-onset cancers remain poorly documented (Hall et al., 2013; Swash, 
Hulbert-Williams, & Bramwell, 2014). A systematic review by Swash, Hulbert-Williams, and 
Bramwell (2014) in the UK that recently investigated the unmet psychosocial needs in HC 
patients only found two articles (from 14,549 titles identified by the search) that specifically 
included haematology-only samples in the post treatment phase. The first was an Australian 
study by Lobb et al. (2009) that focused on short-term survivors following treatment. The most 
frequently reported unmet need was help to manage concerns about cancer reoccurrence 
(42%), the need for an on-going case manager (33%) and the need to know that doctors 
communicate and coordinate care with each other (31%). The second study by Hammond et al. 
(2008) assessed needs of more long-term HC survivors during the follow-up phase. However, 
this study only focused on the presence of unmet information needs specifically relating to 
fertility and sexual functioning, reporting that, in young people, (61 %) expressed the need for 
more information about fertility issues (cited by Swash, Hulbert-Williams, & Bramwell, 
2014). This current study attempted to address this limitation, however, much remains 
unknown regarding the late or long-term effects of cancer treatment and how to attend to them.  
Patient Advocacy. 
Finally, in terms of resilience theory contributions, two of the six factors that made a 
unique contribution to the model of resilience in the quantitative study were active coping 
strategies and being able to positively reframe the cancer experience. The interviews in Phase 
One also highlighted that, for the many interviewees, one way of positively reframing the 
cancer experience and actively coping was through patient advocacy participation. Assisting 
community support agencies and/or partaking in fundraising initiatives are examples of 
individual patient advocacy. In doing so, advocacy provides a sense of purpose/meaning and 
the belief that, as survivors, they are contributing to making a difference in the lives of others 
with cancer. However, it is important, to highlight that there are differences between consumer 
involvement in decision making, individual advocacy and system level advocacy (e.g. grass 
roots lobbying to improve cancer care/support for everyone). For example, there are 
organisations such as Cancer Voices for patients who are interested in becoming involved in 
system level advocacy.  
More recently, the beneficial role to the survivor themselves, as well as to the research 
endeavour of patient advocates in the evaluation of research submissions is also becoming 
more widely acknowledged. According to Wagstaff (2015), patient advocates consider that 
their involvement in the research decision-making process is paramount to ensure that 
appropriate questions are explored in the correct manner. In 2011, Alessandro Liberati, a 
clinical statistician with multiple myeloma, appealed for a new research governance strategy, 
highlighting the disparity between what patients actually require and the issues researchers 
tend to investigate. For example, topics that are often investigated include matters that are 
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central to pharmaceutical companies and researchers. Yet, inevitably those priorities are not 
always shared by the individuals who are most affected, such as the patients and their clinical 
team. Liberati advocated for redefining the research agenda in the interests of patients, using a 
collaborative process that would include all stakeholders (Wagstaff, 2015).  
Positive steps toward involving patients in research initiatives are underway. In the 
UK, patient advocate involvement has been included the UK’s National Cancer Research 
Institute guidelines (Wagstaff, 2015). In general, the patient advocate’s role is to examine trial 
applications from the patient perspective, ensuring they address relevant questions and are 
sufficiently attractive to patients in order to realise recruitment goals. For example, the purpose 
of the clinical trial has to be clear and reflect the concerns of patients, either for themselves or 
for individuals with similar diagnosis in the future (Wagstaff, 2015). Similar efforts to involve 
patient advocates in research initiatives have begun within Australia. For example, as part of 
the Consumer Involvement in Research Program at Cancer Council NSW, specifically trained 
cancer survivors, patients and carers can represent the community by examining funding 
applications. Following a peer-review process, the patient advocate’s role is to identify 
research submissions that are of most benefit to them as consumers (Miller & Tang, 2015). 
Importantly, cancer not only affects the patient, but can also impact on the emotional balance 
of the family. It is, therefore, essential to also include carers as research advocates. As the 
healthcare system is under constant pressure to discharge cancer patients as soon as possible, 
the responsibility of providing care often falls to family members. This will become especially 
pertinent as we witness an ageing population. Miller and Tang (2015) state that cancer 
survivors and carers should have the opportunity to be the focus of research given their 
personal understanding of the issues confronting those living with cancer.  
Knowledge is power and for many cancer patients, life meaning and finding positives 
from the cancer experience can be achieved by having a voice in the decisions regarding 
cancer survivorship research initiatives. For example, patient advocate and cancer survivor, 
Chapman (2015), expressed his desire that, in the future, every major oncology centre would 
provide a cancer survivor ‘coach’ on staff, to support cancer patients navigate the various 
issues that arise as a result of having cancer. However, for these improvements to occur, a 
change in the research culture is required to acknowledge the full involvement of ‘expert’ 
patients in research. This will take time and commitment from all stakeholders.  
 This study has contributed to theoretical progress in several areas including: the 
concept of resilience, demographic variations (e.g., age-related factors) among HC survivors, 
the long-term effects experienced, and, by highlighting the benefits of participating as a patient 
advocate. However, these research findings also have implications for national and state 
government policy, which will be detailed.  
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Policy 
Research that takes into consideration the relevant national and state policy 
implications is also important, as policy decisions can impact on the healthcare services and 
quality of care that cancer survivors receive. For example, the management of chronic illness 
among an ageing population is one of several major health priorities for government policy. In 
the future, we are faced with not only an increase in the number of individuals living with 
cancer, but also a reduction in the number of people contributing to the workforce. In addition, 
the majority of these cancer survivors will present with numerous other health problems. Data 
from Medicare beneficiaries in the US (patients 65+ years) indicates that 90% of cancer 
patients have at least one other chronic illness and a further 20% of patients will have five or 
more chronic conditions (Koczwara, 2015). A relevant question for government policy is how 
Australia’s healthcare system will manage to deliver effective care to the increasing number of 
those living with chronic illness in the future. Initiating the development of cost-effective 
models of care, promoting community involvement and funding research into rare cancers that 
have a high mortality may assist toward accomplishing this objective.  
Models of Follow-up Care. 
 This research has identified that HC survivors present with diverse needs. For 
example, the result of this study found younger HC survivors to be more at risk of 
experiencing anxiety than older cancer survivors. Therefore, in order to provide a holistic 
healthcare service, the models of follow-up care delivered to HC survivors need to be flexible 
and individualised. This has implications for state and federal policy as we witness an increase 
in the number, and a change in demographics, of those living with cancer. These findings 
concur with Koczwara (2015), who proposes that it is unlikely one model will be effective 
across all settings at all times. It more is probable, that different models will be required to suit 
different contexts.  
There are various models of follow-up care for cancer survivors that have been trialed 
within Australia and overseas. Many of these may include shared care between specialists and 
GPs, nurse-led follow-up clinics and/or one-off consultation by specialist physicians (Brennan 
& Jefford, 2009; Koczwara, 2015). However, currently little data exist on which of these 
models is most useful. In addition, according to Brennan and Jefford (2009), the diversity of 
settings and scenarios create the greatest challenge in successful model development. For 
example, a particular model may work within one specific context (e.g., clinical team, cancer 
type, patient demographic and geographical area, etc.) but may be unsuitable in another 
setting. One suggestion offered by Brennan and Jefford (2009) is the inclusion of general 
practitioner specialists. As providers of continuous care throughout an individual’s life, 
general medical practitioners are ideally placed to oversee long-term cancer survivorship 
issues. However, their specific role would require further investigation as specialized medical 
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practitioners may not be suitable for all patients (Brennan & Jefford, 2009).  
The emerging movement to improve follow-up care models among Australian cancer 
survivors is well underway. In 2012, the Clinical Oncology Society of Australia (COSA) 
established a Cancer Survivorship Group to address the concerns of not only survivors, but 
also their caregivers and HCP’s regarding the challenges of delivering patient-centred high-
quality care (Dhillon, 2015). More recently, COSA led a national discussion among its 
members regarding a model of survivorship care most suitable for the Australian healthcare 
system. COSA’s Model of Survivorship Care, which was launched at a recent Australian 
conference, is now in the process of evaluation (Dhillon, 2015).  
In addition, a recent article published in The West Australian newspaper, highlighted a 
newly established Survivorship collaborative set up by the WA Cancer and Palliative Care 
Network, which will investigate the development and implementation of care plans in order to 
optimise each patient’s long-term health (Rasdien, 2015). According to Christobel Saunders, 
collaborative member and Winthrop Professor of surgical oncology at the University of 
Western Australia, deliberations are under way to open clinics, initially, for breast cancer 
patients in two major Perth hospitals. The purpose is to ensure patients receive the opportunity 
for an ‘exit interview’ with their clinical team. The main aim is to enable survivors to improve 
their overall health and wellbeing when active treatment ends, stating, “we should use that 
brush with health services as a chance to do preventative treatment not just as a response to 
illness” (p.2). According to Professor Saunders, implementing such models also has potential 
implications for state policy in terms of reducing health service costs suggesting that “if you 
can try to get people back into a healthy frame of mind and take care of their own health 
afterwards then ultimately we will be saving a lot of money for our health services in the 
future and doing people good” (Rasdien, 2015, p.2).  
Community and Not-For-Profit Involvement. 
Another important finding in this research was the beneficial influence for HC 
survivors of community and non-for-profit agencies. Community agencies not only provided 
support to HC survivors and their families, but also advocated for public health initiatives to 
improve cancer survival and potentially lower the incidence of cancer diagnoses. For instance, 
over the last ten years, the Cancer Council NSW has encouraged cancer survivors to become 
actively involved by sharing their personal narratives, in order to generate policy change. 
Through the CanAct community campaigns, cancer survivors have achieved policy reform in 
areas such as: increased funding for bowel cancer screening; increases to subsidy rates; 
patient-assisted transport; smoke-free legislation; and, the prohibition of tobacco displays in 
shops (Miller & Tang, 2015). More recent efforts are also evident, for example the Cancer 
Council of Western Australia (WA) has enlisted 50,000 patients and supporters to address 
important cancer issues, such as healthcare staff deficiencies, as an election priority. WA 
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Cancer Council president Christobel Saunders expects there will be powerful community 
support for priorities identified stating that, “it is estimated there are also more than 75,000 
people in WA living with cancer” and “with almost 11,000 West Australians diagnosed with 
cancer a year, this translates to many thousands more family, friends and colleagues who are 
also impacted” (O’Leary, 2015 p. 4). 
Patient survivors who have a vision of survivorship care and involvement within the 
community can be a positive experience for cancer survivors, which was evident in the results 
of the current study. However, few HC survivors are prepared to participate in consumer 
advocacy roles that highlight several areas of improvement for policy makers. Some of the 
barriers preventing community and patient involvement include a lack of confidence, training, 
financial reimbursement and awareness regarding survivor led initiatives (Marker, 2015). 
However, cancer survivors and their families are a valuable source of ideas and knowledge 
about survivorship, including the solutions we as a society face in the future.  Therefore, 
community and consumer engagement is imperative, this also includes health disciplines that 
traditionally had less involvement outside their own area of expertise, but are essential if we 
are to address the healthcare challenges of cancer survivors.  
Unified Theory/Research Agenda for Rare Cancers.  
The common themes persisting throughout the literature, including this study, are the 
need for unified research of rare cancers, including HC. One particular issue raised by current 
participants was the need for more cancer-related information. This was particularly evident 
among those with more rare types of HC (i.e., CML). More specifically, the HC survivors in 
this research, highly valued being fully informed about advances in new treatment regimens 
for their specific diagnosis. This information provided a sense of control, helped these 
individuals to plan ahead and also facilitated acceptance. However, providing patients with up-
to-date cancer-related information on every type of HC can be challenging. Blood cancers are 
noticeably heterogeneous, with over 35 subtypes of non-Hodgkin lymphoma, 35 subtypes of 
acute leukaemia’s and six subtypes of Hodgkin lymphoma currently documented (Chew & 
Roberts, 2015). While HCs account for approximately one-sixth of all cancer diagnoses 
(excluding skin cancers), each individual subtype of HC is rare.  
This study has highlighted that a lack of cancer-related information may impede 
resilience among the HC survivor population, potentially impacting on their QOL. However, 
experts within the cancer survivorship field have acknowledged that there is less information 
available on rare cancers and are making progress toward addressing this research gap. For 
example, a support program has been provided by a charity called Rare Cancers Australia, 
whose aim is to increase awareness and provide support to Australian patients and their 
families with rare and less common cancers (Ananda & Scott; 2015). In addition, in Western 
Australia, many cancer survivors are participating in one of the world’s largest studies run by 
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the Cancer Council of Victoria of ‘forgotten cancers’. The aim is to recruit 15,000 individuals 
nationally, comprising leukaemia, pancreatic and brain cancer patients, to explore the causes 
of less common cancers (O’Leary, 2015). This is important, as, although these cancers are 
considered rare, they account for over half of all cancer deaths. According to researcher Fiona 
Bruinsma, “historically research dollars have been spent on the five most common cancers, 
which is reasonable given the number of people affected, but while they account for 54% of 
diagnoses, they are only responsible for 46% of cancer deaths” (O’Leary, 2015, p.4). Thus, to 
date, and due to their low profile, less common cancers have tended to miss out on the 
majority of research and funding. 
 According to Swash, Hulbert-Williams, and Bramwell (2014), given the inadequate 
evidence concerning patient needs among those with blood cancers, more research is required 
to establish the most suitable approach to the assessment and care of this patient group. 
Consequently, this has implications regarding the government policy on research funding 
allocations, which requires a more fair and equal distribution among all cancers. If government 
policy is to address the diversity among the increasing numbers of cancer survivors, together 
with workforce reduction issues, much effort is required. This includes paying attention to the 
lack of information available (i.e., treatment options) about less common cancers. On a 
national policy level, as Michal Jefford the Australian Cancer Survivorship Centre Director, 
stated, “there are gaps and there are barriers and, if we have a greater push for much better care 
and much more attention to the post-treatment phase, we will be able to see things improve 
further” (Rasdien, 2015, p.2).  
 
Practice  
Finally, this study identified many factors that are important to HC survivors, yet the 
results also highlighted a disparity between what is beneficial for cancer patients and what 
actually occurs in clinical practice. For example, although psychosocial interventions by 
clinicians are widely recommended, many participants in this study felt abandoned stating that 
their psychological needs were not always met by the healthcare system following treatment. 
Participants expressed that they had health-related concerns, but did always know whom to ask 
or where to find help. Addressing this gap will not only improve the quality of care, but also 
assist to normalise psychosocial service use and facilitate the breakdown other attitudinal 
barriers. HCP’s working with cancer survivors should to be aware of the type of psychosocial 
needs most commonly experienced by their patients. This may be achieved through: effective 
therapeutic relationships; appropriate screening and assessment; timely interventions; and, 
relevant referrals to other allied HCP’s by clinicians. The practical implications of these 
interventions, each of which will be discussed, will assist HC survivors enjoy improved QOL, 
rather than just living longer. 
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Clinician’s Therapeutic Relationship.  
First, according to the literature and the participants in this research, the ability of 
clinicians to empathize and connect with patients is perceived as a vital aspect of holistic care. 
One of the most important contributions clinicians can provide their HC patients is the gift of 
understanding (Munhall, 1994). By communicating an understanding of the lived experience 
of a cancer diagnosis, clinicians can portray a sense of empathy (perceive and communicate 
understanding of the meanings and feelings of another person). For example, providing 
reassurance, listening actively to fears and concerns, asking about the patient’s emotional 
status, and, being sensitive, hopeful, yet remaining honest, will assist in maintaining an 
effective therapeutic relationship. Likewise, respondents in this research also highlighted an 
appreciation of clinicians who were able to respond with humour. When initiated by the 
patient, humour was one of many factors considered to be an invaluable form of emotional 
support. Therefore, having a sense of what it is like to experience a HC diagnosis can help 
each clinician build a stronger therapeutic relationship.  
However, there are many healthcare system deficiencies, one of which is the lack of 
resources and time available for patient appointments. It can, therefore, be challenging for 
clinicians to provide holistic patient-centred care. Yet, according to Miller and Tang (2015), 
HCP’s are very influential advocates for patients. Therefore, despite the healthcare system 
inadequacies, each clinician should challenge himself or herself to bring about improvements 
within their own healthcare setting. One way this may be achieved is through the recognition 
of their interpersonal strengths and weaknesses and by participating in ongoing professional 
development. Even among busy healthcare settings, clinicians can reduce stress and learning 
how to best assist patients by appropriately attending to their needs.  
Screening and Assessment. 
Second, in terms of practical implications, this study also highlighted the importance 
of effective and timely patient screening and assessment. This is essential as many 
psychosocial health concerns experienced by cancer patients are not identified by clinicians 
and remain untreated (Butow et al., 2015; Girgis, Delaney, & Miller, 2015). For instance, 
research has shown that cancer patients experience more distress at the completion of active 
treatment, a point in time when expected routines end, placing patients in a position of 
uncertainty (Knott et al., 2012). Therefore, a useful time to ask patients about coping is before 
they enter the next phase following treatment. 
The findings of this research invite a more systematic approach in clinical assessment 
and follow-up that screens for anxiety, rather than just depression. Questions such as, “How 
much time do you spend worrying about your cancer?’’ and “What helps you to best cope or 
not?” may also assist clinicians to better recognize what support each HC survivor requires. 
Considering these questions, in conjunction with an awareness of when distress is most likely 
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to occur for cancer survivors, will ultimately improve patient care. These findings are 
consistent with recent Australian research among adult cancer patients that investigated a 
clinical pathway, developed for the screening, assessment and management of anxiety and 
depression to improve quality of care. This study by Butow et al. (2015), involved reviewing 
existing guidelines, structured interviews with 12 multidisciplanary staff, an online Delphi 
process including two rounds of feedback from 87 Psycho-Oncology Co-operative Research 
Group stakeholders, and input from a expert advisory panel. The results recommended that a 
formalized stepped care model should be included for all cancer patients, at key points along 
their survivorship trajectory, to screen for anxiety/depression. It was also suggested that if 
anxiety and/or depression is detected, the assessment, referral and follow-up care of cancer 
patients should be co-ordinated by one member of the treating team, taking into account 
patient preference (Butow et al., 2015). As discussed by Butow et al. (2015), using appropriate 
assessment tools is one way of identifying psychologically vulnerable patients early in the 
treatment process. Assessment tools are valuable as they can highlight the need for more 
timely provision of emotional support and other relevant psychosocial interventions. 
Patient Assessment Tools.  
A vital step toward achieving patient-centred care is through the use of survivorship 
care plans (SCP’s). In general, SCP’s consist of a treatment summary, follow-up care plan and 
communication tools to promote patient education, treatment compliance and long-term health 
management. However, since the introduction of SCP’s a decade ago, there has been limited 
success in their implementation by clinicians due to several barriers. Some of these include the 
time required to complete a SCP, absence of role clarity and co-ordination between HCP’s and 
the lack of financial reimbursement for preparation time (Mayer et al., 2014). The above 
obstacles, identified through research evaluations by the American Society of Clinical 
Oncology (ASCO) members, resulted in the issue of a new SCP template that is easy to 
complete, takes less time and is more focused on critical patient information (Mayer et al., 
2014). This highlights the necessity for clinicians to regularly evaluate existing care plans in 
order to gauge their effectiveness. Research that evaluates assessment tools may also help to 
develop a more accurate and systematic responses by clinicians to the crucial needs of 
individual patients. Moreover, future research into cancer-specific templates and support tools 
may be considered to better understand the benefits of SCP’s in providing individualised 
quality care for cancer survivors. 
In addition to the face-to-face implementation of paper-based SCP’s between patients 
and clinicians, evaluating the effectiveness of other assessment delivery methods is also 
beneficial. For example, in order to capture those cancer survivors with fewer socioeconomic 
resources and physical limitations such as those in remote communities, interventions need to 
be cost-effective and portable (i.e., Internet or telephone-based). Within Australia, in NSW, an 
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ehealth system is being piloted which supports Electronic Patient Reported Outcomes (ePRO). 
According to Girgis, Delaney, and Miller (2015), ePRO’s: can be delivered in a range of 
languages; provide automated scoring; and, produce real-time feedback reports to clinicians 
and enable access to resources that assist survivors to better manage their own health 
behaviour. Thus, in certain situations, ePro’s are considered to be more effective than paper-
based assessments. However, more research is required to evaluate the effectiveness of 
alternative assessment tools. 
Education and Information Resources. 
Participants in this study also alluded to their informational needs and the lack of 
education provided to them by their clinical team. For example, many participants wanted to 
know more information about their illness, the possibility of recurrence and how to improve 
their health through nutrition, complementary and alternative health services, exercise and 
mental health programs. Public interventions and resources can be improved to help develop 
resilience- building factors highlighted within this study. More specifically, strategies that help 
increase healthy behaviour choices may be of particular importance. An effective way to 
establish this might be through education packages that ideally comprise individually-tailored 
information based on a thorough assessment of survivors’ educational needs. A theme that 
surfaced when participants discussed programs designed for cancer survivors was the 
importance of similarity (i.e., age, diagnosis, gender, treatment history, etc.). Likewise, 
although it is challenging to incorporate all participants’ preferences, programs may be prove 
more appealing if they provide participants with some level of choice in how they achieve 
behaviour change goals. 
The current research also identified the need for HCP’S to not only understand the 
resources their patients use, but also where they source this information and whether it is 
reliable and readily accessible. The 2006 IOM report noted that in order to meet the needs of 
all individuals, survivorship information should be available in a wide variety of formats (face-
to-face, audio, video, print, Internet, radio, and telephone). For example, Web-based programs 
may be particularly attractive to young adults, as this demographic is generally very 
accustomed to using Internet technology. However, the challenge will be accomplishing this in 
an all-inclusive and cost-effective manner. To achieve this, more thorough trials of educational 
interventions are needed, with larger sample sizes and longer follow-up assessments.  
Health Behaviour Change. 
The current findings suggest that the majority of HC survivors make conscious steps 
toward positive health behaviours (exercise, diet, self-care, etc.), re-evaluate what is important 
to them and attempt to find purpose in their lives. Of interest is why it takes a health crisis for 
these changes to occur? Specifically, health behaviour change, following a cancer diagnosis,  
is a relatively new area of investigation, which has implications for clinical practice. 
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According to several studies (Bellizzi et al., 2008; Cormie et al., 2015; Murphy, 2013), due to 
lack of research, clinicians have a limited understanding of the most effective approaches to 
health behaviour modification; including: (1) the ideal delivery method for behavioural 
interventions (i.e., couples, group, individual home-based or community based, etc.); (2) the 
most effectual frequency, mode and duration for behavioural interventions; (3) the most 
beneficial types of behavioural interventions (i.e., traditional western or alternative 
interventions); and, (4) the HCP’s who are best qualified to deliver the health behaviour 
change interventions (e.g., psychologists, dieticians, nurses, exercise physiologists, etc.). 
Specifically, exercise was found to make a unique contribution to the model of 
resilience in this study. This has important implications, as, despite endorsement from major 
cancer organisations and the findings from previous research, the majority of Australian cancer 
survivors are not achieving adequate levels of physical activity (Cormie et al., 2015). Survivor-
led exercise programs can offer insights into addressing this challenge. However, our current 
health system is not fully coordinated or prepared to manage all of the allied health systems 
required to assist cancer survivors initiate health behaviour change (Marker, 2015). For 
example, more effective referral pathways need to be established. 
Referral Intentions. 
The insight of this thesis provides clinicians with knowledge regarding the experience 
of cancer survivorship and the need for support not only at the time of diagnosis and during 
treatment but for many years afterwards. Thus, the current results also have implications for 
other allied health practitioners, working with HC survivors across the survivorship trajectory. 
Although the literature reports on the importance of allied healthcare providers, for several 
reasons many clinicians/specialists are not adequately referring to these services. Some of 
these reasons include a lack of time and awareness of the allied healthcare services available. 
Yet, the present findings concur with the literature, recognizing that many HC survivors would 
have found it helpful to attend other available allied healthcare services (i.e., psychologist, 
dietician, exercise physiologist, etc.). Therefore, more effective strategies are required by 
clinicians to ensure that appropriate referrals to the ‘right professional at the right time’ are 
provided. 
Psychological Interventions.  This study has indicated several areas that are 
relevant to psychologists working therapeutically with individuals. For example, depression 
anxiety and stress are disorders that psychologists are skilled at assessing, monitoring, and 
treating. More specifically, addressing the fear of recurrence and uncertainty associated with a 
cancer diagnosis is of particular interest within psycho-oncology. For example, according to 
Butow, Fardell, and Smith (2015), there are currently at least two registered research 
interventions underway in Australia that are delivered by psychologists and psychiatrists, that 
specifically focus on the fear of cancer recurrence. The first is a multi-centre randomised trial 
RESILIENCE IN HC SURVIVORS 253	
comparing a psychological intervention titled ‘Conquer Fear’ to relaxation training for cancer 
patients. The second is also a randomised trial, but compares a psycho-educational intervention 
among melanoma patients to the current standard care.  
Although such interventions to reduce fear, anxiety, distress, and depression are 
important, this study has shown that it is also beneficial to focus on strengthening positive 
emotions such as resilience, to enhance long-term adjustment and improved QOL. 
Psychological strategies to reduce the focus on negative information, and direct the cancer 
survivor’s attention to positive information would help facilitate emotional wellbeing. 
Individual therapy is a suitable platform to teach coping strategies that strengthen self-efficacy, 
encourages realistic optimism and builds acceptance of negative events that are outside one’s 
control. Strategies can also be put into place to help reduce or eliminate risk factors, such as 
self-blame, and help motivate HC survivors to implement more adaptive coping strategies 
and/or positive health behaviours. This is particularly salient given the negative impact of self-
blame on resilience identified in the current survey study. 
Several psychological treatments (described in more detail in the following 
recommendations section) that may be useful in achieving the above outcomes include 
cognitive behavioural therapy (CBT), acceptance and commitment therapy (ACT), and 
logotherapy. Logotherapy, developed by Viktor Frankl, is a well-known therapeutic technique, 
which focuses on improving an individual’s awareness of their personal life meaning, through 
attitude modification (Schulenberg, Hutzell, Nassif, & Rogina, 2013). Logotherapy has an 
extensive clinical evidence base, with research reporting on the effectiveness of logo theapy in 
treating: despair associated with incurable diseases, alcoholism, depression, anxiety, psychosis, 
aging, rehabilitation, family therapy, work-related stress and relationship counselling 
(Batthyany & Guttmann, 2006; Schulenberg et al., 2013). Recent research by Ebrahimi, Bahari 
and Zare-Bahramabadi (2014), has also identified that group logotherapy enhanced hope 
among leukaemia patients. A variety of logotherapy tools have been implemented over the 
years, to quantify and study the meaning construct. One example is the The Purpose in Life 
(PIL) test, which is one of the earliest and most widely studied and validated Logotherapy 
measures (Crumbaugh & Maholick, 1964).  
 In addition, relaxation therapies such as mindfulness techniques are also reported in 
the literature to benefit cancer survivors. A recent Australian study reported that mindfulness 
based interventions effectively increased QOL including spiritual wellbeing, and reduced 
psychological distress in cancer survivors and carers (Fish, Ettridge, Sharplin, Hancock, & 
Knott, 2014). Furthermore, according to a recent article in The West Australian newspaper 
(Health and Medicine), a mindfulness program has assisted Elaine Burtneshaw a lymphoma 
survivor to achieve a sense of peace (Rasdien, 2015b). Ms Burtneshaw stated that “…cancer 
unfortunately is going to be with me for the rest of my life now, so l had to find an equilibrium 
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and have my mind rested…mindfulness restores balance and allows you to get perspective in 
life, because we let our thoughts get away from us, we catastrophize everything and before you 
know it we have got ourselves in a real state” (p. 3). Ms Burtneshaw maintains that 
mindfulness has been a valuable tool in overcoming numerous obstacles in her life following 
cancer (Rasdien, 2015b). 
In summary, psychologists are well positioned to help to normalize and validate the 
cancer experience by dedicating time to explore these factors. This research has provided 
important contributions, as understanding how survivors cope will assist psychologists to 
develop more effective strategies and therapeutic interventions (i.e., health promotion). This 
will help to build personal resilience and assist each HC survivor to maintain or at least work 
toward a healthy well-being. 
 
Conclusion – Theory, Policy and Practice 
Greater knowledge regarding risk and protective factors within the context of HC 
survivors has been provided by this study, with findings contributing to theory, policy and 
practise. Based on an understanding of the factors that usually enhance resilience and how 
each patient has successfully dealt with severe stress in the past, each clinician can learn to 
reinforce optimal responses to adversity. For example, clinicians may be able to identify 
protective or risk characteristics (e.g., purpose in life, lack of purpose) and then facilitate 
coping by responding appropriately to the individual needs of each survivor. This could be as 
simple as expressing concern, providing information, helping with problem solving or 
referring on to other more suitable services. This therapeutic approach pertains to all cancer 
patients at any stage, as this research has identified that the characteristics and outcomes of 
resilience, are relatively similar across all cancer types throughout all phases of the cancer 
trajectory. 
Given the number of people who will be diagnosed with cancer in their lifetime, and if 
health system reform is to be effective, improving cancer survivorship must be a common goal 
throughout the healthcare system. When HCP’s isolate survivorship in various stages, for 
which someone else is accountable, we miss opportunities to improve the care of cancer 
patients. Therefore, initiating the discussion between all HCP’s, consumer groups, cancer 
support agencies, government bodies and individuals affected by cancer has the potential to 
have a notable impact on cancer-related care. Moving forward, more efficient targeting and 
provision of clinical services that meet these needs should be deemed as a key objective for 
healthcare services in the future. However, due to the limited research evidence relating to 
needs of HC survivors long-term, more investigation is necessary. The next section will 
outline a number of these beneficial areas for future research. The final section of this thesis, 
will propose several recommendations that are based on the findings of this study. 
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Future Research 
As more individuals survive cancer, greater consideration is being given to QOL 
outcomes and how people adapt to this chronic disease. The knowledge gained from this study 
has improved our understanding of the patient experience of living with HC and highlighted 
resiliency factors that may improve psychological wellbeing. Yet, the findings raise further 
questions regarding psychological adjustment and the conditions under which resilience occurs 
in those with cancer. Consequently, there are several worthwhile directions for future research.  
First, the current study only recruited a small number of rural HC survivors and, 
therefore, did not provide a clear understanding of this sample of individuals. A cancer 
survivor’s geographical location can limit access to support, with those living in remote areas 
reportedly experiencing greater unmet needs and poorer outcomes (Hutchinson et al., 2011; 
Marker, 2015). Thus, further research recruiting from rural areas is recommended.  
This study also targeted an adult population and those under 18 years of age were 
excluded from this sample. Data on adolescents and children could have identified other 
distinctive coping styles and risk factors. For example, the ability of a younger HC survivor to 
implement internal coping strategies may be limited, as they may not have the same learned 
experience as an older survivor. Conversely, as we have an ageing population in Australia and 
the burden of disease is increasing, more thorough research among older adults would be 
valuable. Older adults may experience additional challenges as the long-term effects of cancer 
often coexist along with co-morbid health problems associated with aging. This is also 
important, as cancer is predominantly a disease of the elderly, with 70% of diagnoses in those 
over 60 years of age (AIHW, 2014). Thus, it is essential to identify subgroups of older cancer 
survivors at greatest risk, such as those who have low social support, poor functioning or 
whom require aggressive treatment.  
In addition, larger sample sizes, that include a much wider diversity of respondents, 
are necessary if a more complete and thorough understanding of the experience of HC is to be 
obtained. For example, stigma around a cancer diagnosis can be an influential barrier in some 
communities such as indigenous populations. Therefore, it is important to consider not only 
the patient’s life stage, but also cultural differences and variables that may affect how people 
utilise internal and external resources. The ethnic profile of survivors will change, as 
Australian society becomes a more heterogeneous cultural mix. Different recruitment methods 
through improved design development could be employed in order to capture minority ethnic 
or low socioeconomic groups, including those individuals with lower education levels or those 
who are not proficient in the English language. This is imperative as culturally prescribed 
norms may affect the availability of family support, health-seeking behaviour and self-care 
practices.  
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Fourth, this study focused on survivors, therefore the perspective of others, such as 
HCP’s, community organisations or carers were not included. It is imperative that cancer 
survivors are included early in the research process so that the collected data deliver a 
meaningful direction to prevention and intervention plans. Yet, studies of resilience among 
significant others may be beneficial and would further inform this population, particularly 
given the findings on the importance of social support. Diverse contexts create varying needs 
and the impact of risks and protective processes are dependent on these contexts. Therefore, 
future research should examine not only the cancer survivor’s experience, but also include 
other significant parties involved in the patient’s journey.  
In addition, while survivors in this study were classified in psychosocial terms as 
being in the extended and permanent phases of survival, data on specific disease stage were 
not available. It is likely that resilient outcomes and or psychological needs differ according to 
disease stage. In future studies, the examination of the relationship between stage of cancer 
and levels of distress will provide a deeper perspective. This is important, as research suggests 
that psychosocial needs are not being met adequately for those who are in the advanced stages 
of cancer, but have not yet reached the palliative care phase (Maher & Fenlon, 2010). 
Moreover, prospective cohort studies that have the potential to follow patients throughout the 
diagnostic, treatment and recovery phases, would add further valuable knowledge as to the 
antecedents of a resilient outcome and provide valuable information as to whether ‘resilience’ 
fluctuates or varies throughout these stages. 
Finally, in the evolving cancer survivorship environment, ensuring that care is holistic, 
cost effective, evidence-based and adaptable to different health settings remains an ongoing 
challenge. Yet, delivering quality care to cancer survivors is not simply about effective 
medical treatment, but rather improving overall QOL through effective healthcare initiatives. 
Future research involving the effort of experts within diverse interdisciplinary teams will be of 
benefit, given the challenges and complexity facing cancer survivorship care. 
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Recommendations 
Based on the current research findings, the following recommendations are proposed. 
These recommendations have been categorised according to their relevance for state/federal 
policy, employers, HC survivors, community support networks and the clinical team, with 
particular reference to psychologists. 
 
State/Federal Policy 
 The field of cancer survivorship has evolved due to the combined international and 
Australian endeavours involving researchers, survivor advocates and HCP’s. The incentive to 
attend to the needs of the increasing cancer survivor population has in part motivated these 
initiatives. Lobbying the federal and state government may achieve supportive government 
responses. The following recommendations directed at federal and state policy could further 
enhance research in the area of cancer survivorship.  
• Promote national advocacy 
o Guiding public policy decisions involving cancer care (i.e., by providing links 
and information online for HC survivors to be informed about national public 
policy) 
• Increase public awareness 
o Available resources for cancer survivors via several avenues (i.e., healthcare 
literature, media, online) 
o Relevant issues faced by HC survivors and their families in Australia  
• Provide relevant information and resources available to rural communities 
o To overcome the unique issues faced by these individuals by improving 
referral pathways and communication between healthcare providers  
• Greater improvement in the access to care such as: 
o Counselling and allied healthcare services  
o Respite care  
o Financial assistance for those experiencing difficulty 
• Evaluate existing funding policies to assess their effectiveness, for example: 
o Conducting a review of current cancer survivor entitlements and assessing the 
suitability of these payments 
o The flexibility in accessing financial government funding and how this can be 
most effectively utilised 
• Promote ongoing research to evaluate and improve the development and testing of 
various survivorship care models  
o Re-evaluate funding allocation for rarer cancers 
Employer/Organisations 
Greater assistance by employers could alleviate some of the stress and anxiety 
associated with returning to work.  However, initiating changes in the workplace remains a 
challenge. Many organisations have an emphasis on productivity and are dealing with cost 
cutting. Yet, the findings in this study indicate that returning to work is important for HC 
survivors in their recovery as employment provides an essential source of social and financial 
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support. Therefore, the following initiatives by organisations/employers are recommended to 
benefit HC survivors. 
• Raising awareness is the first step towards improving support 
o Provide training to employers to assist them be more informed as to the needs 
of cancer survivors  
 
• Provide easy access to information on support services and employee entitlements  
 
• Identify barriers that inhibit employers from implementing supportive policies in the 
workplace  
 
• Introduce flexible working hours to assist with:  
o Attending medical appointments  
o Transitioning back into the workforce 
o Increasing employee productivity 
 
HC Survivors 
The challenge for every HC survivor is identifying how to return to everyday life while 
adjusting to the effects of the cancer and its treatment (ASCO, 2014). An important theme 
throughout this study emphasised what HC survivors can do to help themselves in order to 
cope more effectively. As a result of these findings and previous research, there are a several 
recommended coping strategies that survivors can personally employ in order to enhance their 
personal resilience and improve their mental wellbeing.  
 1. Be aware of your emotions – avoid ignoring fear, anxiety and depression as these 
feelings may intensify. Consider:  
• Discussing your concerns with clinical team members 
• Expressing your thoughts in a diary 
o starts a process of self-discovery  
• Blogging/using social media – as a more public forum helps you gather 
information and may also connect you with people with similar diagnoses 
• Joining cancer-related support groups   
• Re-evaluating priorities – exploring what is most important in your life 
• Avoid taking everything personally  
 2. Use alternative resources – some cancer survivors do not find cancer-related support 
groups beneficial. In this scenario consider other coping strategies that may include:  
• Talking with family, friends, religious communities or significant others 
• Consider a referral for individual counselling  
o having regular professional consultation even when life is going well 
will enhance resilience (Rees, 2011).  
• Participate in other enjoyable activities  
• Allow space and time to process 
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3. Self-care - provides a sense of control, reduces the chances of cancer recurrence, and 
improves psychological well-being and QOL. For example:   
• Maintain a healthy diet   
• Do regular and appropriate exercise  
• Get adequate sleep 
• Use community services such as “Look Good....Feel Better” 
o They provide supportive care in appearance i.e., makeup, wigs etc.  
• Limit or cease alcohol consumption, smoking, recreational drug taking 
• Manage your stress  
o Relaxation - meditating, reading, drawing, playing music, yoga, etc.  
o Alternative/Complementary therapies – acupuncture, etc. 
o Know your limitations – learn to say no! 
o Recognising your challenges - know how and when to ask for support  
 4. Effective communication is essential. Question your clinical team regarding: 
• Cancer recurrence –symptoms to watch for, is this likely? 
• Survivorship – additional treatment, role of your healthcare team 
• Long- and short-term side-effects – screening, management, secondary 
cancers 
• Follow-up care plan – who will oversee my care and how often?  
• Emotional wellbeing- ways of dealing with fear, anxiety, uncertainty 
• Spiritual support – available organisations or services  
• Relationships – intimacy, sexuality, parenting  
• Having children – cancer-related fertility issues 
• Employment concerns – planning return to work, work culture, 
privacy/disclosure with co-workers, disability management programs, flexible 
working hours, legal rights 
• Finances – assistance with medical bills, insurance cover 
• Cancer rehabilitation - health behaviour change, available services 
• Allied health support - dietician, psychologist, exercise physiologist, etc. 
 5. Participate as a self-advocate by being an informed healthcare consumer and 
supporting your specific cause. Cancer survivors often aspire to ‘give back’ to the 
community. This can facilitate not only personal recovery but also provide a sense of 
control while supporting others. Personal advocacy can be achieved by: 
 
• Collecting accurate medical information and keeping a personal health record 
o Use a survivorship or follow-up care plan/passport to monitor future 
health and follow-up visits  
• Seek second opinions if necessary 
• Locate and access resources – wigs, scarves, books etc. 
• Take part in and/or facilitate support groups  
• Provide education and awareness to schools, workplaces, social media, etc. 
• Volunteer in fundraising and event planning 
• Participate on committees and speak publicly about survivorship issues 
• Involvement in peer support groups, information sharing and research  
• Collaborate in the design and development of health systems planning 
• Advocate for employment, access to health, insurance and privacy rights  
(ASCO, 2014; Connerty & Knott, 2013; Hoffman & Stovall, 2006; Marker, 2015; Rees, 2011). 
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Community Support Agencies 
  The findings indicated that community-based organisations played a significant role in 
supporting cancer survivors and their families. Cancer councils across Australia have a range 
of community-based services to support cancer survivors, such as access to financial, legal, 
and return to work assistance and emotional support, yet many do not utilise the services 
provided. Community and cancer support networks can also be an essential partner to HCP’s 
by complementing clinical care, throughout survivorship (Dhillon, 2015). According to Miller 
and Tang (2015), the community and not-for-profit sector can be successfully integrated into 
the cancer care team. The following recommendations are proposed in order to improve the 
service delivery and uptake of cancer-related community organisations. 
1. Support the community network 
• In the form of education and counselling for employees and volunteers 
 
2. Engage survivors in the advocacy work of cancer support services   
• Provides a voice on the issues that matter most to cancer survivors  
 
 
3. Facilitate cancer rehabilitation - encourage HC survivors to remain independent, 
productive and regain control over their lives by implementing programs to:  
• Improving physical strength and psychological wellbeing 
• Educate HC survivors on way to become more independent and less reliant on 
caregivers  
 
4. Educational resources and interventions 
• Provide transition education sessions for HC survivors during the last month of 
treatment: - assists cancer patients as they transition from active treatment.  
• Offer multicultural education to:  - cater for cultural diversities - enhance support among those with ethnic differences 	
• Develop a wider variety of educational resources  - to meet the specific needs of cancer survivors and to improve patients’ 
satisfaction with the information they receive (i.e., web-based, one-to-
one contact, telephone service, DVD’s, reading material, etc.)  
• Inform patients on the significance of their family and peer support network  - considered a strong predictor of adjustment and coping. 
• Educate family members and carers of those with cancer - empower carers by providing intervention programs to assist with 
managing cancer-related problems among loved ones. i.e., enhance 
skills that provide ‘invisible support’ so as to avoid enabling learned 
helplessness among cancer survivors (Hou et al., 2010). 
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5. Improve and deliver appropriate cancer-related support programs that take into 
account the following considerations: 
• Clear outline of group aim - i.e., educational or counselling 
• Participant criteria  - offer survivor-matching programs - many cancer patients prefer 
groups with similar diagnosis, gender, ages, time since diagnosis etc. - size of group - cancer patients, carers or family   
• Facilitator experience - i.e., volunteer cancer survivor advocates or qualified professionals 
• Atmosphere/setting and structure - venue, time, frequency 
• Follow- up processes 
• Evaluation  
 
Clinicians and Allied Health Professionals 
The results of this study emphasised the importance of clinicians and allied HCP’s in 
the recovery process of HC survivors. In order to improve the QOL, physical health and 
mental wellbeing among HC survivors, the following recommendations for HCP’s are offered. 
• Effective Interpersonal Skills and Holistic Care  
o When interacting with HC patients: - avoid medical jargon and insensitive remarks  - involve patients in the decision-making process  - provide timely and useful information about your patient’s health in 
an honest, direct, factual, and compassionate manner  - maintain a realistic appreciation of your patient’s situation - respect patient’s concerns  - avoid unwelcome pressure on HC survivors to always be positive  - be optimistic in interactions with patients but do not create false hope  
o Consider the needs of family and carers: - provide clear information to ensure understanding regarding treatment  
      and expected changes (i.e., relationship issues, coping style,  
      autonomy, fear, etc.)	
o A brief conversation may be enough to encourage families, carers and HC 
survivors to initiate action themselves to locate services that support their recovery 
o Contemplate a gradual decrease in support by tapering off appointments, rather 
than suddenly ceasing contact following treatment 
 
• Appropriate Assessments 
o Complete a mental health/distress assessment. Recognising the existence of signs 
of distress is a first step in enabling HCP’s to provide suitable support: - awareness of anxiety and fear experienced, not just at the time of 
diagnosis or during treatment, but also follow up appointments - ask your HC patient, “How are you coping? “What helps you to cope?”  - encourage positive psychosocial outcomes and become familiar with 
methods of adaptation most likely to foster positive psychosocial 
outcomes and promote resilience  
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o Anticipate potential obstacles to coping (i.e., a lack of service coordination) or 
potential triggers for anxiety and depression  - a service that is well-coordinated, but lacks cohesion and effective 
communication between HCP’s, can impact on patient recovery (Norris et 
al., 2011). - look for persistent failures to cope - Identify potential protective or risk factors concerning psychosocial 
outcomes 
o Ensure, as a HCP, that you are educated on the necessary skills to identify those 
cancer patients experiencing difficulty with coping. Research reports that a 
subgroup of HC survivors would likely have benefited from a completion of 
treatment interview in which effects of cancer and treatment could be investigated 
(Lobb et al., 2009).  - emotions can be easily misinterpreted by HCP’s which may lead to 
inaccurate assessments - examine premorbid risk factors  
o Involve feedback from significant others (i.e., family, carers, etc.) 
o Where possible conduct longer appointments.  
o Facilitate exit interviews after treatment 
o Coordinate immediate access to test results  - anxiety is exacerbated by long waits for follow-up appointments to 
receive results (Marker, 2015).  
o Arrange follow up by telephone calls/email if appropriate (i.e., six-monthly)   
 
• Timely Interventions 
o Provide clinically appropriate interventions at the time of diagnosis, during, and 
beyond treatment:  - HCP’s should offer timely counselling services and/or clinical 
interventions that can effectively target those identified as at risk of 
psychological distress 
o Focus on interventions targeted during the first year following diagnosis and/or 
treatment: - the stress of recurrence anxiety dominates during this phase 
o Individualise interventions:  - focus on survivor preference with attention to minimising deficits and 
reinforcing strengths 
o Consider utilising rehabilitation programs  - provides a practical intervention to maximize the dignity and 
independence in cancer survivors - have the potential to help make positive changes to patients health 
behaviours  
 
• Relevant information, resources and education 
o Ensure HC survivors are aware of existing resources:  - through cancer registries, at events sponsored by cancer-related 
organisations, in specialist waiting rooms, social media, etc. 
o Offer educational forums to enhance coping skills and minimise uncertainty 
during long-term survival  - information and education should be offered with equal intensity as those 
provided at time of diagnosis (Mullan, 1984).  - individual sessions, workshops, and group education for both survivors 
and families, written and web-based materials from reputable sources etc.  
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• Referral and ongoing support 
o Understand how, when, and where to refer patients who require specialised allied 
health care services, some of which are provided by:  - Dieticians  - Occupational Therapists  - Social workers  - Exercise Physiologists - Psychologists/Counsellors  
o Inform  HC survivors of supportive care, advocacy and research opportunities 
available within their community 
o Collaborate with community organisations such as Cancer Council.  - provide a gateway to many services that HC survivors can access over 
their lifetime  
 
 
Psychologists. 
Psychologists offer an important role at critical times along the cancer patient’s 
survivorship journey, and are in a unique position to deliver long-term management. For 
example, psychologists keep cancer patients engaged in life by: providing emotional and 
practical support; delivering advice on a range of psychological issues related to illness; 
promoting healthy behaviour choices; and, assisting cancer survivors to maintain a sense of 
normality. This occurs, in part, through the use of effective psychosocial interventions and a 
positive therapeutic relationship. The following are examples of therapeutic interventions 
recommended for psychologists working with cancer patients. These five interventions have 
been selected as they are reported in the literature to promote and foster protective factors, 
shown in this study to boost resilience.  
 
• Cognitive Behavioural Therapy (CBT) – helps individuals to change unhealthy 
thoughts, feelings and behaviours. CBT reduces anxiety, stress, depression, fear and 
uncertainty by assisting cancer survivors to:  
o reframe obstacles as challenges 
o recognise negative self-talk and dysfunctional thought patterns 
o learn distraction techniques to prevent rumination about their cancer  
o explore previous adversity and identifying coping strategies that were 
successful in the past 
o improve emotion- and problem-focused coping  
o identify personally meaningful goals  
o motivate positive health behaviour change  
(Maher & Fenlon, 2010; Molina et al., 2014; Norris et al., 2011) 
 
• Mindfulness involves, in a non-judgmental way, deliberately paying attention to 
thoughts and sensations of an experience, in the present moment (e.g., form of 
meditation) (Sharplin et al., 2010). Mindfulness improves physical and mental 
wellbeing by allowing patients to take a break from thinking about their cancer. This 
leads to improved QOL and spiritual wellbeing (Bartley, 2012; Fish et al., 2014). 
Other benefits of mindfulness include:  
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o stress relief and reducing rumination 
o improving sleep  
o reducing pain 
o improving cognitive flexibility 
o boosting memory and focus 
o decreasing emotional reactivity 
o enhancing self-insight thus motivating positive behaviour change  
 
• Logotherapy is a ‘meaning centred’ psychotherapy approach founded by Viktor Frankl 
(1905-1997). Frankl believed that the desire to find meaning is the primary motivation 
of human beings. In practice, physiologically, logotherapy is recognised for its 
effectiveness in reducing despair in unavoidable suffering. Psychologically and 
spiritually, logotherapy also helps individuals to reduce anxiety by overcoming 
feelings of emptiness and restablishing purpose in their lives (Schulenber et al., 2008). 
The literature (Ameli & Dattilio, 2013; Saraswathi, 2014; van der Spek et al., 2013), 
reports that logotherapy can also assist HC survivors by:  
o facilitating the development of an individual’s sense of purpose 
o protecting against emotional instability 
o assisting in perceiving and removing factors that hinder the pursuit of 
meaningful goals  
o enabling survivors to cope with cancer-related symptoms by regaining control 
and by building empowerment, self-determination and hope.  
o providing opportunities to develop mastery in areas that are meaningful  
o encouraging autonomous behaviour. 
o guiding in achieving self-efficacy, openness, flexibility and optimism  
  
• Acceptance and Commitment Therapy (ACT) helps cancer survivors to develop clarity 
about what is important in their life and assists to establish behavioural goals in 
accordance with those values. ACT also offers clinically useful strategies for treating 
fear of cancer recurrence by:  
o facilitating change by encouraging patients’ flexibility and acceptance of what 
cannot be altered and focusing their efforts to what can be achieved 
o redirecting their perceptions of stressful experiences and focusing on positive 
reframing and personal growth (Butow, Fardell, & Smith, 2013; Carver, 
2005). 
 
• Visualisation and Guided Imagery is effective in easing the side-effects of treatment 
(i.e., pain and fatigue), reducing anxiety and facilitating relaxation and promoting a 
sense of control over the cancer experience (Rossman, 2002; Serra et al., 2012). 
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Conclusion 
As a growing number of individuals survive HC, it is becoming increasingly clear that 
prolonging life is not the only criterion for effective cancer treatment. For many patients, 
enduring cancer and treatment is just one step of an arduous journey, in which their QOL can 
change dramatically. For example, many HC survivors experience diverse late or long-lasting 
physical and/or psychosocial effects, which may impact on their mental health. Therefore, 
cancer survivorship is considered a potentially traumatic, yet, unique journey for every 
individual, who has to find their own way of navigating the challenges that occur as a result of 
living with cancer. 
Encouragingly, resilience is reported to play a vital role in the success in coping with 
cancer-related adversity. Indeed, studies have reported that resilience can be enhanced in 
people at any stage in life and should be the emphasis of psychosocial interventions with 
cancer patients. For example, personal traits and/or factors such as self-efficacy, self-esteem, 
purpose/meaning in life, and perceived control have all been identified as resilience enhancing 
factors in the literature, and the results of this research concur. However, more detailed 
evidence-based research was required, in order to better understand this resilience process. 
Thus, the purpose of this research was to identify and then examine other factors that may also 
influence resilience. The broad aim was to develop a model of resilience for HC survivors. 
This mixed method study identified several factors, both positive and negative, that 
contributed to or impeded the ability of HC survivors to cope following their HC diagnosis. In 
addition, elements of the model that emerged from this study also found that multiple 
individual, family and community level processes occurred simultaneously in the resilience 
process. The six variables that significantly contributed to the model of resilience, when 
combined with the other 18 variables, included active coping, positive reframing, self-blame, 
family support, friend support and exercise. One variable, self-blame, was related to lower 
resilience scores. Other factors found to enhance resilience included emotional and 
instrumental support, planning, humour, acceptance, religion, social support (HCP’s and 
significant others), time out, care in appearance, researching information, alternative 
treatments and diet. The other negatively correlated factors included denial and behavioural 
disengagement, which impeded resilience among these respondents. This study also identified 
that resilience protects against depression and anxiety, which highlights the importance of 
developing resilience among HC survivors. In addition, through this research, a potential ‘at 
risk cohort’ was identified. Younger adults and those within five years of diagnosis were found 
to have significantly higher scores on depression and anxiety. The present results further 
support the majority of earlier research findings identified among other chronic illness 
populations.  
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Several recommendations based on the sound empirical evidence resulting from this 
study were offered for the deliberation of relevant stakeholders. Should these 
recommendations be implemented in an efficient and timely manner, the psychosocial 
wellbeing of HC cancer survivors could be considerably enhanced. However, the dilemmas 
and challenges of survivorship are complex and require considerable practice improvements. 
In addition, our understanding of the cancer survivorship trajectory, especially among less 
common cancers, is still in the early stages. Therefore, it is essential that clinicians remain 
informed and involved in future research. For example, psychologists have the potential to 
contribute significantly to this body of literature by documenting their experiences with cancer 
survivors and by providing data on successful psychosocial interventions.  
With the help of this study, we now have both qualitative and quantitative data about 
the challenges and support needs of HC survivors. Understanding all the relevant aspects of 
the cancer survivorship experience will certainly move toward closing the gap between 
medical treatment and more holistic patient outcomes. In the future, as our appreciation of 
cancer survivorship improves, clinicians will need to ensure the desires of cancer survivors are 
central to their care, not merely an afterthought once therapy has ended. Such awareness will 
empower clinicians to provide more effective individualized patient-centred care, which 
attends to patients’ unique needs. However, various avenues of support identified in this study 
can only be addressed through a collective and coordinated effort across different sectors. The 
federal and state governments, employers, organisations, and HCP’s can all play a vital role in 
better supporting HC survivors. 
The findings of the current study have offered insights into important factors that 
influence resilience. This is a worthwhile endeavour that will assist every HC survivor live and 
function more effectively with his or her illness. Finally, it seems fitting to conclude this thesis 
with a quote that was communicated in an article about Kareem Abdul-Jabbar, an American 
National Basketball Association athlete, activist, writer, and leukaemia survivor (Gallo, 2010). 
This advice was conveyed by a ‘savvy’ doctor whose perspective appropriately expresses the 
viewpoint also shared by many of the HC participants in this study.  
 “If you want to live a long life, do not dismay at a sudden and surprising diagnosis, 
just confront it and take care of it. Consider the intrusion of this, as your unwelcome 
malady and something you have to put in its place” (Gallo, 2010). 
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Appendix A 
History and Attributes to the Developing Cancer Survivorship Movement  
The historical construct of survivorship as a concept was associated with living 
through unexpected atrocities, such as being captive as a prisoner of war or surviving 
natural disasters (Boyle, 2008; Dow, 1990). The term survivorship first became 
apparent in the medical literature in the 1960s, with mention to life following a 
myocardial infarction (Lew, 1967). However, as the number of cancer survivors 
increased throughout the 1970s and 1980s, a cancer survivorship community arose 
(Doyle, 2008). 
In 1980, Shanfield identified the psychological consequences of surviving 
cancer, prior to this there had been insignificant research efforts on the survivorship 
topic, in relation to adults (Doyle, 2008; Shanfield, 1980). The research prior to this 
point, had focused on paediatric survivors reaching adulthood, as it was in this arena 
that the most dramatic treatment success stories were witnessed (Rowland & Baker, 
2005). Shanfield suggested that the cancer experience lasted a lifetime and was 
characterized by an enduring sense of one’s own mortality and vulnerability, coupled 
with vivid memories of the illness and recovery period.  
Then in July of 1985, Mullan published his paper entitled "Seasons of Survival: 
Reflections of a Physician with Cancer" in The New England Journal of Medicine 
(Feuerstein, 2007a). This article written by Dr. Fitzhugh Mullan, would create a major 
medical and cultural shift in the United States (US) moving from cancer ‘patients’ to 
cancer ‘survivors’ (Feuerstein, 2007a; Hoffman & Stovall, 2006).  
Mullan (1985) projected that survivorship should be researched as a cancer 
experience in itself, rather than an afterthought of medical research on treatment. In 
addition, Mullan’s view of survivorship reflected more a “diverse experience” 
involving phases that cancer patient’s transitioned through. Mullan referred to these as 
“seasons of survival” that included acute, extended, and permanent stages following a 
cancer diagnosis (which will be discussed shortly in more detail). Mullan also detailed 
many of the challenges faced by those living with a cancer diagnosis and argued the 
need for a fresh way of perceiving surviving with cancer (Feuerstein, 2007a). 
Survivorship, Mullan maintained, should viewed as a concept that can be used to help 
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explain, describe, better manage, and avert the many challenges and inadequacies 
faced by those living with a diagnosis of cancer (Feuerstein, 2007c; Mullan, 1985).  
At this time, researchers had begun collecting statistics on survival rates in 
order to reflect the severity and prognosis of cancer. However, Mullan was the first to 
represent the experience of cancer from diagnosis to the end of life (Bartels, 2010). 
Mullan was instrumental in founding the National Coalition for Cancer Survivorship 
(NCCS) in 1986. As a result, clinicians began to acknowledge what cancer patients 
required, beyond the initial diagnosis and immediate medical treatment (Hoffman & 
Stovall, 2006). For example, medical, physical, psychosocial, economic and legal 
issues were slowly starting to be realised as a potential cost of having had cancer 
(Doyle, 2008; Feuerstein, 2007a). Accordingly, the survivorship movement slowly 
began to appear in the cancer-related literature (Doyle, 2008). 
By the 1990s, there was an increase in autobiographical literature recounting 
the experience of surviving cancer from the individual’s perspective, which extended 
throughout the cancer trajectory (Doyle, 2008). This interest initiated the beginning of 
influential cancer survivorship associations. For example, in the United States (US) in 
1996, the National Cancer Institute (NCI) established the Office of Cancer 
Survivorship (OCS). Following the foundation of OCS, related organisations, such as 
the American Cancer Society and the American Institute for Cancer Research, 
consequently placed "survivorship" as a primary focus for their research initiatives 
(NCCS, 2012). Hence, within the past decade, the survivorship movement has 
encouraged a radical redefinition of care, with health care professionals highlighting an 
emphasis on the survivor trajectory (Hewitt, Greenfield, & Stovall, 2005). In the US 
during 2004, The Centers for Disease Control and Prevention, along with the Lance 
Armstrong Foundation, took a lead in these efforts by delivering a National Action 
Plan for Cancer Survivorship (Bartels, 2009). 
In 2005, the Psycho-oncology Co-operative Research Group (PoCoG) was 
established between Australia and New Zealand in response to an identified need to 
develop a synchronized partnership for the conduct of large-scale, multi-centre 
psycho-oncology and supportive care research (Hagerty & Butow, 2006; Rankin, 
2011). With a membership of over 480 individuals PoCoG, represented the majority of 
key stakeholders involved in psycho-oncology in Australia and New Zealand (Rankin 
et al, 2011). One of the main concerns for PoCoG was to ensure that research activities 
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supported clinical practice, in order to enhance psychosocial care for cancer patients 
nationwide (Rankin et al., 2011).  
Then, in the US during 2006, the Institute of Medicine (IOM) published a 
landmark study, “From Cancer Patient to Cancer Survivor: Lost in Transition”, which 
presented effective protocols for improving the QOL and the long-term care of 
survivors (Hewitt, Greenfield, & Stovall, 2005). The four central elements of 
survivorship care include prevention, surveillance, intervention and co-ordination 
(Brennan & Jefford, 2009). The IOM report included ten recommendations, seven 
dealt with the need for legislative change, while three were targeted at health care 
providers (Wheeler, 2010). It was during this time that an extensive body of literature 
was published, in relation to the treatment and care provided by clinicians (Bartels, 
2009; Feuerstein, 2007a). In addition, a proliferation of survivorship terminology 
became accessible within the cancer survivorship forums, on websites, within support 
agencies and through autobiographies by those personally affected (Bartels, 2009). 
In the same year, The National Services Improvement Framework for Cancer 
was formulated in Australia, which recommended a guiding principle behind the 
survivorship movement (Girgis & Butow, 2009). This principle proposed that cancer 
support should span the continuum of care that includes the life course of the illness. It 
was recognised that there was a need to embrace prevention, screening, diagnosis, 
management, rehabilitation, living with the condition and palliation where required 
(Girgis & Butow). This report also concluded that, within Australia, the relative lack of 
attention outside the treatment context was due to the absence of information regarding 
current practice and effective guidelines (Girgis & Butow). In addition, according to 
Girgis and Butow (2009), there had been no co-ordinated Australian efforts to develop 
a specific survivorship agenda.  
As discussed, despite being a relatively new field, there has been a significant 
increase in survivorship research over the last 10 years. The historical progression of 
the survivorship movement discussed above can be viewed in Table 2. This not only 
outlines a visual timeline detailing the influential contributors in developing the cancer 
survivorship movement from 1985-2006, but also illustrates the agenda and research 
considerations. 	
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Appendix B 
Cancer Survivorship Development Timeline from 1985-2006 
 
Table A1.  
Cancer Survivorship Development Timeline from 1985-2006 
____________________________________________________________________ 
Year Contributors and Agenda towards the Cancer Survivorship  Movement 
____________________________________________________________________ 
1985 - Fitzhugh Mullan, a physician diagnosed with anaplastic seminoma, proposed the first 
survivorship model that focused on the patient and also recognized the impact of 
family, friends, extended community and clinicians (Mullan, 1985).  
1986 - Building on Mullan’s model, representatives from 20 organisations re-defined 
survivorship after founding the NCCS. This coalition advocated on behalf of cancer 
survivors by identifying different needs experienced across the course of the illness 
and recovery (Hoffman & Stovall, 2006; Wheeler, 2010).  
1989 - Mullan’s framework was later supported by Carter (1989) in her review of research on 
the cancer survivor topic, which was adopted by NCCS as their membership criterion 
(Wheeler, 2010). 
1995 -  National Cancer Institute (NCI) sponsored the First National Congress on Cancer 
Survivorship (NCCS). The NCCS clearly set the agenda for cancer survivorship 
research by addressing the physical, psychosocial and economic realms of a cancer 
diagnosis and its treatments (NCCS, 2012). 
 
1996 -  The Office of Cancer Survivorship was founded at the NCI in response to consumer 
backing for more thorough understanding of the unique and poorly identified needs of 
cancer survivors. The directive of the OCS was to improve the length and quality of 
life of those diagnosed with cancer (Wheeler, 2010).  
2005 -  A panel was invited by the IOM to research the variety of medical and psychosocial 
issues faced by adult cancer survivors. The first goal was to educate clinicians and the 
community of the unique needs of cancer survivors and to establish cancer 
survivorship as a distinct phase of cancer care (Brennan & Jefford, 2009). 
2005 - Psycho-oncology Co-operative Research Group (PoCoG) was established in Australia 
and New Zealand. The main agenda was to ensure that research activities maintained 
broad application within clinical practice to improve psychosocial care for cancer 
patients nationwide (Rankin, 2011) 
2006 - The IOM in the United States released a landmark report written by Hewitt, 
Greenfields and Stoval titled ‘From cancer patient to cancer survivor – lost in 
transition’. This report portrayed survivorship as a distinct phase in the cancer journey 
(Brennan & Jefford, 2009). 
 
2006 -  The National Services Improvement Framework for Cancer in Australia proposed a 
guiding principle behind the survivorship framework. This principle proposed that 
cancer support should span the continuum of care that includes the life course of the 
illness (Girgis & Butow, 2009).  
____________________________________________________________________  
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Appendix C 
Interview Participant Invitation Letter 			Thank	you	for	your	time......		My	name	is	Kate	Gallager	and	I	am	currently	completing	a	PhD	in	Psychology	at	Edith	Cowan	University	(ECU).	I	am	writing	to	invite	you	to	participate	in	my	thesis,	which	has	been	approved	by	the	Human	Research	Ethics	Committee	at	ECU.		I	am	researching	the	experiences	of	haematological	cancer	survivors.	I	have	chosen	this	research,	as	I	feel	it	is	important	to	understand	how	you	and	others	in	your	situation	have	coped.	I	hope	this	research	will	identify	what	was	most	or	least	helpful	in	dealing	with	your	illness.	It	is	expected	that	this	information	will	assist	others	who	face	similar	circumstances.		If	you	were	diagnosed	at	least	12	months	ago	and	are	not	currently	undergoing	inpatient	hospital	treatment	for	your	cancer,	would	you	be	interested	in	participating	in	a	short	interview?	This	will	be	at	a	time	and	place	convenient	to	you.	Each	interview	will	take	approximately	30-40	minutes.	All	interviews	will	remain	confidential,	therefore	only	I	will	know	your	identity.	The	interviews	will	be	digitally	recorded	and	then	transcribed	afterwards,	following	which	all	identifying	features	will	be	removed	from	the	paperwork	and	recordings	will	be	erased.	Results	from	this	project	may	be	shared	in	conferences	or	publications,	but	no	participants	will	be	identified.	You	are	free	to	withdraw	participation	at	any	time	during	the	interview	process,	in	which	case	any	information	you	have	already	provided	will	be	destroyed.			If	you	are	over	18	years	of	age	and	willing,	I	would	like	to	invite	you	to	participate	in	this	research	by	contacting	me	either	by	phone	or	email	(details	below).	If	you	have	any	queries	regarding	this	research	or	require	further	information,	please	don’t	hesitate	to	contact	me,	or	one	of	my	supervisors,	Professor	Ken	Greenwood	(6304	2769	or	
k.greenwood@ecu.edu.au)	and	Professor	Anne	Wilkinson	(6304	3540	or	
anne.wilkinson@ecu.edu.au).	Alternatively,	if	you	would	like	to	speak	with	an	independent	person	please	contact	the	ECU	Research	Ethics	Officer,	Kim	Gifkins	on	(08)	
6304	2170.		It	is	expected	that	the	interview	will	not	be	distressing.	However,	if	you	experience	any	stress	or	are	uncomfortable,	the	interview	will	stop	and	a	list	of	counselling	and	support	services	will	be	provided.			Thank	you,	l	appreciate	your	time	and	consideration	and	I	look	forward	to	your	participation	in	this	valuable	research.			
Kate Gallager Kate	Gallager	(School	of	Psychology,	Edith	Cowan	University)	Mb:	0438	401	427		kgallage@our.ecu.edu.au	
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Appendix D 
Interview Consent Form 
 
 
Informed Consent 
 
In signing this letter of consent, you agree to the following: 
• I have read the information sheet provided, understand the nature and purpose of the 
study and have freely agreed to participate. 
• I have been given opportunity to ask questions and received satisfactory answers in 
regard to all aspects of the research. 
• I am aware that the researcher is not a counsellor and that the interview is non-
therapeutic. 
• I understand that participation in this project will involve an interview that will be 
audio recorded.  
• I am aware that the information obtained from the interview will form the basis for a 
publishable report. 
• I understand that the audio recording will be transcribed after the interview (possibly by 
a third party who will not know my identity).  
• I give permission to be contacted by the researcher to clarify information.  
• I am aware that all efforts will be made to maintain confidentiality and understand that 
the researcher will secure all documentation relating to myself and my interview whilst 
the research project is ongoing. 
• I understand that, at the completion of the research project, all identifying information 
will be destroyed, and all transcripts, questionnaires, and consent forms will be stored 
by Edith Cowan University for a period of five years before being destroyed. 
• I understand that my participation is voluntary and I may withdraw permission or cease 
to participate at any time.  
• I understand that the researcher will advise me if my results indicate possible clinical 
levels of depression or anxiety.  
Participant Signature __________________________ Date _______________________ 
Contact Details: Email_________________________ Mb ________________________ 
Participant Name (Printed) ___________________________________________________ 
Researcher Signature __________________________ Date _______________________ 
 
Name of Investigator: Kate Gallager 
Name of Supervisors: (Professor Ken Greenwood and Professor Anne Wilkinson)	
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Appendix E 
Support Services Information 
 
 
After discussing your experience following treatment for cancer, you may have 
encountered some unresolved issues. These may not seem significant however it is 
important that if you feel this way, you seek help. This is to ensure that no underlying 
events raised as a result of this research study continue to cause a negative impact on 
you currently and/or in the future. This brochure has been compiled to provide you 
with a list of available support services that you may wish to contact if you want to 
further discuss any concerns. 
 
Cancer Related Support/ Counselling 
Cancer Council Helpline    13 11 20 or   
       www.cancerwa.asn.au 
(A non government, community supported organisation that provides a comprehensive 
and professional counselling service for people diagnosed with cancer, including 
family and friends)  
Leukaemia Foundation     1800 620 420 (Mon – Fri) or 
       www.leukaemia.org.au 
(Provides support to individuals and families who have experienced haematological 
cancer through emotional support, counselling, practical assistance, peer support, 
education and seminars 
 
 
Psychological Support Services 
ECU Psychological Services Centre   9301 0011 
Joondalup House, 8 Davidson Terrace, Joondalup    
   (Provides psychological counselling, treatment and assessment) 
Centrecare       9300 7300 
Level 1/85 Boas Ave, Joondalup      
 (Provides workshops, in home visiting and individual, couple and family 
counselling) 
Psychologists (Fee Based) 
To find a psychologist in your area visit: 
http://www.psychology.org.au/FindaPsychologist 
 
 
Telephone Support 
Life Line WA       13 11 14  (24 hour 
support) 
Mental Health Direct     1800 220 400	
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Appendix F 
Interview	Participant	Demographic	Information	Sheet	
	
		Name:	 	Age:	 	Sex:	 	Marital	status:	 	Number	of	children:	 	 	 	 	Country	of	Birth/Nationality:	 	Current	or	Previous	Occupation:	 	Current	employment	status:	 	Residential	postcode:	 	Haematological	cancer	diagnosis:	 	Date	of	diagnosis:	 	Type(s)	of	treatment:	 		Date	of	last	treatment:	 	Treating	hospital:	 	Current	medications 		Any	relapses,	significant	illness	information	or	complications	since	last	treatment:	 			Have	you	been	diagnosed	with	any	other	health	problems	or	illnesses	(these	may	be	in	addition	to	your	cancer	diagnosis)	 				If	applicable	have	you	been	prescribed	psychotropic	medications	(for	mental	health	or	psychiatric	illness).	If	so	please	provide	details:			Current	status	of	cancer	diagnosis	(Please	circle)		A	-	Cured	B	-	In	remission		C	-	Not	sure		Thank	you	for	your	time...	
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     Appendix G 
 
Participant Interview Schedule 
 
1. Please can you tell me about your experience following treatment for 
haematological cancer?  
 
2. How has this experience changed your life?  
 
3. Do you believe that you have coped well during this time? 
 
4. What has helped you to adjust?  
 
• Prompts:  Social support (partner, children, friends, support groups) 
Personal characteristics (personality traits, psychological 
factors)  
   External factors (employment, hobbies, physical exercise) 
   Cancer related (heath care professional and facility support) 
 
5. What else may have helped you following treatment? 
 
6. Please describe the most difficult time for you since ending treatment and why? 
 
• Prompts: What got you through this? 
 
7. Some individuals consider themselves to be resilient, can you tell me what this 
means to you? 
 
• Prompts:  Do you consider yourself resilient? 
   What has helped you become resilient? 
   What has made it difficult for you to be resilient? 
   How has this been affected by your cancer experience? 
 
8. On a scale of 1 – 10 (with 10 being excellent) how would you rate your current 
mental health? 
 
9. What three factors have helped you the most to recover following treatment? 
 
10.  What three factors have resulted in recovery being more difficult for you? 
 
11. What advice would you give to a cancer survivor who has just completed 
treatment that would help their recovery process? 
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Appendix H 
Interview Thankyou Letter 	
DATE	
	
	
ADDRESS	
	
Dear	_____________	
Thank	you	for	taking	the	time	to	participate	in	my	research	investigating	resilience	
among	haematological	cancer	survivors.	Your	input	is	important,	as	it	will	allow	us	to	
better	understand	how	you	have	coped	since	diagnosis.	This	may	help	to	identify	
those	survivors	at	risk	of	developing	psychological	illness	such	as	depression	and	
anxiety.	This	will	also	contribute	to	the	body	of	knowledge	among	cancer	survivors	
and	better	inform	healthcare	professionals	of	patients’	needs	following	
haematological	cancer	treatment.	
Over	the	past	few	weeks	if	you	have	experienced	any	distress,	which	may	be	as	a	
result	of	participation	in	this	research,	please	contact	one	of	the	counselling	services	
listed	on	your	information	sheet.		
Thank	you	for	your	time	and	consideration.		It	is	with	your	assistance	that	our	
research	can	be	successful.	I	wish	you	all	the	best	in	the	future.		
	
Yours	sincerely,	
	
	
___________________	
Kate	Gallager	
School of Psychology, Edith Cowan University 
kgallage@our.ecu.edu.au 	
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Appendix IA – E  
Pilot Questionnaire Scales  
 
Multidimensional Scale of Perceived Social Support 
(Zimet, Dahlem, Zimet, & Farley, 1988) 
 
___________________________________________________________________________ 
 
Instructions: We are interested in how you feel about the following statements. Read each 
statement carefully. Indicate how you feel about each statement  
 
Circle the “1” if you Very Strongly Disagree  
Circle the “2” if you Strongly Disagree  
Circle the “3” if you Mildly Disagree  
Circle the “4” if you are Neutral 
Circle the “5” if you Mildly Agree  
Circle the “6” if you Strongly Agree  
Circle the “7” if you Very Strongly Agree 
1. There is a special person who is around when I am in need 1    2    3     4    5    6     7   SO 
2. There is a special person with whom I can share my joys and sorrows  1  2  3  4  5  6  7   SO 
3. My family really tries to help me.    1     2     3     4     5     6     7    Fam 
4. I get the emotional help and support I need from my family 1   2   3   4   5   6   7  Fam  
5. I have a special person who is a real source of comfort to me 1   2   3   4   5   6   7    SO 
6. My friends really try to help me    1     2     3     4     5     6     7    Fri 
7. I can count on my friends when things go wrong  1     2     3     4     5     6     7    Fri 
8. I can talk about my problems with my family 1     2     3     4     5     6     7   Fam 
9. I have friends with whom I can share my joys and sorrows 1   2   3   4   5   6   7   Fri 
10. There is a special person in my life who cares about my feelings     1   2   3    4   5   6   7   SO 
11. My family is willing to help me make decisions  1     2     3     4     5     6     7   Fam 
12. I can talk about my problems with my friends  1     2     3     4     5     6     7 Fri 
The items tended to divide into factor groups relating to the social support, namely family (Fam), 
friends (Fri) or significant other (SO). 
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Appendix IB 
Brief COPE Scale (Carver, 1997) 
These items deal with ways you’ve been coping with the stress of surviving the diagnosis and 
treatment for haematological cancer. There are many ways to try to deal with problems. These 
items ask what you’ve been doing to cope. Obviously, different people deal with things in 
different ways, but we are interested in how you’ve tried to deal with your experiences 
following haematological cancer treatment. Each item says something about a particular way 
of coping. We want to know to what extent you’ve been doing what the item says. How much 
or how frequently. Don’t answer on the basis of whether it seems to be working or not – just 
whether or not you’re doing it. Use these response choices. Try to rate each item separately in 
your mind from the others. Make your answers as true FOR YOU as you can. 
The rating scale is as follows: 
1  I haven’t been doing this at all 
2  I’ve been doing this a little bit 
3  I’ve been doing this a medium amount 
4  I’ve been doing this a lot 
I’ve been turning to work or other activities to take my mind off things   1   2   3   4 
I’ve been concentrating my efforts on doing something about the situation l’m in 1   2   3   4 
I’ve been saying to myself “this isn’t real.”      1   2   3   4 
I’ve been using alcohol or other drugs to make myself feel better   1   2   3   4 
I’ve been getting emotional support from others      1   2   3   4 
I’ve been giving up trying to deal with it      1   2   3   4 
I’ve been taking action to try and make the situation better    1   2   3   4 
I’ve been refusing to believe that it has happened     1   2   3   4 
I’ve been saying things to let my unpleasant feelings escape    1   2   3   4 
I’ve been getting help and advice from other people     1   2   3   4 
I’ve been using alcohol or other drugs to help me get through it    1   2   3   4 
I’ve been trying to see it in a different light, to make it seem more positive 1   2   3   4 
I’ve been criticising myself        1   2   3   4 
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I’ve been trying to come up with a strategy about what to do    1   2   3   4 
I’ve been getting comfort and understanding from someone    1   2   3   4 
I’ve been giving up the attempt to cope       1   2   3   4 
I’ve been looking for something good in what is happening    1   2   3   4 
I’ve been making jokes about it        1   2   3   4 
I’ve been doing something to think about it less, such as going to movies,   1   2   3   4 
watching TV, reading, daydreaming, sleeping or shopping     
I’ve been accepting the reality of the fact that it has happened    1   2   3   4 
I’ve been expressing my negative feelings      1   2   3   4 
I’ve been trying to find comfort in my religion or spiritual beliefs   1   2   3   4 
I’ve been trying to get advice or help from other people about what to do  1   2   3   4 
I’ve been learning to live with it       1   2   3   4 
I’ve been thinking hard about what steps to take      1   2   3   4 
I’ve been blaming myself for things that happened     1   2   3   4 
I’ve been praying or meditating        1   2   3   4 
I’ve been making fun of the situation       1   2   3   4 
__________________________________________________________________________ 
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Appendix IC 	
Hospital	Anxiety	and	Depression	Scale		(Zigmond	&	Snaith,	1983)	(Scale	was	purchased	as	per	copyright	guidelines)		Clinicians	are	aware	that	emotions	play	an	important	part	in	most	illnesses.	This	questionnaire	is	designed	to	help	better	understand	how	you	feel.	Read	each	item	below	and	underline	the	reply	which	comes	closest	to	how	you	have	been	feeling	in	the	past	week.			Don’t	take	too	long	over	your	replies,	your	immediate	reaction	to	each	item	will	probably	be	more	accurate	than	a	long,	thought-out	response.		
___________________________________________________________________________ 	
I	feel	tense	or	‘wound	up	 	 	 	 I	feel	as	if	l	am	slowed	down	Most	of	the	time	 	 	 	 	 Nearly	all	the	time	A	lot	of	the	time	 	 	 	 	 Very	often	From	time	to	time,	occasionally	 	 	 Sometimes	Not	at	all	 	 	 	 	 	 Not	at	all		
I	still	enjoy	the	things	l	used	to	enjoy	 I	get	a	sort	of	frightened	feeling	
like	‘butterflies’	in	the	stomach	Definitely	as	much	 	 	 	 	 Not	at	all	Not	quite	so	much	 	 	 	 	 Occasionally	Only	a	little	 	 	 	 	 	 Quite	often	Hardly	at	all	 	 	 	 	 	 Very	often		
I	get	a	sort	of	frightened	feeling	as	if	 I	have	lost	interest	appearance	
something	awful	is	about	to	happen	 	 in	my	appearance	Very	definitely	and	quite	badly	 	 	 Definitely	Yes,	but	not	too	badly	 I	don’t	take	as	much	care	as	l	should	A	little	but	it	doesn’t	worry	me	 	 	 I	may	not	take	quite	as	much	care	Not	at	all	 	 	 	 	 	 I	take	just	as	much	care	as	ever		
I	can	laugh	and	see	the	funny	side	of	things	 I	feel	restless	as	if	l	have	to	be	on	
the	move	
	 	 	 	 	 	 	 	 	 	 	 			As	much	as	l	always	could	 	 	 	 Very	much	indeed	Not	quite	so	much	now	 	 	 	 Quite	a	lot	Definitely	not	so	much	now	 	 	 	 Not	very	much	Not	at	all	 	 	 	 	 	 Not	at	all		
Worrying	thoughts	go	through	my	mind	 I	look	forward	with	enjoyment	to	
things	A	great	deal	of	the	time	 	 	 	 As	much	as	l	ever	did	A	lot	of	the	time	 	 	 	 	 Rather	less	than	l	used	to		Not	too	often	 	 	 	 	 	 Definitely	less	than	l	used	to		Very	little	 	 	 	 	 	 Hardly	at	all	
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I	feel	cheerful	 	 	 I	get	sudden	feelings	of	panic	Never	 	 	 	 	 	 	 Very	often	indeed	Not	often	 	 	 	 	 	 Quite	often	Sometimes		 	 	 	 	 	 Not	very	often	Most	of	the	time	 	 	 	 	 Not	at	all		
I	can	sit	at	ease	and	feel	relaxed	 I	can	enjoy	a	good	book	or	radio	
or	Television	program	Definitely	 	 	 	 	 	 Often	Usually		 	 	 	 	 	 Sometimes	Not	at	all	 	 	 	 	 	 Not	often	Not	at	all	 	 	 	 	 	 Very	seldom				 	
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Appendix IE 
Health Behaviour Change Scale  
(created scale) 
 
These questions deal with certain health behaviour changes. Please consider how you have 
best coped with your cancer diagnosis and select the answer that is most true for YOU.  
Strongly Disagree (SD)  Disagree (D) Somewhat Disagree (SOD) 
Somewhat Agree (SOA) Agree (A) Strongly Agree (SA) 
 
      SD D SOD SOA A SA 
___________________________________________________________________________________
1.  Taking time out to relax improves the way   
     l feel     ¢ ¢ ¢ ¢ ¢ ¢  
2.  When l maintain a healthy diet l cope better  ¢ ¢ ¢ ¢ ¢ ¢ 
3.  I worry more when l don't find time to  
     exercise        ¢ ¢ ¢ ¢ ¢ ¢ 
4.  My appearance is important to me  ¢ ¢ ¢ ¢ ¢ ¢ 
5.  When l take time out for myself l cope better  ¢ ¢ ¢ ¢ ¢ ¢ 
6.  I worry more when l don't eat properly  ¢ ¢ ¢ ¢ ¢ ¢ 
7.  My concerns are less when l do some form    
   of regular exercise     ¢ ¢ ¢ ¢ ¢ ¢ 
8.  When l look good l feel better   ¢ ¢ ¢ ¢ ¢ ¢ 
9.  I feel more stressed when l don't get time out  
    for myself      ¢ ¢ ¢ ¢ ¢ ¢ 
10. Taking care of my dietary needs is important  
     to me      ¢ ¢ ¢ ¢ ¢ ¢ 
11. When l do regular exercise l cope better  ¢ ¢ ¢ ¢ ¢ ¢ 
12. I worry more if l am unhappy with the way  
      l look      ¢ ¢ ¢ ¢ ¢ ¢ 
 
_____________________________________________________________________ 
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Appendix J 
 
Invitation to Participate in Pilot Study 
 	
 
 
Dear Potential Participant 
 
I am conducting a pilot study as part of a PhD that aims to explore the resilience 
shown by cancer survivors. I am hoping you would be able to help by participating. It 
would involve you answering two 15 min surveys. The first now and the next one in 
two weeks, this is to make sure it is good enough to use. The results of this pilot test 
are important as they will form the basis for a larger study. 
 
I have included the link below if you are able to assist me.  
 
Importantly, you will also see a question asking you to make up a personal ID (on the 
first page when you open the survey). This is because l will be asking you to take the 
survey again in two weeks and will need to match the surveys.  
 
 
Survey link: to click or (copy and paste): 
 
https://ecuau.qualtrics.com/SE/?SID=SV_6YGrABsDXFVxY2N 
 
The study has been approved by the Human Research Ethics Committee at ECU. 
 
If you have any queries regarding this research or require further information, please 
don’t hesitate to contact me (details below), or my supervisors, Professor Ken 
Greenwood [k.greenwood@ecu.edu.au] and Professor Anne Wilkinson 
[anne.wilkinson@ecu.edu.au]. Alternatively, if you would like to speak with an 
independent person, please contact the ECU Research Ethics Officer, Kim Gifkins on 
(08) 6304 2170. 
 
Thanking you in advance for your consideration. 
 
Kate Gallager 
(School of Psychology, Edith Cowan University) 
kgallage@our.ecu.edu.au 
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Appendix K 
 
Final	Survey	Information	and	Consent		
 		Thank	you	for	your	interest.	My	name	is	Kate	Gallager	and	I	am	currently	completing	a	PhD	in	Psychology	at	Edith	Cowan		University	(ECU)	in	Perth,	Western	Australia.	I	am	writing	to		invite	you	to	participate	in	my	thesis,	which	has	been	approved	by	the	Human	Research	Ethics	Committee	at	ECU.		I	am	conducting	research	that	aims	to	explore	the	resilience	shown	by	haematological	(i.e.,	blood	and	lymph	node)	cancer	survivors.	I	hope	this	
research	will	identify	what	was	most	or	least	helpful	in	dealing	with	your	
illness	following	your	diagnosis.	It	is	expected	that	this	information	will	assist	others	who	face	similar	circumstances.	All	information	will	remain	confidential.	Results	from	this	project	may	be	shared	in	conferences	or	publications,	but	no	participants	will	be	identified.			If	you	meet	the	following	criteria	l	would	like	to	invite	you	to	participate	in	this	valuable	research:	
• over	18	years	of	age,		
• English	speaking	and	
• diagnosed	with	haematological	cancer	(i.e.,	Leukaemia,	Lymphoma,	Myeloma)		To	be	involved,	you	will	be	asked	to	complete	an	online	survey	by	copying	and	pasting	the	online	link	provided	below:				https://ecuau.qualtrics.com/SE/?SID=SV 8CgEblKwPxMgUpT		If	you	would	like	more	information	prior	to	proceeding,	please	feel	free	to	contact	either	myself	or	my	supervisors.	Alternatively,	if	you	have	any	concerns	or	complaints	about	the	research	and	wish	to	talk	to	an	independent	person	you	may	contact	the	ECU	Research	Ethics	Officer,	Kim	Gifkins	by	email	research.ethics@ecu.edu.au			It	is	not	expected	that	you	will	experience	any	distress	as	a	result	of	completing	this	survey.	However,	if	you	experience	any	discomfort,	I	encourage	you	to	contact	your	local	counselling	and	support	services.	If	you	reside	in	Australia	these	are	listed	below.		
Leukaemia	Foundation	 		 1800	620	420	(Free	call)	
Cancer	Council	Helpline	 	 	13	11	20	
Lifeline	WA	 	 	 	 	13	11	14	(available	7	days	a	week,	24	hours)	
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Continued: 
INFORMED CONSENT  
I understand that: 
 * Participation in this study will involve completion of an on-line survey  
* My responses will be recorded electronically through the Qualtrics Survey tool  
* I have read the information and understand the nature and purpose of the study  
* I am aware that the information obtained from the survey will form the basis for a 
publishable report. 
* The researcher will secure all information relating to my responses whilst the study 
is ongoing. 
* At the completion of the research project, all survey responses will be stored by ECU 
for a period of seven years.  
* I may cease to participate at any time during the on-line survey.  
In	completing	the	survey,	it	will	be	assumed	that	you	meet	the	necessary	criteria	
and	have	provided	consent	to	participant	in	the	research.		
	
¢ I	understand	and	accept	the	conditions	
¢ I	do	not	accept	
	
Thank	you	for	your	time	and	consideration,	I	look	forward	to	your	
participation.	
 
 
Kate Gallager 
Principle	Researcher	
Kate	Gallager	[PhD	Candidate	School	of	Psychology	and	Social	Science	ECU]	Email:	kgallage@our.ecu.edu.au	or	katherine.gallager@bigpond.com			
	
Supervisors:		
Professor	Ken	Greenwood,	k.greenwood@ecu.edu.au	
Professor	Anne	Wilkinson,		anne.wilkinson@ecu.edu.au			 	
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Appendix L 
 
Final Survey Questionnaire 
 Thank	you	for	your	assistance.		My	name	is	Kate	Gallager	and	I	am	currently	completing	a	PhD	in	Psychology	at	Edith	Cowan	University	(ECU)	in	Perth,	Western	Australia.	I	am	conducting	research	that	aims	to	explore	the	resilience	shown	by	haematological	(i.e.,	blood	and	lymph	node)	cancer	survivors.	I	hope	this	research	will	identify	what	was	
most	or	least	helpful	in	dealing	with	your	illness	following	your	diagnosis.	It	is	expected	that	this	information	will	assist	others	who	face	similar	circumstances.			If	you	have	previously	been	diagnoses	with	haematological	cancer,	are	over	18	years	of	age	and	English	speaking,	l	would	like	to	invite	you	to	participate	in	this	study,	which	has	been	approved	by	the	Human	Research	Ethics	Committee	at	ECU.	Participation	is	purely	voluntary	and	all	information	provided	by	you	is	strictly	confidential,	only	the	researcher	and	supervisors	will	have	access	to	it.	However,	the	results	from	this	project	may	be	shared	in	conferences	or	publications,	but	no	participants	will	be	identified.			If	you	would	like	more	information	prior	to	proceeding,	please	feel	free	to	contact	either	myself,	or	my	supervisors.	Alternatively,	if	you	have	any	concerns	or	complaints	about	the	research	and	wish	to	talk	to	an	independent	person	you	may	contact	the	ECU	Research	Ethics	Officer,	Kim	Gifkins	by	email	research.ethics@ecu.edu.au			
Kate	Gallager	PhD	Candidate		School	of	Psychology	and	Social	Science	ECU	Mb…………………	or	kgallage@our.ecu.edu.au	or		
	
Supervisors:		Professor	Ken	Greenwood,	08	63045979	Professor	Anne	Wilkinson,		08	63043450			It	is	not	expected	that	you	will	experience	any	distress	as	a	result	of	completing	this	survey.	However,	if	you	experience	any	discomfort,	I	encourage	you	to	contact	your	local	counselling	and	support	services.	If	you	reside	in	Australia	these	are	listed	below.		
Leukaemia	Foundation	 		 1800	620	420	(Free	call)	
Cancer	Council	Helpline	 	 	13	11	20	
Lifeline	WA	 	 	 	 	13	11	14	(available	7	days	a	week,	24	hours)	
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INFORMED CONSENT  
I understand that:  
* Participation in this study will involve completion of an on-line survey  
* My responses will be recorded electronically through the Qualtrics Survey tool  
* I have read the information and understand the nature and purpose of the study.  
* I am aware that the information obtained from the survey will form the basis for a 
publishable report. 
* The researcher will secure all information relating to my responses whilst the study 
is ongoing. 
* At the completion of the research project, all survey responses will be stored by ECU 
for a period of seven years.  
* I may cease to participate at any time during the on-line survey.  
In	completing	the	survey,	it	will	be	assumed	that	you	meet	the	necessary	criteria	
and	have	provided	consent	to	participant	in	the	research.			
m I	understand	and	accept	the	conditions		
m I	do	not	accept		
If	I	do	not	accept	Is	Selected,	Then	Skip	To	End	of	Survey		Q1.2	INSTRUCTIONS	FOR	COMPLETING	THE	SURVEY		Below	are	a	series	of	demographic	questions	and	statements	relating	to	haematological	cancer.	Each	question	requires	a	response.	Your	progress	through	the	survey	is	indicated	by	the	bar	at	the	bottom	of	each	page.	The	answers	to	most	questions	are	in	the	form	of	multiple	choices	or	a	scale.	To	answer	these	questions	you	need	to	select	the	option	that	best	represents	your	level	of	agreement.					You	may	save	a	partially	completed	survey	to	continue	later,	but	you	may	only	submit	one	completed	survey.	Thanking	you	in	advance	for	taking	part.	Please	click	on	the	>>	arrow	below	to	begin.									2.1	Are	you	18	years	of	age	or	over?	
m Yes		
m No		
If	No	Is	Se ected,	Then	Sk p	To	End	of	Survey			Q2.2	What	is	your	age	(in	years)		Q2.3	Are	you?	
m Male		
m Female			 	
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Q2.4	What	was	your	haematological	cancer	diagnosis?	
m Hodgkin	Lymphoma/Hodgkins	Disease		
m Non-Hodgkins	Lymphoma	(NHL)		
m Acute	Myeloid	Leukaemia	(AML)		
m Acute	Lymphoblastic	Leukaemia	(ALL)		
m Chronic	Myeloid	Leukaemia	(CML)		
m Chronic	Lymphocytic	Leukaemia	(CLL)		
m Multiple	Myeloma		
m Other	-	Please	specify		 		Q2.5	What	type	of	treatment	did	you/do	you	require?	(please	select	those	applicable)	
q Radiotherapy		
q Chemotherapy		
q Oral	Medication		
q Stem	cell	transplant	
q Bone	marrow	transplant		
q N/A	-	No	treatment	was	required		
q Other	-	please	specify	 		Q2.6	How	long	ago	were	you	diagnosed	with	cancer	(in	years)?		Q2.7	Which	scenario	best	describes	your	current	treatment	regime	
m I	have	completed	treatment	for	my	cancer	(If	so	how	many	years	ago?)	 	
m N/A	-	l	did	not	require	active	treatment		
m I	am	currently	undergoing	active	treatment	(which	WILL	NOT	continue	indefinitely)		
m My	treatment	is	ongoing	(i.e.,	at	this	point	in	time	l	will	always	need	to	take	some	form	of	medication)		
m Other	-	please	specify		 		Q2.8	Have	you	experienced	a	cancer	relapse?	
m Yes		
m No			Q2.9	Have	you	since	been	diagnosed	with	a	secondary	cancer?	
m If	Yes	-	please	specify	cancer	type		 	
m No			Q2.10	What	is	your	ethnic	background?	
m White;	(including	Caucasian,	Anglo,	European	and	others	-	NOT	HISPANIC)		
m Hispanic	or	Latino;	(including	Central	American,	Mexican	American	and	others)		
m Asian;	(including	Chinese,	Japanese,	Korean	and	others)		
m Middle	Eastern		
m Black;	including	African	American,	African,	African-European,	African	Australian		
m Aboriginal		
m Torres	Strait	Islander		
m Other	-	Please	specify	 		Q2.11	What	is	the	main	language	spoken	at	home?	
m English		
m Other	-	please	specify		 		Q2.12	Which	best	describes	your	religious	beliefs?	
m Non-practising		
m Christian	(including	Uniting,	Anglican,	Baptist,	Catholic	and	others)		
m Buddhist		
m Hindu		
m Islamic		
m Jewish		
m Other	-	please	specify		 		 	
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	Q2.13	Where	do	you	live?	Postal	Code/Zip	code	 	State			 	 	City/Town	 	 	Country		 	 		Q2.14	What	area	best	describes	where	you	live?	
m Urban		
m Rural/Country			Q2.15	What	type	of	relationship	do	you	have?	
m Single		
m Married		
m De-facto/Partnered		
m Widowed		
m Separated		
m Other	-	please	specify	 		Q2.16	How	many	children	do	you	have?		Q2.17	Are	you	MAINLY:	
m Employed	full-time		
m Employed	part-time		
m Unemployed		
m A	student		
m Retired		
m A	pensioner	or	on	security	benefits		
m A	homemaker		
m Self-employed	-	please	specify	part	or	full-time		 	
m Other	-	please	specify	 		Q2.18	What	is	the	highest	level	of	education	you	completed?	
m Year	10-11/	prior	to	final	school	year		
m Year	12	/	VCE	/	HSC/	Graduated	Final	school	year		
m Tertiary	diploma	or	trade	certificate	/	TAFE		
m Tertiary	Degree		
m Post	graduate	degree		
m Word	of	mouth	(i.e.	family	or	friends)		
m Social	Media	(i.e.,	Facebook)		
m Email		
m Leukaemia	Foundation		
m Mailed	Letter		
m Other	-	please	specify		 				 	
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th nk	about	 t	 ess,	
such	as	go ng	to	
mov es,	watch ng	TV,	
read ng,	
daydream ng,	
s eep ng	or	shopp ng		
I	accept	the	rea ty	of	
the	fact	that	 t	has	
happened		
m 	 m 	 m 	 m 	
I	express	my	
negat ve	fee ngs		 m 	 m 	 m 	 m 	
I	try	to	f nd	comfort	
n	my	re g ous	or	
sp r tua 	be efs		
m 	 m 	 m 	 m 	
I	try	to	get	adv ce	or	
he p	from	other	
peop e	about	what	
to	do		
m 	 m 	 m 	 m 	
I	 earn	to	 ve	w th	 t		 m 	 m 	 m 	 m 	
I	th nk	hard	about	
what	steps	to	take		 m 	 m 	 m 	 m 	
I	b ame	myse f	for	
the	th ngs	that	
happened		
m 	 m 	 m 	 m 	
I	pray	or	med tate		 m 	 m 	 m 	 m 	
I	make	fun	of	the	
s tuat on		 m 	 m 	 m 	 m 				 	
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I	get	the	
emot ona 	
support	 	
need	from	
my	
hea thcare	
prov der		
m 	 m 	 m 	 m 	 m 	 m 	 m 	
At	 east	one	
fam y	
member	 s	
w ng	to	
make	
dec s ons		
m 	 m 	 m 	 m 	 m 	 m 	 m 	
My	fr ends	
rea y	try	to	
he p	me		
m 	 m 	 m 	 m 	 m 	 m 	 m 	
There	 s	a	
spec a 	
person	who	
s	around	
when	 	am	
n	need		
m 	 m 	 m 	 m 	 m 	 m 	 m 	
I	can	ta k	
about	my	
prob ems	
w th	my	
hea thcare	
prov ders		
m 	 m 	 m 	 m 	 m 	 m 	 m 	
I	get	the	
emot ona 	
support	 	
need	from	
my	fam y		
m 	 m 	 m 	 m 	 m 	 m 	 m 	
I	can	ta k	
about	my	
prob ems	
w th	my	
fr ends		
m 	 m 	 m 	 m 	 m 	 m 	 m 	
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Q6	INSTRUCTIONS:	The	next	set	of	questions	relate	to	how	you	feel.	Please	read	each	question	and	select	the	option	that	best	describes	how	YOU	have	been	feeling	in	the	past	week.	To	access	the	questions	please	click	on	the	arrow	>>	(on	the	right	side)	below				Q6.1	I	feel	tense	or	 wound	up 	
m Most	of	the	time	(3)	
m A	lot	of	the	time	(2)	
m From	time	to	time,	occasionally	(1)	
m Not	at	all	(0)		Q6.2	I	still	enjoy	the	things	l	used	to	enjoy	
m Definitely	as	much	(0)	
m Not	quite	so	much	(1)	
m Only	a	little	(2)	
m Hardly	at	all	(3)		Q6.3	I	get	a	sort	of	frightened	feeling	as	if	something	awful	is	about	to	happen	
m Very	definitely	and	quite	badly	(3)	
m Yes,	but	not	too	badly	(2)	
m A	little,	but	it	doesn t	worry	me	(1)	
m Not	at	all	(0)		Q6.4	I	can	laugh	and	see	the	funny	side	of	things	
m As	much	as	l	always	could	(0)	
m Not	quite	so	much	now	(1)	
m Definitely	not	so	much	now	(2)	
m Not	at	all	(3)		Q6.5	Worrying	thoughts	go	through	my	mind	
m A	great	deal	of	the	time	(3)	
m A	lot	of	the	time	(2)	
m Not	too	often	(1)	
m Very	little	(0)		Q6.6	I	feel	cheerful	
m Never	(3)	
m Not	often	(2)	
m Sometimes	(1)	
m Most	of	the	time	(0)		Q6.7	I	can	sit	at	ease	and	feel	relaxed	
m Definitely	(0)	
m Usually	(1)	
m Not	often	(2)	
m Not	at	all	(3)		Q6.8	I	feel	as	if	l	am	slowed	down	
m Nearly	all	the	time	(3)	
m Very	often	(2)	
m Sometimes	(1)	
m Not	at	all	(0)		Q6.9	I	get	a	sort	of	frightened	feeling	like	 butterflies 	in	the	stomach	
m Not	at	all	(0)	
m Occasionally	(1)	
m Quite	often	(2)	
m Very	often	(3)		
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Q6.10	I	have	lost	interest	in	my	appearance	
m Definitely	(3)	
m I	don t	take	as	much	care	as	l	should	(2)	
m I	may	not	take	quite	as	much	care	(1)	
m I	take	just	as	much	care	as	ever	(0)		Q6.11	I	feel	restless	as	if	l	have	to	be	on	the	move	
m Very	much	indeed	(3)	
m Quite	a	lot	(2)	
m Not	very	much	(1)	
m Not	at	all	(0)		Q6.12	I	look	forward	with	enjoyment	to	things	
m As	much	as	l	ever	did	(0)	
m Rather	less	than	l	used	to	(1)	
m Definitely	less	than	l	used	to	(2)	
m Hardly	at	all	(3)		Q6.13	I	get	sudden	feels	of	panic	
m Very	often	indeed	(3)	
m Quite	often	(2)	
m Not	very	often	(1)	
m Not	at	all	(0)		Q6.14	I	can	enjoy	a	good	book	or	radio	or	television	programme	
m Often	(0)	
m Sometimes	(1)	
m Not	often	(2)	
m Very	seldom	(3)			 	

RESILIENCE IN HC SURVIVORS 331	
	Q8	This	final	section	allows	you	the	opportunity	to	provide	more	details	on	your	personal	coping	experience.	Thank	you	for	taking	the	time	to	participate.	To	access	the	questions	please	click	on	the	>>	arrow	(on	the	right	side	below).				Q8.1	Where	did	you	receive	the	MOST	HELPFUL	cancer	related	INFORMATION?	Please	select	the	most	appropriate	answer	below.		
m Medical	Specialist	(i.e.,	oncologist,	haematologist	and	others)	(1)	
m Nurses	(2)	
m Community	support	group	(i.e.,	Cancer	council,	leukaemia	foundation	and	others)	(3)	
m Internet	(i.e.,	Facebook,	social	media)	(4)	
m General	Practitioner	(5)	
m Other	cancer	survivors	(7)	
m Psychologist/Counsellor	(8)	
m Other	-	please	specify	(9)	 			Q8.2	In	your	experience	who	in	your	CLINICAL	TEAM	has	HELPED	OR	SUPPORTED	you	the	MOST	following	your	cancer	diagnosis?	(i.e.	specialist,	nurses,	psychologist,	general	practitioner,	pharmacist	or	others).	Please	provide	details	below.	 				Q8.3	If	applicable,	who	in	your	clinical	team	was	the	LEAST	supportive?	Please	provide	anonymous	details.	 					Q8.4	Based	on	your	personal	experience	is	there	anything	else	you	would	like	to	share	that	may	assist	others	to	cope	when	facing	a	similar	situation.	Please	provide	details	below.				 												
	
YOUR	PERSONAL	EXPERIENCE	IS	IMPORTANT!!	THANK	YOU	FOR	YOUR	PARTICIPATION	J	J	
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Appendix M 
 
Normal Q-Q (Quantile-Quantile) and Detrended Normal Q-Q Plot of 
Normal Distribution of Data 
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Appendix N 
 
Normal Probability Plot of Standardised Residuals for Predicting 
Resilience among HC survivors 
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Appendix O 
 
Scatterplots of Standardised Residuals and Standardised Predicted Values 
for Predicting Resilience among HC survivors 
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Appendix P 
 
Non-Parametric vs Parametric Tests Comparing Demographic Outcomes Among HC Survivors. 
 
Table 2A  
Non-Parametric and Parametric Tests Investigating Differences in Resilience, Depression and Anxiety Across Years Since Diagnosis  
___________________________________________________________________________________________________________ 
Mann-Whitney U Test      Independent t-test  
STS  LTS  STS vs. LTS   STS   LTS  STS vs. LTS  
Mean Rank Mean Rank χ2 p   M  M  t p 
_____________________________________________________________________________________________________________________ 
Time Since Diagnosis 
Resilience  102.44   120.56  -2.10 <.05   166.32  172.09  -1.60 ns 
Depression   122.37  100.63  -2.67 <.05   4.41  3.47  2.15 ns 
Anxiety   120.37  102.63  -2.07 <.05   7.21  6.23  1.90 ns 
______________________________________________________________________________________________________________________ 
Note. STS = Short-term survivors (< 5 years); LTS = Long-term survivors (6 + years); ns = Non-significant 
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Table 2B  
Non-Parametric and Parametric Tests Investigating Differences in Resilience, Depression and Anxiety Across Gender 
___________________________________________________________________________________________________________ 
Mann-Whitney U Test     Independent t-test  
Male   Female  Male vs. Female Male   Female  Male vs. Female  
Mean Rank Mean Rank χ2 p  M  M  t p 
___________________________________________________________________________________________________________ 
Resilience   112.12  111.06  -0.13 ns  170.36  168.50  0.49 ns 
Depression   105.18  115.35  -1.15 ns  3.68  4.09  -0.92 ns 
Anxiety   104.85  115.85  -1.30 ns  6.11  7.09  -1.83 ns 
________________________________________________________________________________________________________________ ____ 
Note. Mdn = ns = Non-significant 
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Table 2C  
Non-Parametric and Parametric Tests Investigating Differences in Resilience, Depression and Anxiety Across Age  
___________________________________________________________________________________________________________  
     Kruskal-Wallis Test      One-way ANOVA   
YA vs. MA vs. OA       YA vs. MA vs. OA 
Mean Rank  χ2 p    M   t p 
_____________________________________________________________________________________________________________________ 
 
Resilience  118.13 vs. 106.41 vs. 115.26 1.32 ns   170.25 vs. 167.63 vs. 169.20 0.34 ns 
Depression  100.64 vs. 117.12 vs. 108.94 2.00 ns   3.86 vs. 4.19 vs. 3.64  0.66 ns 
Anxiety   133.68 vs. 113.90 vs. 98.34 7.86 <.05   8.03 vs. 6.88 vs. 5.91  3.96 <.05 
_____________________________________________________________________________________________________________________ 
Note. YA = Young Adult (18–40 years); MA = Middle Age Adult (41-60 years); OA = Older Adult (61 + years);  
ns = Non-significant 
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Appendix Q 
Survey	Participant’s	Advice	to	Newly	Diagnosed	Individuals		________________________________________________________________________________Participant		 	 Advice	Number		 1. Do	not	see	myself	as	a	patient	but	a	cancer	client,	therefore	be	part	of	decision	making	-	being	educated	and	informed	on	condition	-	be	your	own	wellness	advocate	2. Spiritual	Beliefs	3. For	me	research	is	a	good	tool	and	also	finding	a	support	group.	It's	these	people	who	really	understand	you	and	what	you	are	going	through!	4. Find	a	support	group.	If	you're	not	happy	with	your	GP	or	specialist	find	a	new	one	this	is	a	long-term	relationship	and	it	has	to	work	for	you.	5. Go	to	support	groups.	6. Take	your	time	to	absorb	all	the	information	7. Make	holiday	plans	and	get	away.	8. Stay	away	from	the	Internet	for	information	until	you	have	spoken	to	a	specialist	(oncologist,	haematologist,	etc.)	as	the	amount	of	information	available	on	the	Web	can	be	overwhelming	and	quite	scary.		Each	person's	journey	through	this	illness	is	different	and	with	new	therapies,	prognoses	are	so	much	better	than	some	websites	make	it	appear.	9. Keep	a	positive	attitude,	it	works	wonders.		Don't	concentrate	on	side-effects	or	problems	more	than	needed.		Do	as	many	of	the	things	that	you	did	before	diagnosis	to	keep	a	normal	life.	11 Looking	back,	although	I	didn't	believe	it	at	the	time,	I	was	in	denial.	I	was	going	through	some	pretty	significant	side-effects	and	drugs	to	try	and	combat	them,	and	consequently	was	quite	detrimental	to	my	health.		I	pushed	myself	to	do	things,	so	that	it	looked	like	I	was	coping	and	wasn't	going	to	give	in.	I	was	very	fortunate	that	I	had	a	very	supportive	boss	and	staff	who	helped	carry	me	as	I	had	a	very	demanding	job.	At	lunchtime,	I	would	sit	in	my	car	and	have	a	20	minute	power	nap	if	I	didn't	have	meetings	so	that	I	didn't	go	to	sleep	at	my	desk!	Having	the	power	nap	was	really	beneficial	in	coping.	The	first	2	years	were	the	hardest.	Having	been	a	nurse,	I	was	very	pedantic	about	researching	and	discovering	as	much	as	I	could	about	my	cancer	and	o	this	end,	I	spent	hours	on	the	internet,	CML	groups	getting	support	and	then	in	turn	giving	support.	I	also	do	not	like	not	being	in	control	and	have	a	mandate	about	being	my	own	advocate	and	ensuring	that	I	am	getting	best	practice	care	and	feel	confident	in	my	medical	team	that	we	are	on	the	"same"	page.	When	my	GP	would	refer	me	to	another	specialist	for	a	pre	existing	illness,	he	would	say	to	me	"	don't	expect	Dr	X	to	be	touchy	feely	and	sit	and	talk	to	you",	he	knew	me	so	well.	Whether	it's	family,	friend	or	a	fellow	cancer	patient,	it	is	important	you	have	someone	you	can	talk	to	and	express	your	feelings	,	fears,	frustrations	etc.	without	feeling	like	you	are	whinging	all	the	time	and	believe	me	I	have	done	more	than	that!	I	used	to	feel	guilty	about	it,	especially	when	there	is	always	someone	worse	off	and	I	wasn't	having	"conventional"	chemo,	so	didn't	look	sick	as	such,	except	that	my	whole	appearance	changed	dramatically	in	the	first	year	due	to	the	drug	I	was	on	and	among	things,	couldn't	wear	makeup	any	more,	put	on	weight	and	felt	bloated	all	the	time,	was	fatigued,	felt	sick	and	was	hard	to	enjoy	a	lot	of	things.	I	was	lucky,	I	was	able	to	change	drugs	and	with	the	new	drug	felt	a	new	person	12 Learn	ALL	you	can	about	yourself	and	your	medications.		Don't	take	any	medication	you	don't	absolutely	have	to	have	to	live.		Eat	healthy,	exercise,	stay	hydrated,	don't	depend	too	much	on	others,	and	look	inward	for	strength.		If	you're	a	person	of	faith	talk	to	the	creator	on	a	regular	basis.	15 Nothing	I	can	think	of.	I	was	fortunate	to	have	my	CML	diagnosed	early	so	did	not	have	the	problems	many	others	have	had.	16 Cowboy	Up	as	we	say.	Don't	feel	sorry	for	yourself.		Deal	with	it.		Your	attitude	is	your	strongest	medicine.	17 There	is	always	something	good/positive	to	find	in	ANY	situation.	Your	attitude	can	be	your	best	ally	or	worst	enemy.	
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	 18 While	I	try	to	laugh	and	find	funny	things	to	keep	me	occupied,	I	have	a	near	constant	anger	that	makes	me	more	cynical.	In	fact,	I'm	seriously	angry	and	have	no	one	or	thing	at	which	to	direct	the	anger	(which	makes	it	even	more	frustrating).	Any	semblance	of	religious	belief	I	may	have	had	before	diagnosis	is	gone.	CML	is	my	second	bout	with	cancer	in	addition	to	a	neuromuscular	disease.	When	people	tell	me	that	everything	happens	for	a	reason,	I	always	hit	back	with	something	like,	"Really?,	find	me	a	*ing	reason	for	this."	I	really	find	that	I'm	happier	when	I	don't	have	to	deal	with	other	people	and	their	stupid	platitudes.	21	 When	first	diagnosed,	my	mantra	was	one	day	at	a	time;	not	looking	too	far	ahead.		I	read	everything	I	could	and	saw	the	best	Dr.	for	my	cml	(Dr.	Druker)	to	ease	my	worry.		I	worked	hard	at	staying	positive,	not	that	it	will	change	the	outcome	of	things,	it	will	make	you	feel	much	better.		I	still	do	this	10	years	later,	but	focus	on	doing	things	I	enjoy	doing,	spending	time	with	family,	doing	yoga	and	meditation	and	exercise	daily.			These	help	control	worry	and	negative	thoughts	22 Trust	your	doctor.	Follow	your	medicine	routine.	Research	you	condition	and	various	treatments	-	knowledge	is	power.	Be	positive	about	your	treatment	outcomes.	Join	social	media	groups	with	similar	cancers.	Be	an	example	to	others.	Share	your	progress	and	failures.	Trust	your	own	judgement	and	decisions.	Live	for	the	day.	23 Don't	blame	every	ache	and	pain	on	your	cancer	or	meds.	26 I	wish	there	were	more	support	groups	locally	 	27 Believe	in	your	treatment.	Listen	to	your	body	and	take	time	out	when	you	need	it,	no	matter	when	or	where.		Don't	listen	to	negative	stories.	30 It	has	been	much,	much	harder	to	deal	with	my	blood	cancer	than	with	my	previous	tumour	based	cancer	which	had	a	very	clear	end	of	treatment	35 People	with	same	problem	are	the	safest	sort	of	support	36 Doctors	don't	always	recognize	symptoms	as	side-effects	of	medicines.	Trust	your	own	instincts	and	fight	for	the	answers.	38 Positive	mental	attitude	is	the	key	to	coping.	You	can't	do	anything	about	your	diagnosis	so	don't	waste	your	life	feeling	sorry	for	yourself	-	life	it	to	the	full!!	Also	support	groups	are	great	-	you	are	never	alone	42 Make	your	decision	on	the	outcome	you	want	and	be	a	part	of	your	medical	solution.	43 Stay	strong,	retain	a	positive	attitude,	always	look	on	the	bright	side,	live	your	life	to	the	full,	retain	your	sense	of	humour,	another	day	is	a	bonus	in	your	life	47 Join	a	social	media	group.	I	joined	the	Chronic	Myloid	Leukaemia	group	and	talking	to	people	with	the	same	condition	as	me	has	helped	immensely	49 For	me	having	all	the	information	right	from	the	start.	I	got	all	info	from	the	Internet	initially	and	got	tremendous	info	and	support	from	a	website	cml.org.uk		I	then	changed	Dr’s	and	hospital	and	now	have	the	best	care	I	could	hope	for	51 You	need	medical	and	psychological	help	when	you're	told	you	have	a	cancer	that	can't	be	cut	out,	blasted	or	cured!	It's	a	very	hard	journey	and	the	NHS	doesn't	factor	that	into	your	care	programme.	As	long	as	you	respond	to	the	drugs	and	your	blood	count	go	back	to	normal	then	you're	ok...	In	reality,	you're	far	from	it.	52 Connect	with	other	patients	and	support	groups	53 Specialist	to	be	more	sympathetic.	Told	had	CML	on	a	Wednesday	chemo	on	Friday!	Told	go	back	to	work	Monday!!!	Given	leaflet	with	outdated	information	and	I	had	5	years	to	live!!!!!!!		No	follow	up	by	any	nurses	or	medical	professionals!!!	Felt	completely	alone	and	lost.	54 I	joined	a	CML	support	group	on	social	media	which	is	monitored	really	well	and	I	found	talking	to	other	people	in	the	same	situation	as	me	really	did	help.	55 Join	a	support	group	asap.	56 Medical	staff	do	not	take	a	holistic	view	of	you	-		they	are	only	interested	in	treating	the	problem,	they	have	little	consideration	for	your	emotional	well-being.		Also	in	my	experience	they	are	completely	disinterested	in	any	side-effects	you	experience	as	long	as	the	treatment	is	keeping	the	cancer	in	check.	Specialists	also	carefully	need	to	consider	how	they	phrase	things	at	consultations	to	ensure	you	do	not	experience	unnecessary	worry	especially	when	they	do	not	have	much	experience	of	your	particular	type	of	blood	cancer	-	I	would	think	more	of	them	if	they	actually	admitted	they	were	not	sure	and	needed	to	liaise	with	colleagues/centers	of	excellence	rather	than	trying	to	bluff	their	way	through	things.		There	have	been	several	occasions	when	my	specialist	has	asserted	
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something	contrary	to	what	conversations	on	the	CML	Facebook	area	would	seem	to	indicate	other	CML	sufferers	have	experienced.		The	Facebook	CML	community	info		usually	turns	out	to	be	right	leaving	my	specialist	trying	to	justify	themselves.		I	am	currently	pursuing	a	change	of	hospital	and	am	willing	to	travel	any	distance		to	attend	a	Centre	of	Excellence	for	my	particular	type	of	blood	cancer.	57 Remain	positive,	because	life	still	goes	on.	59 Don't	be	afraid	to	ask	questions.		Don't	just	role	over	and	die.		Demand	support.	60 For	me,	CML	is	a	"lonely"	disease	since	I	have	never	personally	met	anyone	with	the	disease	other	than	on	Facebook	or	the	internet.		I	have	no	one	who	can	give	me	advice	on	coping.	65 Be	prepared	to	go	through	this	primarily	alone.	In	my	opinion	it	is	better	that	way.				 People	don't	need	to	be	dragged	down	by	feeling	obligated	to	give	a	hoot.	66 Easy	availability	of	TKIs	must	be	helpful	with	competitive	price.	68 Having	a	good	doctor	makes	all	the	difference.		Also	have	found	Facebook	a	great	help	in	finding	out	about	the	illness	direct	from	other	suffers	69 Be	prepared	for	a	new	normal.	It’s	ok	to	take	time	to	assimilate	to	a	new	lifestyle.	The	cancer	is	not	all	you	are.	70 Find	a	good	Psychiatrist	and	Psychologist	as	you	will	need	them,	but	ABOVE	ALL.	find	a	GREAT	GP	one	who	you	can	call	by	her	/	his	first	name,	one	who	will	not	hurry	you	up	as	your	20	minute	slot	is	up.......I	did	mention	that	all	G.P.	appointments	should	be	2	minutes	i.e.	a	DOUBLE	;)	things	will	happen	between	visits	to	Haemotology	/	Oncology.	Your	GP	is	usually	closer	and	can	take	the	time	to	go	through	it	with	you	and	help	you	:)		Try	to	find	yourself	a	"Cancer	Buddy,	Blood	Sister"	these	are	people	who	will	be	therefore	you	even	just	a	short	you	are	doing	alright	is	all	it	takes....	(This	person	must	have	a	cancer,	better	still	a	cancer	like	yours,	the	best	if	it	is	the	same	and	you	are	on	the	same	drug	combo,	same	gender	and	roughly	same	stage)	71 Everyone's	response	to	their	diagnosis	is	individual	and	you're	entitled	to	the	way	YOU	feel.	It	is	okay	to	be	sad,	it	is	okay	to	use	black	humour,	it	is	okay	to	cope	one	day	and	not	the	next.	The	hidden	cancer	is	the	hardest-	you	look	well	on	the	outside	but	inside	your	body	is	fighting	really	hard.	Let	people	know	that	you're	tired,	you	have	bone	pain,	you	feel	like	poos.	If	people	don't	know,	they	will	assume	you	are	fine.		CML	is	not	the	best	cancer	to	have	if	you're	going	to	get	a	cancer.	All	cancers	come	with	their	own	level	of	shittiness!!	72 In	the	first	few	months	it	is	just	horrific	but	you	just	have	to	get	through	it	with	the	love	and	help	of	your	doctors,	family,	friends	and	prayer	I	think	I	am	very	lucky	as	I	had	a	wonderful	support	group	and	wanted	to	survive.	Luckily	I	did	survive	and	now	enjoy	every	single	day	74 Stay	hopeful	and	ask	yourself	what	are	you	doing	to	improve	your	situation.	We	can't	always	rely	on	others	75 Maintain	a	positive	attitude.		Accept	realities	of	treatment	side-effects.	76 Exercise	everyday	in	some	way	77	 Get	all	the	information	you	can	from	reputable	sources	and	reject	anything	that	is	not	supported	by	sound	evidence.	Find	a	good	doctor	whom	you	can	trust	but	also	question.	78 I	felt	guilty	that	I	had	to	put	my	partner	(x)	and	child	through	this	I	wish	I	received	counselling	to	make	me	realise	early	on	that	I	should	not	have	to	felt	that	way	79 Ensure	you	surround	yourself	with	family	who	can	support	you	on	an	ongoing	basis.	80 Ask	what	you	are	doing	to	help	yourself	and	be	accountable	for	your	own	choices	and	decisions	81 Keep	a	sense	of	humour	 	82 It	is	important	to	give	yourself	time	to	process	your	diagnosis	83 Look	after	your	general	health.	Take	a	list	of	questions	to	the	doctor	when	you	have	appts	as	they	are	busy	and	it’s	easy	to	forget.	84 I	have	found	meditation	to	be	helpful	and	knowledge	is	power	85 Just	go	with	it	and	don't	stress	too	much!	87 In	my	situation	I	did	not	dwell	on	the	fact	that	I	had	cancer,	discovered	at	stage	4.	After	the	initial	shock	my	thoughts	and	actions	were	purely	related	to	what	was	required	to	battle	the	cancer	and	get	better	for	my	family.	My	specialist	(Professor	Ross	Baker)	was	also	a	major	support;	and	his	straight	forward	and	truthful	approach	about	my	situation	was	very	much	appreciated	and	a	benefit.	
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91 Remain	positive,	be	kind	to	yourself,	pick	your	battles	and	put	yourself	first	during	this	time.	!!	92 Keep	up	your	social	contacts,	your	exercise	and	as	many	as	possible	of	the	activities	you	pursued	prior	to	diagnosis	and	treatment.	In	other	words	don't	allow	the	disease	to	define	you.	93 This	one	is	hard	because	everyone	is	different.		But	you	have	to	fight	-	and	fight	hard.		But	stay	positive.	And	don't	get	bitter	that	it	was	you	that	got	cancer	-	never	ask	"Why	me?"	.	That's	just	wasting	your	time.	94 I	have	read	many	people's	stories	so	survival	and	courage.	Connecting	with	people	who	have	cancer	or	are	in	remission	is	credible	and	encouraging.	So	I	would	offer	all	options	I'd	ways	to	get	support	outside	of	family	and	loved	ones	so	there	is	multiple	options.	95 As	mine	is	an	indolent	cancer	-Walderstrom's	syndrome-	I	have	had	no	trouble	with	coping	over	the	years.,	but	I	could	offer	no	advice	for	anyone	with	a	different	cancer			.I	was	supported	by	my	very	positive	wife	until	her	death	recently.	Be	open	about	it	discuss	with	family	and	friends	--lots	of	moral	support.	96 Accept	your	diagnosis.		Ask	as	many	questions	as	possible.		If	you	are	unhappy	with	your	specialist	or	their	treatment	plan	ask	for	a	second	opinion.		Be	honest	and	open	with	your	family,	tell	them	when	you	get	the	diagnosis,	obviously	there	will	be	tears	and	despair	but	this	passes	and	their	support	is	invaluable.		Tell	people	that	you	deal	with	regularly	e.g.	friends	or	work	colleagues.		I	found	it	much	easier	if	they	knew	and	I	didn't	have	to	pretend	if	I	was	having	a	bad	time.		Accept	help!		Don't	try	and	answer	every	message	of	goodwill,	accept	them	for	the	expressions	of	care	that	they	are.		Love	your	family	and	confide	in	them	-	they	go	on	this	journey	with	you	and	will	love	you	regardless	of	what	happens.		Indulge	yourself,	buy	that	dress	that	you	like,	have	that	decadent	piece	of	cake.		Stop	and	smell	the	roses,	give	yourself	time,	dream,	listen	to	music,	sing,	pray,	meditate,	cuddle	the	dog	or	cat,	go	for	a	walk,	cry,	shout	or	scream	-	it	is	your	disease	and	your	journey	-	own	it!	Believe	in	yourself	and	all	those	caring	for	you.		Try	not	to	listen	to	those	who	will	try	and	give	you	negative	advice.		It	is	a	tough	journey	but	one	you	have	a	good	chance	of	surviving,	a	positive	attitude	makes	the	world	of	difference.		Realise	you	and	your	life	may	never	be	the	same,	accept	any	deficiencies	or	any	ongoing	side-effects	-	you	are	alive	to	enjoy	the	things	you	thought	you	would	never	be	able	to	do.	97 Have	Faith	in	a	higher	Deity	.	98 If	you	find	a	lump	go	straight	away	to	the	doctor-don't	forget	it,	as	I	did!!!	 	99 Make	sure	you	have	a	sympathetic	specialist	who	is	careful	to	check	condition,	and		encouraging	to	persist.		Not	too	keen	to	tell	all	the	worse	things	that	can	develop,	but	rather	encouraging	patient	to	live	normally	and	keeps	a	careful	watching	brief.	100 I	found	these	questions	strange	they	assume	that	the	experience	of	cancer	was	traumatic.		I	was	diagnosed	because	my	wife	took	me	to	our	Doctor	after	I	was	eating	very	well	and	still	losing	weight.		After	an	ultrasound	when	a	lump	the	size	of	a	fist	was	found	in	my	abdomen	and	a	sample	returned	a	positive	diagnosis	I	cancelled	a	holiday	to	Alaska	and	started	Chemo.		I	also	went	to	Sydney	for	radiology.		My	only	problems	have	been	some	hyperactivity	after	prednisone	injections	after	Chemo	and	nausea	the	evening	after	the	first	radiology	treatment.		I	have	never	been	depressed	or	concerned	at	having	cancer	it	just	happened	to	me.		There	is	no	use	crying	over	spilt	milk.		I	was	a	lucky	survivor	and	have	since	had	prostate	cancer	with	a	prostatectomy,	squamous	cell	and	basal	cell	carcinomas	all	of	which	I	have	so	far	survived.		If	others	could	be	more	pragmatic	and	maybe	stoical	perhaps	they	could	manage	their	stresses	better.		I	fear	I	feel	a	fraud	when	I	hear	how	people	cope	heroically	with	their	cancers	mine	were	not	problems	for	me.	101 I	held	the	belief	I	should	just	ignore	and	work	through	the	treatment	period,	when	I				realised	this	was	not	possible	and	accepted	the	fact	it	was	a	lot	easier.	A	supportive	boss	and	work	colleagues	really	helped,	as	did	relaxation	CD.	102 Learn	to	accept,	listen	to	your	specialist,	ask	questions	and	get	on	with	life	and	enjoy	as	much	as	possible.		It	helps	if	you	have	a	very	supportive	partner	who	is	an	RN	and	who	can	explain	anything	you	missed	with	the	specialist.		103 Positive	attitude	is	extremely	important	to	recovery.	104 Up	until	you	are	diagnosed	you	are	going	down	hill.	Once	diagnosed	you	are	on	the	road			to	recovery.	Stay	on	that	road	and	do	not	let	the	procedures	no	matter	how	daunting	allow	you	to	waiver.	Enjoy	every	carer	be	it	Dr,	nurse,	family	or	friends	and	celebrate	every	day.	People	feel	better	if	you	let	them	help	in	their	own	way	so	let	them.	It	is	a	win	win	situation.	Do	not	look	for	the	negatives	because	they	are	there	ready	to	bring	you	
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down.	You	being	strong	helps	other	around	you	feel	strong.	Do	not	push	yourself	to	maintain	your	old	routine,	let	your	body	rest	and	get	on	with	healing	and	fighting.	Good	luck	with	your	Phd	105 Belong	to	as	many	support/social	groups	as	you	have	time	for.	Keep	busy	if	you	are	well	enough.	I	was	lucky	to	be	able	to	continue	all	my	activities	during	and	after	treatment.	106	Always	believe	in	yourself	and	don't	pay	too	much	attention	to	the	negative	opinions	of	others.	You	are	the	person	with	the	cancer	and	you	know	how	you	feel	better	than	anyone	else.	People	are	generally	ignorant	when	it	comes	to	understanding	the	different	types	of	some	cancers	and	are	of	the	opinion	that	once	someone	is	diagnosed	then	they	are	as	god	as	dead.	Don't	let	opinions	like	that	get	you	down	and	keep	a	positive	attitude.	I	had	no	idea	how	important	a	positive	attitude	is	until	I	was	diagnosed.	It	can	make	the	difference	between	survival	and	giving	up	leading	to	a	premature	and	unnecessary	death.	108 Being	informed	of	what	is	happening	and	why	is	critical,	do	not	choose	to	ignore	what	is	happening.	109 Keep	a	positive	mind,	Don't	think	the	worse...	110 Do	not	listen	to	negative	people,	who	only	see	doom	and	gloom.	Have	faith	in	your	treating	specialist	and	ask	questions.	111	talk	to	others	with	cancer.	I	found	that	solaris	care	support	group	were	very	open	and	helpful.	113 All	I	can	suggest	is	to	seek	a	support	group	and	talk	to	other's	that	are	in	the	same	boat.	114	1.	Joining	a	support	group	has	been	very	helpful	and	supportive.		2.	Informing	yourself	about	the	condition	/	treatment	options.		3.	Taking	a	holistic	approach	to	your	health	-	treating	your	whole	body	/	mind	(healthy	diet	/	exercise	/	mindfulness	/	etc.)	116 Remain	positive	117 Please	give	answers	when	first	diagnosed	as	it	would	of	made	me	feel	a	lot	better	understanding	CLL.		I	was	told	I	had	Leukaemia	by	my	GP	&	not	to	ask	questions	&	did	not	see	the	specialist	for	over	a	month!	I	was	left	high	&	dry	&	would	not	like	anyone	to	go	through	that	horrible	feeling	of	not	knowing.	I	purchased	books	on	Leukaemia	to	even	hand	out	to	patients	when	first	diagnosed.	The	Leukaemia	foundation	has	been	wonderful	&	I	should	of	contacted	them	straight	away	for	the	information	&	they	would	of	sent	it	to	me	straight	away.	118 I'm	always	unsure	of	what	to	say	when	it	comes	to	these	questions...I've	learnt	that	everyone's	experiences	are	individual,	from	the	treatment	ups	&	downs	to	character	of	the	people	they	have	supporting	them.			The	medical	team	I	was	under	at	Royal	North	Shore	in	Sydney	were	brilliant;	the	booklets	provided	by	the	Leukaemia	Foundation	and	Cancer	Council	were	very	helpful	to	me	&	my	family	in	understanding	my	disease	and	treatment;	there	was	nothing	better	for	me	than	having	my	husband	and	Mum	by	my	side	al	the	way.			Therefore	in	my	experience,	I'd	say	your	best	to	surround	yourself	with	supportive	people	(Family,	Friends,	Nurses,	Psychologist’s	etc.)		they'll	be	with	you	through	the	highs	and	lows	of	the	journey,	they'll	help	bring	out	the	best	in	you	when	it	feels	lost.	119 Take	ownership	of	you	situation	and	do	all	you	can	to	recover.	121 We	all	have	to	face	challenges	at	some	point.	Keep	informed	and	look	after	your	health	and	expect	it	to	take	time	to	fully	accept	your	diagnosis.	122 Accept	help	don't	be	a	martyr	123 You	have	good	and	bad	days.	Take	each	day	at	a	time.	Don’t	rush	your	recovery.	124 Spend	time	with	your	mates	as	much	as	you	can	125 Get	in	contact	with	others	who	are	going	through	the	same	treatment.	No	one	else	can	fully	understand	unless	they	walk	in	your	shoes	128 Just	to	be	treated	like	a	person	not	a	patient	129 Get	as	much	information	as	possible	and	join	a	group	with	others	with	the	same	cancer	it	is	very	comforting	and	very	helpful	to	have	contact	either	others	going	through	the	same	things	,	the	same	treatment	side-effects	133 Mindfulness	techniques	were	really	helpful,	as	was	linking	up	with	an	alternative	health	center	for	supportive	therapies	alongside	conventional	ones.	on-line	groups	134 I	recently	joined	a	social	media	group.		This	has	given	me	a	boost.	135 You	are	going	to	have	a	long-term	relationship	with	your	specialist	and	GP	so	make	sure	you	are	a	'good	fit'	and	can	communicate	and	understand	each	other	well.		If	you	are	not	feeling	supported	-	change	doctor.	
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136 Sometimes	I	think	we	don't	always	get	enough	answers	from	our	specialist	mostly	because	in	the	beginning	and	even	now	for	me	I	still	do	not	always	know	what	questions	to	ask.	And	then	when	I	do	it's	always	straight	after	I	have	had	my	check	up	and	weeks	away	from	my	next	opportunity.	137 I	saw	a	hypnotherapist	who	helped	me	a	lot	138 Viewing	blogs	can	be	depressing	when	you	see	how	many	issues	others	have	with	the	TKI's.		You	must	remember	that	everyone's	journey	is	different	and	not	allow	yourself	to	be	sucked	into	the	negatives.		Just	sitting	on	your	butt	and	doing	nothing,	feeling	sorry	for	yourself	and	not	taking	charge	of	your	cancer,	only	makes	it	more	of	a	mental	challenge.	Don’t	be	afraid	to	share	with	others	and	if	you	get	worn	down,	go	to	bed	and	don’t	feel	guilty	about	it.		You	control	your	fate.	141 Things	have	been	difficult	but	also	routine.		It’s	been	painful,	emotional	and	can	take	a	lot	of	your	life.		I	have	found	discrimination	in	the	workplace	and	in	social	settings.		Generally	I	have	heard	a	lot	of	people	having	a	relatively	easy	process	however	there	are	cases	(including	mine)	that	have	constant	hiccups	and	ups	and	down’s,	my	latest	is	the	T315l	mutation.		My	experience	is	to	take	and	deal	with	each	step	as	it	comes.		This	illness	is	like	a	game	of	poker,	it’s	not	about	the	hand	you're	dealt	but	he	way	in	which	you	play	it.	143 Positive	attitude	that	I	don't	have	144 Stay	active!	145 Get	a	second	opinion	make	your	haematologist	take	the	time	to	listen	to	you.	Don't	worry	that	they	are	busy,	make	them	listen	to	you	and	understand	what	you	are	dealing	with.		Join	a	social	network	with	other	dealing	with	the	same	things.	146 I'm	a	late	comer	to	social	media.	It	is	now	a	much	better	source	of	information	for	me	than	it	was	at	diagnosis.	At	diagnosis,	meeting	someone	else	with	the	same	disease	was	the	most	important	thing	for	me	other	than	the	basic	information	provided	by	the	Leukaemia	Foundation	printed	information,	which	was	wonderful	for	me	and	for	sharing.	1.	good	source	of	clinical	info	to	refer	to	as	much	or	as	little	as	you	need	2.	social	support	through	others	in	the	same	boat	148 Be	informed.		Ask	lots	of	questions.		Speak	to	other	patients/survivors.	As	my	Oncologist	told	me	"Exercise,	Nobody	does	too	much!"		Research	shows	the	physical	benefits,	helping	you	cope	with	chemo,	but	it	also	has	a	massive	part	to	play	mentally.		It	was	one	of	my	ways	to	fight,	instead	of	allowing	myself	to	focus	on	the	disease	or	treatment.	All	of	this	was	supported	by	my	family,	friends	and	faith	community.	149 Support	groups	and	information	sessions	with	other	people	151 I	became	extremely	active	with	the	Leukemia	&	Lymphoma	Society	and	did	a	lot	of	fundraising	for	research	grants	by	joining	Team	in	Training.		I	volunteer	by	speaking	with	newly	diagnosed	patients	who	have	the	exact	form	of	the	disease	as	I	do.		I	know	that	I	benefit	other	people	as	well	as	myself	by	doing	this.		Unfortunately,	I	have	an	unrelated	secondary	cancer	which	was	diagnosed	right	after	I	lost	my	husband	so	there	has	been	a	lot	going	on	to	cope	with.		But	I'm	getting	professional	help	with	all	of	this.	152 Learn	about	your	disease	and	talk	with	others	who	have	been	similarly	diagnosed.	Online	support	groups	are	essential	155 There	is	always	my	GP	to	turn	to,	I	am	very	fortunate,	my	GP	and	I	are	both	Christians	and	can	discuss	prayer	and	my	belief	in	God,	that	HE	is	always	by	my	side	caring	for	me.	157 Fellow	CML	patients		just	getting	together	and	sharing	ideas	helps									158	We	are	all	going	to	drop	off	the	perch,	maintain	your	sense	of	humour.									159	I	would	have	really	appreciated	counselling	at	the	time	of	diagnosis.	It	was	not	offered	+	l	probably	didn't	know	how	to	access	amongst	the	chaos.	I	think	long-term	this	has	been	an	issue	as	l	coped	alone.	Despite	support	"cancer"	is	a	very	lonely	experience.	You/I	protect	family	from	the	truth	and	reality	of	how	l	really	felt	at	risk	of	hurting	them.								160	Very	helpful	to	join	support	group	(i.e.,	leukaemia	foundation	-	specific	to	diagnosis)	to	meet	others	with	same	-	support,	friendship	etc		161	 Green	smoothies	helped	with	'brain	fog'.			Exercise	is	good	too.		'Rest'	-	l	wasn't	working	the	first	4	months	it	helped	to	be	at	home.		Everyone	is	surprisingly	lovely	which	has	helped	so	much	because	l	felt	so	'lost'	its	not	depression	its	the	drugs	–	l	am	on	'sprycel'.		Again	leukaemia	foundation.	They	seek	you	out	which	is	good	as	you	need	help	+	don't	know	where	to	turn.	I	am	glad	they	found	me.	The	doctors	should	really	give	the	hand	outs	as	well	-	they	don't.	They	are	left	in	the	rooms	&	usually	all	one.	I	was	lucky	on	day	after	3	months	there	was	a	lady	there		(from	the	leukaemia	foundation)	who	found	me	&	
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talked	to	me.	I	was	still	a	mess.	Also	the	drug	company	had	a	nurse	that	calls	&	checks	on	you,	but	again	you	have	to	sign	to	receive	the	info	et	to	receive	service.	The	drug	company	had	to	call	chemist	and	asked	them	several	times	to	contact	me.	Whey	didn't	the	specialist	organise	these	things?							162		I	was	too	casual	after	finding	the	lump	in	my	neck	and	promptly	'forgot	about	it'	NOT	a	good	idea.		I	refuse	to	look	on	the	'dark	side'	although	ALL	of	my	immediate	family	have	died	from	various	cancers	(l	think	it	must	be	the	POM	in	my	upbringing	KEEP	CAM	DON'T	PANIC.	Kate	-	How	can	l	possibly	make	a	fuss.	Both	my	parents	faced	cancer	and	death	so	bravely.	I	cannot	let	the	side	down	-	however	it	is	early	in	my	diagnosis.		Dad	was	46	Mum	59	+	11	months.								172	 Look	forward	not	back.	Stay	positive								180	 Be	Positive								184	 I	believe	cancer	has	been	a	blessing	for	me	and	helped	me	see	the	REAL	importance	of	living	life	while	l	still	have	it.										185	 Join	groups	eg.	exercise	group,	walking	group,	Keep	in	touch	with	colleagues.	Thus	you	always	have	support	and	activities	to	keep	you	busy	and	interested	in	life.									186	In	my	particular	case	(CLL)	the	cancer	has	made	little	change	in	the	6.5	years	since	diagnosis,	INDOLENT	is	the	term	used	by	the	haematologist.	Therefore	l	have	not	shared	the	fact	that	l	have	cancer	with	my	friends,	only	my	family.	I	think	in	a	way	this	as	helped	me	to	generally	ignore	the	fact	that	l	have	cancer	and	to	get	on	with	enjoying	life.	I	would	not	enjoy	being	questioned	every	time	l	ran	into	friends	on	how	l	was	feeling.	Should	my	condition	worsen	and	the	need	for	treatment	arise	then	l	would	eek	the	support	of	friends.	In	the	mean	time	my	partner	gives	me	the	emotional	support	l	need	and	a	smile	from	the	haematologist	on	my	once	a	year	check	ups	relieves	any	anxieties	l	might	have.				188	 Never	give	up	and	think	you	are	not	going	to	survive.	Keep	a	positive	attitude	and	trust	in	your	doctor.					189		If	possible	get	on	with	life,	enjoy	family	and	friends,	have	goals,	know	that	you	have	cancer	and	take	steps	to	keep	it	at	bay	eg.	diet,	exercise,	social	gatherings								190		Finding	a	cure	for	the	continual	pain	and	numbness	in	feet.	Numbness	in	fingers					192		The	situation	can	be	"made	better"	with	an	unemotional	pragmatic	assessment	one's	situation	-	ie	look	at	the	stats	and	percentages,	the	advances	in	medical	science,	the	amount	of	time	and	$	being	spent	on	research.		Also	consider	the	poor	bastards	outside	any	oncology	clinic	-	most	of	them	much	worse	off	and	see	this	positively.								193		Provide	as	much	info	on	the	costs	involved	i.e.	meds	tests	as	it	can	get	expensive.	Openly																	discuss	fertility	and	possible	affects	from	the	very	start	Carers	also	need	support	too!								194		That	when	the	word	'cancer'	is	mentioned	it	is	not	a	death	sentence,	it	is	a	journey					195		Try	to	continue	with	as	normal	a	life	as	possible.	Accept	the	situation	and	don't	try	to	be	super	human.					196		The	clinic	l	attended	was	purely	focused	on	administering	treatment	and	did	an	excellent	and	friendly	caring	job	but	no	additional	support	services	were	offered.	There	was	a	rack	of	brochures	but	little	else.		Having	finished	treatment	a	vacuum	exists	-	here	appear	to	be	very	few	programs	designed	to	communicate	and	support	patients	who	after	intensive	and	prolonged	treatment	-	and	ensuring	communication-	are	suddenly	cut	off	after	completion.	There	is	a	considerable	period	of	adjustment	which	can	be	very	difficult	especially	for	those	returning	to	regional	and	remote	areas.	Access	to	a	network	of	"fellow	travellers"	would	seem	to	be	a	solution	(shared	experience).	It	is	totally	understandable	that	urgency	and	focus	is	placed	on	the	immediacy	of	treatment	but	adjustment	during	post	recovery	phase	can	be	a	very	prolonged	process,	which	appears	to	be	of	little	interest	to	the	cancer	"industry"	(If	l	was	a	researcher	l	would	be	extremely	interested	in	studying	the	issues	of	communication	and	isolation	during	the	post	recovery	period).		I	think	cancer	"peak"	bodies	have	failed	in	this	regard	and	are	impersonal	bureaucracies	a	minor	issue	relates	to	the	seemingly	officially	supported	dominance	of	"pink"	in	cancer	promotions,	research	and	campaigns.	This	is	very	evident	even	in	hospitals	and	can	be	quite	disconcerting	to	those	male	&	females	suffering	from		other	cancers.								197	 Get	all	the	correct	information	you	can								198	 I	think	persons	coping	ability	is	different.	I	have	always	just	got	on	with	life	as	normally	as	possible.	I	don't	give	my	diagnosis	any	thought	at	all.	Too	busy	and	l	just	don't	need	to	think	about	it	at	all.								199	 I	found	that	being	positive	and	having	a	sense	of	humour	helped	me	a	lot								201	 Avoid	religion	for	atheists	-	like	me	
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				202		Don't	feel	ashamed	to	tall	other	people	you	fear	your	future	Have	someone	close	to	you	that	you	can	vent	and	cry	to	Do	not	dwell	on	it	too	much.	Find	activities	to	keep	your	mind	on	other	thoughts.	Keep	busy					203	 Ask	questions!	The	more	you	find	out	the	easier	it	is	to	cope.	Ask	about	the	side-effects	of	the	drugs	so	you	don't	get	any	nasty	shocks					204	Anyone	who	has	been	told	they	have	cancer	needs	to	join	a	group	with	similar	cancer.	You	gain	so	much	knowledge	from	like	minded	people.		Also	take	your	partner	or	family	member	with	you	to	any	meetings	or	Dr	appts.	There	is	too	much	information	that	those	with	cancer	cannot	take	in,	especially	in	the	beginning.	The	brain	seems	to	shut	down			 Don't	try	and	cope	alone.	Also	ask	questions	as	many	as	you	can.							205	 Stay	strong							208	 Taking	time	everyday	to	just	"be"	and	reflect	on	your	own	journey.	There	is	so	much	to	be	grateful	for.				209	 Suck	it	up,	be	grateful	for	being	alive,	keep	busy	with	a	normal	life.	Don't	"live	your	disease".	Keep	thinking	about	what	others	need	and	trying	to	be	useful	and	helpful	.							211	 Don't	give	in.	Best	motto...."To	strive,	to	serve	and	not	to	yield"	 							211		Ask	yourself	what	can	l	do?	Others	can	help	but	ultimately	you	are	responsible	for	your	wellbeing!				213	 Join	support	groups	on-line	(ie		Facebook).	No	one	really	knows	how	we	feel	unless	they	are	dealing	with	the	same	issues.				214	 In	all	my	years	as	a	CML	patient	l	have	truly	been	blessed	with	an	amazing	doctor	and	team	to	keep	me	alive	as	when	l	was	dxd.	l	was	given	3	yrs.	to	live....people	today	don’t	get	that	death	sentence	that	so	many	of	us	got.....but.....if	you	cannot	say	what	l	have	stated	above	with	the	excellent	care	l	have	received	then	u	might	want	to	search	for	a	doc	&	team	that	will	fight	for	u	to	keep	u	alive...this	is	your	life....you	have	a	choice....make	it	one	you	will	have	no	doubt	with	them	doing	everything	they	can	24/7,	365	to	keep	you	alive!		god	bless!				215	 Practise	being	in	the	new.	Worrying	about	the	future	creates	stress.	Commit	to	believing	in	a	positive	outcome.	Express	your	fears	and	worries	to	those	that	care	about	you.							216			Live	each	day	to	its	fullest	If	you	are	not	happy	with	your	doctor,	change				218			To	have	family	and	friends	around	you	supporting,	BUT	l	firmly	believe	it	was	much	harder	for	the	family	as	they	felt	helpless,	whilst	l	felt	l	knew	l	could	with.		The	other	great	think	was	the	alternative	treatment	which	l	began	to	take	after	treatment	was	completed.	I	still	take	it	to	this	day	and	the	clinical	team	cannot	believe	l	am	still	here,	they	are	amazed.	I	had	amazing	support	from	my	church	family	both	near	and	far	and	with	my	faith	and	their	constant	prayers	for	me	l	was	constantly	reassured	which	l'm	sure	helped	me	recover	feeling	loved	and	needed.	God	bless				219	 For	me	"Acceptance"	of	the	situation	and	changes	to	my	health	and	lifestyle!		I	have	had	NHL	for	22	years,	7	relapses,	lost	my	hair	5	times	so	acceptance	did	not	happen	easily,	it	took	time!				221	 If	other	ongoing	medical	issues	persist,	keep	talking	to	your	doctors	about	them	to	find	a	solution.	I	have	noticed	many	people	undergoing	the	treatments	that	I	am	with	TKIs	are	often	fatigued.	I	have	kept	talking	to	my	doctors	and	now	starting	to	investigate	the	issue	through	referral	to	a	sleep	study	to	at	least	ensure	that	there	are	no	sleep	cycle	problems	compounding	the	fatigue	issue.				222	 This	is	no	longer	the	death	sentence	it	used	to	be.	These	medications	that	save	your	life	but	are	obscenely	expensive.	DO	NOT	be	ashamed	to	ask	for	financial	assistance.	Every	oncologist	should	have	ways	to	get	the	meds	for	you	at	little	or	no	cost.	It	would	be	in	human	on	the	part	of	the	pharmaceuticals	to	with	hold	medications	that	can	save	your	life.	Take	your	meds,	live	your	life,	warrior	on....	♫♫ _______________________________________________________________________________ 
